<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41364787</PMID><DateCompleted><Year>2025</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1929-0748</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2025</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study.</ArticleTitle><Pagination><StartPage>e76013</StartPage><MedlinePgn>e76013</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e76013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/76013</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Antipsychotic-induced weight gain is a common side effect of antipsychotic drug treatment, particularly with second-generation medications such as clozapine and olanzapine. Weight gain in patients undergoing antipsychotic therapies is a significant concern, often compounded by factors related to their condition that can be particularly challenging in a secure care setting. While there is significant evidence to support the benefits of semaglutide, one of the available glucagon-like peptide-1 receptor agonists, in promoting weight loss for those who have a general weight-related health issue and meet the referral criteria for specialist services, it is unclear whether it will be as successful in people who have specifically gained weight due to medication-associated side effects and who reside in a secure care setting.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aims to assess the impact of semaglutide in combination with a lifestyle behavior change intervention on the physical health measures of patients in a secure setting who have atypical antipsychotic-induced weight gain and identify enhancements to the intervention, specifically geared toward improving adherence and acceptability from both staff and patient perspectives.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This 2-year uncontrolled pretest-posttest pilot study aims to recruit 20 inpatient participants. Adult patients of any diabetic status with a minimum BMI of 35.0 kg/m2 (or a BMI of 32.5 kg/m2 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean descent) who are receiving inpatient treatment and are treated with either olanzapine or clozapine will be eligible for inclusion in the study. Patients will receive semaglutide (Wegovy) at a maintenance dose of 2.4 mg once a week for 2 years. All participants will also receive a lifestyle behavior change intervention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The findings will reveal whether the format of the interventional approach is both sustainable and effective for adult patients diagnosed with severe mental illness and living with obesity who are currently residing in a secure mental health setting. Implementation changes that could improve the acceptability of and adherence to the intervention will be explored.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This research should be beneficial for patients with severe mental illness who are living with obesity and are residing in a secure setting as the findings may ultimately reduce the mortality risk in this patient group.</AbstractText><CopyrightInformation>&#xa9; Kristina Brenisin, Florence Kinnafick, James King, Louise Millard, Donna Arya, Elizabeth Hodgson, Michelle Huggins, Andrew Simmons-Roberts, Martin O'Dowd, Nick Rayment, Parul Shah, Kieran C Breen. Originally published in JMIR Research Protocols (https://www.researchprotocols.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brenisin</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3512-5535</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinnafick</LastName><ForeName>Florence</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3095-7116</Identifier><AffiliationInfo><Affiliation>National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8174-9173</Identifier><AffiliationInfo><Affiliation>National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0000-0787-1763</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arya</LastName><ForeName>Donna</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0003-1839-3033</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodgson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0004-2935-7326</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8293-9289</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons-Roberts</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0007-9789-2664</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Dowd</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0005-8351-9362</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayment</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0001-5688-5405</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Parul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0007-5779-2271</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breen</LastName><ForeName>Kieran C</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0003-3974-4237</Identifier><AffiliationInfo><Affiliation>St Andrew's Healthcare, Billing Road, Northampton, NN1 5DG, United Kingdom, +44 1604 616049.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>62340-29-8</RegistryNumber><NameOfSubstance UI="D004763">Glucagon-Like Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>N7U69T4SZR</RegistryNumber><NameOfSubstance UI="D000077152">Olanzapine</NameOfSubstance></Chemical><Chemical><RegistryNumber>89750-14-1</RegistryNumber><NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>53AXN4NNHX</RegistryNumber><NameOfSubstance UI="D000099194">Semaglutide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004763" MajorTopicYN="Y">Glucagon-Like Peptides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="Y">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077152" MajorTopicYN="N">Olanzapine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052216" MajorTopicYN="N">Glucagon-Like Peptide 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000099194" MajorTopicYN="N">Semaglutide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GLP-1</Keyword><Keyword MajorTopicYN="N">antipsychotics</Keyword><Keyword MajorTopicYN="N">body weight loss</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">glucagonlike peptide-1</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">semaglutide</Keyword><Keyword MajorTopicYN="N">severe mental illness</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>12</Month><Day>9</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>12</Month><Day>9</Day><Hour>19</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>12</Month><Day>9</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41364787</ArticleId><ArticleId IdType="pmc">PMC12688052</ArticleId><ArticleId IdType="doi">10.2196/76013</ArticleId><ArticleId IdType="pii">v14i1e76013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Williams J, Stubbs B, Richardson S, et al. &#x201c;Walk this way&#x201d;: results from a pilot randomised controlled trial of a health coaching intervention to reduce sedentary behaviour and increase physical activity in people with serious mental illness. BMC Psychiatry. 2019 Sep 18;19(1):287. doi: 10.1186/s12888-019-2274-5. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2274-5</ArticleId><ArticleId IdType="pmc">PMC6749630</ArticleId><ArticleId IdType="pubmed">31533686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw T, Mairs H. Obesity and serious mental ill health: a critical review of the literature. Healthcare (Basel) 2014 Apr 1;2(2):166&#x2013;182. doi: 10.3390/healthcare2020166. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare2020166</ArticleId><ArticleId IdType="pmc">PMC4934464</ArticleId><ArticleId IdType="pubmed">27429268</ArticleId></ArticleIdList></Reference><Reference><Citation>Every-Palmer S, Huthwaite MA, Elmslie JL, Grant E, Romans SE. Long-term psychiatric inpatients&#x2019; perspectives on weight gain, body satisfaction, diet and physical activity: a mixed methods study. BMC Psychiatry. 2018 Sep 18;18(1):300. doi: 10.1186/s12888-018-1878-5. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-018-1878-5</ArticleId><ArticleId IdType="pmc">PMC6145113</ArticleId><ArticleId IdType="pubmed">30227840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondo L, Baldessarini RJ. Psychotropic medicines: increased appetite rather than weight gain. Lancet Psychiatry. 2022 Feb;9(2):e8. doi: 10.1016/S2215-0366(21)00500-9. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00500-9</ArticleId><ArticleId IdType="pubmed">35065726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon R, Lenderking WR, Weiss C, et al. The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey. Ann Gen Psychiatry. 2020 Jul 13;19:42. doi: 10.1186/s12991-020-00292-5. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-020-00292-5</ArticleId><ArticleId IdType="pmc">PMC7359579</ArticleId><ArticleId IdType="pubmed">32684942</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan LC, Clarke WP, Berg KA. Atypical antipsychotics and inverse agonism at 5-HT2 receptors. Curr Pharm Des. 2015;21(26):3732&#x2013;3738. doi: 10.2174/1381612821666150605111236. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612821666150605111236</ArticleId><ArticleId IdType="pmc">PMC5543701</ArticleId><ArticleId IdType="pubmed">26044975</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231&#x2013;2241. doi: 10.2147/NDT.S113099. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S113099</ArticleId><ArticleId IdType="pmc">PMC5574691</ArticleId><ArticleId IdType="pubmed">28883731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen GL. Drug-induced hyperphagia: what can we learn from psychiatric medications? JPEN J Parenter Enteral Nutr. 2008;32(5):578&#x2013;581. doi: 10.1177/0148607108321708. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607108321708</ArticleId><ArticleId IdType="pubmed">18753398</ArticleId></ArticleIdList></Reference><Reference><Citation>Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013 Sep 14;382(9896):951&#x2013;962. doi: 10.1016/S0140-6736(13)60733-3. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60733-3</ArticleId><ArticleId IdType="pubmed">23810019</ArticleId></ArticleIdList></Reference><Reference><Citation>Leucht S, Leucht C, Huhn M, et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry. 2017 Oct 1;174(10):927&#x2013;942. doi: 10.1176/appi.ajp.2017.16121358. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2017.16121358</ArticleId><ArticleId IdType="pubmed">28541090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness. Front Endocrinol (Lausanne) 2020 Oct 9;11:573479. doi: 10.3389/fendo.2020.573479. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.573479</ArticleId><ArticleId IdType="pmc">PMC7581736</ArticleId><ArticleId IdType="pubmed">33162935</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jan;7(1):64&#x2013;77. doi: 10.1016/S2215-0366(19)30416-X. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(19)30416-X</ArticleId><ArticleId IdType="pmc">PMC7029416</ArticleId><ArticleId IdType="pubmed">31860457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner RF, Calanna S, Davies M, et al. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity (Silver Spring) 2020 Jun;28(6):1050&#x2013;1061. doi: 10.1002/oby.22794. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22794</ArticleId><ArticleId IdType="pmc">PMC7318657</ArticleId><ArticleId IdType="pubmed">32441473</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens H, Smith J, Bussey L, et al. Weight management interventions for adults living with overweight or obesity and severe mental illness: a systematic review and meta-analysis. Br J Nutr. 2023 Aug 14;130(3):536&#x2013;552. doi: 10.1017/S0007114522003403. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114522003403</ArticleId><ArticleId IdType="pmc">PMC10331435</ArticleId><ArticleId IdType="pubmed">36325987</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber JP, Solomonov N. Toward a personalized approach to psychotherapy outcome and the study of therapeutic change. World Psychiatry. 2019 Oct;18(3):291&#x2013;292. doi: 10.1002/wps.20666. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20666</ArticleId><ArticleId IdType="pmc">PMC6732683</ArticleId><ArticleId IdType="pubmed">31496098</ArticleId></ArticleIdList></Reference><Reference><Citation>Walburg FS, van Meijel B, Hoekstra T, et al. Effectiveness of a lifestyle intervention for people with a severe mental illness in Dutch outpatient mental health care: a randomized clinical trial. JAMA Psychiatry. 2023 Sep 1;80(9):886&#x2013;894. doi: 10.1001/jamapsychiatry.2023.1566. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1566</ArticleId><ArticleId IdType="pmc">PMC10285675</ArticleId><ArticleId IdType="pubmed">37342055</ArticleId></ArticleIdList></Reference><Reference><Citation>Vancampfort D, Stubbs B, Ward PB, Teasdale S, Rosenbaum S. Integrating physical activity as medicine in the care of people with severe mental illness. Aust N Z J Psychiatry. 2015 Aug;49(8):681&#x2013;682. doi: 10.1177/0004867415590831. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004867415590831</ArticleId><ArticleId IdType="pubmed">26041791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty K, Gandhi S, Krishna Prasad M, et al. Effectiveness of lifestyle intervention on prevention/management of antipsychotic-induced weight gain among persons with severe mental illness: a systematic review and meta-analysis. J Health Psychol. 2024 Jun;29(7):690&#x2013;706. doi: 10.1177/13591053241227384. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053241227384</ArticleId><ArticleId IdType="pubmed">38251661</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernea S, Dima L, Correll CU, Manu P. Pharmacological management of glucose dysregulation in patients treated with second-generation antipsychotics. Drugs. 2020 Nov;80(17):1763&#x2013;1781. doi: 10.1007/s40265-020-01393-x. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01393-x</ArticleId><ArticleId IdType="pubmed">32930957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang W, Hui X, Li M, et al. Pharmacological treatments for adults with overweight and obesity without diabetes. Cochrane Database Syst Rev. 2024 Apr 18;2024(4):CD015861. doi: 10.1002/14651858.CD015861. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015861</ArticleId></ArticleIdList></Reference><Reference><Citation>Stogios N, Agarwal SM, Ahsan Z, et al.  A systematic review and meta-analysis of pharmacological interventions for reduction of weight gain in people with schizophrenia: 2019 update.  [29-11-2025];Biol Psychiatry. 2020 May;87(9):S357.  https://www.biologicalpsychiatryjournal.com/article/S0006-3223(20)31027-1/abstract URL. Accessed.</Citation></Reference><Reference><Citation>Vancampfort D, Firth J, Correll CU, et al. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry. 2019 Feb;18(1):53&#x2013;66. doi: 10.1002/wps.20614. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20614</ArticleId><ArticleId IdType="pmc">PMC6313230</ArticleId><ArticleId IdType="pubmed">30600626</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson Lewis K, Sloan CE, Bessesen DH, Arterburn D. Effectiveness and safety of drugs for obesity. BMJ. 2024 Mar 25;384:e072686. doi: 10.1136/bmj-2022-072686. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072686</ArticleId><ArticleId IdType="pubmed">38527759</ArticleId></ArticleIdList></Reference><Reference><Citation>Siskind D, Hahn M, Correll CU, et al. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis. Diabetes Obes Metab. 2019 Feb;21(2):293&#x2013;302. doi: 10.1111/dom.13522. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13522</ArticleId><ArticleId IdType="pubmed">30187620</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes. 2002 Dec;51 Suppl 3:S434&#x2013;S442. doi: 10.2337/diabetes.51.2007.s434. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.51.2007.s434</ArticleId><ArticleId IdType="pubmed">12475787</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1) Mol Metab. 2019 Dec;30:72&#x2013;130. doi: 10.1016/j.molmet.2019.09.010. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2019.09.010</ArticleId><ArticleId IdType="pmc">PMC6812410</ArticleId><ArticleId IdType="pubmed">31767182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Wang M, Wen Z, et al. GLP-1 receptor agonists: beyond their pancreatic effects. Front Endocrinol (Lausanne) 2021 Aug 23;12:721135. doi: 10.3389/fendo.2021.721135. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.721135</ArticleId><ArticleId IdType="pmc">PMC8419463</ArticleId><ArticleId IdType="pubmed">34497589</ArticleId></ArticleIdList></Reference><Reference><Citation>Semaglutide for managing overweight and obesity. National Institute for Health and Care Excellence. 2023.  [29-11-2025]. https://www.nice.org.uk/guidance/ta875/resources/semaglutide-for-managing-overweight-and-obesity-pdf-82613674831813 URL. Accessed.</Citation><ArticleIdList><ArticleId IdType="pubmed">40080622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensterle M, Rizzo M, Haluz&#xed;k M, Jane&#x17e; A. Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review. Adv Ther. 2022 Jun;39(6):2452&#x2013;2467. doi: 10.1007/s12325-022-02153-x. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-022-02153-x</ArticleId><ArticleId IdType="pmc">PMC9063254</ArticleId><ArticleId IdType="pubmed">35503498</ArticleId></ArticleIdList></Reference><Reference><Citation>Moiz A, Levett JY, Filion KB, Peri K, Reynier P, Eisenberg MJ. Long-term efficacy and safety of once-weekly semaglutide for weight loss in patients without diabetes: a systematic review and meta-analysis of randomized controlled trials. Am J Cardiol. 2024 Jul 1;222:121&#x2013;130. doi: 10.1016/j.amjcard.2024.04.041. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2024.04.041</ArticleId><ArticleId IdType="pubmed">38679221</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilding JP, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021 Mar 18;384(11):989&#x2013;1002. doi: 10.1056/NEJMoa2032183. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2032183</ArticleId><ArticleId IdType="pubmed">33567185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao AM, Tronieri JS, Amaro A, Wadden TA. Clinical insight on semaglutide for chronic weight management in adults: patient selection and special considerations. Drug Des Devel Ther. 2022 Dec 29;16:4449&#x2013;4461. doi: 10.2147/DDDT.S365416. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S365416</ArticleId><ArticleId IdType="pmc">PMC9807016</ArticleId><ArticleId IdType="pubmed">36601368</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022 Oct;28(10):2083&#x2013;2091. doi: 10.1038/s41591-022-02026-4. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02026-4</ArticleId><ArticleId IdType="pmc">PMC9556320</ArticleId><ArticleId IdType="pubmed">36216945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023 Dec 14;389(24):2221&#x2013;2232. doi: 10.1056/NEJMoa2307563. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2307563</ArticleId><ArticleId IdType="pubmed">37952131</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017 Sep;19(9):1242&#x2013;1251. doi: 10.1111/dom.12932. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.12932</ArticleId><ArticleId IdType="pmc">PMC5573908</ArticleId><ArticleId IdType="pubmed">28266779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nat Med. 2024 Jul;30(7):2049&#x2013;2057. doi: 10.1038/s41591-024-02996-7. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02996-7</ArticleId><ArticleId IdType="pmc">PMC11271387</ArticleId><ArticleId IdType="pubmed">38740993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak M, Campforts B, Domen P, van Amelsvoort T, Drukker M. Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: a systematic review and meta-analysis. Acta Psychiatr Scand. 2024 Dec;150(6):516&#x2013;529. doi: 10.1111/acps.13734. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.13734</ArticleId><ArticleId IdType="pubmed">39048532</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad F, De R, Korann V, et al. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series. Ther Adv Psychopharmacol. 2023 Apr 19;13:20451253231165169. doi: 10.1177/20451253231165169. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20451253231165169</ArticleId><ArticleId IdType="pmc">PMC10126648</ArticleId><ArticleId IdType="pubmed">37113745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass MR, Danielsen AA, K&#xf6;hler-Forsberg O, et al. Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) BMJ Open. 2023 Jan 31;13(1):e068652. doi: 10.1136/bmjopen-2022-068652. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-068652</ArticleId><ArticleId IdType="pmc">PMC9890830</ArticleId><ArticleId IdType="pubmed">36720576</ArticleId></ArticleIdList></Reference><Reference><Citation>Siskind D, Baker A, Russell A, et al. Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST) BJPsych Open. 2023 Jul;9(4):e136. doi: 10.1192/bjo.2023.532. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2023.532</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal J, Wu HX, Hu N, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev. 2022 Jun;23(6):e13435. doi: 10.1111/obr.13435. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13435</ArticleId><ArticleId IdType="pubmed">35194917</ArticleId></ArticleIdList></Reference><Reference><Citation>Winchester CL, Salji MJ, Kasivisvanathan V. Gathering preliminary data. J Clin Urol. 2017 Aug;10(6):205141581772471. doi: 10.1177/2051415817724713. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2051415817724713</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton M, Finlayson G, Hill A, Blundell J. Preliminary validation and principal components analysis of the Control of Eating Questionnaire (CoEQ) for the experience of food craving. Eur J Clin Nutr. 2015 Dec;69(12):1313&#x2013;1317. doi: 10.1038/ejcn.2015.57. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2015.57</ArticleId><ArticleId IdType="pubmed">25852028</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlayson G, King N, Blundell J. The role of implicit wanting in relation to explicit liking and wanting for food: implications for appetite control. Appetite. 2008 Jan;50(1):120&#x2013;127. doi: 10.1016/j.appet.2007.06.007. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.appet.2007.06.007</ArticleId><ArticleId IdType="pubmed">17655972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolotkin RL, Williams VS, Ervin CM, et al. Validation of a new measure of quality of life in obesity trials: impact of weight on quality of life-lite clinical trials version. Clin Obes. 2019 Jun;9(3):e12310. doi: 10.1111/cob.12310. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12310</ArticleId><ArticleId IdType="pmc">PMC6593657</ArticleId><ArticleId IdType="pubmed">30993900</ArticleId></ArticleIdList></Reference><Reference><Citation>Olorunfemi D. Diary studies in research: more than a research method. Int J Market Res. 2024;66(4):410&#x2013;427. doi: 10.1177/14707853231222139. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14707853231222139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SH, Tan ZY, Cheng LJ, Lau ST. Wearable technology-delivered lifestyle intervention amongst adults with overweight and obese: a systematic review and meta-regression. Int J Nurs Stud. 2022 Mar;127:104163. doi: 10.1016/j.ijnurstu.2021.104163. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2021.104163</ArticleId><ArticleId IdType="pubmed">35092872</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava A, Thomson S. Framework analysis: a qualitative methodology for applied policy research.  [29-11-2025];J Admin Govern. 2009 72(4) https://ssrn.com/abstract=2760705 URL. Accessed.</Citation></Reference><Reference><Citation>Gabe MB, Breitschaft A, Knop FK, et al. Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled trial. Diabetes Obes Metab. 2024 Oct;26(10):4480&#x2013;4489. doi: 10.1111/dom.15802. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.15802</ArticleId><ArticleId IdType="pubmed">39082206</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra MK, Karuppasamy M, Sahoo BM. Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Rev Endocr Metab Disord. 2022 Jun;23(3):521&#x2013;539. doi: 10.1007/s11154-021-09699-1. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09699-1</ArticleId><ArticleId IdType="pmc">PMC8736331</ArticleId><ArticleId IdType="pubmed">34993760</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J, Xu J, Hu S, Ye H, Xie L, Ouyang S. Advances in small-molecule insulin secretagogues for diabetes treatment. Biomed Pharmacother. 2024 Sep;178:117179. doi: 10.1016/j.biopha.2024.117179. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2024.117179</ArticleId><ArticleId IdType="pubmed">39059347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017 Oct;29(S1):S3&#x2013;S14. doi: 10.1002/2327-6924.12510. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2327-6924.12510</ArticleId><ArticleId IdType="pmc">PMC6088226</ArticleId><ArticleId IdType="pubmed">29024553</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino D, Angelene H, Fabricatore A, Ard J. Efficacy and safety of semaglutide 2.4&#x2009;mg by race and ethnicity: a post hoc analysis of three randomized controlled trials. Obesity (Silver Spring) 2024 Jul;32(7):1268&#x2013;1280. doi: 10.1002/oby.24042. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.24042</ArticleId><ArticleId IdType="pubmed">38932728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38941479</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2470-9468</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>96</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Science immunology</Title><ISOAbbreviation>Sci Immunol</ISOAbbreviation></Journal><ArticleTitle>Circulating KLRG1<sup>+</sup> long-lived effector memory T cells retain the flexibility to become tissue resident.</ArticleTitle><Pagination><StartPage>eadj8356</StartPage><MedlinePgn>eadj8356</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciimmunol.adj8356</ELocationID><Abstract><AbstractText>KLRG1<sup>+</sup> CD8 T cells persist for months after clearance of acute infections and maintain high levels of effector molecules, contributing protective immunity against systemic pathogens. Upon secondary infection, these long-lived effector cells (LLECs) are incapable of forming other circulating KLRG1<sup>-</sup> memory subsets such as central and effector memory T cells. Thus, KLRG1<sup>+</sup> memory T cells are frequently referred to as a terminally differentiated population that is relatively short lived. Here, we show that after viral infection of mice, effector cells derived from LLECs rapidly enter nonlymphoid tissues and reduce pathogen burden but are largely dependent on receiving antigen cues from vascular endothelial cells. Single-cell RNA sequencing reveals that secondary memory cells in nonlymphoid tissues arising from either KLRG1<sup>+</sup> or KLRG1<sup>-</sup> memory precursors develop a similar resident memory transcriptional signature. Thus, although LLECs cannot differentiate into other circulating memory populations, they still retain the flexibility to enter tissues and establish residency.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Erin D</ForeName><Initials>ED</Initials><Identifier Source="ORCID">0000-0001-7705-2069</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1407-8207</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Changwei</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0710-9573</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Minnesota Supercomputing Institute, University of Minnesota, Saint Paul, MN 55108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gress</LastName><ForeName>Abigail R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thefaine</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-2162-4325</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehm</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6672-4122</Identifier><AffiliationInfo><Affiliation>Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-9137-1146</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3768-7622</Identifier><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI155468</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Immunol</MedlineTA><NlmUniqueID>101688624</NlmUniqueID><ISSNLinking>2470-9468</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C451496">Klrg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Immunol. 2024 Oct 18;9(100):eadt4549. doi: 10.1126/sciimmunol.adt4549.</RefSource><PMID Version="1">39423287</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="Y">Immunologic Memory</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037181" MajorTopicYN="Y">Lectins, C-Type</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091246" MajorTopicYN="Y">Memory T Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="Y">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38941479</ArticleId><ArticleId IdType="mid">NIHMS2081655</ArticleId><ArticleId IdType="pmc">PMC12175144</ArticleId><ArticleId IdType="doi">10.1126/sciimmunol.adj8356</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jameson SC, Masopust D, Diversity in T cell memory: An embarrassment of riches. Immunity 31, 859&#x2013;871 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957815</ArticleId><ArticleId IdType="pubmed">20064446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech SM, Cui W, Transcriptional control of effector and memory CD8<sup>+</sup> T cell differentiation. Nat. Rev. Immunol. 12, 749&#x2013;761 (2012).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137483</ArticleId><ArticleId IdType="pubmed">23080391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R, Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191&#x2013;1198 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14625547</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkema KR, Huggins MA, Borges da Silva H, Knutson TP, Henzler CM, Hamilton SE, KLRG1<sup>+</sup> memory CD8 T cells combine properties of short-lived effectors and long-lived memory. J. Immunol. 205, 1059&#x2013;1069 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415731</ArticleId><ArticleId IdType="pubmed">32611727</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner JJ, Nguyen H, Omilusik K, Reina-Campos M, Tsai M, Toma C, Delpoux A, Boland BS, Hedrick SM, Chang JT, Goldrath AW, Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population. Proc. Natl. Acad. Sci. U.S.A. 117, 25667&#x2013;25678 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568335</ArticleId><ArticleId IdType="pubmed">32978300</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JA, McDonald-Hyman C, Jameson SC, Hamilton SE, Effector-like CD8<sup>+</sup> T cells in the memory population mediate potent protective immunity. Immunity
38, 1250&#x2013;1260 (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703254</ArticleId><ArticleId IdType="pubmed">23746652</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, Masopust D, Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512&#x2013;516 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Ha SJ, Vezys V, Ahmed R, Stimulation history dictates memory CD8 T cell phenotype: Implications for prime-boost vaccination. J. Immunol. 177, 831&#x2013;839 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16818737</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, H&#xf6;chst B, Eickhoff S, Rieckmann JC, Russo C, Bauer T, Flecken T, Giesen D, Engel D, Jung S, Busch DH, Protzer U, Thimme R, Mann M, Kurts C, Schultze JL, Kastenm&#xfc;ller W, Knolle PA, Functional classification of memory CD8<sup>+</sup> T cells by CX3CR1 expression. Nat. Commun. 6, 8306 (2015).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4667439</ArticleId><ArticleId IdType="pubmed">26404698</ArticleId></ArticleIdList></Reference><Reference><Citation>von Andrian UH, Mempel TR, Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867&#x2013;878 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14668803</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, Lefrancois L, Initial T cell frequency dictates memory CD8<sup>+</sup> T cell lineage commitment. Nat. Immunol. 6, 793&#x2013;799 (2005).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849311</ArticleId><ArticleId IdType="pubmed">16025119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach C, Moseman EA, Loughhead SM, Alvarez D, Zwijnenburg AJ, Waanders L, Garg R, de la Torre JC, von Andrian UH, The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity 45, 1270&#x2013;1284 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177508</ArticleId><ArticleId IdType="pubmed">27939671</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Masopust D, Tissue-resident memory T cells. Immunity 41, 886&#x2013;897 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276131</ArticleId><ArticleId IdType="pubmed">25526304</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D, T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98&#x2013;101 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4449618</ArticleId><ArticleId IdType="pubmed">25170049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok L, Masopust D, Schumacher TN, The precursors of CD8<sup>+</sup> tissue resident memory T cells: From lymphoid organs to infected tissues. Nat. Rev. Immunol. 22, 283&#x2013;293 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415193</ArticleId><ArticleId IdType="pubmed">34480118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurd NS, He Z, Louis TL, Milner JJ, Omilusik KD, Jin W, Tsai MS, Widjaja CE, Kanbar JN, Olvera JG, Tysl T, Quezada LK, Boland BS, Huang WJ, Murre C, Goldrath AW, Yeo GW, Chang JT, Early precursors and molecular determinants of tissue-resident memory CD8<sup>+</sup> T lymphocytes revealed by single-cell RNA sequencing. Sci. Immunol. 5, eaaz6894 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7341730</ArticleId><ArticleId IdType="pubmed">32414833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, Tscharke DC, Heath WR, Inouye M, Carbone FR, Gebhardt T, The developmental pathway for CD103<sup>+</sup>CD8<sup>+</sup> tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294&#x2013;1301 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24162776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan BS, Pham QM, Lee YT, Cauley LS, Puddington L, Lefrancois L, Oral infection drives a distinct population of intestinal resident memory CD8<sup>+</sup> T cells with enhanced protective function. Immunity
40, 747&#x2013;757 (2014).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4045016</ArticleId><ArticleId IdType="pubmed">24792910</ArticleId></ArticleIdList></Reference><Reference><Citation>Slutter B, Van Braeckel-Budimir N, Abboud G, Varga SM, Salek-Ardakani S, Harty JT, Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci. Immunol. 2, eaag2031 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5590757</ArticleId><ArticleId IdType="pubmed">28783666</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari A, Harty JT, Secondary memory CD8<sup>+</sup> T cells are more protective but slower to acquire a central-memory phenotype. J. Exp. Med. 203, 919&#x2013;932 (2006).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118270</ArticleId><ArticleId IdType="pubmed">16567385</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom JR, Luster AD, CXCR3 in T cell function. Exp. Cell Res. 317, 620&#x2013;631 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065205</ArticleId><ArticleId IdType="pubmed">21376175</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner JJ, Toma C, Yu B, Zhang K, Omilusik K, Phan AT, Wang D, Getzler AJ, Nguyen T, Crotty S, Wang W, Pipkin ME, Goldrath AW, Runx3 programs CD8<sup>+</sup> T cell residency in non-lymphoid tissues and tumours. Nature
552, 253&#x2013;257 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5747964</ArticleId><ArticleId IdType="pubmed">29211713</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner JJ, Toma C, He Z, Kurd NS, Nguyen QP, McDonald B, Quezada L, Widjaja CE, Witherden DA, Crowl JT, Shaw LA, Yeo GW, Chang JT, Omilusik KD, Goldrath AW, Heterogenous populations of tissue-resident CD8<sup>+</sup> T cells are generated in response to infection and malignancy. Immunity
52, 808&#x2013;824.e7 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784612</ArticleId><ArticleId IdType="pubmed">32433949</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Sjaastad FV, Pierson M, Kucaba TA, Swanson W, Staley C, Weingarden AR, Jensen IJ, Danahy DB, Badovinac VP, Jameson SC, Vezys V, Masopust D, Khoruts A, Griffith TS, Hamilton SE, Microbial exposure enhances immunity to pathogens recognized by TLR2 but increases susceptibility to cytokine storm through TLR4 sensitization. Cell Rep. 28, 1729&#x2013;1743.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SC, Masopust D, Understanding subset diversity in T cell memory. Immunity 48, 214&#x2013;226 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Herndler-Brandstetter D, Ishigame H, Shinnakasu R, Plajer V, Stecher C, Zhao J, Lietzenmayer M, Kroehling L, Takumi A, Kometani K, Inoue T, Kluger Y, Kaech SM, Kurosaki T, Okada T, Flavell RA, KLRG1<sup>+</sup> effector CD8<sup>+</sup> T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity. Immunity
48, 716&#x2013;729 e718 (2018).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6465538</ArticleId><ArticleId IdType="pubmed">29625895</ArticleId></ArticleIdList></Reference><Reference><Citation>Best JA, Blair DA, Knell J, Yang E, Mayya V, Doedens A, Dustin ML, Goldrath AW; Immunological Genome Project Consortium, Transcriptional insights into the CD8<sup>+</sup> T cell response to infection and memory T cell formation. Nat. Immunol. 14, 404&#x2013;412 (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689652</ArticleId><ArticleId IdType="pubmed">23396170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilt ZT, Pariser DN, Ture SK, Mohan A, Quijada P, Asante AA, Cameron SJ, Sterling JA, Merkel AR, Johanson AL, Jenkins JL, Small EM, McGrath KE, Palis J, Elliott MR, Morrell CN, Platelet-derived beta2M regulates monocyte inflammatory responses. JCI Insight 4, e122943 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483513</ArticleId><ArticleId IdType="pubmed">30702442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiege JK, Block KE, Pierson MJ, Nanda H, Shepherd FK, Mickelson CK, Stolley JM, Matchett WE, Wijeyesinghe S, Meyerholz DK, Vezys V, Shen SS, Hamilton SE, Masopust D, Langlois RA, Mice with diverse microbial exposure histories as a model for preclinical vaccine testing. Cell Host Microbe 29, 1815&#x2013;1827.e6 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665115</ArticleId><ArticleId IdType="pubmed">34731647</ArticleId></ArticleIdList></Reference><Reference><Citation>Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA, Jameson SC, Transcriptional downregulation of <i>S1pr1</i> is required for the establishment of resident memory CD8<sup>+</sup> T cells. Nat. Immunol. 14, 1285&#x2013;1293 (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844557</ArticleId><ArticleId IdType="pubmed">24162775</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igyarto BZ, Southern PJ, Masopust D, Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161, 737&#x2013;749 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426972</ArticleId><ArticleId IdType="pubmed">25957682</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL, Masopust D, Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209&#x2013;222 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Huggins MA, Wanhainen KM, Knutson TP, Lu H, Georgiev H, Mittelsteadt KL, Jarjour NN, Wang H, Hogquist KA, Campbell DJ, Borges da Silva H, Jameson SC, Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8<sup>+</sup> tissue-resident memory T cells. Immunity
55, 98&#x2013;114.e5 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755622</ArticleId><ArticleId IdType="pubmed">34932944</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team, R: A language and environment for statistical computing (2020); https://r-project.org.</Citation></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck III WM, Hao Y, Stoeckius M, Smibert P, Satija R, Comprehensive integration of single-cell data. Cell 177, 1888&#x2013;1902.e21 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas ED, Hamilton SE, Circulating KLRG1<sup>+</sup> memory T cells retain the flexibility to become tissue-resident, Dryad (2024), 10.5061/dryad.dncjsxm68.</Citation><ArticleIdList><ArticleId IdType="doi">10.5061/dryad.dncjsxm68</ArticleId><ArticleId IdType="pmc">PMC12175144</ArticleId><ArticleId IdType="pubmed">38941479</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk D, Sharma R, Nainys J, Yim K, Kathail P, Carr AJ, Burdziak C, Moon KR, Chaffer CL, Pattabiraman D, Bierie B, Mazutis L, Wolf G, Krishnaswamy S, Pe&#x2019;er D, Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716&#x2013;729.e27 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771278</ArticleId><ArticleId IdType="pubmed">29961576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38689133</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>PD1 blockade improves survival and CD8<sup>+</sup> cytotoxic capacity, without increasing inflammation, during normal microbial experience in old mice.</ArticleTitle><Pagination><StartPage>915</StartPage><EndPage>925</EndPage><MedlinePgn>915-925</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-024-00620-4</ELocationID><Abstract><AbstractText>By 2030, individuals 65&#x2009;years of age or older will make up approximately 20% of the world's population<sup>1</sup>. Older individuals are at the highest risk for mortality from infections, largely due to the pro-inflammatory, dysfunctional immune response, which is collectively known as immunosenescence<sup>2</sup>. During aging, CD8<sup>+</sup> T cells acquire an exhausted phenotype, including increased expression of inhibitory receptors, such as programmed cell death 1 (PD1), a decline in effector function and elevated expression of inflammatory factors<sup>3-7</sup>. PD1 reduces T cell receptor activity via SHP2-dependent dephosphorylation of multiple pathways; accordingly, inhibiting PD1 activity through monoclonal antibodies increases CD8<sup>+</sup> T cell effector response in young mice<sup>8-11</sup>. Attempts to improve CD8<sup>+</sup> T cell responses by blocking inhibitory receptors are attractive; however, they can lead to adverse immune events due to overamplification of T cell receptor signaling and T cell activation<sup>12,13</sup>. Here we investigated the effect of monoclonal anti-PD1 immunotherapy during normal microbial experience, otherwise known as exposure to dirty mice, to determine whether it either improves exhausted CD8<sup>+</sup> T cell responses in old mice or leads to a heightened inflammatory response and increased mortality.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dahlquist</LastName><ForeName>Korbyn J V</ForeName><Initials>KJV</Initials><Identifier Source="ORCID">0000-0002-0415-1338</Identifier><AffiliationInfo><Affiliation>Biochemistry, Molecular Biology and Biophysics Graduate Program, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousefzadeh</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-2869-1029</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia Center for Translational Immunology, Columbia Center for Healthy Longevity, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto-Palma</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholensky</LastName><ForeName>Stephanie H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Declan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camell</LastName><ForeName>Christina D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0001-7847-3543</Identifier><AffiliationInfo><Affiliation>Biochemistry, Molecular Biology and Biophysics Graduate Program, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA. ccamell@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, MN, USA. ccamell@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN, USA. ccamell@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00AG058800</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</Agency><Country/></Grant><Grant><GrantID>R01AG079913</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</Agency><Country/></Grant><Grant><GrantID>R00 AG058800</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21AG078638</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</Agency><Country/></Grant><Grant><GrantID>R01 AI155468</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG029796</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>McKnight Land-Grant Professorship</GrantID><Agency>University of Minnesota (UM)</Agency><Country/></Grant><Grant><GrantID>AFAR postdoctoral transition award</GrantID><Agency>Glenn Family Foundation</Agency><Country/></Grant><Grant><GrantID>T32AG029796</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</Agency><Country/></Grant><Grant><GrantID>AFAR Grants for Junior Faculty</GrantID><Agency>Glenn Foundation for Medical Research</Agency><Country/></Grant><Grant><GrantID>R01 AG079913</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG078638</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Fesler-Lampert Chair on Aging Studies</GrantID><Agency>University of Minnesota (UM)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061026">Programmed Cell Death 1 Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491383">Pdcd1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000082082">Immune Checkpoint Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061026" MajorTopicYN="Y">Programmed Cell Death 1 Receptor</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000082082" MajorTopicYN="N">Immune Checkpoint Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>19</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>1</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>30</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38689133</ArticleId><ArticleId IdType="mid">NIHMS2082008</ArticleId><ArticleId IdType="pmc">PMC12142680</ArticleId><ArticleId IdType="doi">10.1038/s43587-024-00620-4</ArticleId><ArticleId IdType="pii">10.1038/s43587-024-00620-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Decade of healthy ageing: baseline report. https://www.who.int/publications/i/item/9789240017900 (2021).</Citation></Reference><Reference><Citation>Nikolich-&#x17d;ugich J The twilight of immunity: emerging concepts in aging of the immune system. Nat. Immunol. 19, 10&#x2013;19 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29242543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA
et al. 
Characterization of age-associated exhausted CD8<sup>+</sup> T cells defined by increased expression of Tim-3 and PD-1. Aging Cell
15, 291&#x2013;300 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783346</ArticleId><ArticleId IdType="pubmed">26750587</ArticleId></ArticleIdList></Reference><Reference><Citation>Decman V et al. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J. Immunol. 188, 1933&#x2013;1941 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320034</ArticleId><ArticleId IdType="pubmed">22246631</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn KM et al. Age-related decline in primary CD8+ T cell responses is associated with the development of senescence in virtual memory CD8+ T cells. Cell Rep. 23, 3512&#x2013;3524 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29924995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry EJ &amp; Kurachi M Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486&#x2013;499 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4889009</ArticleId><ArticleId IdType="pubmed">26205583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry EJ
et al. 
Molecular signature of CD8<sup>+</sup> T cell exhaustion during chronic viral infection. Immunity
27, 670&#x2013;684 (2007).
</Citation><ArticleIdList><ArticleId IdType="pubmed">17950003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe AH &amp; Pauken KE The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153&#x2013;167 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28990585</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry RV et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543&#x2013;9553 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1265804</ArticleId><ArticleId IdType="pubmed">16227604</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokosuka T et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201&#x2013;1217 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3371732</ArticleId><ArticleId IdType="pubmed">22641383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui E et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355, 1428&#x2013;1433 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286077</ArticleId><ArticleId IdType="pubmed">28280247</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins F et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat. Rev. Clin. Oncol. 16, 563&#x2013;580 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31092901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang PF et al. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: a meta-analysis. Front. Pharmacol. 8, 730 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651530</ArticleId><ArticleId IdType="pubmed">29093678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE et al. New insights into the immune system using dirty mice. J. Immunol. 205, 3&#x2013;11 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316151</ArticleId><ArticleId IdType="pubmed">32571979</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512&#x2013;516 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA et al. Microbial exposure enhances immunity to pathogens recognized by TLR2 but increases susceptibility to cytokine storm through TLR4 sensitization. Cell Rep. 28, 1729&#x2013;1743 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell CD et al. Senolytics reduce coronavirus-related mortality in old mice. Science 373, eabe4832 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputa G et al. Intracellular infection and immune system cues rewire adipocytes to acquire immune function. Cell Metab. 34, 747&#x2013;760 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35508110</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Blomberg BB &amp; Paganelli R Aging, obesity, and inflammatory age-related diseases. Front. Immunol. 8, 1745 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725402</ArticleId><ArticleId IdType="pubmed">29270179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouchani ET &amp; Kajimura S Metabolic adaptation and maladaptation in adipose tissue. Nat Metab. 1, 189&#x2013;200 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941795</ArticleId><ArticleId IdType="pubmed">31903450</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KG et al. Cutting edge: intravascular staining redefines lung CD8 T cell responses. J. Immunol. 189, 2702&#x2013;2706 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3436991</ArticleId><ArticleId IdType="pubmed">22896631</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomayko MM, Steinel NC, Anderson SM &amp; Shlomchik MJ Cutting edge: hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185, 7146&#x2013;7150 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3133669</ArticleId><ArticleId IdType="pubmed">21078902</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn SD
et al. 
Coregulation of CD8<sup>+</sup> T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29&#x2013;37 (2009).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605166</ArticleId><ArticleId IdType="pubmed">19043418</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber DL et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682&#x2013;687 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16382236</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsoukis N, Wang Q, Strauss L &amp; Boussiotis VA Revisiting the PD-1 pathway. Sci. Adv. 6, eabd2712 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500922</ArticleId><ArticleId IdType="pubmed">32948597</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogilenko DA
et al. 
Comprehensive profiling of an aging immune system reveals clonal GZMK<sup>+</sup> CD8<sup>+</sup> T cells as conserved hallmark of inflammaging. Immunity
54, 99&#x2013;115 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33271118</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltra J-C
et al. 
Developmental relationships of four exhausted CD8<sup>+</sup> T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity
52, 825&#x2013;841 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360766</ArticleId><ArticleId IdType="pubmed">32396847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson WH
et al. 
Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1<sup>+</sup> stem-like CD8<sup>+</sup> T cells during chronic infection. Immunity
51, 1043&#x2013;1058 (2019).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6920571</ArticleId><ArticleId IdType="pubmed">31810882</ArticleId></ArticleIdList></Reference><Reference><Citation>Im SJ
et al. 
Defining CD8<sup>+</sup> T cells that provide the proliferative burst after PD-1 therapy. Nature
537, 417&#x2013;421 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5297183</ArticleId><ArticleId IdType="pubmed">27501248</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkema KR
et al. 
KLRG1<sup>+</sup> memory CD8 T cells combine properties of short-lived effectors and long-lived memory. J. Immunol. 205, 1059&#x2013;1069 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415731</ArticleId><ArticleId IdType="pubmed">32611727</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn SD, Shin H, Freeman GJ &amp; Wherry EJ Selective expansion of a subset of exhausted CD8 T cells by &#x3b1;PD-L1 blockade. Proc. Natl Acad. Sci. USA 105, 15016&#x2013;15021 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2567485</ArticleId><ArticleId IdType="pubmed">18809920</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai Y et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA 99, 12293&#x2013;12297 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129438</ArticleId><ArticleId IdType="pubmed">12218188</ArticleId></ArticleIdList></Reference><Reference><Citation>Polesso F et al. PD-1-specific &#x2018;blocking&#x2019; antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments. Eur. J. Immunol. 51, 1473&#x2013;1481 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33684223</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins C et al. Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells. Sci. Rep. 12, 12491 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9304406</ArticleId><ArticleId IdType="pubmed">35864188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TW et al. Blocking PD-L1&#x2013;PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358&#x2013;364 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36323784</ArticleId></ArticleIdList></Reference><Reference><Citation>Utzschneider DT
et al. 
T cell factor 1-expressing memory-like CD8<sup>+</sup> T cells sustain the immune response to chronic viral infections. Immunity
45, 415&#x2013;427 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27533016</ArticleId></ArticleIdList></Reference><Reference><Citation>He R
et al. 
Follicular CXCR5-expressing CD8<sup>+</sup> T cells curtail chronic viral infection. Nature
537, 412&#x2013;428 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27501245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lages CS, Lewkowich I, Sproles A, Wills-Karp M &amp; Chougnet C Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/PD-L1 pathway. Aging Cell 9, 785&#x2013;798 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941565</ArticleId><ArticleId IdType="pubmed">20653631</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias R et al. Efficacy of PD-1 &amp; PD-L1 inhibitors in older adults: a meta-analysis. J. Immunother. Cancer 6, 26 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885356</ArticleId><ArticleId IdType="pubmed">29618381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima TF, Muss HB, Shachar SS &amp; Moschos SJ Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis. Cancer Treat. Rev. 45, 30&#x2013;37 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26946217</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JH &amp; Ley TJ Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323&#x2013;370 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11861606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK et al. PGC-1&#x3b1;-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267&#x2013;273 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417&#x2013;425 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38439559</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-6310</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Pediatric obesity</Title><ISOAbbreviation>Pediatr Obes</ISOAbbreviation></Journal><ArticleTitle>Satisfaction with a meal kit delivery program and feasibility of a phase I trial in the intervening in food insecurity to reduce and mitigate (InFoRM) childhood obesity study.</ArticleTitle><Pagination><StartPage>e13111</StartPage><MedlinePgn>e13111</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijpo.13111</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Food and nutrition security interventions have been demonstrated to optimize health, prevent and treat chronic diseases among adult populations. Despite the increasing prevalence and intersection of food insecurity and childhood obesity in the United States, there are few food and nutrition security interventions targeted to children and families.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The primary purpose of this phase I randomized, crossover trial was to assess the safety, acceptability and satisfaction of a meal kit delivery program among children with obesity living in households with food insecurity. Secondarily, we assessed the feasibility of our study design, recruitment and retention to inform future larger scale trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We delivered 6&#x2009;weeks of healthy meal kits, which included fresh pre-portioned ingredients and simple picture-based recipes (two recipes/week) in English or Spanish to prepare one-pot, under 30-min meals (after preparation ~&#x2009;10 servings/week).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Caregivers received and prepared the meal kits and reported overall satisfaction with the meal kit delivery program.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A meal kit delivery intervention for children with obesity and food insecurity is acceptable and a phase I randomized, crossover trial is feasible.</AbstractText><CopyrightInformation>&#xa9; 2024 World Obesity Federation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Allison J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-3162-5439</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8230-7329</Identifier><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hsin-Tao Grace</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Health Sciences, Boston University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caballero-Gonzalez</LastName><ForeName>Arlette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalvie</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battista</LastName><ForeName>Erica Di</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Health Sciences, Boston University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taveras</LastName><ForeName>Elsie M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiechtner</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health and Research, The Greater Boston Food Bank, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 HL159680</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK040561</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK111022</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Obes</MedlineTA><NlmUniqueID>101572033</NlmUniqueID><ISSNLinking>2047-6302</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000084884" MajorTopicYN="N">Food Insecurity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063766" MajorTopicYN="Y">Pediatric Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010549" MajorTopicYN="N">Personal Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">childhood obesity</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">food insecurity</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>2</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38439559</ArticleId><ArticleId IdType="mid">NIHMS1969218</ArticleId><ArticleId IdType="pmc">PMC11006563</ArticleId><ArticleId IdType="doi">10.1111/ijpo.13111</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stierman B, Afful J, Carroll M, et al. National Health and Nutrition Examination Survey 2017&#x2013;March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. National Center for Health Statistics (U.S.); 2021. doi: 10.15620/cdc:106273</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:106273</ArticleId><ArticleId IdType="pmc">PMC11513744</ArticleId><ArticleId IdType="pubmed">39380201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat. 2002;11(246):1&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">12043359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu AJ, Aris IM, Hivert MF, et al. Association of Changes in Obesity Prevalence With the COVID-19 Pandemic in Youth in Massachusetts. JAMA Pediatrics. 2022;176(2):198&#x2013;201. doi: 10.1001/jamapediatrics.2021.5095</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.5095</ArticleId><ArticleId IdType="pmc">PMC8669600</ArticleId><ArticleId IdType="pubmed">34901998</ArticleId></ArticleIdList></Reference><Reference><Citation>Social Determinants of Health. Healthy People 2030. Accessed April 27, 2022. https://health.gov/healthypeople/priority-areas/social-determinants-health</Citation></Reference><Reference><Citation>Thorndike AN, Gardner CD, Kendrick KB, et al. Strengthening US Food Policies and Programs to Promote Equity in Nutrition Security: A Policy Statement From the American Heart Association. Circulation. 2022;145(24):e1077&#x2013;e1093. doi: 10.1161/CIR.0000000000001072</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001072</ArticleId><ArticleId IdType="pubmed">35535604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung HC, Shen A, Oo S, Tilahun H, Berkowitz S. Food Insecurity and Body Mass Index: A Longitudinal Mixed Methods Study, Chelsea, Massachusetts, 2009&#x2013;2013. Prev Chronic Dis. 2015;12(150001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565511</ArticleId><ArticleId IdType="pubmed">26247425</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz SA, Terranova J, Randall L, Cranston K, Waters DB, Hsu J. Association Between Receipt of a Medically Tailored Meal Program and Health Care Use. JAMA Intern Med. 2019;179(6):786. doi: 10.1001/jamainternmed.2019.0198</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.0198</ArticleId><ArticleId IdType="pmc">PMC6547148</ArticleId><ArticleId IdType="pubmed">31009050</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz SA, Delahanty LM, Terranova J, et al. Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: a Randomized Cross-over Trial. J Gen Intern Med. 2019;34(3):396&#x2013;404. doi: 10.1007/s11606-018-4716-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-018-4716-z</ArticleId><ArticleId IdType="pmc">PMC6420590</ArticleId><ArticleId IdType="pubmed">30421335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tester JM, Xiao L, Tinajero-Deck L, Juarez L, Rosas LG. Food Insecurity Influences Weight Trajectory in Children with Obesity. Child Obes. Published online February 15, 2022:epub.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9634962</ArticleId><ArticleId IdType="pubmed">35171045</ArticleId></ArticleIdList></Reference><Reference><Citation>Czajkowski SM, Powell LH, Adler N, et al. From Ideas to Efficacy: The ORBIT Model for Developing Behavioral Treatments for Chronic Diseases. Health Psychol. 2015;34(10):971&#x2013;982. doi: 10.1037/hea0000161</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/hea0000161</ArticleId><ArticleId IdType="pmc">PMC4522392</ArticleId><ArticleId IdType="pubmed">25642841</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattu RK, Paik G, Wang Y, Ray P, Lichenstein R, Black MM. The Hunger Vital Sign Identifies Household Food Insecurity among Children in Emergency Departments and Primary Care. Children (Basel). 2019;6(10):107. doi: 10.3390/children6100107</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children6100107</ArticleId><ArticleId IdType="pmc">PMC6827017</ArticleId><ArticleId IdType="pubmed">31581751</ArticleId></ArticleIdList></Reference><Reference><Citation>Eat Well Meal Kits. Accessed November 2, 2023. https://www.eatwellmealkits.com/</Citation></Reference><Reference><Citation>Rifas-Shiman SL, Willett WC, Lobb R, Kotch J, Dart C, Gillman MW. PrimeScreen, a brief dietary screening tool: reproducibility and comparability with both a longer food frequency questionnaire and biomarkers. Public Health Nutr. 2001;4(2):249&#x2013;254. doi: 10.1079/PHN200061</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/PHN200061</ArticleId><ArticleId IdType="pubmed">11299098</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik SH, Fox RS, Mills SD, et al. Reliability and validity of the Perceived Stress Scale-10 in Hispanic Americans with English or Spanish language preference. J Health Psychol. 2019;24(5):628&#x2013;639. doi: 10.1177/1359105316684938</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105316684938</ArticleId><ArticleId IdType="pmc">PMC6261792</ArticleId><ArticleId IdType="pubmed">28810432</ArticleId></ArticleIdList></Reference><Reference><Citation>USDA ERS - Survey Tools. https://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in-the-u-s/survey-tools/#household</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics. 2009;42(2):377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo Baidal JA, Meyer D, Partida I, et al. Feasibility of Food FARMacia: Mobile Food Pantry to Reduce Household Food Insecurity in Pediatric Primary Care. Nutrients. 2022;14(5):1059. doi: 10.3390/nu14051059</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14051059</ArticleId><ArticleId IdType="pmc">PMC8912842</ArticleId><ArticleId IdType="pubmed">35268034</ArticleId></ArticleIdList></Reference><Reference><Citation>Carman K, Sweeney LH, House LA, Mathews AE, Shelnutt KP. Acceptability and Willingness to Pay for a Meal Kit Program for African American Families with Low Income: A Pilot Study. Nutrients. 2021;13(8):2881. doi: 10.3390/nu13082881</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082881</ArticleId><ArticleId IdType="pmc">PMC8398692</ArticleId><ArticleId IdType="pubmed">34445040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38339791</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1557-9891</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>American journal of men's health</Title><ISOAbbreviation>Am J Mens Health</ISOAbbreviation></Journal><ArticleTitle>Bridging the Gap: Engaging Black Men in Lung Cancer Research Through Barbershop Collaboration.</ArticleTitle><Pagination><StartPage>15579883241229417</StartPage><MedlinePgn>15579883241229417</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15579883241229417</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/15579883241229417</ELocationID><Abstract><AbstractText>Health disparities persist among Black men, notably in the context of lung cancer and stress-related health outcomes. This study explores these disparities through a community-based participatory research (CBPR) approach, citizen science, and social network theory, leveraging the expertise and trust of Black barbers as community leaders. The purpose is to understand the nuanced connections between stress and lung cancer in this demographic. Engaging 161 Black men across four Chicago neighborhoods, the study successfully collected hair samples and survey data, emphasizing the importance of culturally sensitive recruitment strategies. Findings highlight the effectiveness of the collaboration, showcasing the role of barbershops as community hubs for research. The study concludes by advocating for sustained partnerships with community leaders, emphasizing transparency in research communication, and promoting culturally grounded approaches to address health disparities and enhance research participation among underrepresented populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Negrete</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5227-8897</Identifier><AffiliationInfo><Affiliation>University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ademiluyi</LastName><ForeName>Adeolu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karayeva</LastName><ForeName>Evgenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskridge</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>George's Barber Shop, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beauti PRO, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskridge</LastName><ForeName>Curtis M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Cut It Out Curt, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Bobby D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Principle Barbers, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendinskas</LastName><ForeName>Kestutis G</ForeName><Initials>KG</Initials><Identifier Source="ORCID">0000-0002-0275-520X</Identifier><AffiliationInfo><Affiliation>Oswego State University of New York, Oswego, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Karriem S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>National Institutes of Health (NIH) All of Us Research Program, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sage J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MD014839</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Mens Health</MedlineTA><NlmUniqueID>101287723</NlmUniqueID><ISSNLinking>1557-9883</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055812" MajorTopicYN="N">Community-Based Participatory Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006293" MajorTopicYN="Y">Health Promotion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001461" MajorTopicYN="N">Barbering</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">barbershops</Keyword><Keyword MajorTopicYN="N">hair samples</Keyword><Keyword MajorTopicYN="N">lung cancer</Keyword><Keyword MajorTopicYN="N">recruitment</Keyword><Keyword MajorTopicYN="N">stress</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Bendinskas declares a significant financial interest as the founder and the CEO of Stress Bioanalytics LLC, where hair cortisol was assessed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>2</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38339791</ArticleId><ArticleId IdType="pmc">PMC10859066</ArticleId><ArticleId IdType="doi">10.1177/15579883241229417</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Affleck W., Carmichael V., Whitley R. (2018). Men&#x2019;s mental health: Social determinants and implications for services. Canadian Journal of Psychiatry, 63(9), 581&#x2013;589. 10.1177/0706743718762388</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0706743718762388</ArticleId><ArticleId IdType="pmc">PMC6109884</ArticleId><ArticleId IdType="pubmed">29673270</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen J. O., Watkins D. C., Chatters L., Geronimus A. T., Johnson-Lawrence V. (2019). Cortisol and racial health disparities affecting Black men in later life: Evidence from MIDUS II. American Journal of Men&#x2019;s Health, 13(4), 1557988319870969. 10.1177/1557988319870969</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1557988319870969</ArticleId><ArticleId IdType="pmc">PMC6710693</ArticleId><ArticleId IdType="pubmed">31423887</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison K., Patel D., Kaur R. (2022). Assessing multiple factors affecting minority participation in clinical trials: Development of the clinical trials participation barriers survey. Cureus, 14(4), Article e24424. 10.7759/cureus.24424</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24424</ArticleId><ArticleId IdType="pmc">PMC9127181</ArticleId><ArticleId IdType="pubmed">35637812</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias E., Xu J. (2022). United States life tables, 2020. National Vital Statistics Reports, 71(1), 1&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">35947823</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett N. J., Ingraham K. L., Vann Hawkins T., Moorman P. G. (2017). Engaging African Americans in research: The recruiter&#x2019;s perspective. Ethnicity &amp; Disease, 27(4), 453&#x2013;462. 10.18865/ed.27.4.453</Citation><ArticleIdList><ArticleId IdType="doi">10.18865/ed.27.4.453</ArticleId><ArticleId IdType="pmc">PMC5720956</ArticleId><ArticleId IdType="pubmed">29225447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernab&#xe9; D. G., Tamae A. C., Biasoli &#xc9;. R., Oliveira S. H. (2011). Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells. Brain, Behavior, and Immunity, 25(3), 574&#x2013;583. 10.1016/j.bbi.2010.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.012</ArticleId><ArticleId IdType="pubmed">21187140</ArticleId></ArticleIdList></Reference><Reference><Citation>Blodgett J., Walter D., MacKenzie J., Gump B., Bendinskas K. (2017). Both hair cortisol and perceived stress during fall exams decrease after the winter break. Austin Biochemistry, 2(1), Article 1007.</Citation></Reference><Reference><Citation>Bollig-Fischer A., Chen W., Gadgeel S. M., Wenzlaff A. S., Cote M. L., Schwartz A. G., Bepler G. (2015). Racial diversity of actionable mutations in non&#x2013;small cell lung cancer. Journal of Thoracic Oncology, 10(2), 250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305026</ArticleId><ArticleId IdType="pubmed">25376516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond M. J., Herman A. A. (2016). Lagging life expectancy for Black Men: A public health imperative. American Journal of Public Health, 106(7), 1167&#x2013;1169. 10.2105/ajph.2016.303251</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.2016.303251</ArticleId><ArticleId IdType="pmc">PMC4984780</ArticleId><ArticleId IdType="pubmed">27285253</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe4;nstr&#xf6;m R., Hatzenbuehler M. L., Pachankis J. E. (2016). Sexual orientation disparities in physical health: Age and gender effects in a population-based study. Social Psychiatry and Psychiatric Epidemiology, 51, 289&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4747986</ArticleId><ArticleId IdType="pubmed">26298574</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. (2018). Lung Cancer Statistics. Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/lung/statistics/index.htm</Citation></Reference><Reference><Citation>Chae D. H., Nuru-Jeter A. M., Adler N. E., Brody G. H., Lin J., Blackburn E. H., Epel E. S. (2014). Discrimination, racial bias, and telomere length in African-American men. American Journal of Preventive Medicine, 46(2), 103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407682</ArticleId><ArticleId IdType="pubmed">24439343</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chicago Health Atlas. (2021). Homicide Mortality Rate. Illinois Department of Public Health https://chicagohealthatlas.org/indicators/VRHOR?topic=homicide-mortality-rate</Citation></Reference><Reference><Citation>Chida Y., Hamer M., Wardle J., Steptoe A. (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival? Nature Clinical Practice Oncology, 5(8), 466&#x2013;475. 10.1038/ncponc1134</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncponc1134</ArticleId><ArticleId IdType="pubmed">18493231</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper G. A. A., Kronstrand R., Kintz P. (2012). Society of Hair Testing guidelines for drug testing in hair. Forensic Science International, 218(1&#x2013;3), 20&#x2013;24. 10.1016/j.forsciint.2011.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.forsciint.2011.10.024</ArticleId><ArticleId IdType="pubmed">22088946</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin S. S., Matthews-Juarez P., Juarez P. D., Melton C. E., King M. (2014). Opportunities to address lung cancer disparities among African Americans. Cancer Medicine, 3(6), 1467&#x2013;1476. 10.1002/cam4.348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.348</ArticleId><ArticleId IdType="pmc">PMC4298372</ArticleId><ArticleId IdType="pubmed">25220156</ArticleId></ArticleIdList></Reference><Reference><Citation>de Groot P. M., Wu C. C., Carter B. W., Munden R. F. (2018). The epidemiology of lung cancer. Translational Lung Cancer Research, 7(3), 220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037963</ArticleId><ArticleId IdType="pubmed">30050761</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake B. F., Boyd D., Carter K., Gehlert S., Thompson V. S. (2017). Barriers and strategies to participation in tissue research among African-American men. Journal of Cancer Education, 32(1), 51&#x2013;58. 10.1007/s13187-015-0905-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13187-015-0905-1</ArticleId><ArticleId IdType="pmc">PMC4779426</ArticleId><ArticleId IdType="pubmed">26341221</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias A., Paradies Y. (2021). The costs of institutional racism and its ethical implications for healthcare. Journal of Bioethical Inquiry, 18(1), 45&#x2013;58. 10.1007/s11673-020-10073-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11673-020-10073-0</ArticleId><ArticleId IdType="pmc">PMC7778398</ArticleId><ArticleId IdType="pubmed">33387263</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcinelli M., Thaker P. H., Lutgendorf S. K., Conzen S. D., Flaherty R. L., Flint M. S. (2021). The role of psychologic stress in cancer initiation: Clinical relevance and potential molecular mechanisms. Cancer Research, 81(20), 5131&#x2013;5140. 10.1158/0008-5472.Can-21-0684</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.Can-21-0684</ArticleId><ArticleId IdType="pmc">PMC8530873</ArticleId><ArticleId IdType="pubmed">34266894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford J. L., Boch S. J., McCarthy D. O. (2016). Feasibility of hair collection for cortisol measurement in population research on adolescent health. Nursing Research, 65(3), 249&#x2013;255. 10.1097/nnr.0000000000000154</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nnr.0000000000000154</ArticleId><ArticleId IdType="pmc">PMC4852400</ArticleId><ArticleId IdType="pubmed">27124260</ArticleId></ArticleIdList></Reference><Reference><Citation>George S., Duran N., Norris K. (2014). A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. American Journal of Public Health, 104(2), e16&#x2013;e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935672</ArticleId><ArticleId IdType="pubmed">24328648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert K. L., Ray R., Siddiqi A., Shetty S., Baker E. A., Elder K., Griffith D. M. (2016). Visible and invisible trends in black men&#x2019;s health: Pitfalls and promises for addressing racial, ethnic, and gender inequities in health. Annual Review of Public Health, 37, 295&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531286</ArticleId><ArticleId IdType="pubmed">26989830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez S. L., Shariff-Marco S., DeRouen M., Keegan T. H., Yen I. H., Mujahid M., Satariano W. A., Glaser S. L. (2015). The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions. Cancer, 121(14), 2314&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490083</ArticleId><ArticleId IdType="pubmed">25847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith D. M., Ellis K. R., Allen J. O. (2013). An intersectional approach to social determinants of stress for African American men: Men&#x2019;s and women&#x2019;s perspectives. American Journal of Men&#x2019;s Health, 7(4_suppl), 19S&#x2013;30S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697096</ArticleId><ArticleId IdType="pubmed">23462019</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel L. M., Penner L. A., Albrecht T. L., Heath E., Gwede C. K., Eggly S. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327&#x2013;337. 10.1177/107327481602300404</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107327481602300404</ArticleId><ArticleId IdType="pmc">PMC5131730</ArticleId><ArticleId IdType="pubmed">27842322</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley A. E., Frazer D., Weber T., Edwards T. C., Carnegie N. (2020). No longer an island: A social network intervention engaging Black Men through CBPR. American Journal of Mens Health, 14(2), 1557988320913387. 10.1177/1557988320913387</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1557988320913387</ArticleId><ArticleId IdType="pmc">PMC7092655</ArticleId><ArticleId IdType="pubmed">32202194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes T. B., Varma V. R., Pettigrew C., Albert M. S. (2017). African Americans and clinical research: Evidence concerning barriers and facilitators to participation and recruitment recommendations. Gerontologist, 57(2), 348&#x2013;358. 10.1093/geront/gnv118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnv118</ArticleId><ArticleId IdType="pmc">PMC6075213</ArticleId><ArticleId IdType="pubmed">26553736</ArticleId></ArticleIdList></Reference><Reference><Citation>
Illinois Department of Public Health. (2016). Lung Cancer Incidence. Illinois Department of Public Health, Illinois State Cancer Registry. http://www.idph.state.il.us/cancer/statistics.htm</Citation></Reference><Reference><Citation>Iob E., Steptoe A. (2019). Cardiovascular disease and hair cortisol: A novel biomarker of chronic stress. Current Cardiology Reports, 21(10), Article 116. 10.1007/s11886-019-1208-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-019-1208-7</ArticleId><ArticleId IdType="pmc">PMC6717172</ArticleId><ArticleId IdType="pubmed">31471749</ArticleId></ArticleIdList></Reference><Reference><Citation>Juster R.-P., McEwen B. S., Lupien S. J. (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience &amp; Biobehavioral Reviews, 35(1), 2&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19822172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalliokoski O., Jellestad F. K., Murison R. (2019). A systematic review of studies utilizing hair glucocorticoids as a measure of stress suggests the marker is more appropriate for quantifying short-term stressors. Scientific Reports, 9(1), Article 11997. 10.1038/s41598-019-48517-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48517-2</ArticleId><ArticleId IdType="pmc">PMC6701156</ArticleId><ArticleId IdType="pubmed">31427664</ArticleId></ArticleIdList></Reference><Reference><Citation>Karl&#xe9;n J., Ludvigsson J., Hedmark M., Faresj&#xf6; &#xc5;., Theodorsson E., Faresj&#xf6; T. (2015). Early psychosocial exposures, hair cortisol levels, and disease risk. Pediatrics, 135(6), e1450&#x2013;e1457. 10.1542/peds.2014-2561</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2014-2561</ArticleId><ArticleId IdType="pubmed">25941311</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Chung S., Wei E. K., Luft H. S. (2018). New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low. BMC Health Services Research, 18(1), 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034213</ArticleId><ArticleId IdType="pubmed">29976189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch R., Flores-Torres M. H., Hinojosa G., Aspelund T., Hauksd&#xf3;ttir A., Kirschbaum C., Catzin-Kuhlmann A., Lajous M., Valdimarsdottir U. (2022). Perceived stress and hair cortisol concentration in a study of Mexican and Icelandic women. PLOS Global Public Health, 2(8), Article e0000571. 10.1371/journal.pgph.0000571</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0000571</ArticleId><ArticleId IdType="pmc">PMC10021558</ArticleId><ArticleId IdType="pubmed">36962547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Kroemer G. (2023). The cancer-immune dialogue in the context of stress. Nature Reviews Immunology. 10.1038/s41577-023-00949-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00949-8</ArticleId><ArticleId IdType="pubmed">37833492</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews A. K., Murray M., Ben Levi J., Odell D., Jeremiah R., Moore L., Oyaluade D., Chappel A., Burke L., Watson K. (2022). Preliminary evaluation of a Citizen Scientist educational curriculum aimed at engaging Black Men in lung cancer early detection screening. American Journal of Men&#x2019;s Health, 16(3), 15579883221099417. 10.1177/15579883221099417</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15579883221099417</ArticleId><ArticleId IdType="pmc">PMC9201322</ArticleId><ArticleId IdType="pubmed">35694882</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer O. L., Castro-Schilo L., Aguilar-Gaxiola S. (2014). Determinants of mental health and self-rated health: A model of socioeconomic status, neighborhood safety, and physical activity. American Journal of Public Health, 104(9), 1734&#x2013;1741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4151927</ArticleId><ArticleId IdType="pubmed">25033151</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazha B., Mishra M., Pentz R., Owonikoko T. K. (2019). Enrollment of racial minorities in clinical trials: Old problem assumes new urgency in the age of immunotherapy. American Society of Clinical Oncology Educational Book, 39, 3&#x2013;10. 10.1200/edbk_100021</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/edbk_100021</ArticleId><ArticleId IdType="pubmed">31099618</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt S., Palomarez R. E. (2016). Review: Increasing awareness and education on health disparities for health care providers. Ethnicity &amp; Disease, 26(2), 181&#x2013;190. 10.18865/ed.26.2.181</Citation><ArticleIdList><ArticleId IdType="doi">10.18865/ed.26.2.181</ArticleId><ArticleId IdType="pmc">PMC4836898</ArticleId><ArticleId IdType="pubmed">27103768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmon L., Artino A. R., Jr., Varpio L. (2019). Social network theory in interprofessional education: Revealing hidden power. Journal of Graduate Medical Education, 11(3), 247&#x2013;250. 10.4300/jgme-d-19-00253.1</Citation><ArticleIdList><ArticleId IdType="doi">10.4300/jgme-d-19-00253.1</ArticleId><ArticleId IdType="pmc">PMC6570428</ArticleId><ArticleId IdType="pubmed">31210849</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoro O. N., Nelson C. S., Witherspoon S. P., Witherspoon S. F., Simmons G. E., Jr (2020). Culturally responsive health promotion to address health disparities in African American Men: A program impact evaluation. American Journal of Men&#x2019;s Health, 14(4), 1557988320951321. 10.1177/1557988320951321</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1557988320951321</ArticleId><ArticleId IdType="pmc">PMC7450466</ArticleId><ArticleId IdType="pubmed">32840146</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaku O. O., Taylor E. A. (2017). Cancer in the medically underserved population. Primary Care: Clinics in Office Practice, 44(1), 87&#x2013;97</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5314211</ArticleId><ArticleId IdType="pubmed">28164822</ArticleId></ArticleIdList></Reference><Reference><Citation>Releford B. J., Frencher S. K., Jr., Yancey A. K. (2010). Health promotion in barbershops: Balancing outreach and research in African American communities. Ethnicity &amp; Disease, 20(2), 185&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4244298</ArticleId><ArticleId IdType="pubmed">20503901</ArticleId></ArticleIdList></Reference><Reference><Citation>Renzaho A. M., Houng B., Oldroyd J., Nicholson J. M., D&#x2019;Esposito F., Oldenburg B. (2014). Stressful life events and the onset of chronic diseases among Australian adults: Findings from a longitudinal survey. The European Journal of Public Health, 24(1), 57&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">23397581</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes S. D., Mann-Jackson L., Alonzo J., Sim&#xe1;n F. M., Vissman A. T., Nall J., Abraham C., Aronson R. E., Tanner A. E. (2017). Engaged for change: A community-engaged process for developing interventions to reduce health disparities. AIDS Education and Prevention, 29(6), 491&#x2013;502. 10.1521/aeap.2017.29.6.491</Citation><ArticleIdList><ArticleId IdType="doi">10.1521/aeap.2017.29.6.491</ArticleId><ArticleId IdType="pmc">PMC5798238</ArticleId><ArticleId IdType="pubmed">29283276</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers D., August E. M., Sehovic I., Green B. L., Quinn G. P. (2013). A systematic review of the factors influencing African Americans&#x2019; participation in cancer clinical trials. Contemporary Clinical Trials, 35(2), 13&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">23557729</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sapong E. (2014). Black barbershops draw customers back with a blend of camaraderie, culture. The Buffalo News. https://buffalonews.com/news/local/black-barbershops-draw-customers-back-with-a-blend-of-camaraderie-culture/article_7a5e9bdf-828e-5666-96bf-751f7d1de371.html</Citation></Reference><Reference><Citation>Sherrow V. (2023). Encyclopedia of hair: A cultural history. ABC-CLIO.</Citation></Reference><Reference><Citation>Simons R. L., Lei M. K., Klopack E., Beach S. R. H., Gibbons F. X., Philibert R. A. (2021). The effects of social adversity, discrimination, and health risk behaviors on the accelerated aging of African Americans: Further support for the weathering hypothesis. Social Science &amp; Medicine, 282, Article 113169. 10.1016/j.socscimed.2020.113169</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113169</ArticleId><ArticleId IdType="pmc">PMC7790841</ArticleId><ArticleId IdType="pubmed">32690336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin M. K. (2017). Lung cancer disparities and African-Americans. Public Health Nursing, 34(4), 359&#x2013;362. 10.1111/phn.12335</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/phn.12335</ArticleId><ArticleId IdType="pubmed">28485475</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R. A., Andrews K. S., Brooks D., Fedewa S. A., Manassaram-Baptiste D., Saslow D., Wender R. C. (2019). Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 69(3), 184&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">30875085</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith W. A., Hung M., Franklin J. D. (2011). Racial battle fatigue and the miseducation of Black men: Racial microaggressions, societal problems, and environmental stress. Journal of Negro Education, 80(1), 63&#x2013;82.</Citation></Reference><Reference><Citation>Spence C. T., Oltmanns T. F. (2011). Recruitment of African American men: Overcoming challenges for an epidemiological study of personality and health. Cultural Diversity &amp; Ethnic Minority Psychology, 17(4), 377&#x2013;380. 10.1037/a0024732</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0024732</ArticleId><ArticleId IdType="pmc">PMC3192307</ArticleId><ArticleId IdType="pubmed">21767002</ArticleId></ArticleIdList></Reference><Reference><Citation>Staufenbiel S. M., Penninx B. W. J. H., Spijker A. T., Elzinga B. M., van Rossum E. F. C. (2013). Hair cortisol, stress exposure, and mental health in humans: A systematic review. Psychoneuroendocrinology, 38(8), 1220&#x2013;1235. 10.1016/j.psyneuen.2012.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2012.11.015</ArticleId><ArticleId IdType="pubmed">23253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Taggart T., Sawyer S., Andreou A., Kershaw T., Milburn N. G. (2023). &#x201c;But I live here too&#x201d;: Social-structural stressors, racial discrimination, and resiliency among urban dwelling black emerging adult men. American Journal of Community Psychology, 72(1&#x2013;2), 48&#x2013;59. 10.1002/ajcp.12667</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajcp.12667</ArticleId><ArticleId IdType="pmc">PMC10523859</ArticleId><ArticleId IdType="pubmed">37042933</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D., Tian M., Han G., Li J. L. (2019). Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer. Scientific Reports, 9(1), Article 11257. 10.1038/s41598-019-47696-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47696-2</ArticleId><ArticleId IdType="pmc">PMC6677795</ArticleId><ArticleId IdType="pubmed">31375708</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega Ocasio D., Stewart-Ibarra A. M., Sippy R., Li C., McCue K., Bendinskas K. G., Gump B. B., Cueva-Aponte C., Ayala E. B., Morrell C. N., Dye T. D. (2021). Social stressors, arboviral infection, and immune dysregulation in the Coastal Lowland Region of Ecuador: A mixed methods approach in ecological perspective. American Journal of Tropical Medicine and Hygiene, 105(3), 756&#x2013;765. 10.4269/ajtmh.20-1625</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-1625</ArticleId><ArticleId IdType="pmc">PMC8592363</ArticleId><ArticleId IdType="pubmed">34339390</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson K. S., Henderson V., Murray M., Murphy A. B., Levi J. B., McDowell T., Holloway-Beth A., Gogana P., Dixon M. A., Moore L. (2019). Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress. Progress in Community Health Partnerships: Research, Education, and Action, 13(5), Article 103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693518</ArticleId><ArticleId IdType="pubmed">31378740</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson K. S., Siegel L. D., Henderson V. A., Murray M., Chukwudozie I. B., Odell D., Stinson J., Ituah O., Ben Levi J., Fitzgibbon M. L., Kim S., Matthews P. (2020). The SHARED project: A novel approach to engaging African American Men to address lung cancer disparities. American Journal of Men&#x2019;s Health, 14(5), 155798832095893. 10.1177/1557988320958934</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1557988320958934</ArticleId><ArticleId IdType="pmc">PMC7503018</ArticleId><ArticleId IdType="pubmed">32938277</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D. R. (2018). Stress and the mental health of populations of color: Advancing our understanding of race-related stressors. Journal of Health and Social Behavior, 59(4), 466&#x2013;485. 10.1177/0022146518814251</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022146518814251</ArticleId><ArticleId IdType="pmc">PMC6532404</ArticleId><ArticleId IdType="pubmed">30484715</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D. R., Cooper L. A. (2019). Reducing racial inequities in health: Using what we already know to take action. International Journal of Environmental Research and Public Health, 16(4), Article 606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6406315</ArticleId><ArticleId IdType="pubmed">30791452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosu A. C., Valdimarsd&#xf3;ttir U., Shields A. E., Williams D. R., Williams M. A. (2013). Correlates of cortisol in human hair: Implications for epidemiologic studies on health effects of chronic stress. Annals of Epidemiology, 23(12), 797&#x2013;811.e792. 10.1016/j.annepidem.2013.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2013.09.006</ArticleId><ArticleId IdType="pmc">PMC3963409</ArticleId><ArticleId IdType="pubmed">24184029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright K. D., Ford J. L., Perazzo J., Jones L. M., Mahari S., Sullenbarger B. A., Laudenslager M. L. (2018). Collecting hair samples for hair cortisol analysis in African Americans. Journal of Visualized Experiments, 136, Article 57288. 10.3791/57288</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/57288</ArticleId><ArticleId IdType="pmc">PMC6101699</ArticleId><ArticleId IdType="pubmed">29939172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani-Gallaher E. M., Polite V. C. (2012). The state of the African American male. MSU Press.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37976553</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2684</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Dementia (London, England)</Title><ISOAbbreviation>Dementia (London)</ISOAbbreviation></Journal><ArticleTitle>Competency development for a volunteer navigation program to support caregivers of people living with dementia: A modified e-Delphi method.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>90</EndPage><MedlinePgn>69-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/14713012231216768</ELocationID><Abstract><AbstractText>Caregivers of people living with dementia are pillars of the care community. Providing them with adequate support throughout their caregiving journey is essential to their quality of life and may also contribute to improving the care of people living with dementia. Nav-CARE (Navigation - Connecting, Advocating, Resourcing, Engaging) is a volunteer-led navigation program that provides support to older adults with life-limiting illnesses who are living in the community. However, Nav-CARE does not provide support directly to caregivers of people living with dementia. To adapt Nav-CARE to support caregivers, we needed to establish caregivers' needs and the competencies volunteer navigators should be trained in to support caregivers to meet these needs. To do so, a modified e-Delphi method was utilized, which consisted of administering three sequential questionnaires to a panel of 35 individuals with expertise in a variety of dementia related domains. Through this, two final lists of 46 caregivers' needs and 41 volunteer competencies were established to inform the development of volunteer navigator training curriculum. Findings suggest that trained volunteer navigators may be able to support caregivers of people living with dementia throughout the disease trajectory and can be used to inform the development of future dementia navigation programs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-3391-1182</Identifier><AffiliationInfo><Affiliation>Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna BC, Canada.</Affiliation><Identifier Source="RINGGOLD">97950</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puurveen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0359-5866</Identifier><AffiliationInfo><Affiliation>Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna BC, Canada.</Affiliation><Identifier Source="RINGGOLD">97950</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesut</LastName><ForeName>Barb</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1063-7190</Identifier><AffiliationInfo><Affiliation>Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna BC, Canada.</Affiliation><Identifier Source="RINGGOLD">97950</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rush</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0879-7187</Identifier><AffiliationInfo><Affiliation>Faculty of Health and Social Development, University of British Columbia Okanagan, Kelowna BC, Canada.</Affiliation><Identifier Source="RINGGOLD">97950</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9985-2796</Identifier><AffiliationInfo><Affiliation>Faculty of Health, Dalhousie University, Halifax, NS, Canada.</Affiliation><Identifier Source="RINGGOLD">3688</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dementia (London)</MedlineTA><NlmUniqueID>101128698</NlmUniqueID><ISSNLinking>1471-3012</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014838" MajorTopicYN="N">Volunteers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">competency development</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">e-Delphi</Keyword><Keyword MajorTopicYN="N">navigation</Keyword><Keyword MajorTopicYN="N">needs</Keyword><Keyword MajorTopicYN="N">volunteers</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>17</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37976553</ArticleId><ArticleId IdType="pmc">PMC10797849</ArticleId><ArticleId IdType="doi">10.1177/14713012231216768</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allison T., Balbino R., Covinsky K. (2019). Caring community and relationship centred care on an end-stage dementia special care unit. Age and Ageing, 48(5), 727&#x2013;734. 10.1093/ageing/afz030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afz030</ArticleId><ArticleId IdType="pubmed">31220199</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer Society of Canada . (2022). Navigating the path forward for dementia in Canada/The landmark study/Path. https://alzheimer.ca/sites/default/files/documents/LandmarkStudy-1-Path-Forward-Alzheimer-Society-of-Canada-2022-wb.pdf</Citation></Reference><Reference><Citation>Amjad H., Wong S. K., Roth D. L., Huang J., Willink A., Black B. S., Johnston D., Rabins P. V., Gitlin L. N., Lyketsos C. G., Samus Q. M. (2017). Health services utilization in older adults with dementia receiving care coordination: The MIND at home trial. Health Services Research, 53(1), 556&#x2013;579. 10.1111/1475-6773.12647</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1475-6773.12647</ArticleId><ArticleId IdType="pmc">PMC5785326</ArticleId><ArticleId IdType="pubmed">28083879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashworth R. (2017). Perceptions of stigma among people affected by early- and late-onset Alzheimer&#x2019;s disease. Journal of Health Psychology, 25(4), 490&#x2013;510. 10.1177/1359105317720818</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105317720818</ArticleId><ArticleId IdType="pubmed">28810495</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhouse A., Ukoumunne O. C., Richards D. A., McCabe R., Watkins R., Dickens C. (2017). The effectiveness of community-based coordinating interventions in dementia care: A meta-analysis and subgroup analysis of intervention components. BMC Health Services Research, 17(1), 717. 10.1186/s12913-017-2677-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-017-2677-2</ArticleId><ArticleId IdType="pmc">PMC5683245</ArticleId><ArticleId IdType="pubmed">29132353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein A., Harrison K. L., Dulaney S., Merrilees J., Bowhay A., Heunis J., Choi J., Feuer J. E., Clark A. M., Chiong W., Lee K., Braley T. L., Bonasera S. J., Ritchie C. S., Dohan D., Miller B. L., Possin K. L. (2019). The role of care navigators working with people with dementia and their caregivers. Journal of Alzheimer's Disease, 71(1), 45&#x2013;55. 10.3233/JAD180957. PMID: 31322558.; PMCID: PMC7004209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD180957</ArticleId><ArticleId IdType="pmc">PMC7004209</ArticleId><ArticleId IdType="pubmed">31322558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein A., Merrilees J., Dulaney S., Harrison K. L., Chiong W., Ong P., Heunis J., Choi J., Walker R., Feuer J. E., Lee K., Dohan D., Bonasera S. J., Miller B. L., Possin K. L. (2020). Using care navigation to address caregiver burden in dementia: A qualitative case study analysis. Alzheimer's and Dementia, 6(1), Article e12010. 10.1002/trc2.12010. http://mc.manuscriptcentral.com/dementia</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12010</ArticleId><ArticleId IdType="pmc">PMC7201177</ArticleId><ArticleId IdType="pubmed">32377557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieber A., Nguyen N., Meyer G., Stephan A. (2019). Influences on the access to and use of formal community care by people with dementia and their informal caregivers: A scoping review. BMC Health Services Research, 19(1), 88. 10.1186/s12913-018-3825-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-018-3825-z</ArticleId><ArticleId IdType="pmc">PMC6359781</ArticleId><ArticleId IdType="pubmed">30709345</ArticleId></ArticleIdList></Reference><Reference><Citation>Black B. S., Johnston D., Leoutsakos J., Reuland M., Kelly J., Amjad H., Davis K., Willink A., Sloan D., Lyketsos C., Samus Q. M. (2019). Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics. International Psychogeriatrics, 31(11), 1643&#x2013;1654. 10.1017/s1041610218002296</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610218002296</ArticleId><ArticleId IdType="pmc">PMC6679825</ArticleId><ArticleId IdType="pubmed">30714564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressan V., Visintini C., Palese A. (2020). What do family caregivers of people with dementia need? A mixed&#x2010;method systematic review. Health and Social Care in the Community, 28(6), 1942&#x2013;1960. 10.1111/hsc.13048</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.13048</ArticleId><ArticleId IdType="pubmed">32542963</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H., Donkin M. (2009). Family caregivers of people with dementia. Dialogues in Clinical Neuroscience, 11(2), 217&#x2013;228. 10.31887/dcns.2009.11.2/hbrodaty</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/dcns.2009.11.2/hbrodaty</ArticleId><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J., Chen S. (2008). Help-seeking patterns of older spousal caregivers of older adults with dementia. Issues in Mental Health Nursing, 29(8), 839&#x2013;852. 10.1080/01612840802182854</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01612840802182854</ArticleId><ArticleId IdType="pubmed">18649210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S., Li K., Losada A., Zhang F., Au A., Thompson L. W., Gallagher-Thompson D. (2020). The effectiveness of nonpharmacological interventions for informal dementia caregivers: An updated systematic review and meta-analysis. Psychology and Aging, 35(1), 55&#x2013;77. 10.1037/pag0000401</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pag0000401</ArticleId><ArticleId IdType="pubmed">31985249</ArticleId></ArticleIdList></Reference><Reference><Citation>De Witt L., Fortune D. (2019). Relationship-centered dementia care: Insights from a community-based culture change coalition. Dementia, 18(3), 1146&#x2013;1165. 10.1177/1471301217708814</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217708814</ArticleId><ArticleId IdType="pubmed">28523966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert A. R., Kulibert D., McFadden S. H. (2020). Effects of dementia knowledge and dementia fear on comfort with people having dementia: Implications for dementia friendly communities. Dementia, 19(8), 2542&#x2013;2554. 10.1177/1471301219827708</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301219827708</ArticleId><ArticleId IdType="pubmed">30739490</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler N. R., Hansen A. S., Barnato A. E., Garand L. (2013). Association between anticipatory grief and problem solving among family caregivers of persons with cognitive impairment. Journal of Aging and Health, 25(3), 493&#x2013;509. 10.1177/0898264313477133</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264313477133</ArticleId><ArticleId IdType="pmc">PMC3614338</ArticleId><ArticleId IdType="pubmed">23428394</ArticleId></ArticleIdList></Reference><Reference><Citation>Frias C. E., Cabrera E., Zabalegui A. (2020). Informal caregivers&#x2019; roles in dementia: The impact on their quality of life. Life, 10(11), 251. 10.3390/life10110251</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life10110251</ArticleId><ArticleId IdType="pmc">PMC7690694</ArticleId><ArticleId IdType="pubmed">33113995</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel C., Reilly S., Gabbay M., Dickinson J., Tetlow H., Hogan H., Griffiths A., Cooper C. (2023). Dementia care navigation: A systematic review on different service types and their prevalence. International Journal of Geriatric Psychiatry, 38(8), Article e5977. 10.1002/gps.5977</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5977</ArticleId><ArticleId IdType="pubmed">37526320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gresham M., Heffernan M., Brodaty H. (2018). The going to stay at home program: Combining dementia caregiver training and residential respite care. International Psychogeriatrics, 30(11), 1697&#x2013;1706. 10.1017/S1041610218000686</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610218000686</ArticleId><ArticleId IdType="pubmed">30019662</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkin D. J., O&#x2019;Connor C., Birch M. R., Poulos C. J. (2020). Perspectives of Australian family carers of people with dementia on the 'cottage' model of respite: Compared to traditional models of residential respite provided in aged care facilities. Health and Social Care in the Community. 28(3), 850&#x2013;861. 10.1111/hsc.12916. Epub 2019 Dec 20. PMID: 31863540; PMCID: PMC7Article 187172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.12916</ArticleId><ArticleId IdType="pmc">PMC7187172</ArticleId><ArticleId IdType="pubmed">31863540</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P. B., Caporella C. A. (2014). An intergenerational choir formed to lessen Alzheimer's disease stigma in college students and decrease the social isolation of people with Alzheimer's disease and their family members: A pilot study. American Journal of Alzheimer's Disease and Other Dementias, 29(3), 270&#x2013;281. 10.1177/1533317513517044</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317513517044</ArticleId><ArticleId IdType="pmc">PMC10852642</ArticleId><ArticleId IdType="pubmed">24413542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennelly N., O&#x2019;Shea E. (2022). A multiple perspective view of personhood in dementia. Ageing and Society, 42(9), 2103&#x2013;2121. 10.1017/S0144686X20002007</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X20002007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovland C. (2018). Welcoming death: Exploring pre-death grief experiences of caregivers of older adults with dementia. Journal of Social Work in End-of-Life and Palliative Care, 14(4), 274&#x2013;290. 10.1080/15524256.2018.1508538</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15524256.2018.1508538</ArticleId><ArticleId IdType="pubmed">30457443</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins M., Pesut B., Puurveen G. (2023). Interventions for caregivers of older adults with dementia living in the community: A rapid review of reviews. Canadian Journal on Aging/La Revue canadienne du vieillissement, 42(3), 425&#x2013;433. 10.1017/s0714980823000016</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0714980823000016</ArticleId><ArticleId IdType="pubmed">36799030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings L. A., Laffan A. M., Schlissel A. C., Colligan E., Tan Z., Wenger N. S., Reuben D. B. (2019). Health care utilization and cost outcomes of a comprehensive dementia care program for Medicare beneficiaries. JAMA Internal Medicine, 179(2), 161&#x2013;166. 10.1001/jamainternmed.2018.5579</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.5579</ArticleId><ArticleId IdType="pmc">PMC6439653</ArticleId><ArticleId IdType="pubmed">30575846</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeste D. V., Mausbach B., Lee E. E. (2021). Caring for caregivers/care partners of persons with dementia. International Psychogeriatrics, 33(4), 307&#x2013;310. 10.1017/S1041610221000557</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610221000557</ArticleId><ArticleId IdType="pmc">PMC8752059</ArticleId><ArticleId IdType="pubmed">33970060</ArticleId></ArticleIdList></Reference><Reference><Citation>Keane J. M., Franklin N. F., Vaughan B. (2020). Simulation to educate healthcare providers working within residential age care settings: A scoping review. Nurse Education Today, 85, 104228. 10.1016/j.nedt.2019.104228. http://mc.manuscriptcentral.com/dementia
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nedt.2019.104228</ArticleId><ArticleId IdType="pubmed">31765870</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeney S., McKenna H., Hasson F. (2011). The Delphi technique in nursing and health research. John Wiley &amp; Sons.</Citation></Reference><Reference><Citation>Kim J., Song J. (2021). Personhood communication with persons with dementia: Concept analysis. Journal of Korean Gerontological Nursing, 23(4), 406&#x2013;417. 10.17079/jkgn.2021.23.4.406</Citation><ArticleIdList><ArticleId IdType="doi">10.17079/jkgn.2021.23.4.406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Werner P., Richardson A., Anstey K. J. (2019). Dementia stigma reduction (Deserve): Study protocol for a randomized controlled trial of an online intervention program to reduce dementia-related public stigma. Contemporary Clinical Trials Communications, 14, 100351. 10.1016/j.conctc.2019.100351</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2019.100351</ArticleId><ArticleId IdType="pmc">PMC6453665</ArticleId><ArticleId IdType="pubmed">30997434</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokorelias K. M., Shiers-Hanley J. E., Li Z., Hitzig S. L. (2023). A systematic review on navigation programs for persons living with dementia and their caregivers. The Gerontologist, 63(8), 1341&#x2013;1350. 10.1093/geront/gnac054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnac054</ArticleId><ArticleId IdType="pubmed">35439813</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMantia M. A., Alder C. A., Callahan C. M., Gao S., French D. D., Austrom M. G., Boustany K., Livin L., Bynagari B., Boustani M. A. (2015). The aging brain care medical home: Preliminary data. Journal of the American Geriatrics Society, 63(6), 1209&#x2013;1213. 10.1111/jgs.13447</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13447</ArticleId><ArticleId IdType="pubmed">26096394</ArticleId></ArticleIdList></Reference><Reference><Citation>Laparidou D., Middlemass J., Karran T., Siriwardena A. N. (2019). Caregivers&#x2019; interactions with health care services &#x2013; Mediator of stress or added strain? Experiences and perceptions of informal caregivers of people with dementia &#x2013; a qualitative study. Dementia, 18(7-8), 2526&#x2013;2542. 10.1177/1471301217751226</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217751226</ArticleId><ArticleId IdType="pubmed">29385819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X., Zhao M., Li T., Yuan C., Zhang H., Pu C., Li Z., Zhang N., Yu X., Wang H. (2021). Effects of an enhanced training on primary care providers knowledge, attitudes, service and skills of dementia detection: A cluster randomized trial. Frontiers in Neurology, 12, 651826. 10.3389/fneur.2021.651826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.651826</ArticleId><ArticleId IdType="pmc">PMC8342805</ArticleId><ArticleId IdType="pubmed">34367045</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe M., You E., Tatangelo G. (2016). Hearing their voice: A systematic review of dementia family caregivers&#x2019; needs. The Gerontologist, 56(5), Article e70&#x2013;e88. 10.1093/geront/gnw078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw078</ArticleId><ArticleId IdType="pubmed">27102056</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrilees J. J., Bernstein A., Dulaney S., Heunis J., Walker R., Rah E., Choi J., Gawlas K., Carroll S., Ong P., Feuer J., Braley T., Clark A. M., Lee K., Chiong W., Bonasera S. J., Miller B. L., Possin K. L. (2018). The care ecosystem: Promoting self-efficacy among dementia family caregivers. Dementia, 19(6), 1955&#x2013;1973. 10.1177/1471301218814121</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301218814121</ArticleId><ArticleId IdType="pmc">PMC6541533</ArticleId><ArticleId IdType="pubmed">30497302</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller L. M., Lee C. S., Whitlatch C. J., Lyons K. S. (2018). Involvement of hospitalized persons with dementia in everyday decisions: A dyadic study. The Gerontologist, 58(4), 644&#x2013;653. 10.1093/geront/gnw265</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw265</ArticleId><ArticleId IdType="pmc">PMC6044333</ArticleId><ArticleId IdType="pubmed">28379352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M. R., Davies S., Brown J., Keady J., Nolan J. (2004). Beyond &#x2018;person-centred&#x2019; care: A new vision for gerontological nursing. Journal of Clinical Nursing, 13(s1), 45&#x2013;53. 10.1111/j.1365-2702.2004.00926.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2004.00926.x</ArticleId><ArticleId IdType="pubmed">15028039</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor D., Phinney A., Smith A., Small J., Purves B., Perry J., Drance E., Donnelly M., Chaudhury H., Beattie L. (2007). Personhood in dementia care: Developing a research agenda for broadening the vision. Dementia, 6(1), 121&#x2013;142. 10.1177/1471301207075648</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301207075648</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsulic-Jeras S., Whitlatch C. J., Szabo S. M., Shelton E. G., Johnson J. (2016). The SHARE program for dementia: Implementation of an early-stage dyadic care-planning intervention. Dementia, 18(1), 360&#x2013;379. 10.1177/1471301216673455</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216673455</ArticleId><ArticleId IdType="pubmed">27738110</ArticleId></ArticleIdList></Reference><Reference><Citation>Penrod J., Yu F., Kolanowski A., Fick M., Loeb S. J., Hupcey J. E. (2007). Reframing person centered nursing care for persons with dementia. Research and Theory for Nursing Practice, 21(1), 57&#x2013;72. 10.1891/rtnpij-v21i1a007. PMID: 17378465; PMCID: PMC2 844333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/rtnpij-v21i1a007</ArticleId><ArticleId IdType="pmc">PMC2844333</ArticleId><ArticleId IdType="pubmed">17378465</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B., Duggleby W., Warner G., Ghosh S., Bruce P., Dunlop R., Puurveen G. (2022). Scaling out a palliative compassionate community innovation: Nav-CARE. Palliative Care and Social Practice, 16, 26323524221095102. 10.1177/26323524221095102</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/26323524221095102</ArticleId><ArticleId IdType="pmc">PMC9112317</ArticleId><ArticleId IdType="pubmed">35592240</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B., Duggleby W., Warner G., Kervin E., Bruce P., Antifeau E., Hooper B. (2020). Implementing volunteer-navigation for older persons with advanced chronic illness (NavCARE): A knowledge to action study. BMC Palliative Care, 19(1), 72. 10.1186/s12904-020-00578-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12904-020-00578-1</ArticleId><ArticleId IdType="pmc">PMC7245025</ArticleId><ArticleId IdType="pubmed">32443979</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson K., Hahn H., Lee A. J., Madison C. A., Atri A. (2016). In the information age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers&#x2019; education needs, barriers, and preferences. BMC Geriatrics, 16(1), 164. 10.1186/s12877-016-0338-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-016-0338-7</ArticleId><ArticleId IdType="pmc">PMC5035467</ArticleId><ArticleId IdType="pubmed">27662829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro O., Brand&#xe3;o D., Oliveira A. F., Teixeira L., Pa&#xfa;l C. (2019). Positive aspects of care in informal caregivers of community&#x2010;dwelling dementia patients. Journal of Psychiatric and Mental Health Nursing, 27(4), 330&#x2013;341. 10.1111/jpm.12582</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpm.12582</ArticleId><ArticleId IdType="pubmed">31811684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan T., Nolan M., Reid D., Enderby P. (2008). Using the senses framework to achieve relationship-centred dementia care services. Dementia, 7(1), 71&#x2013;93. 10.1177/1471301207085368</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301207085368</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell&#x2010;Smith G., Moyle W., Kellett U. (2018). The impact of early&#x2010;stage dementia on community&#x2010;dwelling care recipient/carer dyads&#x2019; capacity to self&#x2010;manage. Journal of Clinical Nursing, 28(3-4), 629&#x2013;640. 10.1111/jocn.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.14657</ArticleId><ArticleId IdType="pubmed">30182488</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J., Chang C. (2020). Association between family caregiver burden and affiliate stigma in the families of people with dementia. International Journal of Environmental Research and Public Health, 17(8), 2772. 10.3390/ijerph17082772</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082772</ArticleId><ArticleId IdType="pmc">PMC7215659</ArticleId><ArticleId IdType="pubmed">32316454</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H., Yuan Q., Devi F., Wang P., Ng L., Goveas R., Chong A., Subramaniam M. (2021). Dementia knowledge and its demographic correlates amongst informal dementia caregivers in Singapore. Aging &amp; Mental Health, 25(5), 864&#x2013;872. 10.1080/13607863.2020.1740914. PMID: 32228179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1740914</ArticleId><ArticleId IdType="pubmed">32228179</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann B., Gkioka M., Kruse A., Tsolaki M. (2022). Informal caregivers' attitude toward dementia: The impact of dementia knowledge, confidence in dementia care, and the behavioral and psychological symptoms of the person with dementia. A cross-sectional study. Journal of Alzheimer's Disease: JAD, 88(3), 971&#x2013;984. 10.3233/JAD-215731. PMID: 35723101; PMCID: PMC9484115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215731</ArticleId><ArticleId IdType="pmc">PMC9484115</ArticleId><ArticleId IdType="pubmed">35723101</ArticleId></ArticleIdList></Reference><Reference><Citation>Tranv&#xe5;g O., Petersen K. A., N&#xe5;den D. (2015). Relational interactions preserving dignity experience: Perceptions of persons living with dementia. Nursing Ethics, 22(5), 577&#x2013;593. 10.1177/0969733014549882</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0969733014549882</ArticleId><ArticleId IdType="pubmed">25319119</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandepitte S., Van Den Noortgate N., Putman K., Verhaeghe S., Faes K., Annemans L. (2016). Effectiveness of supporting informal caregivers of people with dementia: A systematic review of randomized and non-randomized controlled trials. Journal of Alzheimer's Disease: JAD, 52(3), 929&#x2013;965. 10.3233/jad-151011</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-151011</ArticleId><ArticleId IdType="pubmed">27079704</ArticleId></ArticleIdList></Reference><Reference><Citation>Waligora K., Bahouth M., Han H. (2019). The self-care needs and behaviors of dementia informal caregivers: A systematic review. The Gerontologist, 59(5), Article e565&#x2013;e583. 10.1093/geront/gny076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gny076</ArticleId><ArticleId IdType="pubmed">29931147</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch C. J., Orsulic-Jeras S. (2018). Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers. The Gerontologist, 58(suppl_1), S58&#x2013;S73. 10.1093/geront/gnx162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnx162</ArticleId><ArticleId IdType="pubmed">29361068</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . (2017). Global action plan on the public health response to dementia 2017&#x2013;2025. Licence: CC BY-NC-SA 3.0 IGO.</Citation></Reference><Reference><Citation>Zwingmann I., Hoffmann W., Michalowsky B., Dreier-Wolfgramm A., Hertel J., Wucherer D., Eichler T., Kilimann I., Thiel F., Teipel S., Thyrian J. R. (2019). Supporting family dementia caregivers: Testing the efficacy of dementia care management on multifaceted caregivers&#x2019; burden. Aging &amp; Mental Health, 22(7), 889&#x2013;896. 10.1080/13607863.2017.1399341</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1399341</ArticleId><ArticleId IdType="pubmed">29156941</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37848234</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-6723</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Emergency medicine Australasia : EMA</Title><ISOAbbreviation>Emerg Med Australas</ISOAbbreviation></Journal><ArticleTitle>What effect did the New Zealand COVID-19 lockdown have on computed tomography-head scan utilisation in patients presenting to the emergency department with traumatic head injuries?</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>100</EndPage><MedlinePgn>94-100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1742-6723.14322</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To explore the unique impact the first COVID-19 national lockdown in New Zealand (NZ) had on the utility of computed tomography (CT)-head&#xa0;scanning in patients presenting to the ED with head injuries.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective observational study of CT-head use in head-injured patients presenting to the ED during the 2020 COVID-19 lockdown compared to the corresponding time period in 2019.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the lockdown period in 2020, the total number of ED presentations reduced by 30.3% (95% confidence interval [CI] 28.8-31.6) from 13&#x2009;477 to 9403. The total number of head injury presentations also reduced by 32% (95% CI 27-36.7) from 523 to 356. The proportion of head-injured patients remained similar (3.9% [n&#x2009;=&#x2009;523] in 2019 vs 3.8% [n&#x2009;=&#x2009;356] in 2020). Of the head injured patients, 185 (51.9%, 95% CI 44.5-59.4) had CT-head scans performed in 2020 compared to 269 (51.4%, 95% CI 45.2-57.5) in 2019; a reduction of 31.2% (95% CI 24.5-37.9). The proportion of patients who had a CT-head scan remained similar (51.4% [95% CI 45.2-57.5] in 2019 vs 51.9% [95% CI 44.5-59.4] in 2020). There were no significant differences in the proportion of CT-head scans with acute traumatic pathology (13.0% [95% CI 8.7-17.3] in 2019 vs 12.4% [95% CI 7.4-17.5] in 2020, P&#x2009;=&#x2009;0.86).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">During the first COVID-19 lockdown in NZ, the total number of patients presenting to the ED decreased by one third. Reassuringly, the proportion of patients who presented with head injuries, had a CT-head scan performed, and had positive CT-head findings remained the same as the previous year.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Emergency Medicine Australasia published by John Wiley &amp; Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Eden</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6658-6321</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Anaesthesia, University of Otago, Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery and Anaesthesia, University of Otago, Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery and Anaesthesia, University of Otago, Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Compson</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Wellington Emergency Department, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgery and Anaesthesia, University of Otago, Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogan</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1305-0325</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Anaesthesia, University of Otago, Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellington Emergency Department, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Emerg Med Australas</MedlineTA><NlmUniqueID>101199824</NlmUniqueID><ISSNLinking>1742-6723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006259" MajorTopicYN="Y">Craniocerebral Trauma</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CT-head</Keyword><Keyword MajorTopicYN="N">TBI</Keyword><Keyword MajorTopicYN="N">traumatic brain injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37848234</ArticleId><ArticleId IdType="doi">10.1111/1742-6723.14322</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>World Health Organization. WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020. [Cited Sep 2022.] Available from URL: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020</Citation></Reference><Reference><Citation>Lucero AD, Lee A, Hyun J et al. Underutilization of the emergency department during the COVID-19 pandemic. West J. Emerg. Med. 2020; 21: 15-23.</Citation></Reference><Reference><Citation>Christey G, Amey J, Campbell A, Smith A. Variation in volumes and characteristics of trauma patients admitted to a level one trauma centre during national level 4 lockdown for COVID-19 in New Zealand. N. Z. Med. J. 2020; 133: 81-88.</Citation></Reference><Reference><Citation>Allen MT, Thompson BC, Atkinson B et al. Emergency department presentations in the Southern District of New Zealand during the 2020 COVID-19 pandemic lockdown. Emerg. Med. Australas. 2021; 33: 534-540.</Citation></Reference><Reference><Citation>Saxon L, Fazio TN, Gumm K, Tong SYC, Read DJ. Quality of care was not compromised during the COVID-19 pandemic at a level 1 trauma centre. ANZ J. Surg. 2022; 92: 172-179.</Citation></Reference><Reference><Citation>Rogan A, Patel V, Birdling J et al. Acute traumatic brain injury and the use of head computed tomography scans in the emergency department. Trauma 2022; 24: 327-336.</Citation></Reference><Reference><Citation>Pozzato I, Meares S, Kifley A et al. Challenges in the acute identification of mild traumatic brain injuries: results from an emergency department surveillance study. BMJ Open 2020; 10: e034494.</Citation></Reference><Reference><Citation>Pinggera D, Klein B, Thome C, Grassner L. The influence of the COVID-19 pandemic on traumatic brain injuries in Tyrol: experiences from a state under lockdown. Eur. J. Trauma Emerg. Surg. 2021; 47: 653-658.</Citation></Reference><Reference><Citation>Santing JAL, van den Brand CL, Jellema K. Traumatic brain injury during the SARS-CoV-2 pandemic. Neurotrauma Rep. 2020; 1: 5-7.</Citation></Reference><Reference><Citation>Agarwal M, Udare A, Patlas M et al. Effect of COVID-19 on computed tomography usage and critical test results in the emergency department: an observational study. CMAJ Open 2020; 8: E568-E576.</Citation></Reference><Reference><Citation>Aprato A, Bini N, Ferro S, Favella L, Conforti L, Masse A. Trauma workload during COVID19 lockdown: an analysis of incidence in 4 million people. Ir. J. Med. Sci. 2022; 191: 39-43.</Citation></Reference><Reference><Citation>Thornton J. Covid-19: A&amp;E visits in England fall by 25% in week after lockdown. BMJ 2020; 369: m1401.</Citation></Reference><Reference><Citation>Ministry of Health New Zealand. History of the COVID-19 Alert System. [Cited May 2022.] Available from URL: https://covid19.govt.nz/about-our-covid-19-response/history-of-the-covid-19-alert-system/</Citation></Reference><Reference><Citation>Jones P, Le Fevre J, Harper A et al. Effect of the shorter stays in emergency departments time target policy on key indicators of quality of care. N. Z. Med. J. 2017; 130: 1455.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). Head Injury: Assessment and Early Management NICE Clinical Guideline NG232. 2014. [Cited Jul 2022.] Available from URL: https://www.nice.org.uk/guidance/cg176/resources/imaging-algorithm-pdf-498950893; www.guidance.nice.org.uk/CG176</Citation></Reference><Reference><Citation>Nguyen R, Fiest KM, McChesney J et al. The international incidence of traumatic brain injury: a systematic review and meta-analysis. Can. J. Neurol. Sci. 2016; 43: 774-785.</Citation></Reference><Reference><Citation>Feigin VL, Theadom A, Barker-Collo S et al. Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol. 2013; 12: 53-64.</Citation></Reference><Reference><Citation>Rogan A, Patel V, Birdling J et al. Alcohol and acute traumatic brain injury in the emergency department. Emerg. Med. Australas. 2021; 33: 718-727.</Citation></Reference><Reference><Citation>Smyth H, Breslin D, Mullany L et al. Silver Trauma Review Clinic: a novel model of care to manage non-operative injuries in older patients. Emerg. Med. J. 2023; 40: 721-5.</Citation></Reference><Reference><Citation>Samaras N, Chevalley T, Samaras D, Gold G. Older patients in the emergency department: a review. Ann. Emerg. Med. 2010; 56: 261-269.</Citation></Reference><Reference><Citation>World Health Organization. Active Ageing: A Policy Framework. 2002. Available from URL: hqlibdoc.who.int/hq/2002/who_nmh_nph_02.8.pdf</Citation></Reference><Reference><Citation>Fairfax L, Hsee L, Civil I. An ageing trauma population: the Auckland experience. N. Z. Med. J. 2015; 128: 1414.</Citation></Reference><Reference><Citation>CODA. Trauma and Age: Coda Change - Clinical Conferences and Podcasts. [Cited Feb 2023.] Available from URL: https://codachange.org/trauma-and-age</Citation></Reference><Reference><Citation>Cubitt M, Braitberg G, Curtis K, Maier AB. Models of acute care for injured older patients-Australia and New Zealand practice. Injury 2023; 54: 223-231.</Citation></Reference><Reference><Citation>Ziegenhain F, Scherer J, Kalbas Y et al. Age-dependent patient and trauma characteristics and hospital resource requirements-can improvement be made? An analysis from the German trauma registry. Medicina (Kaunas) 2021; 57: 330.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37800606</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-7633</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>24</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Chembiochem : a European journal of chemical biology</Title><ISOAbbreviation>Chembiochem</ISOAbbreviation></Journal><ArticleTitle>Impact of Metabolic Stress on BeWo Syncytiotrophoblast Function.</ArticleTitle><Pagination><StartPage>e202300410</StartPage><MedlinePgn>e202300410</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cbic.202300410</ELocationID><Abstract><AbstractText>During placental formation, cytotrophoblasts (CTBs) fuse into multinucleate, microvilli-coated syncytiotrophoblasts (STBs), which contact maternal blood, mediating nutrient, metabolite, and gas exchange between mother and fetus, and providing a barrier against fetal infection. Trophoblasts remodel the surrounding extracellular matrix through the secretion of matrix metalloproteinases (MMPs). Maternal obesity and diabetes mellitus can negatively impact fetal development and may impair trophoblast function. We sought to model the impact of metabolic stress on STB function by examining MMP and hormone secretion. The BeWo CTB cell line was syncytialized to STB-like cells with forskolin. Cell morphology was examined by electron microscopy and immunofluorescence; phenotype was further assessed by ELISA and RT-qPCR. STBs were exposed to a metabolic stress cocktail (MetaC: 30&#x2005;mM glucose, 10&#x2005;nM insulin, and 0.1&#x2005;mM palmitic acid). BeWo syncytialization was demonstrated by increased secretion of HCG&#x3b2; and progesterone, elevated syncytin gene expression (ERVW-1 and ERVFRD-1), loss of tight junctions, and increased surface microvilli. MetaC strongly suppressed syncytin gene expression (ERVW-1 and ERVFRD-1), suppressed HCG&#x3b2; and progesterone secretion, and altered both MMP-9 and MMP-2 production. Metabolic stress modeling diabetes and obesity altered BeWo STB hormone and MMP production in&#x2005;vitro.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, 545 Barnhill Dr., EH 305, Indianapolis, IN, 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doster</LastName><ForeName>Ryan S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Department of Microbiology and Immunology, University of Louisville, Louisville, KY, 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omage</LastName><ForeName>Joel I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaddy</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastman</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronoff</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0003-4587-6121</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, 545 Barnhill Dr., EH 305, Indianapolis, IN, 46202, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Chembiochem</MedlineTA><NlmUniqueID>100937360</NlmUniqueID><ISSNLinking>1439-4227</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4G7DS2Q64Y</RegistryNumber><NameOfSubstance UI="D011374">Progesterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="Y">Placenta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011374" MajorTopicYN="Y">Progesterone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014327" MajorTopicYN="N">Trophoblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">developmental origins of health and disease</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">placenta</Keyword><Keyword MajorTopicYN="N">syncytialization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37800606</ArticleId><ArticleId IdType="doi">10.1002/cbic.202300410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>M. Knofler, S. Haider, L. Saleh, J. Pollheimer, T. Gamage, J. James, Cell. Mol. Life Sci. 2019, 76, 3479-3496;</Citation></Reference><Reference><Citation>F. Liu, M. J. Soares, K. L. Audus, Am. J. Physiol. 1997, 273, C1596-1604.</Citation></Reference><Reference><Citation>W. J. Hamilton, J. D. Boyd, J. Anat. 1960, 94, 297-328.</Citation></Reference><Reference><Citation>Y. Wang, S. Zhao, San Rafael (CA) 2010.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>E. Alsat, A. Malassin&#xe9;, A. Tarrade, P. Merviel, D. Evain-Brion, MS-medecine Sciences 1999, 15, 1236-1243;</Citation></Reference><Reference><Citation>A. Tarrade, R. Lai Kuen, A. Malassine, V. Tricottet, P. Blain, M. Vidaud, D. Evain-Brion, Lab. Invest. 2001, 81, 1199-1211.</Citation></Reference><Reference><Citation>L. Guariguata, U. Linnenkamp, L. E. Makaroff, K. Ogurtsova, S. Colagiuri, in Nutrition and Diet in Maternal Diabetes, Springer, 2018, pp. 3-15.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>G. Desoye, M. van Poppel, Best Practice &amp; Research 2015, 29, 15-23;</Citation></Reference><Reference><Citation>E. A. H. Sims, Jama 1980, 243, 519-520.</Citation></Reference><Reference><Citation>G. J. Burton, A. L. Fowden, Philos. Trans. R. Soc. London Ser. B 2015, 370, 20140066.</Citation></Reference><Reference><Citation>J. L. Jameson, A. N. Hollenberg, Endocr. Rev. 1993, 14, 203-221.</Citation></Reference><Reference><Citation>J. R. Robbins, K. M. Skrzypczynska, V. B. Zeldovich, M. Kapidzic, A. I. Bakardjiev, PLoS Pathog. 2010, 6, e1000732.</Citation></Reference><Reference><Citation>K. A. Jurado, Msphere 2020, 5, e00639-00620.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>N. Iwahashi, M. Ikezaki, K. Nishitsuji, M. Yamamoto, I. Matsuzaki, N. Kato, N. Takaoka, M. Taniguchi, S. I. Murata, K. Ino, Y. Ihara, Cells 2021, 10, 1305;</Citation></Reference><Reference><Citation>M. Mansilla, Y. Wang, R. Lim, K. Palmer, G. Nie, Sci. Rep. 2021, 11, 14363;</Citation></Reference><Reference><Citation>K. Orendi, M. Gauster, G. Moser, H. Meiri, B. Huppertz, Reproduction (Cambridge, England) 2010, 140, 759-766.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>Y. Chen, M. Allars, X. Pan, K. Maiti, G. Angeli, R. Smith, R. C. Nicholson, Reprod. Biol. Endocrinol. 2013, 11, 30;</Citation></Reference><Reference><Citation>S. S. Malhotra, S. K. Gupta, Cell. Mol. Biol. Lett. 2017, 22, 15.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>T. M. Butler, P. A. Elustondo, G. E. Hannigan, D. J. MacPhee, Reprod. Biol. Endocrinol. 2009, 7, 51;</Citation></Reference><Reference><Citation>H. P. Hohn, M. Linke, B. Ugele, H. W. Denker, Exp. Cell Res. 1998, 244, 249-258;</Citation></Reference><Reference><Citation>L. C. Kao, S. Caltabiano, S. Wu, J. F. Strauss,&#x2005;3rd, H. J. Kliman, Developmental biology 1988, 130, 693-702.</Citation></Reference><Reference><Citation>X. Lu, R. Wang, C. Zhu, H. Wang, H. Y. Lin, Y. Gu, J. C. Cross, H. Wang, Cell Rep. 2018, 23, 3979.</Citation></Reference><Reference><Citation>S. J. Heaton, J. J. Eady, M. L. Parker, K. L. Gotts, J. R. Dainty, S. J. Fairweather-Tait, H. J. McArdle, K. S. Srai, R. M. Elliott, Am. J. Physiol. Cell Physiol. 2008, 295, C1445-1453.</Citation></Reference><Reference><Citation>H. Inadera, S. Tachibana, I. Takasaki, M. Tatematsu, A. Shimomura, Endocr. J. 2010, 57, 567-577.</Citation></Reference><Reference><Citation>Z. J. W. Easton, F. Delhaes, K. Mathers, L. Zhao, C. M. G. Vanderboor, T. R. H. Regnault, Reproduction (Cambridge, England) 2021, 161, 73-88.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>M. Kratz, B. R. Coats, K. B. Hisert, D. Hagman, V. Mutskov, E. Peris, K. Q. Schoenfelt, J. N. Kuzma, I. Larson, P. S. Billing, R. W. Landerholm, M. Crouthamel, D. Gozal, S. Hwang, P. K. Singh, L. Becker, Cell Metab. 2014, 20, 614-625;</Citation></Reference><Reference><Citation>L. M. Rogers, C. H. Serezani, A. J. Eastman, A. H. Hasty, L. Englund-Ogge, B. Jacobsson, K. C. Vickers, D. M. Aronoff, Placenta 2020, 90, 45-51;</Citation></Reference><Reference><Citation>P. Tiwari, A. Blank, C. Cui, K. Q. Schoenfelt, G. Zhou, Y. Xu, G. Khramtsova, F. Olopade, A. M. Shah, S. A. Khan, M. R. Rosner, L. Becker, J. Exp. Med. 2019, 216, 1345-1358;</Citation></Reference><Reference><Citation>L. Zhang, Y. J. Han, X. Zhang, X. Wang, B. Bao, W. Qu, J. Liu, Diabetologia 2016, 59, 2219-2228.</Citation></Reference><Reference><Citation>R. M. Roberts, T. Ezashi, L. C. Schulz, J. Sugimoto, D. J. Schust, T. Khan, J. Zhou, Placenta 2021, 113, 8-14.</Citation></Reference><Reference><Citation>S. Saha, S. Chakraborty, A. Bhattacharya, A. Biswas, R. Ain, Sci. Rep. 2017, 7, 16548.</Citation></Reference><Reference><Citation>A. Vargas, J. Moreau, S. Landry, F. LeBellego, C. Toufaily, E. Rassart, J. Lafond, B. Barbeau, J. Mol. Biol. 2009, 392, 301-318.</Citation></Reference><Reference><Citation>M. Morgan, D. Kniss, S. McDonnell, Exp. Cell Res. 1998, 242, 18-26.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>P. Bischof, M. Martelli, A. Campana, Y. Itoh, Y. Ogata, H. Nagase, Early Pregnancy 1995, 1, 263-269;</Citation></Reference><Reference><Citation>S. J. Fisher, T. Y. Cui, L. Zhang, L. Hartman, K. Grahl, G. Y. Zhang, J. Tarpey, C. H. Damsky, J. Cell Biol. 1989, 109, 891-902.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>C. L. Librach, Z. Werb, M. L. Fitzgerald, K. Chiu, N. M. Corwin, R. A. Esteves, D. Grobelny, R. Galardy, C. H. Damsky, S. J. Fisher, J. Cell Biol. 1991, 113, 437-449;</Citation></Reference><Reference><Citation>E. Staun-Ram, S. Goldman, D. Gabarin, E. Shalev, Reprod. Biol. Endocrinol. 2004, 2, 59;</Citation></Reference><Reference><Citation>P. Xu, N. Alfaidy, J. R. Challis, J. Clin. Endocrinol. Metab. 2002, 87, 1353-1361.</Citation></Reference><Reference><Citation>&#xa0;</Citation></Reference><Reference><Citation>C. A. de Jager, E. A. Linton, I. Spyropoulou, I. L. Sargent, C. W. Redman, Placenta 2003, 24, 84-91;</Citation></Reference><Reference><Citation>G. Sawicki, M. W. Radomski, B. Winkler-Lowen, A. Krzymien, L. J. Guilbert, Biol. Reprod. 2000, 63, 1390-1395;</Citation></Reference><Reference><Citation>S. Shimonovitz, A. Hurwitz, M. Dushnik, E. Anteby, T. Geva-Eldar, S. Yagel, Am. J. Obstet. Gynecol. 1994, 171, 832-838.</Citation></Reference><Reference><Citation>M. Duszyk, Y. Shu, G. Sawicki, A. Radomski, S. F. Man, M. W. Radomski, Can. J. Physiol. Pharmacol. 1999, 77, 529-535.</Citation></Reference><Reference><Citation>G. Sawicki, E. Salas, J. Murat, H. Miszta-Lane, M. W. Radomski, Nature 1997, 386, 616-619.</Citation></Reference><Reference><Citation>C. Fernandez-Patron, M. W. Radomski, S. T. Davidge, Circ. Res. 1999, 85, 906-911.</Citation></Reference><Reference><Citation>J. J. Faust, B. A. Millis, M. J. Tyska, Curr. Biol. 2019, 29, 3457-3465 e3453.</Citation></Reference><Reference><Citation>R. Wang, Y. L. Dang, R. Zheng, Y. Li, W. W. Li, X. Y. Lu, L. J. Wang, C. Zhu, H. Y. Lin, H. M. Wang, Biol. Reprod. 2014, 90 (117), 1-10.</Citation></Reference><Reference><Citation>N. Reunanen, V. K&#xe4;h&#xe4;ri, in Madame Curie Bioscience Database [Internet], Landes Bioscience, 2013.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37074206</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>210</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>Natural Microbial Exposure from the Earliest Natural Time Point Enhances Immune Development by Expanding Immune Cell Progenitors and Mature Immune Cells.</ArticleTitle><Pagination><StartPage>1740</StartPage><EndPage>1751</EndPage><MedlinePgn>1740-1751</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2300061</ELocationID><Abstract><AbstractText>Microbial experience fundamentally shapes immunity, particularly during the perinatal period when the immune system is underdeveloped, and novel microbial encounters are common. Most animal models are raised in specific pathogen-free (SPF) conditions with relatively uniform microbial communities. How SPF housing conditions alter early-life immune development relative to natural microbial exposure (NME) has not been thoroughly investigated. In this article, we compare immune development in SPF-raised mice with mice born from immunologically experienced mothers in microbially diverse environments. NME induced broad immune cell expansion, including naive cells, suggesting mechanisms besides activation-induced proliferation contribute to the increase in immune cell numbers. We found NME conditions also expanded immune cell progenitor cell populations in the bone marrow, suggesting microbial experience enhances immune development at the earliest stages of immune cell differentiation. Multiple immune functions characteristically impaired in infants were also enhanced by NME, including T cell memory and Th1 polarization, B cell class switching and Ab production, proinflammatory cytokine expression, and bacterial clearance after Listeria monocytogenes challenge. Collectively, our studies reveal numerous impairments in immune development in SPF conditions relative to natural immune development.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burger</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenger</LastName><ForeName>Terran</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8199-0880</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sridhar</LastName><ForeName>Adhvaith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucaba</LastName><ForeName>Tamara A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffith</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-7205-9859</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Minneapolis VA Health Care System, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3768-7622</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuldt</LastName><ForeName>Nathaniel J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0001-7692-4814</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX001324</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>IK6 BX006192</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI155468</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM140881</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008089" MajorTopicYN="Y">Listeria monocytogenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001853" MajorTopicYN="N">Bone Marrow</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>DECLARATION OF INTERESTS. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37074206</ArticleId><ArticleId IdType="mid">NIHMS1886837</ArticleId><ArticleId IdType="pmc">PMC10192123</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.2300061</ArticleId><ArticleId IdType="pii">263626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, Umesaki Y, Mathis D, Benoist C, Relman DA, and Kasper DL. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149: 1578&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442780</ArticleId><ArticleId IdType="pubmed">22726443</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith K, McCoy KD, and Macpherson AJ. 2007. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19: 59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">17118672</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M, Thaiss CA, and Elinav E. 2016. Metabolites: messengers between the microbiota and the immune system. Genes &amp; Development 30: 1589&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973288</ArticleId><ArticleId IdType="pubmed">27474437</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabilas C, Iu DS, Daly CWP, Yee Mon KJ, Reynaldi A, Wesnak SP, Grenier JK, Davenport MP, Smith NL, Grimson A, and Rudd BD. 2022. Early microbial exposure shapes adult immunity by altering CD8+ T cell development. Proc Natl Acad Sci U S A 119: e2212548119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894172</ArticleId><ArticleId IdType="pubmed">36442114</ArticleId></ArticleIdList></Reference><Reference><Citation>Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, and Blumberg RS. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437652</ArticleId><ArticleId IdType="pubmed">22442383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez de Ag&#xfc;ero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, Steinert A, Heikenwalder M, Hapfelmeier S, Sauer U, McCoy KD, and Macpherson AJ. 2016. The maternal microbiota drives early postnatal innate immune development. Science 351: 1296&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pubmed">26989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim AI, McFadden T, Link VM, Han SJ, Karlsson RM, Stacy A, Farley TK, Lima-Junior DS, Harrison OJ, Desai JV, Lionakis MS, Shih HY, Cameron HA, and Belkaid Y. 2021. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science 373.</Citation><ArticleIdList><ArticleId IdType="pubmed">34446580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, Hickman HD, McCulloch JA, Badger JH, Ajami NJ, Trinchieri G, Pardo-Manuel de Villena F, Yewdell JW, and Rehermann B. 2017. Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. Cell 171: 1015&#x2013;1028.e1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887100</ArticleId><ArticleId IdType="pubmed">29056339</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, McCulloch JA, Anastasakis DG, Sarshad AA, Leonardi I, Collins N, Blatter JA, Han SJ, Tamoutounour S, Potapova S, Foster St Claire MB, Yuan W, Sen SK, Dreier MS, Hild B, Hafner M, Wang D, Iliev ID, Belkaid Y, Trinchieri G, and Rehermann B. 2019. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377314</ArticleId><ArticleId IdType="pubmed">31371577</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G, and Brinster C. 2009. Isolation of dendritic cells. Curr. Protoc. Immunol Chapter 3: Unit 3 7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19653207</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman RM, Kaplan G, Witmer MD, and Cohn ZA. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med 149: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2184752</ArticleId><ArticleId IdType="pubmed">762493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd P 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8: 223&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">12946237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaouat G 2007. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 29: 95&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">17626305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mysore V, Tahir S, Furuhashi K, Arora J, Rosetti F, Cullere X, Yazbeck P, Sekulic M, Lemieux ME, Raychaudhuri S, Horwitz BH, and Mayadas TN. 2022. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med 219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006314</ArticleId><ArticleId IdType="pubmed">35404389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain CC, and Schridde A. 2018. Origin, Differentiation, and Function of Intestinal Macrophages. Front Immunol 9: 2733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277706</ArticleId><ArticleId IdType="pubmed">30538701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B, Agace WW, and Mowat AM. 2013. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6: 498&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3629381</ArticleId><ArticleId IdType="pubmed">22990622</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmes EC, Chen JL, Goswami R, Burt TD, Permar SR, and Fouda GG. 2020. Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health. Front Immunol 11: 595297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7858666</ArticleId><ArticleId IdType="pubmed">33552052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen SCA, and Boyd SD. 2019. New technologies and applications in infant B cell immunology. Current Opinion in Immunology 57: 53&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511472</ArticleId><ArticleId IdType="pubmed">30825678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Zheng Z, and Cheng T. 2020. New paradigms on hematopoietic stem cell differentiation. Protein &amp; Cell 11: 34&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949320</ArticleId><ArticleId IdType="pubmed">31201709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack U, Burkhardt U, Borte M, Sch&#xe4;dlich H, Berg K, and Emmrich F. 1998. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 5: 28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC121386</ArticleId><ArticleId IdType="pubmed">9455875</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker ML, Grobusch MP, and Ritz N. 2017. Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children-A Systematic Review. Front Pediatr 5: 255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5735141</ArticleId><ArticleId IdType="pubmed">29312902</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgountzou A, and Papadopoulos NG. 2017. Postnatal Innate Immune Development: From Birth to Adulthood. Front Immunol 8: 957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554489</ArticleId><ArticleId IdType="pubmed">28848557</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl S, and Rinc&#xf3;n M. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39: 531&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">12431386</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, and Levy O. 2006. Innate Immunity of the Human Newborn Is Polarized Toward a High Ratio of IL-6/TNF-&#x3b1; Production In Vitro and In Vivo. Pediatric Research 60: 205&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">16864705</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, and Masopust D. 2016. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532: 512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Sjaastad FV, Pierson M, Kucaba TA, Swanson W, Staley C, Weingarden AR, Jensen IJ, Danahy DB, Badovinac VP, Jameson SC, Vezys V, Masopust D, Khoruts A, Griffith TS, and Hamilton SE. 2019. Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization. Cell Rep 28: 1729&#x2013;1743.e1725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Strugnell RA, Wijburg OL, and Brodnicki TC. 2013. Systemic infection of Mice with Listeria monocytogenes to characterize host immune responses. Methods Mol Biol 1031: 125&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824896</ArticleId></ArticleIdList></Reference><Reference><Citation>King KY, and Goodell MA. 2011. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nature Reviews Immunology 11: 685&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154310</ArticleId><ArticleId IdType="pubmed">21904387</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuettpelz LG, and Link DC. 2013. Regulation of hematopoietic stem cell activity by inflammation. Front Immunol 4: 204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715736</ArticleId><ArticleId IdType="pubmed">23882270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirantes C, Passegu&#xe9; E, and Pietras EM. 2014. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res 329: 248&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250307</ArticleId><ArticleId IdType="pubmed">25149680</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietras EM 2017. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood 130: 1693&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639485</ArticleId><ArticleId IdType="pubmed">28874349</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa H, Boettcher S, and Manz MG. 2012. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119: 2991&#x2013;3002.</Citation><ArticleIdList><ArticleId IdType="pubmed">22246037</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez DA, Apostol AC, Lebish EJ, Valencia CH, Romero-Mulero MC, Pavlovich PV, Hernandez GE, Forsberg EC, Cabezas-Wallscheid N, and Beaudin AE. 2022. Prenatal inflammation perturbs murine fetal hematopoietic development and causes persistent changes to postnatal immunity. Cell Reports 41: 111677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10184520</ArticleId><ArticleId IdType="pubmed">36417858</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsafaras GP, Ntontsi P, and Xanthou G. 2020. Advantages and Limitations of the Neonatal Immune System. Front Pediatr 8: 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6997472</ArticleId><ArticleId IdType="pubmed">32047730</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AK, Hollander GA, and McMichael A. 2015. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 282: 20143085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowling DJ, and Levy O. 2014. Ontogeny of early life immunity. Trends Immunol 35: 299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4109609</ArticleId><ArticleId IdType="pubmed">24880460</ArticleId></ArticleIdList></Reference><Reference><Citation>Saso A, and Kampmann B. 2017. Vaccine responses in newborns. Semin Immunopathol 39: 627&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711983</ArticleId><ArticleId IdType="pubmed">29124321</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, Corrah T, Bennett S, Wheeler J, Huygen K, Aaby P, McAdam KP, and Newport MJ. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Gu&#xe9;rin vaccination. J Immunol 163: 2249&#x2013;2255.</Citation><ArticleIdList><ArticleId IdType="pubmed">10438968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos L, Lunney JK, and Gonzalez-Juarrero M. 2020. Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models. Disease Models &amp; Mechanisms 13: dmm045740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520460</ArticleId><ArticleId IdType="pubmed">32988990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, and Levy O. 2017. Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny. Immunity 46: 350&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez MJ, Nino G, Hong X, and Wang X. 2020. Epigenetic Dynamics of the Infant Immune System Reveals a Tumor Necrosis Factor Superfamily Signature in Early Human Life. Epigenomes 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486026</ArticleId><ArticleId IdType="pubmed">32922965</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidesko S, Wainstock T, Sheiner E, and Pariente G. 2020. Long-Term Infectious Morbidity of Premature Infants: Is There a Critical Threshold? Journal of Clinical Medicine 9: 3008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7563528</ArticleId><ArticleId IdType="pubmed">32961963</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer JR, Blosser EG, Zindl CL, Silberger DJ, Conlan S, Laufer VA, DiToro D, Deming C, Kumar R, Morrow CD, Segre JA, Gray MJ, Randolph DA, and Weaver CT. 2019. Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis. Nat Med 25: 1772&#x2013;1782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250008</ArticleId><ArticleId IdType="pubmed">31700190</ArticleId></ArticleIdList></Reference><Reference><Citation>Torow N, and Hornef MW. 2017. The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis. The Journal of Immunology 198: 557&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">28069750</ArticleId></ArticleIdList></Reference><Reference><Citation>Mold JE, and McCune JM. 2012. Immunological tolerance during fetal development: from mouse to man. Adv Immunol 115: 73&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">22608256</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkins B, Leclerc C, and Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4: 553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">15229474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Fossati V, Israel M, and Snoeck HW. 2008. Lin-Sca1+kit- bone marrow cells contain early lymphoid-committed precursors that are distinct from common lymphoid progenitors. J Immunol 181: 7507&#x2013;7513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596664</ArticleId><ArticleId IdType="pubmed">19017940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietras EM, Lakshminarasimhan R, Techner J-M, Fong S, Flach J, Binnewies M, and Passegu&#xe9; E. 2014. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. Journal of Experimental Medicine 211: 245&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920566</ArticleId><ArticleId IdType="pubmed">24493802</ArticleId></ArticleIdList></Reference><Reference><Citation>Buza-Vidas N, Woll P, Hultquist A, Duarte S, Lutteropp M, Bouriez-Jones T, Ferry H, Luc S, and Jacobsen SE. 2011. FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells. Blood 118: 1544&#x2013;1548.</Citation><ArticleIdList><ArticleId IdType="pubmed">21628405</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostol AC, Jensen KDC, and Beaudin AE. 2020. Training the Fetal Immune System Through Maternal Inflammation-A Layered Hygiene Hypothesis. Front Immunol 11: 123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026678</ArticleId><ArticleId IdType="pubmed">32117273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornef MW, and Torow N. 2020. &#x2018;Layered immunity&#x2019; and the &#x2018;neonatal window of opportunity&#x2019; &#x2013; timed succession of non&#x2010;redundant phases to establish mucosal host&#x2013;microbial homeostasis after birth. Immunology 159: 15&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6904599</ArticleId><ArticleId IdType="pubmed">31777069</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz H, Adkins BD, Bartfeld S, Blumberg RS, Farber DL, Garssen J, Ghazal P, Hackam DJ, Marsland BJ, Mccoy KD, Penders J, Prinz I, Verhasselt V, Von Mutius E, Weiser JN, Wesemann DR, and Hornef MW. 2018. The neonatal window of opportunity&#x2014;early priming for life. Journal of Allergy and Clinical Immunology 141: 1212&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6214658</ArticleId><ArticleId IdType="pubmed">29247715</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada H, Kuhn C, Feillet H, and Bach J-F. 2010. The &#x2018;hygiene hypothesis&#x2019; for autoimmune and allergic diseases: an update. Clinical and Experimental Immunology 160: 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2841828</ArticleId><ArticleId IdType="pubmed">20415844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Badovinac VP, Beura LK, Pierson M, Jameson SC, Masopust D, and Griffith TS. 2020. New Insights into the Immune System Using Dirty Mice. J Immunol 205: 3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316151</ArticleId><ArticleId IdType="pubmed">32571979</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, Olin A, Wang J, Mikes J, Tan Z, Chen Y, Ehrlich AM, Bernhardsson AK, Mugabo CH, Ambrosiani Y, Gustafsson A, Chew S, Brown HK, Prambs J, Bohlin K, Mitchell RD, Underwood MA, Smilowitz JT, German JB, Frese SA, and Brodin P. 2021. Bifidobacteria-mediated immune system imprinting early in life. Cell 184: 3884&#x2013;3898.e3811.</Citation><ArticleIdList><ArticleId IdType="pubmed">34143954</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnesen H, Hitch TCA, Steppeler C, M&#xfc;ller MHB, Knutsen LE, Gunnes G, Angell IL, Ormaasen I, Rudi K, Paulsen JE, Clavel T, Carlsen H, and Boysen P. 2021. Naturalizing laboratory mice by housing in a farmyard-type habitat confers protection against colorectal carcinogenesis. Gut Microbes 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8583187</ArticleId><ArticleId IdType="pubmed">34751603</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37042254</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1710-1107</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Canadian journal on aging = La revue canadienne du vieillissement</Title><ISOAbbreviation>Can J Aging</ISOAbbreviation></Journal><ArticleTitle>Interventions for Caregivers of Older Adults with Dementia Living in the Community: A Rapid Review of Reviews-ERRATUM.</ArticleTitle><Pagination><StartPage>521</StartPage><MedlinePgn>521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0714980823000090</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pesut</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Puurveen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Aging</MedlineTA><NlmUniqueID>8708560</NlmUniqueID><ISSNLinking>0714-9808</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Can J Aging. 2023 Sep;42(3):425-433. doi: 10.1017/S0714980823000016.</RefSource><PMID Version="1">36799030</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37042254</ArticleId><ArticleId IdType="doi">10.1017/S0714980823000090</ArticleId><ArticleId IdType="pii">S0714980823000090</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36799030</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1710-1107</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Canadian journal on aging = La revue canadienne du vieillissement</Title><ISOAbbreviation>Can J Aging</ISOAbbreviation></Journal><ArticleTitle>Interventions for Caregivers of Older Adults with Dementia Living in the Community: A Rapid Review of Reviews.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>433</EndPage><MedlinePgn>425-433</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0714980823000016</ELocationID><Abstract><AbstractText>This rapid review of systematic reviews examines non-professional interventions that have been implemented to support family caregivers of older adults with dementia who are living in the community. There is a robust body of empirical literature examining such interventions for family caregivers; therefore, this rapid review includes only systematic reviews. MEDLINE, CINAHL, and EMBASE databases were searched from September 2020 to December 2020, and 19 systematic reviews were selected for a full review. Psychosocial, psychoeducational, social support, and multicomponent interventions consistently show positive impacts on a variety of outcomes. The evidence suggests that multicomponent interventions that are tailored to the needs of individual caregivers are the most impactful interventions and should be utilized in future program development. The most effective combination of interventions is unknown and warrants further investigation. However, the repeated success of psychoeducational, psychosocial, and social support interventions suggests that when used together, they may be a successful combination that contributes to positive impacts on caregivers. This multicomponent intervention should be flexible, as interventions are most effective when they are tailored to the individual needs of caregivers and adapted over time as the needs of the caregiver and person living with dementia change with disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Ethics and Diversity Lab, University of British Columbia Okanagan, School of Nursing Asc, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesut</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Palliative and End of Life Care, University of British Columbia Okanagan, School of Nursing Asc, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puurveen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Ethics and Diversity Lab, University of British Columbia Okanagan, School of Nursing Asc, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Aging</MedlineTA><NlmUniqueID>8708560</NlmUniqueID><ISSNLinking>0714-9808</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Aging. 2023 Sep;42(3):521. doi: 10.1017/S0714980823000090.</RefSource><PMID Version="1">37042254</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">a&#xee;n&#xe9;s vivant dans la communaut&#xe9;</Keyword><Keyword MajorTopicYN="N">b&#xe9;n&#xe9;ficiaire de soins</Keyword><Keyword MajorTopicYN="N">community dwelling</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">d&#xe9;mence</Keyword><Keyword MajorTopicYN="N">family caregivers</Keyword><Keyword MajorTopicYN="N">interventions</Keyword><Keyword MajorTopicYN="N">person living with dementia</Keyword><Keyword MajorTopicYN="N">proches aidants</Keyword><Keyword MajorTopicYN="N">review</Keyword><Keyword MajorTopicYN="N">revue</Keyword><Keyword MajorTopicYN="N">vieillissement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36799030</ArticleId><ArticleId IdType="doi">10.1017/S0714980823000016</ArticleId><ArticleId IdType="pii">S0714980823000016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36426978</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>209</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>Reduced T Cell Priming in Microbially Experienced "Dirty" Mice Results from Limited IL-27 Production by XCR1+ Dendritic Cells.</ArticleTitle><Pagination><StartPage>2149</StartPage><EndPage>2159</EndPage><MedlinePgn>2149-2159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2200324</ELocationID><Abstract><AbstractText>Successful vaccination strategies offer the potential for lifelong immunity against infectious diseases and cancer. There has been increased attention regarding the limited translation of some preclinical findings generated using specific pathogen-free (SPF) laboratory mice to humans. One potential reason for the difference between preclinical and clinical findings lies in maturation status of the immune system at the time of challenge. In this study, we used a "dirty" mouse model, where SPF laboratory mice were cohoused (CoH) with pet store mice to permit microbe transfer and immune system maturation, to investigate the priming of a naive T cell response after vaccination with a peptide subunit mixed with polyinosinic-polycytidylic acid and agonistic anti-CD40 mAb. Although this vaccination platform induced robust antitumor immunity in SPF mice, it failed to do so in microbially experienced CoH mice. Subsequent investigation revealed that despite similar numbers of Ag-specific naive CD4 and CD8 T cell precursors, the expansion, differentiation, and recall responses of these CD4 and CD8 T cell populations in CoH mice were significantly reduced compared with SPF mice after vaccination. Evaluation of the dendritic cell compartment revealed reduced IL-27p28 expression by XCR1+ dendritic cells from CoH mice after vaccination, correlating with reduced T cell expansion. Importantly, administration of recombinant IL-27:EBI3 complex to CoH mice shortly after vaccination significantly boosted Ag-specific CD8 and CD4 T cell expansion, further implicating the defect to be T cell extrinsic. Collectively, our data show the potential limitation of exclusive use of SPF mice when testing vaccine efficacy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sjaastad</LastName><ForeName>Frances V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Erin D</ForeName><Initials>ED</Initials><Identifier Source="ORCID">0000-0001-7705-2069</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skon-Hegg</LastName><ForeName>Cara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0703-3553</Identifier><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swanson</LastName><ForeName>Whitney</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6247-5920</Identifier><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-4169-7724</Identifier><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado</LastName><ForeName>Oscar C</ForeName><Initials>OC</Initials><Identifier Source="ORCID">0000-0002-9363-8649</Identifier><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dileepan</LastName><ForeName>Thamotharampillai</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2810-6996</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucaba</LastName><ForeName>Tamara A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffith</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-7205-9859</Identifier><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Minneapolis VA Health Care System, Minneapolis, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007313</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX001324</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI155468</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IK6 BX006192</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM115462</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DA007313</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM140881</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064094">Interleukin-27</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019013">CD40 Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064094" MajorTopicYN="Y">Interleukin-27</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019013" MajorTopicYN="N">CD40 Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36426978</ArticleId><ArticleId IdType="mid">NIHMS1840256</ArticleId><ArticleId IdType="pmc">PMC10065988</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.2200324</ArticleId><ArticleId IdType="pii">237336</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hand TW, and Kaech SM. 2009. Intrinsic and extrinsic control of effector T cell survival and memory T cell development. Immunol. Res 45: 46&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">18629449</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SC, and Masopust D. 2018. Understanding Subset Diversity in T Cell Memory. Immunity 48: 214&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SN, Gebhardt T, Carbone FR, and Heath WR. 2013. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol 31: 137&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">23215646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumai T, Yamaki H, Kono M, Hayashi R, Wakisaka R, and Komatsuda H. 2022. Antitumor Peptide-Based Vaccine in the Limelight. Vaccines (Basel) 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778374</ArticleId><ArticleId IdType="pubmed">35062731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M, Liu J, Jin S, and Wang L. 2020. Development of tumour peptide vaccines: From universalization to personalization. Scand. J. Immunol 91: e12875.</Citation><ArticleIdList><ArticleId IdType="pubmed">32090366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghattas M, Dwivedi G, Lavertu M, and Alameh MG. 2021. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines (Basel) 9: 1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708925</ArticleId><ArticleId IdType="pubmed">34960236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastola R, Noh G, Keum T, Bashyal S, Seo JE, Choi J, Oh Y, Cho Y, and Lee S. 2017. Vaccine adjuvants: smart components to boost the immune system. Arch. Pharm. Res 40: 1238&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pubmed">29027637</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Sivula CP, and Jameson SC. 2017. Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology. J. Immunol 199: 383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512602</ArticleId><ArticleId IdType="pubmed">28696328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Badovinac VP, Beura LK, Pierson M, Jameson SC, Masopust D, and Griffith TS. 2020. New Insights into the Immune System Using Dirty Mice. J. Immunol 205: 3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316151</ArticleId><ArticleId IdType="pubmed">32571979</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Jameson SC, and Hamilton SE. 2019. Embracing microbial exposure in mouse research. J. Leukoc. Biol 105: 73&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318123</ArticleId><ArticleId IdType="pubmed">30260516</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster HL 1959. Housing of disease-free vertebrates. Ann. N. Y. Acad. Sci 78: 80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">13824112</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, and Masopust D. 2016. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532: 512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Sjaastad FV, Pierson M, Kucaba TA, Swanson W, Staley C, Weingarden AR, Jensen IJ, Danahy DB, Badovinac VP, Jameson SC, Vezys V, Masopust D, Khoruts A, Griffith TS, and Hamilton SE. 2019. Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization. Cell Rep 28: 1729&#x2013;1743 e1725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese TA, Bi K, Kambal A, Filali-Mouhim A, Beura LK, Burger MC, Pulendran B, Sekaly RP, Jameson SC, Masopust D, Haining WN, and Virgin HW. 2016. Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response. Cell Host Microbe 19: 713&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896745</ArticleId><ArticleId IdType="pubmed">27107939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, McCulloch JA, Anastasakis DG, Sarshad AA, Leonardi I, Collins N, Blatter JA, Han SJ, Tamoutounour S, Potapova S, Foster St Claire MB, Yuan W, Sen SK, Dreier MS, Hild B, Hafner M, Wang D, Iliev ID, Belkaid Y, Trinchieri G, and Rehermann B. 2019. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365: eaaw4361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377314</ArticleId><ArticleId IdType="pubmed">31371577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, Hickman HD, McCulloch JA, Badger JH, Ajami NJ, Trinchieri G, Pardo-Manuel de Villena F, Yewdell JW, and Rehermann B. 2017. Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. Cell 171: 1015&#x2013;1028 e1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887100</ArticleId><ArticleId IdType="pubmed">29056339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahonen CL, Doxsee CL, McGurran SM, Riter TR, Wade WF, Barth RJ, Vasilakos JP, Noelle RJ, and Kedl RM. 2004. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med 199: 775&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212721</ArticleId><ArticleId IdType="pubmed">15007094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgore AM, Welsh S, Cheney EE, Chitrakar A, Blain TJ, Kedl BJ, Hunter CA, Pennock ND, and Kedl RM. 2018. IL-27p28 Production by XCR1(+) Dendritic Cells and Monocytes Effectively Predicts Adjuvant-Elicited CD8(+) T Cell Responses. Immunohorizons 2: 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5771264</ArticleId><ArticleId IdType="pubmed">29354801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson M, Merley A, and Hamilton SE. 2021. Generating Mice with Diverse Microbial Experience. Curr. Protoc 1: e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906426</ArticleId><ArticleId IdType="pubmed">33621444</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, and Jenkins MK. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2200089</ArticleId><ArticleId IdType="pubmed">17707129</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon JJ, Chu HH, Hataye J, Pagan AJ, Pepper M, McLachlan JB, Zell T, and Jenkins MK. 2009. Tracking epitope-specific T cells. Nat. Protoc 4: 565&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517879</ArticleId><ArticleId IdType="pubmed">19373228</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper M, Pagan AJ, Igyarto BZ, Taylor JJ, and Jenkins MK. 2011. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35: 583&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208313</ArticleId><ArticleId IdType="pubmed">22018468</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagan AJ, Pepper M, Chu HH, Green JM, and Jenkins MK. 2012. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J. Immunol 189: 2909&#x2013;2917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3464098</ArticleId><ArticleId IdType="pubmed">22896637</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson RW, McLachlan JB, Kurtz JR, and Jenkins MK. 2013. CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation. J. Immunol 190: 2828&#x2013;2834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3594488</ArticleId><ArticleId IdType="pubmed">23382562</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho HI, and Celis E. 2009. Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res 69: 9012&#x2013;9019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789207</ArticleId><ArticleId IdType="pubmed">19903852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Stokes KL, Currier MG, Sakamoto K, Lukacs NW, Celis E, and Moore ML. 2012. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. J. Virol 86: 13016&#x2013;13024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3497630</ArticleId><ArticleId IdType="pubmed">23015695</ArticleId></ArticleIdList></Reference><Reference><Citation>Assudani D, Cho HI, DeVito N, Bradley N, and Celis E. 2008. In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. Cancer Res 68: 9892&#x2013;9899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679655</ArticleId><ArticleId IdType="pubmed">19047170</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrios K, and Celis E. 2012. TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunol. Immunother 61: 1307&#x2013;1317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3446251</ArticleId><ArticleId IdType="pubmed">22527249</ArticleId></ArticleIdList></Reference><Reference><Citation>Harty JT, and Badovinac VP. 2008. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol 8: 107&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin MD, and Badovinac VP. 2018. Defining Memory CD8 T Cell. Front. Immunol 9: 2692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6255921</ArticleId><ArticleId IdType="pubmed">30515169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper M, and Jenkins MK. 2011. Origins of CD4(+) effector and central memory T cells. Nat. Immunol 12: 467&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212218</ArticleId><ArticleId IdType="pubmed">21739668</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JJ, and Jenkins MK. 2011. CD4+ memory T cell survival. Curr. Opin. Immunol 23: 319&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">21524898</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkema KR, Huggins MA, Borges da Silva H, Knutson TP, Henzler CM, and Hamilton SE. 2020. KLRG1(+) Memory CD8 T Cells Combine Properties of Short-Lived Effectors and Long-Lived Memory. J. Immunol 205: 1059&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415731</ArticleId><ArticleId IdType="pubmed">32611727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruterbusch M, Pruner KB, Shehata L, and Pepper M. 2020. In Vivo CD4(+) T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm. Annu. Rev. Immunol 38: 705&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori S, Nomura T, and Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">12522256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, Wang YH, and Dong C. 2009. Bcl6 mediates the development of T follicular helper cells. Science 325: 1001&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857334</ArticleId><ArticleId IdType="pubmed">19628815</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, and Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">10761931</ArticleId></ArticleIdList></Reference><Reference><Citation>Badovinac VP, Haring JS, and Harty JT. 2007. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 26: 827&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1989155</ArticleId><ArticleId IdType="pubmed">17555991</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, and Lefrancois L. 2005. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol 6: 793&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849311</ArticleId><ArticleId IdType="pubmed">16025119</ArticleId></ArticleIdList></Reference><Reference><Citation>Obar JJ, Khanna KM, and Lefrancois L. 2008. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2836785</ArticleId><ArticleId IdType="pubmed">18499487</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtsinger JM, and Mescher MF. 2010. Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol 22: 333&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2891062</ArticleId><ArticleId IdType="pubmed">20363604</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Garvin JE, Koretzky GA, and Jordan MS. 2009. T cell activation. Annu. Rev. Immunol 27: 591&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740335</ArticleId><ArticleId IdType="pubmed">19132916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgore AM, Pennock ND, and Kedl RM. 2020. cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8(+) T Cell Memory and Protective Immunity. J. Immunol 204: 510&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6981069</ArticleId><ArticleId IdType="pubmed">31871021</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennock ND, Gapin L, and Kedl RM. 2014. IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization. Proc. Natl. Acad. Sci. U. S. A 111: 16472&#x2013;16477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4246334</ArticleId><ArticleId IdType="pubmed">25267651</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Aziz N, and Poh CL. 2022. Development of Peptide-Based Vaccines for Cancer. J. Oncol 2022: 9749363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941562</ArticleId><ArticleId IdType="pubmed">35342400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingsworth RE, and Jansen K. 2019. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines 4: 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368616</ArticleId><ArticleId IdType="pubmed">30774998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumai T, Yamaki H, Kono M, Hayashi R, Wakisaka R, and Komatsuda H. 2022. Antitumor Peptide-Based Vaccine in the Limelight. Vaccines (Basel) 10: 70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778374</ArticleId><ArticleId IdType="pubmed">35062731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg SA, Yang JC, and Restifo NP. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med 10: 909&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1435696</ArticleId><ArticleId IdType="pubmed">15340416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane-Petter W 1962. Provision of pathogen-free animals. Proc. R. Soc. Med 55: 253&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">14462027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiege JK, Block KE, Pierson MJ, Nanda H, Shepherd FK, Mickelson CK, Stolley JM, Matchett WE, Wijeyesinghe S, Meyerholz DK, Vezys V, Shen SS, Hamilton SE, Masopust D, and Langlois RA. 2021. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing. Cell Host Microbe 29: 1815&#x2013;1827 e1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665115</ArticleId><ArticleId IdType="pubmed">34731647</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau J, and Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521319</ArticleId></ArticleIdList></Reference><Reference><Citation>Klarquist J, Chitrakar A, Pennock ND, Kilgore AM, Blain T, Zheng C, Danhorn T, Walton K, Jiang L, Sun J, Hunter CA, D&#x2019;Alessandro A, and Kedl RM. 2018. Clonal expansion of vaccine-elicited T cells is independent of aerobic glycolysis. Sci. Immunol 3: eaas9822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251947</ArticleId><ArticleId IdType="pubmed">30194241</ArticleId></ArticleIdList></Reference><Reference><Citation>Molle C, Nguyen M, Flamand V, Renneson J, Trottein F, De Wit D, Willems F, Goldman M, and Goriely S. 2007. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol 178: 7607&#x2013;7615.</Citation><ArticleIdList><ArticleId IdType="pubmed">17548596</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman RM, Kaplan G, Witmer MD, and Cohn ZA. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med 149: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2184752</ArticleId><ArticleId IdType="pubmed">762493</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine MM 2010. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 8: 129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958895</ArticleId><ArticleId IdType="pubmed">20920375</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, and Parashar UD. 2012. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 7: e41720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412858</ArticleId><ArticleId IdType="pubmed">22879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, and Curtis N. 2019. Factors That Influence the Immune Response to Vaccination. Clin. Microbiol. Rev 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431125</ArticleId><ArticleId IdType="pubmed">30867162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36260745</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>43</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Responsiveness to interleukin-15 therapy is shared between tissue-resident and circulating memory CD8<sup>+</sup> T cell subsets.</ArticleTitle><Pagination><StartPage>e2209021119</StartPage><MedlinePgn>e2209021119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2209021119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2209021119</ELocationID><Abstract><AbstractText>Interleukin-15 (IL-15) is often considered a central regulator of memory CD8<sup>+</sup> T cells, based primarily on studies of recirculating subsets. However, recent work identified IL-15-independent CD8<sup>+</sup> T cell memory populations, including tissue-resident memory CD8<sup>+</sup> T cells (T<sub>RM</sub>) in some nonlymphoid tissues (NLTs). Whether this reflects the existence of IL-15-insensitive memory CD8<sup>+</sup> T cells is unclear. We report that IL-15 complexes (IL-15c) stimulate rapid proliferation and expansion of both tissue-resident and circulating memory CD8<sup>+</sup> T cell subsets across lymphoid and nonlymphoid tissues with varying magnitude by tissue and memory subset, in some sites correlating with differing levels of the IL-2R&#x3b2;. This was conserved for memory CD8<sup>+</sup> T cells recognizing distinct antigens and elicited by different pathogens. Following IL-15c-induced expansion, divided cells contracted to baseline numbers and only slowly returned to basal proliferation, suggesting a mechanism to transiently amplify memory populations. Through parabiosis, we showed that IL-15c drive local proliferation of T<sub>RM</sub>, with a degree of recruitment of circulating cells to some NLTs. Hence, irrespective of homeostatic IL-15 dependence, IL-15 sensitivity is a defining feature of memory CD8<sup>+</sup> T cell populations, with therapeutic potential for expansion of T<sub>RM</sub> and other memory subsets in an antigen-agnostic and temporally controlled fashion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jarjour</LastName><ForeName>Nicholas N</ForeName><Initials>NN</Initials><Identifier Source="ORCID">0000-0001-9400-4448</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanhainen</LastName><ForeName>Kelsey M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Changwei</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0710-9573</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavil</LastName><ForeName>Noah V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurice</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-2667-472X</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges da Silva</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalzell</LastName><ForeName>Talia S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masopust</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9440-3884</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-9137-1146</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 CA253992</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K00 CA245735</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 CA250321</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI038903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI038903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AI139381</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R29 AI038903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 AI139381</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F99 CA245735</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019409" MajorTopicYN="Y">Interleukin-15</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8+ T cell memory</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">tissue-resident memory</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>14</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36260745</ArticleId><ArticleId IdType="pmc">PMC9618124</ArticleId><ArticleId IdType="doi">10.1073/pnas.2209021119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schenkel J. M., et al. , IL-15-independent maintenance of tissue-resident and boosted effector memory CD8 T cells. J. Immunol. 196, 3920&#x2013;3926 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5145194</ArticleId><ArticleId IdType="pubmed">27001957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson S. C., Masopust D., Understanding subset diversity in T cell memory. Immunity 48, 214&#x2013;226 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner J. J., et al. , Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population. Proc. Natl. Acad. Sci. U.S.A. 117, 25667&#x2013;25678 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568335</ArticleId><ArticleId IdType="pubmed">32978300</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkema K. R., et al. , KLRG1<sup>+</sup> memory CD8 T cells combine properties of short-lived effectors and long-lived memory. J. Immunol.
205, 1059&#x2013;1069 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415731</ArticleId><ArticleId IdType="pubmed">32611727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeyesinghe S., et al. , Expansible residence decentralizes immune homeostasis. Nature 592, 457&#x2013;462 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057530</ArticleId><ArticleId IdType="pubmed">33731934</ArticleId></ArticleIdList></Reference><Reference><Citation>Christo S. N., et al. , Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity. Nat. Immunol. 22, 1140&#x2013;1151 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34426691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Sun S., Hwang I., Tough D. F., Sprent J., Potent and selective stimulation of memory-phenotype CD8<sup>+</sup> T cells in&#xa0;vivo by IL-15. Immunity
8, 591&#x2013;599 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9620680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodolce J. P., et al. , IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669&#x2013;676 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9846488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku C. C., Murakami M., Sakamoto A., Kappler J., Marrack P., Control of homeostasis of CD8<sup>+</sup> memory T cells by opposing cytokines. Science
288, 675&#x2013;678 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10784451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy M. K., et al. , Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771&#x2013;780 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195858</ArticleId><ArticleId IdType="pubmed">10704459</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker T. C., et al. , Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195, 1541&#x2013;1548 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193552</ArticleId><ArticleId IdType="pubmed">12070282</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldrath A. W., et al. , Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8<sup>+</sup> T cells. J. Exp. Med.
195, 1515&#x2013;1522 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193554</ArticleId><ArticleId IdType="pubmed">12070279</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge A. D., Zhang X., Fujii H., Surh C. D., Sprent J., Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8<sup>+</sup> T cells. J. Exp. Med.
196, 935&#x2013;946 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2194030</ArticleId><ArticleId IdType="pubmed">12370255</ArticleId></ArticleIdList></Reference><Reference><Citation>Schluns K. S., Williams K., Ma A., Zheng X. X., Lefran&#xe7;ois L., Cutting edge: Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168, 4827&#x2013;4831 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11994430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein M. P., et al. , Converting IL-15 to a superagonist by binding to soluble IL-15R&#x3b1;. Proc. Natl. Acad. Sci. U.S.A. 103, 9166&#x2013;9171 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1482584</ArticleId><ArticleId IdType="pubmed">16757567</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklasek T. A., Schluns K. S., Lefran&#xe7;ois L., Combined IL-15/IL-15R&#x3b1; immunotherapy maximizes IL-15 activity in&#xa0;vivo. J. Immunol. 177, 6072&#x2013;6080 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847275</ArticleId><ArticleId IdType="pubmed">17056533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandau M. M., Kohlmeier J. E., Woodland D. L., Jameson S. C., IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool. J. Immunol. 184, 35&#x2013;44 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957822</ArticleId><ArticleId IdType="pubmed">19949092</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbist K. C., Field M. B., Klonowski K. D., Cutting edge: IL-15-independent maintenance of mucosally generated memory CD8 T cells. J. Immunol. 186, 6667&#x2013;6671 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110618</ArticleId><ArticleId IdType="pubmed">21572025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay L. K., et al. , The developmental pathway for CD103<sup>+</sup>CD8<sup>+</sup> tissue-resident memory T cells of skin. Nat. Immunol.
14, 1294&#x2013;1301 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24162776</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi T., et al. , Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat. Med. 21, 1272&#x2013;1279 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4636445</ArticleId><ArticleId IdType="pubmed">26479922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay L. K., et al. , T-box transcription factors combine with the cytokines TGF-&#x3b2; and IL-15 to control tissue-resident memory T cell fate. Immunity 43, 1101&#x2013;1111 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26682984</ArticleId></ArticleIdList></Reference><Reference><Citation>Intlekofer A. M., et al. , Effector and memory CD8<sup>+</sup> T cell fate coupled by T-bet and eomesodermin. Nat. Immunol.
6, 1236&#x2013;1244 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16273099</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D., Vezys V., Wherry E. J., Barber D. L., Ahmed R., Cutting edge: Gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176, 2079&#x2013;2083 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16455963</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey K. A., et al. , Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 188, 4866&#x2013;4875 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345065</ArticleId><ArticleId IdType="pubmed">22504644</ArticleId></ArticleIdList></Reference><Reference><Citation>Doedens A. L., et al. , Molecular programming of tumor-infiltrating CD8<sup>+</sup> T cells and IL15 resistance. Cancer Immunol. Res.
4, 799&#x2013;811 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010943</ArticleId><ArticleId IdType="pubmed">27485135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L. J., Acero L. F., Zal T., Schluns K. S., Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8&#x3b1;&#x3b1; IELs. J. Immunol. 183, 1044&#x2013;1054 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2706935</ArticleId><ArticleId IdType="pubmed">19553528</ArticleId></ArticleIdList></Reference><Reference><Citation>Tough D. F., Borrow P., Sprent J., Induction of bystander T cell proliferation by viruses and type I interferon in&#xa0;vivo. Science 272, 1947&#x2013;1950 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8658169</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyman O., Kovar M., Rubinstein M. P., Surh C. D., Sprent J., Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924&#x2013;1927 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyman O., Ramsey C., Kim D. M., Sprent J., Surh C. D., IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia. J. Immunol. 180, 7265&#x2013;7275 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18490726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodolce J. P., Burkett P. R., Boone D. L., Chien M., Ma A., T cell-independent interleukin 15R&#x3b1; signals are required for bystander proliferation. J. Exp. Med. 194, 1187&#x2013;1194 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193508</ArticleId><ArticleId IdType="pubmed">11602647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois S., Mariner J., Waldmann T. A., Tagaya Y., IL-15R&#x3b1; recycles and presents IL-15 In <i>trans</i> to neighboring cells. Immunity
17, 537&#x2013;547 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12433361</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkett P. R., et al. , IL-15R&#x3b1; expression on CD8<sup>+</sup> T cells is dispensable for T cell memory. Proc. Natl. Acad. Sci. U.S.A.
100, 4724&#x2013;4729 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153623</ArticleId><ArticleId IdType="pubmed">12671073</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkett P. R., et al. , Coordinate expression and trans presentation of interleukin (IL)-15R&#x3b1; and IL-15 supports natural killer cell and memory CD8<sup>+</sup> T cell homeostasis. J. Exp. Med.
200, 825&#x2013;834 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213280</ArticleId><ArticleId IdType="pubmed">15452177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandau M. M., Schluns K. S., Lefrancois L., Jameson S. C., Cutting edge: Transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R&#x3b1; by the same cells. J. Immunol. 173, 6537&#x2013;6541 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15557143</ArticleId></ArticleIdList></Reference><Reference><Citation>Schluns K. S., Klonowski K. D., Lefran&#xe7;ois L., Transregulation of memory CD8 T-cell proliferation by IL-15R&#x3b1;<sup>+</sup> bone marrow-derived cells. Blood
103, 988&#x2013;994 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14512307</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony S. M., Howard M. E., Hailemichael Y., Overwijk W. W., Schluns K. S., Soluble interleukin-15 complexes are generated in&#xa0;vivo by type I interferon dependent and independent pathways. PLoS One 10, e0120274 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4354909</ArticleId><ArticleId IdType="pubmed">25756182</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin A. M., et al. , Exploiting a natural conformational switch to engineer an interleukin-2 &#x2018;superkine&#x2019;. Nature 484, 529&#x2013;533 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338870</ArticleId><ArticleId IdType="pubmed">22446627</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D. A., et al. , De novo design of potent and selective mimics of IL-2 and IL-15. Nature 565, 186&#x2013;191 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6521699</ArticleId><ArticleId IdType="pubmed">30626941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spangler J. B., Moraga I., Mendoza J. L., Garcia K. C., Insights into cytokine-receptor interactions from cytokine engineering. Annu. Rev. Immunol. 33, 139&#x2013;167 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4445396</ArticleId><ArticleId IdType="pubmed">25493332</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmann T. A., Miljkovic M. D., Conlon K. C., Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer. J. Exp. Med. 217, e20191062 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7037239</ArticleId><ArticleId IdType="pubmed">31821442</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J. S., et al. , Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: A phase 1 trial. Nat. Med. 28, 392&#x2013;400 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35102335</ArticleId></ArticleIdList></Reference><Reference><Citation>Propper D. J., Balkwill F. R., Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237&#x2013;253 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34997230</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura L. K., et al. , Intravital mucosal imaging of CD8<sup>+</sup> resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory. Nat. Immunol.
19, 173&#x2013;182 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5896323</ArticleId><ArticleId IdType="pubmed">29311694</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S. L., et al. , Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses. Nat. Immunol. 19, 183&#x2013;191 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29311695</ArticleId></ArticleIdList></Reference><Reference><Citation>Skon C. N., et al. , Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8<sup>+</sup> T cells. Nat. Immunol.
14, 1285&#x2013;1293 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844557</ArticleId><ArticleId IdType="pubmed">24162775</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K. G., et al. , Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209&#x2013;222 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Murali-Krishna K., et al. , Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8, 177&#x2013;187 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9491999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech S. M., Ahmed R., Memory CD8<sup>+</sup> T cell differentiation: Initial antigen encounter triggers a developmental program in na&#xef;ve cells. Nat. Immunol.
2, 415&#x2013;422 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760150</ArticleId><ArticleId IdType="pubmed">11323695</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D., Ha S. J., Vezys V., Ahmed R., Stimulation history dictates memory CD8 T cell phenotype: Implications for prime-boost vaccination. J. Immunol. 177, 831&#x2013;839 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16818737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson S. C., Lee Y. J., Hogquist K. A., Innate memory T cells. Adv. Immunol. 126, 173&#x2013;213 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4670568</ArticleId><ArticleId IdType="pubmed">25727290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedl R. M., White J. T., Foreign antigen-independent memory-phenotype CD4<sup>+</sup> T cells: A new player in innate immunity?
Nat. Rev. Immunol.
18, 1 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6191184</ArticleId><ArticleId IdType="pubmed">29480288</ArticleId></ArticleIdList></Reference><Reference><Citation>Haluszczak C., et al. , The antigen-specific CD8<sup>+</sup> T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med.
206, 435&#x2013;448 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646575</ArticleId><ArticleId IdType="pubmed">19188498</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura L. K., et al. , T cells in nonlymphoid tissues give rise to lymph-node-resident memory T cells. Immunity 48, 327&#x2013;338.e5 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5828517</ArticleId><ArticleId IdType="pubmed">29466758</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinert E. M., et al. , Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161, 737&#x2013;749 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426972</ArticleId><ArticleId IdType="pubmed">25957682</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D. A., et al. , The functional requirement for CD69 in establishment of resident memory CD8<sup>+</sup> T cells varies with tissue location. J. Immunol.
203, 946&#x2013;955 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684481</ArticleId><ArticleId IdType="pubmed">31243092</ArticleId></ArticleIdList></Reference><Reference><Citation>White J. T., et al. , Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner. Nat. Commun. 7, 11291 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844673</ArticleId><ArticleId IdType="pubmed">27097762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley J., Monie A., Hung C.-F., Wu T.-C., Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8<sup>+</sup> T cells modifies adoptively transferred T-cell function in <i>cis</i>. Eur. J. Immunol.
39, 491&#x2013;506 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3004157</ArticleId><ArticleId IdType="pubmed">19180469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sowell R. T., et al. , IL-15 complexes induce migration of resting memory CD8 T cells into mucosal tissues. J. Immunol. 199, 2536&#x2013;2546 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605445</ArticleId><ArticleId IdType="pubmed">28814601</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbist K. C., Cole C. J., Field M. B., Klonowski K. D., A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J. Immunol. 186, 174&#x2013;182 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3050553</ArticleId><ArticleId IdType="pubmed">21098221</ArticleId></ArticleIdList></Reference><Reference><Citation>Epardaud M., et al. , Interleukin-15/interleukin-15R&#x3b1; complexes promote destruction of established tumors by reviving tumor-resident CD8<sup>+</sup> T cells. Cancer Res.
68, 2972&#x2013;2983 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18413767</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrack K. S., et al. , Interleukin-15 complex treatment protects mice from cerebral malaria by inducing interleukin-10-producing natural killer cells. Immunity 48, 760&#x2013;772.e4 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5906161</ArticleId><ArticleId IdType="pubmed">29625893</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36177612</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-277X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of human nutrition and dietetics : the official journal of the British Dietetic Association</Title><ISOAbbreviation>J Hum Nutr Diet</ISOAbbreviation></Journal><ArticleTitle>Online nutrition information for cancer survivors.</ArticleTitle><Pagination><StartPage>415</StartPage><EndPage>433</EndPage><MedlinePgn>415-433</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jhn.13095</ELocationID><Abstract><AbstractText Label="BACKGROUND">This research aims to systematically review a comprehensive sample of websites (English-language) that provide information on nutrition after cancer treatment.</AbstractText><AbstractText Label="METHODS">In consultation with cancer survivors and experts, we developed search strings for an internet search (incognito mode in Google Chrome) to be completed in six English-speaking countries (Ireland, the United Kingdom, Australia, New Zealand, Canada and the United States); the first 10 results were chosen for each search). Websites/web pages were included if the links related to sites/content that provided information on health post-treatment in English and aimed at adults (aged above 18 years). Several tools were applied to test the quality, readability and usability of the websites/weblinks.</AbstractText><AbstractText Label="RESULTS">Initially, 720 links were found, with 159 eligible for inclusion. Those eligible for review were charity/support/non-governmental organisation weblinks (49.1%) that originated in the United States (42.8%) and did not specify a particular cancer type (65.4%). One-third (n&#x2009;=&#x2009;59, 37.1%) of these links contained nutrition guidance; however, these lacked practical implementation strategies. Most of the websites/web pages were not Health On the Net certified and lacked overall quality, with a mean International Patient Decision Aids Standards score of 20.4/40 and a Journal of the American Medical Association score of 1/4. Readability failed to meet ideal levels. Only 32.5% (n&#x2009;=&#x2009;13) of the web pages/weblinks met the benchmark for usability.</AbstractText><AbstractText Label="CONCLUSION">Cancer survivors seeking nutrition information online may encounter difficulty locating advice, and where they do, it is unlikely to contain guidance on implementation into day-to-day life. This is concerning, given the important role nutrition can play in cancer survivorship.</AbstractText><CopyrightInformation>&#xa9; 2022 The British Dietetic Association Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keaver</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1369-5035</Identifier><AffiliationInfo><Affiliation>Department of Health and Nutritional Science, Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health and Biomedical Research Centre (HEAL), Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michaela Deane</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Health and Nutritional Science, Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chonaill</LastName><ForeName>Doireann Ni</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0003-2649-0637</Identifier><AffiliationInfo><Affiliation>Department of Health and Nutritional Science, Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Callaghan</LastName><ForeName>Niamh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health and Nutritional Science, Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health and Biomedical Research Centre (HEAL), Atlantic Technological University, Sligo, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hum Nutr Diet</MedlineTA><NlmUniqueID>8904840</NlmUniqueID><ISSNLinking>0952-3871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073116" MajorTopicYN="Y">Cancer Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032882" MajorTopicYN="N">Comprehension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054626" MajorTopicYN="Y">Consumer Health Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">dietary advice</Keyword><Keyword MajorTopicYN="N">online information</Keyword><Keyword MajorTopicYN="N">readability and usability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36177612</ArticleId><ArticleId IdType="doi">10.1111/jhn.13095</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. Early Career Faculty The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11-48.</Citation></Reference><Reference><Citation>O'Callaghan N, Douglas P, Keaver L. The persistence of nutrition impact symptoms in cancer survivors post-treatment. Proc Nutr Soc. 2022;81(OCE4):E156.</Citation></Reference><Reference><Citation>Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J. 2017;93(1096):82-90.</Citation></Reference><Reference><Citation>World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). Cancer prevention recommendations diet, nutrition, physical activity and cancer: a global perspective. continuous update project expert report 2. http://dietandcancerreport.org (2018). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012;96(1):150-63.</Citation></Reference><Reference><Citation>Vergnaud AC, Romaguera D, Peeters PH, van Gils CH, Chan DS, Romieu I, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr. 2013;97(5):1107-20.</Citation></Reference><Reference><Citation>Avery KN, Donovan JL, Horwood J, Neal DE, Hamdy FC, Parker C, et al. The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals. BMC Fam Pract. 2014;15:81.</Citation></Reference><Reference><Citation>Irish Nutrition and Dietetic Institute. Irish Nutrition &amp; Dietetic Institute submission to the national cancer control programme; 2019.</Citation></Reference><Reference><Citation>Trujillo EB, Claghorn K, Dixon SW, Hill EB, Braun A, Lipinski E, et al. Inadequate nutrition coverage in outpatient cancer centers: results of a national survey. J Oncol. 2019;2019:7462940.</Citation></Reference><Reference><Citation>Matsell SL, S&#xe1;nchez-Garc&#xed;a MA, Halliday V, Williams EA, Corfe BM. Investigating the nutritional advice and support given to colorectal cancer survivors in the UK: is it fit for purpose and does it address their needs? J Hum Nutr Diet. 2020;33(6):822-32.</Citation></Reference><Reference><Citation>Beeken RJ, Williams K, Wardle J, Croker H. &#x201c;What about diet?&#x201d; A qualitative study of cancer survivors&#x2019; views on diet and cancer and their sources of information. Eur J Cancer Care. 2016;25(5):774-83.</Citation></Reference><Reference><Citation>Peniamina R, McLean R. Nutrition support in oncology care in Aotearoa New Zealand: current practice, and where to from here? N Z Med J. 2022;135(1549):11-25.</Citation></Reference><Reference><Citation>Bohringer E, Brown L. Nutrition screening and referrals in two rural Australian oncology clinics. Food Nutr Sci. 2016;7:1070-81. https://doi.org/10.4236/fns.2016.712103</Citation></Reference><Reference><Citation>Walsh TM, Volsko TA. Readability assessment of internet-based consumer health information. Respir Care. 2008;53(10):1310-5.</Citation></Reference><Reference><Citation>Lee K, Hoti K, Hughes JD, Emmerton LM. Consumer use of &#x201c;Dr Google&#x201d;: a survey on health information-seeking behaviors and navigational needs. J Med Internet Res. 2015;17(12):e288.</Citation></Reference><Reference><Citation>Leavitt MO, Shneiderman B, Bailey RW, Barnum C, Bosley J, Chaparro B, et al. Research-based web design &amp; usability guidelines [2006 edition]; 2006. Retrieved from: https://commons.erau.edu/publication/1028</Citation></Reference><Reference><Citation>Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013;15(4):e85.</Citation></Reference><Reference><Citation>Antheunis ML, Tates K, Nieboer TE. Patients&#x2019; and health professionals&#x2019; use of social media in health care: motives, barriers and expectations. Patient Educ Couns. 2013;92(3):426-31.</Citation></Reference><Reference><Citation>Eysenbach G, Powell J, Kuss O, Sa ER. Empirical studies assessing the quality of health information for consumers on the world wide web: a systematic review. JAMA. 2002;287(20):2691-700.</Citation></Reference><Reference><Citation>Mead N, Varnam R, Rogers A, Roland M. What predicts patients&#x2019; interest in the Internet as a health resource in primary care in England? J Health Serv Res Policy. 2003;8(1):33-9.</Citation></Reference><Reference><Citation>Dalmer NK. Questioning reliability assessments of health information on social media. J Med Libr Assoc. 2017;105(1):61-8.</Citation></Reference><Reference><Citation>Fox S, Rainie L. The online health care revolution: how the web helps Americans take better care of themselves [Internet]. Washington, DC: The Pew Internet &amp; American Life Project; 1999. Available from: https://www.pewresearch.org/internet/2000/11/26/the-online=health-care-revolution/</Citation></Reference><Reference><Citation>Goodwin BC, Crawford-Williams F, Castro O, Rowe A, De Cocker K. Online physical activity and sedentary behaviour information for cancer survivors. J Cancer Surviv. 2020;14(5):677-88.</Citation></Reference><Reference><Citation>O'Callaghan N, Douglas P, Keaver L. An exploration into the relationship Irish cancer survivors&#x2019; have with nutrition post cancer treatment: a qualitative study. Proc Nutr Soc. 2021;80(OCE3):E134.</Citation></Reference><Reference><Citation>Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417.</Citation></Reference><Reference><Citation>Kelly JT. Assessing Quality. JAMA. 1988;260(18):2715-6.</Citation></Reference><Reference><Citation>Readable. Flesch reading ease and the flesch kincaid grade level [online]. https://readable.com/readability/flesch-reading-ease-flesch-kincaid-grade-level/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>United States Department of Health and Human Services. Saying it clearly. http://www.talkingquality.gov/docs/section3/3_4.htm (2000). Accessed 19 Sep. 2022.</Citation></Reference><Reference><Citation>Devine T, Broderick J, Harris LM, Wu H, Hilfiker SW. Making quality health websites a national public health priority: toward quality standards. J Med Internet Res. 2016;18(8):e211.</Citation></Reference><Reference><Citation>Weymann N, H&#xe4;rter M, Dirmaier J. Quality of online information on type 2 diabetes: a cross-sectional study. Health Promot Int. 2015;30(4):821-31.</Citation></Reference><Reference><Citation>Agree EM, King AC, Castro CM, Wiley A, Borzekowski DL. &#x201c;It's got to be on this page&#x201d;: age and cognitive style in a study of online health information seeking. J Med Internet Res. 2015;17(3):e79.</Citation></Reference><Reference><Citation>Sillence E, Briggs P, Harris PR, Fishwick L. How do patients evaluate and make use of online health information? Soc Sci Med. 2007;64(9):1853-62.</Citation></Reference><Reference><Citation>Siteman Cancer Center. Weight loss or gain-survivorship [online]. https://siteman.wustl.edu/treatment/survivorship/weight-lossgain/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Irish Cancer Society. Body weight and cancer. [online]. https://www.cancer.ie/cancer-information-and-support/cancer-prevention/body-weight-and-cancer (2019). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>American Society of Clinical Oncology (ASCO). Nutrition recommendations during and after treatment [online]. Cancer.net. https://www.cancer.net/survivorship/healthy-living/nutrition-recommendations-during-and-after-treatment (2019). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Breakthrough Cancer Research. Healthy eating for cancer survivors [online]. https://breakthroughcancerresearch.ie/healthy-eating-for-cancer-survivors/(n.d.). Accessed 19 Sep. 2022.</Citation></Reference><Reference><Citation>Macmillan Cancer Support. Lifestyle and well-being after treatment [online]. https://www.macmillan.org.uk/cancer-information-and-support/after-treatment/lifestyle-and-wellbeing-after-treatment (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>American Cancer Society. Eating well after treatment [online]. https://www.cancer.org/treatment/survivorship-during-and-after-treatment/be-healthy-after-treatment/eating-well-after-treatment-ends.html (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Cancer Council. Living with cancer [online]. https://www.cancer.org.au/cancer-information/after-a-diagnosis/living-with-cancer (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>American Institute for Cancer Research. After treatment [online]. https://www.aicr.org/cancer-survival/treatment-tips/after-treatment/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Breast Cancer Now. Healthy eating after breast cancer treatment [online]. https://breastcancernow.org/information-support/facing-breast-cancer/living-beyond-breast-cancer/your-body/healthy-eating-after-treatment-breast-cancer (2017). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Dana-Farber Cancer Institute. Nutrition Services [online]. https://www.dana-farber.org/for-patients-and-families/care-and-treatment/support-services-and-amenities/nutrition-services/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>National Cancer Institute. Coping-follow-up medical care [online]. https://www.cancer.gov/about-cancer/coping/survivorship/follow-up-care#lifestyle (2014). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Chemocare. Nutrition after chemotherapy [online]. https://chemocare.com/chemotherapy/health-wellness/nutrition-after-chemotherapy.aspx (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Marie Keating Foundation. Your health your choice [online]. https://www.mariekeating.ie/your-health-your-choice/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Cancer Support Community. Diet &amp; nutrition for cancer survivors [online]. https://www.cancersupportcommunity.org/diet-nutrition-cancer-survivors (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Rutgers Cancer Institute of New Jersey. Life after cancer treatment [online]. https://www.cinj.org/patient-care/life-after-cancer-treatment#GuidelinesHealthyLife Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Canadian Cancer Society. Eating well [online]. https://cancer.ca/en/living-with-cancer/coping-with-changes/feeling-your-best/eating-well (2017). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>City of Hope. Diet and nutrition after cancer treatment [online]. https://www.cityofhope.org/patients/survivorship/physical-health-and-wellness-after-cancer-treatment/wellness-after-cancer-treatment/diet-and-nutrition-after-treatment (2022). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Cancer Council WA. Nutrition [online]. https://cancerwa.asn.au/cancer-prevention/nutrition/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>BC Cancer. Nutrition information [online]. http://www.bccancer.bc.ca/health-info/coping-with-cancer/nutrition-support (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Cancer Council Victoria. Nutrition and cancer: overview [online]. https://www.cancervic.org.au/living-with-cancer/nutrition/nutrition-overview (2020). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Westmead Breast Cancer Institute. Completed treatment archives [online]. https://www.bci.org.au/resources-category/completed-treatment/#term-1461 (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Breast Cancer Foundation NZ. Maintaining a healthy lifestyle [online]. https://www.breastcancerfoundation.org.nz/support/moving-forward-after-treatment/maintaining-a-healthy-lifestyle (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Fred Hutch. Survivorship [online]. https://www.fredhutch.org/en/research/research-areas/survivorship.html (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Rein in Sarcoma. Rein in sarcoma patient guidebook [online]. https://www.reininsarcoma.org/support-2/sarcoma-patient-guidebook/(n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Staying healthy after cancer treatment [online]. https://www.cdc.gov/cancer/survivors/life-after-cancer/staying-healthy-after-cancer-treatment.htm (2019). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Mayo Clinic. Caring for your body as a cancer survivor [online]. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-survivor/art-20044015 (2018). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Pag&#xe1;n CN. How to stay healthy after cancer treatment. [online]. WebMD. https://www.webmd.com/cancer/cancer-recovery-wellness-plan (2022). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Bupa UK. Eating well during and after cancer | health information | [online]. https://www.bupa.co.uk/health-information/cancer/eating-well-cancer (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Johns Hopkins Breast Center. Reducing risk of breast cancer recurrence [online]. https://www.hopkinsmedicine.org/kimmel_cancer_center/cancers_we_treat/breast_cancer_program/treatment_and_services/survivorship/reducing_recurrence.html (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>URMC Newsroom. How to reduce your risk of breast cancer recurrence: an expert's guide [online]. https://www.urmc.rochester.edu/news/story/how-to-reduce-your-risk-of-breast-cancer-recurrence-an-experts-guide (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>HealthAfter50. How to prevent cancer from returning [online]. Healthcentral.com. https://www.healthcentral.com/slideshow/8-ways-to-prevent-cancer-from-returning (2016). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Haiken M. Cancer survivors: here's how to prevent it from coming back [online]. Forbes. https://www.forbes.com/sites/melaniehaiken/2012/05/01/cancer-survivors-heres-how-to-prevent-it-from-coming-back/?Sh=753461b51049 (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>NIH MedlinePlus Magazine. life after cancer: tips for finding your new normal [online]. https://magazine.medlineplus.gov/article/life-after-cancer-tips-for-finding-your-new-normal (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Providence.org. Living well beyond cancer [online]. https://www.providence.org/locations/or/cancer-institute/supporting-our-patients/living-well-beyond-cancer (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>HealthLink BC. Food and nutrition [online]. https://www.healthlinkbc.ca/healthy-eating-physical-activity/food-and-nutrition (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Link R. 12 beneficial fruits to eat during and after cancer treatment [online]. Healthline. https://www.healthline.com/nutrition/fruits-for-cancer-patients (2019). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Queen Victoria Hospital. Wellbeing and living beyond cancer-Queen Victoria Hospital [online]. https://www.qvh.nhs.uk/for-patients/pals-and-support/beyond-cancer (2022). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Wisely R. The best diets for cancer patients and cancer survivors [online]. https://healthblog.uofmhealth.org/wellness-prevention/best-diets-for-cancer-patients-and-cancer-survivors (2019). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Davis LE. Foods to reduce breast cancer recurrence risk [online]. https://www.verywellhealth.com/diet-and-breast-cancer-risk-430445 (2022). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Tesch D. Living with cancer: lifestyle changes, nutrition and exercise [online]. HealthPartners Blog. https://www.healthpartners.com/blog/living-with-cancer (2018). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Klemm S. Nutrition during and after cancer treatment [online]. https://www.eatright.org/health/diseases-and-conditions/cancer/nutrition-during-and-after-cancer-treatment (2021). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Kaiser Permanente Nutrition Services. Home page [online]. http://www.kphealthyme.com (n.d.). Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Madrigal L, Escoffery C. Electronic health behaviors among US adults with chronic disease: cross-sectional survey. J Med Internet Res. 2019;21(3):e11240.</Citation></Reference><Reference><Citation>Keaver L. Irish cancer patients and survivors have a positive view of the role of nutritional care in cancer management from diagnosis through survivorship. Ir J Med Sci. 2021;190(1971):1387-90.</Citation></Reference><Reference><Citation>Muscaritoli M, Molfino A, Scala F, De Lorenzo F, Christoforidi K, Manneh-Vangramberen I. European survey of 907 people with cancer about the importance of nutrition. Ann Oncol. 2017;28:v513-4.</Citation></Reference><Reference><Citation>Timon CM, Doyle S. The nutrition support needs of cancer survivors in Ireland. Proc Nutr Soc. 2020;79(OCE3):E774.</Citation></Reference><Reference><Citation>Finney Rutten LJ, Agunwamba AA, Wilson P, Chawla N, Vieux S, Blanch-Hartigan D, et al. Cancer-related information seeking among cancer survivors: trends over a decade (2003-2013). J Cancer Educ. 2016;31(2):348-57.</Citation></Reference><Reference><Citation>Wu YP, Yi J, McClellan J, Kim J, Tian T, Grahmann B, et al. Barriers and facilitators of healthy diet and exercise among adolescent and young adult cancer survivors: implications for behavioral interventions. J Adolesc Young Adult Oncol. 2015;4(4):184-91.</Citation></Reference><Reference><Citation>Johnston EA, van der Pols JC, Ekberg S. Needs, preferences, and experiences of adult cancer survivors in accessing dietary information post-treatment: a scoping review. Eur J Cancer Care (Engl). 2021;30(2):e13381.</Citation></Reference><Reference><Citation>Mullee A, O'Donoghue A, Dhuibhir PU, O'Donoghue N, Burke D, McSharry V, et al. Diet and nutrition advice after a solid tumor diagnosis. JCO Oncol Pract. 2021;17(7):e982-91.</Citation></Reference><Reference><Citation>Keaver L, Callaghan H, Walsh L, Houlihan C. Nutrition guidance for cancer patients and survivors-A review of the websites of Irish healthcare and charitable organisations and cancer centres. Eur J Cancer Care (Engl). 2020;29(2):e13216.</Citation></Reference><Reference><Citation>Connaway LS, Dickey TJ, Radford ML. &#x201c;If it is too inconvenient, I'm not going after it:&#x201d; Convenience as a critical factor in information-seeking behaviors. Libr Inf Sci Res. 2011;33(3):179-90.</Citation></Reference><Reference><Citation>Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Canc Netw. 2015;13(8):1012-39.</Citation></Reference><Reference><Citation>Gallaway MS, Townsend JS, Shelby D, Puckett MC. Pain among cancer survivors. Prev Chronic Dis. 2020;17:E54.</Citation></Reference><Reference><Citation>Crowder SL, Najam N, Sarma KP, Fiese BH, Arthur AE. Head and neck cancer survivors&#x2019; experiences with chronic nutrition impact symptom burden after radiation: a qualitative study. J Acad Nutr Diet. 2020;120(10):1643-53.</Citation></Reference><Reference><Citation>Zhang X, Pawlikowski M, Olivo-Marston S, Williams KP, Bower JK, Felix AS. Ten-year cardiovascular risk among cancer survivors: the National Health and Nutrition Examination Survey. PLoS One. 2021;16(3):1-14.</Citation></Reference><Reference><Citation>Sutherland LA, Wildemuth B, Campbell MK, Haines PS. Unraveling the web: an evaluation of the content quality, usability, and readability of nutrition websites. J Nutr Educ Behav. 2005;37(6):300-5.</Citation></Reference><Reference><Citation>Alba-Ruiz R, Berm&#xfa;dez-Tamayo C, Pernett JJ, Garcia-Gutierrez JF, C&#xf3;zar-Olmo JM, Valero-Aguilera B. Adapting the content of cancer websites to the information needs of patients: reliability and readability. Telemed J E Health. 2013;19(12):956-66.</Citation></Reference><Reference><Citation>Zermatten A, Khazaal Y, Coquard O, Chatton A, Bondolfi G. Quality of web-based information on depression. Depress Anxiety. 2010;27(9):852-8.</Citation></Reference><Reference><Citation>Terry N. Access vs quality assurance: the e-health conundrum. JAMA. 2001;285:807.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34932944</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8<sup>+</sup> tissue-resident memory T&#xa0;cells.</ArticleTitle><Pagination><StartPage>98</StartPage><EndPage>114.e5</EndPage><MedlinePgn>98-114.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2021.11.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(21)00509-4</ELocationID><Abstract><AbstractText>Elevated gene expression of the costimulatory receptor Icos is a hallmark of CD8<sup>+</sup> tissue-resident memory (Trm) T&#xa0;cells. Here, we examined the contribution of ICOS in Trm cell differentiation. Upon transfer into WT mice, Icos<sup>-/-</sup> CD8<sup>+</sup> T&#xa0;cells exhibited defective Trm generation but produced recirculating memory populations normally. ICOS deficiency or ICOS-L blockade compromised establishment of CD8<sup>+</sup> Trm cells but not their maintenance. ICOS ligation during CD8<sup>+</sup> T&#xa0;cell priming did not determine Trm induction; rather, effector CD8<sup>+</sup> T&#xa0;cells showed reduced Trm differentiation after seeding into Icosl<sup>-/-</sup> mice. Icos<sup>YF/YF</sup> CD8<sup>+</sup> T&#xa0;cells were compromised in Trm generation, indicating a critical role for PI3K signaling. Modest transcriptional changes in the few Icos<sup>-/-</sup> Trm cells suggest that ICOS-PI3K signaling primarily enhances the efficiency of CD8<sup>+</sup> T&#xa0;cell tissue residency. Thus, local ICOS signaling promotes production of Trm cells, providing insight into the contribution of costimulatory signals in the generation of tissue-resident populations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Changwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanhainen</LastName><ForeName>Kelsey M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knutson</LastName><ForeName>Todd P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Minnesota Supercomputing Institute, University of Minnesota, Saint Paul, MN 55108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Hanbin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiev</LastName><ForeName>Hristo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittelsteadt</LastName><ForeName>Kristen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute and Department of Immunology University of Washington School of Medicine, Seattle, WA 98101, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarjour</LastName><ForeName>Nicholas N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haiguang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogquist</LastName><ForeName>Kristin A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute and Department of Immunology University of Washington School of Medicine, Seattle, WA 98101, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges da Silva</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: james024@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI038903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI145147</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019138">Antibodies, Blocking</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060945">Inducible T-Cell Co-Stimulator Ligand</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060889">Inducible T-Cell Co-Stimulator Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C556694">Icos protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C400230">Icosl protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Trends Immunol. 2022 Apr;43(4):280-282. doi: 10.1016/j.it.2022.02.007.</RefSource><PMID Version="1">35272933</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019264" MajorTopicYN="N">Adoptive Transfer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019138" MajorTopicYN="N">Antibodies, Blocking</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060945" MajorTopicYN="N">Inducible T-Cell Co-Stimulator Ligand</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060889" MajorTopicYN="N">Inducible T-Cell Co-Stimulator Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091246" MajorTopicYN="N">Memory T Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICOS</Keyword><Keyword MajorTopicYN="N">PI3K</Keyword><Keyword MajorTopicYN="N">resident memory T&#xa0;cells</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34932944</ArticleId><ArticleId IdType="mid">NIHMS1766203</ArticleId><ArticleId IdType="pmc">PMC8755622</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2021.11.017</ArticleId><ArticleId IdType="pii">S1074-7613(21)00509-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL, et al. (2014). Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc 9, nprot.2014.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song J-Y, Jacobs H, Haanen JB, and Schumacher TN (2014). Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert. Science 346, 101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">25278612</ArticleId></ArticleIdList></Reference><Reference><Citation>Attanasio J, and Wherry EJ (2016). Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity 44, 1052&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873956</ArticleId><ArticleId IdType="pubmed">27192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltra J-C, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, Casella V, Ngiow SF, Khan O, Huang YJ, et al. (2020). Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity 52, 825&#x2013;841.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360766</ArticleId><ArticleId IdType="pubmed">32396847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram EM, Tafuri A, Shahinian A, Chan VSF, Hunziker L, Recher M, Ohashi PS, Mak TW, and Watts TH (2002). Role of ICOS versus CD28 in antiviral immunity. Eur J Immunol 32, 3376&#x2013;3385.</Citation><ArticleIdList><ArticleId IdType="pubmed">12432568</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges-da-Silva H, Peng C, Wang H, Wanhainen KM, Ma C, Lopez S, Khoruts A, Zhang N, and Jameson SC (2020). Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-&#x3b2;. Immunity 53, 158&#x2013;171.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026201</ArticleId><ArticleId IdType="pubmed">32640257</ArticleId></ArticleIdList></Reference><Reference><Citation>Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam K-P, Coyle AJ, Kroczek RA, and Hutloff A (2008). ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells. J Immunol 180, 774&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">18178815</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, and Satija R (2018). Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36, 411&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, et al. (2012). Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues. J Immunol 188, 4866&#x2013;4875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345065</ArticleId><ArticleId IdType="pubmed">22504644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, and Flies DB (2013). Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13, 227&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786574</ArticleId><ArticleId IdType="pubmed">23470321</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, Monticelli L, Lao C, and Crotty S (2011). ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6. Immunity 34, 932&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3124577</ArticleId><ArticleId IdType="pubmed">21636296</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu K, Batista NV, Girard M, Law JC, and Watts TH (2020). GITR differentially affects lung effector T cell subpopulations during influenza virus infection. J Leukocyte Biol 107, 953&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">32125017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu K-L, Batista NV, Wang KC, Zhou AC, and Watts TH (2019). GITRL on inflammatory antigen presenting cells in the lung parenchyma provides signal 4 for T-cell accumulation and tissue-resident memory T-cell formation. Mucosal Immunol 12, 363&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">30487647</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S (2019). T Follicular Helper Cell Biology: A Decade of Discovery and Diseases. Immunity 50, 1132&#x2013;1148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532429</ArticleId><ArticleId IdType="pubmed">31117010</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels MA, and Jameson SC (2000). Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers. J Exp Medicine 191, 335&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195759</ArticleId><ArticleId IdType="pubmed">10637277</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk D, Sharma R, Nainys J, Yim K, Kathail P, Carr AJ, Burdziak C, Moon KR, Chaffer CL, Pattabiraman D, et al. (2018). Recovering Gene Interactions from Single-Cell Data Using Data Diffusion. Cell 174, 716&#x2013;729.e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771278</ArticleId><ArticleId IdType="pubmed">29961576</ArticleId></ArticleIdList></Reference><Reference><Citation>Durlanik S, Loyal L, Stark R, Alp &#xd6;S, Hartung A, Radbruch A, von Herrath M, Matzmohr N, Frentsch M, and Thiel A (2016). CD40L expression by CD4 + but not CD8 + T cells regulates antiviral immune responses in acute LCMV infection in mice: CD40L expression by CD4+ but not CD8+ T cell regulates. Eur J Immunol 46, 2566&#x2013;2573.</Citation><ArticleIdList><ArticleId IdType="pubmed">27562840</ArticleId></ArticleIdList></Reference><Reference><Citation>Esensten JH, Helou YA, Chopra G, Weiss A, and Bluestone JA (2016). CD28 Costimulation: From Mechanism to Therapy. Immunity 44, 973&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932896</ArticleId><ArticleId IdType="pubmed">27192564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigoux M, Shang J, Pak Y, Xu M, Choe J, Mak TW, and Suh W-K (2009). Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proceedings of the National Academy of Sciences 106, 20371&#x2013;20376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787139</ArticleId><ArticleId IdType="pubmed">19915142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafemeister C, and Satija R (2019). Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol 20, 296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927181</ArticleId><ArticleId IdType="pubmed">31870423</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Wang R, Zhou Y, Fei L, Sun H, Lai S, Saadatpour A, Zhou Z, Chen H, Ye F, et al. (2018). Mapping the Mouse Cell Atlas by Microwell-Seq. Cell 172, 1091&#x2013;1107.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">29474909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrick SM, Michelini RH, Doedens AL, Goldrath AW, and Stone EL (2012). FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12, 649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3875397</ArticleId><ArticleId IdType="pubmed">22918467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, and Kroczek RA (1999). ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">9930702</ArticleId></ArticleIdList></Reference><Reference><Citation>Iborra S, Mart&#xed;nez-L&#xf3;pez M, Khouili SC, Enamorado M, Cueto FJ, Conde-Garrosa R, del Fresno C, and Sancho D (2016). Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+ Dendritic Cells. Immunity 45, 847&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5074364</ArticleId><ArticleId IdType="pubmed">27692611</ArticleId></ArticleIdList></Reference><Reference><Citation>Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Burger MC, Shan Q, Hale JS, Lee J, Nasti TH, et al. (2016). Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5297183</ArticleId><ArticleId IdType="pubmed">27501248</ArticleId></ArticleIdList></Reference><Reference><Citation>Im SJ, Konieczny BT, Hudson WH, Masopust D, and Ahmed R (2020). PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection. Proc National Acad Sci 201917298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7049149</ArticleId><ArticleId IdType="pubmed">32034098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SC, and Masopust D (2018). Understanding Subset Diversity in T Cell Memory. Immunity 48, 214&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, Gallimore A, Gutierrez-Ramos J-C, and Bachmann MF (2000). Inducible Costimulator Protein (Icos) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection. J Exp Medicine 192, 53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887704</ArticleId><ArticleId IdType="pubmed">10880526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar BV, Ma W, Miron M, Granot T, Guyer RS, Carpenter DJ, Senda T, Sun X, Ho S-H, Lerner H, et al. (2017). Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. Cell Reports 20, 2921&#x2013;2934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5646692</ArticleId><ArticleId IdType="pubmed">28930685</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;nzli M, Schreiner D, Pereboom TC, Swarnalekha N, Litzler LC, L&#xf6;tscher J, Ertuna YI, Roux J, Geier F, Jakob RP, et al. (2020). Long-lived T follicular helper cells retain plasticity and help sustain humoral immunity. Sci Immunol 5, eaay5552.</Citation><ArticleIdList><ArticleId IdType="pubmed">32144185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurd NS, He Z, Louis TL, Milner JJ, Omilusik KD, Jin W, Tsai MS, Widjaja CE, Kanbar JN, Olvera JG, et al. (2020). Early precursors and molecular determinants of tissue-resident memory CD8+ T lymphocytes revealed by single-cell RNA sequencing. Sci Immunol 5, eaaz6894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7341730</ArticleId><ArticleId IdType="pubmed">32414833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-Y, Skon CN, Lee YJ, Oh S, Taylor JJ, Malhotra D, Jenkins MK, Rosenfeld MG, Hogquist KA, and Jameson SC (2015). The Transcription Factor KLF2 Restrains CD4+ T Follicular Helper Cell Differentiation. Immunity 42, 252&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409658</ArticleId><ArticleId IdType="pubmed">25692701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefran&#xe7;ois L, Olson S, and Masopust D (1999). A Critical Role for Cd40&#x2013;Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response. J Exp Medicine 190, 1275&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195681</ArticleId><ArticleId IdType="pubmed">10544199</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Burd EM, Coopersmith CM, and Ford ML (2016). Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses. J Immunol 196, 1000&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758455</ArticleId><ArticleId IdType="pubmed">26729800</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Bai X-F, Wen J, Gao J-X, Liu J, Lu P, Wang Y, Zheng P, and Liu Y (2001). B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8+ T Lymphocytes In Vivo. J Exp Medicine 194, 1339&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195972</ArticleId><ArticleId IdType="pubmed">11696598</ArticleId></ArticleIdList></Reference><Reference><Citation>Maazi H, Patel N, Sankaranarayanan I, Suzuki Y, Rigas D, Soroosh P, Freeman GJ, Sharpe AH, and Akbari O (2015). ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity. Immunity 42, 538&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366271</ArticleId><ArticleId IdType="pubmed">25769613</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon M-L, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, et al. (2013). The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat Immunol 14, 1294&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">24162776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Wynne-Jones E, Freestone D, Pellicci DG, Mielke LA, Newman DM, Braun A, Masson F, Kallies A, Belz GT, et al. (2015). T-box Transcription Factors Combine with the Cytokines TGF-&#x3b2; and IL-15 to Control Tissue-Resident Memory T Cell Fate. Immunity 43, 1101&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pubmed">26682984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay LK, Minnich M, Kragten NA, Liao Y, Nota B, Seillet C, Zaid A, Man K, Preston S, Freestone D, et al. (2016). Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">27102484</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik BT, Byrne KT, Vella JL, Zhang P, Shabaneh TB, Steinberg SM, Molodtsov AK, Bowers JS, Angeles CV, Paulos CM, et al. (2017). Resident memory T cells in the skin mediate durable immunity to melanoma. Science Immunology 2, eaam6346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5525335</ArticleId><ArticleId IdType="pubmed">28738020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani V, Bromley SK, &#xc4;ij&#xf6; T, Mora-Buch R, Carrizosa E, Warner RD, Hamze M, Sen DR, Chasse AY, Lorant A, et al. (2019). Migratory DCs activate TGF-&#x3b2; to precondition na&#xef;ve CD8+ T cells for tissue-resident memory fate. Science 366, eaav5728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6939608</ArticleId><ArticleId IdType="pubmed">31601741</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott CL, Carlesso G, Herbst R, and Withers DR (2015). ICOS is required for the generation of both central and effector CD4(+) memory T-cell populations following acute bacterial infection. Eur J Immunol 45, 1706&#x2013;1715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736665</ArticleId><ArticleId IdType="pubmed">25754933</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, and Soerens AG (2019). Tissue-Resident T Cells and Other Resident Leukocytes. Annu Rev Immunol 37, 521&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175802</ArticleId><ArticleId IdType="pubmed">30726153</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Jiang J, Shen H, and Lefran&#xe7;ois L (2001). Direct Analysis of the Dynamics of the Intestinal Mucosa CD8 T Cell Response to Systemic Virus Infection. J Immunol 166, 2348&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160292</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Vezys V, Wherry EJ, Barber DL, and Ahmed R (2006). Cutting Edge: Gut Microenvironment Promotes Differentiation of a Unique Memory CD8 T Cell Population. J Immunol 176, 2079&#x2013;2083.</Citation><ArticleIdList><ArticleId IdType="pubmed">16455963</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, et al. (2010). Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Medicine 207, 553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839151</ArticleId><ArticleId IdType="pubmed">20156972</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner JJ, Toma C, Yu B, Zhang K, Omilusik K, Phan AT, Wang D, Getzler AJ, Nguyen T, Crotty S, et al. (2017). Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours. Nature 552, 253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5747964</ArticleId><ArticleId IdType="pubmed">29211713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelsteadt KL, Hayes ET, and Campbell DJ (2021). ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue. J Exp Med 218, e20201142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8065270</ArticleId><ArticleId IdType="pubmed">33881452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittr&#xfc;cker H-W, Kursar M, K&#xf6;hler A, Yanagihara D, Yoshinaga SK, and Kaufmann SHE (2002). Inducible Costimulator Protein Controls the Protective T Cell Response Against Listeria monocytogenes. J Immunol 169, 5813&#x2013;5817.</Citation><ArticleIdList><ArticleId IdType="pubmed">12421962</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore TV, Clay BS, Ferreira CM, Williams JW, Rogozinska M, Cannon JL, Shilling RA, Marzo AL, and Sperling AI (2011a). Protective Effector Memory CD4 T Cells Depend on ICOS for Survival. Plos One 6, e16529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041765</ArticleId><ArticleId IdType="pubmed">21364749</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore TV, Clay BS, Cannon JL, Histed A, Shilling RA, and Sperling AI (2011b). Inducible Costimulator Controls Migration of T Cells to the Lungs via Down-Regulation of CCR7 and CD62L. American Journal of Respiratory Cell and Molecular Biology 45, 843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208611</ArticleId><ArticleId IdType="pubmed">21421907</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SN, and Mackay LK (2016). Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol 16, 79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">26688350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurieva RI, Mai XM, Forbush K, Bevan MJ, and Dong C (2003). B7h is required for T cell activation, differentiation, and effector function. Proc National Acad Sci 100, 14163&#x2013;14168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283563</ArticleId><ArticleId IdType="pubmed">14615582</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SL, Buzzai A, Rautela J, Hor JL, Hochheiser K, Effern M, McBain N, Wagner T, Edwards J, McConville R, et al. (2019). Tissue-resident memory CD8+ T cells promote melanoma&#x2013;immune equilibrium in skin. Nature 565, 366&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">30598548</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedros C, Zhang Y, Hu JK, Choi YS, Canonigo-Balancio AJ III, J. RY, Altman A, Crotty S, and Kong K-F (2016). A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1. Nat Immunol 17, 825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915981</ArticleId><ArticleId IdType="pubmed">27135603</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, and Jameson SC (2020). The relationship between CD4+ follicular helper T cells and CD8+ resident memory T cells: sisters or distant cousins? Int Immunol 32, dxaa045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478156</ArticleId><ArticleId IdType="pubmed">32620009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope C, Kim S-K, Marzo A, Williams K, Jiang J, Shen H, and Lefran&#xe7;ois L (2001). Organ-Specific Regulation of the CD8 T Cell Response to Listeria monocytogenes Infection. J Immunol 166, 3402&#x2013;3409.</Citation><ArticleIdList><ArticleId IdType="pubmed">11207297</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H (2016). T follicular helper cells in space-time. Nat Rev Immunol 16, 612&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">27573485</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel L, Landekic M, Golizeh M, Gavino C, Zhong M-C, Chen J, Faubert D, Blanchet-Cohen A, Dansereau L, Parent M-A, et al. (2018). Loss of human ICOSL results in combined immunodeficiency. J Exp Med 215, 3151&#x2013;3164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279397</ArticleId><ArticleId IdType="pubmed">30498080</ArticleId></ArticleIdList></Reference><Reference><Citation>Salek-Ardakani S, Moutaftsi M, Sette A, and Croft M (2011). Targeting OX40 Promotes Lung-Resident Memory CD8 T Cell Populations That Protect against Respiratory Poxvirus Infection. J Virol 85, 9051&#x2013;9059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165842</ArticleId><ArticleId IdType="pubmed">21715499</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Fraser KA, Vezys V, and Masopust D (2013). Sensing and alarm function of resident memory CD8+ T cells. Nat Immunol 14, 509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631432</ArticleId><ArticleId IdType="pubmed">23542740</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenkel JM, Fraser KA, and Masopust D (2014). Cutting Edge: Resident Memory CD8 T Cells Occupy Frontline Niches in Secondary Lymphoid Organs. J Immunol 192, 2961&#x2013;2964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965619</ArticleId><ArticleId IdType="pubmed">24600038</ArticleId></ArticleIdList></Reference><Reference><Citation>Skon CN, Lee J-Y, Anderson KG, Masopust D, Hogquist KA, and Jameson SC (2013). Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol 14, 1285&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844557</ArticleId><ArticleId IdType="pubmed">24162775</ArticleId></ArticleIdList></Reference><Reference><Citation>Smigiel KS, Richards E, Srivastava S, Thomas KR, Dudda JC, Klonowski KD, and Campbell DJ (2014). CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J Exp Med 211, 121&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3892972</ArticleId><ArticleId IdType="pubmed">24378538</ArticleId></ArticleIdList></Reference><Reference><Citation>Son YM, Cheon IS, Wu Y, Li C, Wang Z, Gao X, Chen Y, Takahashi Y, Fu Y-X, Dent AL, et al. (2021). Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses. Sci Immunol 6, eabb6852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056937</ArticleId><ArticleId IdType="pubmed">33419791</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igy&#xe1;rt&#xf3; BZ, Southern PJ, and Masopust D (2015). Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance. Cell 161, 737&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426972</ArticleId><ArticleId IdType="pubmed">25957682</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone EL, Pepper M, Katayama CD, Kerdiles YM, Lai C-Y, Emslie E, Lin YC, Yang E, Goldrath AW, Li MO, et al. (2015). ICOS Coreceptor Signaling Inactivates the Transcription Factor FOXO1 to Promote Tfh Cell Differentiation. Immunity 42, 239&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334393</ArticleId><ArticleId IdType="pubmed">25692700</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, and Satija R (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888&#x2013;1902.e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Swallow MM, Wallin JJ, and Sha WC (1999). B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNF&#x3b1;. Immunity 11, 423&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">10549624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarnalekha N, Schreiner D, Litzler LC, Iftikhar S, Kirchmeier D, K&#xfc;nzli M, Son YM, Sun J, Moreira EA, and King CG (2021). T resident helper cells promote humoral responses in the lung. Sci Immunol 6, eabb6808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063390</ArticleId><ArticleId IdType="pubmed">33419790</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo PA, Miron M, and Farber DL (2019). Location, location, location: Tissue resident memory T cells in mice and humans. Sci Immunol 4, eaas9673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778482</ArticleId><ArticleId IdType="pubmed">30952804</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi N, Matsumoto K, Saito H, Nanki T, Miyasaka N, Kobata T, Azuma M, Lee S-K, Mizutani S, and Morio T (2009). Impaired CD4 and CD8 Effector Function and Decreased Memory T Cell Populations in ICOS-Deficient Patients. J Immunol 182, 5515&#x2013;5527.</Citation><ArticleIdList><ArticleId IdType="pubmed">19380800</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, and Blazar BR (2005). Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graftversus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood 105, 3372&#x2013;3380.</Citation><ArticleIdList><ArticleId IdType="pubmed">15618467</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann LL, Cullen JL, Kashgarian M, Dong C, Craft J, and Shlomchik MJ (2015). Local Triggering of the ICOS Coreceptor by CD11c+ Myeloid Cells Drives Organ Inflammation in Lupus. Immunity 42, 552&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456685</ArticleId><ArticleId IdType="pubmed">25786178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al. (2016). Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944528</ArticleId><ArticleId IdType="pubmed">27124452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin JJ, Liang L, Bakardjiev A, and Sha WC (2001). Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation. J Immunol 167, 132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">11418641</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber JP, Fuhrmann F, Feist RK, Lahmann A, Baz MSA, Gentz L-J, Van DV, Mages HW, Haftmann C, Riedel R, et al. (2015). ICOS maintains the T follicular helper cell phenotype by down-regulating Kr&#xfc;ppel-like factor 2. J Exp Med 212, 217&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4322049</ArticleId><ArticleId IdType="pubmed">25646266</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, and Hogquist KA (2009). KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31, 122&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724594</ArticleId><ArticleId IdType="pubmed">19592277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H (2016). ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag; New York: ).</Citation></Reference><Reference><Citation>Xin H, Lian Q, Jiang Y, Luo J, Wang X, Erb C, Xu Z, Zhang X, HeidrichO&#x2019;Hare E, Yan Q, et al. (2020). GMM-Demux: sample demultiplexing, multiplet detection, experiment planning, and novel cell-type verification in single cell sequencing. Genome Biol 21, 188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393741</ArticleId><ArticleId IdType="pubmed">32731885</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Li X, Liu D, Li J, Zhang X, Chen X, Hou S, Peng L, Xu C, Liu W, et al. (2013). Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496, 523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">23619696</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamarin D, Holmgaard RB, Ricca J, Plitt T, Palese P, Sharma P, Merghoub T, Wolchok JD, and Allison JP (2016). Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature Communications 8, ncomms14340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316835</ArticleId><ArticleId IdType="pubmed">28194010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou AC, Wagar LE, Wortzman ME, and Watts TH (2017). Intrinsic 4&#x2013;1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung. Mucosal Immunol 10, 1294&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">28051085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou AC, Batista NV, and Watts TH (2019). 4&#x2013;1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection. J Immunol 202, 2482&#x2013;2492.</Citation><ArticleIdList><ArticleId IdType="pubmed">30867239</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34758799</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-684X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC palliative care</Title><ISOAbbreviation>BMC Palliat Care</ISOAbbreviation></Journal><ArticleTitle>What's suffering got to do with it? A qualitative study of suffering in the context of Medical Assistance in Dying (MAID).</ArticleTitle><Pagination><StartPage>174</StartPage><MedlinePgn>174</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">174</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12904-021-00869-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intolerable suffering is a common eligibility requirement for persons requesting assisted death, and although suffering has received philosophic attention for millennia, only recently has it been the focus of empirical inquiry. Robust theoretical knowledge about suffering is critically important as modern healthcare provides persons with different options at end-of-life to relieve suffering. The purpose of this paper is to present findings specific to the understanding and application of suffering in the context of MAID from nurses' perspectives.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A longitudinal qualitative descriptive study using semi-structured telephone interviews. Inductive analysis was used to construct a thematic account. The study received ethical approval and all participants provided written consent.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty nurses and nurse practitioners from across Canada were interviewed. Participants described the suffering of dying and provided insights into the difficulties of treating existential suffering and the iatrogenic suffering patients experienced from long contact with the healthcare system. They shared perceptions of the suffering that leads to a request for MAID that included the unknown of dying, a desire for predictability, and the loss of dignity. Eliciting the suffering story was an essential part of nursing practice. Knowledge of the story allowed participants to find the balance between believing that suffering is whatever the persons says it is, while making sure that the MAID procedure was for the right person, for the right reason, at the right time. Participants perceived that the MAID process itself caused suffering that resulted from the complexity of decision-making, the chances of being deemed ineligible, and the heighted work of the tasks of dying.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Healthcare providers involved in MAID must be critically reflective about the suffering histories they bring to the clinical encounter, particularly iatrogenic suffering. Further, eliciting the suffering stories of persons requesting MAID requires a high degree of skill; those involved in the assessment process must have the time and competency to do this important role well. The nature of suffering that patients and family encounter as they enter the contemplation, assessment, and provision of MAID requires further research to understand it better and develop best practices.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pesut</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, Kelowna, BC, V1V 1V7, Canada. Barb.pesut@ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>David Kenneth</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Margaret I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Society of Notaries Public of BC, Chair in Applied Legal Studies, School of Criminology, Simon Fraser University, Surrey, BC, V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puurveen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, Kelowna, BC, V1V 1V7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storch</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Victoria, Victoria, BC, V8P 5C2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, Kelowna, BC, V1V 1V7, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Palliat Care</MedlineTA><NlmUniqueID>101088685</NlmUniqueID><ISSNLinking>1472-684X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008483" MajorTopicYN="N">Medical Assistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017236" MajorTopicYN="Y">Suicide, Assisted</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Assisted death</Keyword><Keyword MajorTopicYN="N">End of life</Keyword><Keyword MajorTopicYN="N">Medical assistance in dying</Keyword><Keyword MajorTopicYN="N">Nursing</Keyword><Keyword MajorTopicYN="N">Palliative care</Keyword><Keyword MajorTopicYN="N">Qualitative</Keyword><Keyword MajorTopicYN="N">Suffering</Keyword></KeywordList><CoiStatement>The authors declare they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34758799</ArticleId><ArticleId IdType="pmc">PMC8582137</ArticleId><ArticleId IdType="doi">10.1186/s12904-021-00869-1</ArticleId><ArticleId IdType="pii">10.1186/s12904-021-00869-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Varelius J. Suffering at the end of life. Bioethics. 2019;33(1):195&#x2013;200. doi: 10.1111/bioe.12513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bioe.12513</ArticleId><ArticleId IdType="pubmed">30226280</ArticleId></ArticleIdList></Reference><Reference><Citation>Krikorian A, Limonero JT, Mat&#xe9; J. Suffering and distress at the end-of-life. Psycho-oncology. 2012;21(8):799&#x2013;808. doi: 10.1002/pon.2087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.2087</ArticleId><ArticleId IdType="pubmed">21990213</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartogh GD. Suffering and dying well: on the proper aim of palliative care. Med Health Care Philos. 2017;20(3):413&#x2013;424. doi: 10.1007/s11019-017-9764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-017-9764-3</ArticleId><ArticleId IdType="pmc">PMC5569128</ArticleId><ArticleId IdType="pubmed">28374105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzaro C, Schildmann J. "Suffering" in palliative sedation: conceptual analysis and implications for decision making in clinical practice. J Pain Symptom Manag. 2018;56(2):288&#x2013;294. doi: 10.1016/j.jpainsymman.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2018.04.003</ArticleId><ArticleId IdType="pubmed">29689298</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen LA. Intractable end-of-life suffering and the ethics of palliative sedation: a commentary on Cassell and Rich. Pain Med. 2010;11(3):440&#x2013;441. doi: 10.1111/j.1526-4637.2010.00798.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2010.00798.x</ArticleId><ArticleId IdType="pubmed">20447311</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hooft S. The meanings of suffering. Hastings Cent Rep. 1998;28(5):13&#x2013;19. doi: 10.2307/3528226.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3528226</ArticleId><ArticleId IdType="pubmed">11656764</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hooft S. Suffering and the goals of medicine. Med Health Care Philos. 1998;1(2):125&#x2013;131. doi: 10.1023/A:1009923104175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1009923104175</ArticleId><ArticleId IdType="pubmed">11081289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassell EJ, Rich BA. Intractable end-of-life suffering and the ethics of palliative sedation. Pain Med. 2010;11(3):435&#x2013;438. doi: 10.1111/j.1526-4637.2009.00786.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2009.00786.x</ArticleId><ArticleId IdType="pubmed">20088855</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards SD. Three concepts of suffering. Med Health Care Philo. 2003;6(1):59&#x2013;66. doi: 10.1023/A:1022537117643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1022537117643</ArticleId><ArticleId IdType="pubmed">12710565</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues P, Crokaert J, Gastmans C. Palliative sedation for existential suffering: a systematic review of argument-based ethics literature. J Pain Symptom Manag. 2018;55(6):1577&#x2013;1590. doi: 10.1016/j.jpainsymman.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2018.01.013</ArticleId><ArticleId IdType="pubmed">29382541</ArticleId></ArticleIdList></Reference><Reference><Citation>Parliament of Canada. Bill C-14: An Act to amend the Criminal Code and to make related ammends to other Acts (Medical Assistance in Dying). 14 Apr 2016. Available from https://www.parl.ca/DocumentViewer/en/42-1/bill/C-14/first-reading</Citation></Reference><Reference><Citation>Nicol J, Tiedemann M. Legislative summary: Bill C-14: An Act to amend the Criminal Code and to make related amendments to other Acts (Medical Assistance in Dying). 2018 Sep. 24 p. Publication No. 42&#x2013;1-C14-E. Available from: https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/421C14E</Citation></Reference><Reference><Citation>Beaman LG, Steele C. Transcendence/religion to immanence/nonreligion in assisted dying. Int J Hum Rights Healthc [Internet]. 2018. Available from https://www.emeraldinsight.com/doi/abs/10.1108/IJHRH-09-2017-0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/IJHRH-09-2017-0051</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaltola E. Philosophical narratives of suffering: Nietzsche, Levinas, Weil and their cultural roots. Suomen Antropologi. 2018;43(3):22&#x2013;40. doi: 10.30676/jfas.v43i3.82732.</Citation><ArticleIdList><ArticleId IdType="doi">10.30676/jfas.v43i3.82732</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol J, Tiedeman M. Legislative summary of Bill C-7: an Act to amend the criminal code (Medical Assistance in Dying). 2020 Oct. 20 p. Publication No. 43&#x2013;2-C7-E. Available from: https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/432C7E</Citation></Reference><Reference><Citation>Parliament of Canada. Bill C-7: an Act to amend the Criminal Code (medical assistance in dying). 17 Mar 2021. Available from: https://parl.ca/DocumentViewer/en/43-2/bill/C-7/royal-assent.</Citation></Reference><Reference><Citation>Health Canada. First annual report on Medical Assistance in Dying 2019. Ottawa, ON. July 2020. Available from: https://www.canada.ca/en/health-canada/services/medical-assistance-dying-annual-report-2019.html</Citation></Reference><Reference><Citation>Thorne S. Interpretive description: qualitative research for applied practice. 2nd ed. New York: Routledge; 2016.</Citation></Reference><Reference><Citation>Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing Company; 1967.</Citation></Reference><Reference><Citation>Amonoo HL, Harris JH, Murphy WS, Abrahm JL, Peteet JR. The physician's role in responding to existential suffering: what does it mean to comfort always? J Palliat Care. 2020;35(1):8&#x2013;12. doi: 10.1177/0825859719839332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0825859719839332</ArticleId><ArticleId IdType="pubmed">30968741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce A, Beuthin R. Medically assisted dying in Canada: "beautiful death" is transforming nurses' experiences of suffering. Can J Nurs Res. 2020;52(4):268&#x2013;277. doi: 10.1177/0844562119856234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0844562119856234</ArticleId><ArticleId IdType="pubmed">31188639</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B, Thorne S, Storch J, Chambaere K, Greig M, Burgess M. Riding an elephant: a qualitative study of nurses' moral journeys in the context of Medical Assistance in Dying (MAiD) J Clin Nurs. 2020;29(19&#x2013;20):3870&#x2013;3881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540490</ArticleId><ArticleId IdType="pubmed">32700402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason B, Nanton V, Epiphaniou E, Murray SA, Donaldson A, Shipman C, Daveson BA, Harding R, Higginson IJ, Munday D, Barclay S, Dale J, Kendall M, Worth A, Boyd K. &#x2018;My body is falling apart.&#x2019; Understanding the experiences of patients with advanced multimorbidity to improve care: serial interviews with patients and carers. BMJ Support Palliat Care. 2016;6:60&#x2013;65. doi: 10.1136/bmjspcare-2013-000639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjspcare-2013-000639</ArticleId><ArticleId IdType="pubmed">25023218</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckerblad J, Theander D, Ekdahl A, Unosson M, Wirehn AB, Milberg A, Krevers B, Jaarsma T. Symptom burden in community-dwelling older people with multi-morbidity: a cross-sectional study. BMC Geriatr. 2015;15:1&#x2013;9. doi: 10.1186/1471-2318-15-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-15-1</ArticleId><ArticleId IdType="pmc">PMC4292813</ArticleId><ArticleId IdType="pubmed">25559550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bern-Klug M. The ambiguous dying syndrome. Health Soc Work. 2004;29(1):55&#x2013;65. doi: 10.1093/hsw/29.1.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hsw/29.1.55</ArticleId><ArticleId IdType="pubmed">15024919</ArticleId></ArticleIdList></Reference><Reference><Citation>Stajduhar K. Chronic illness, palliative care, and the problematic nature of dying. Can J Nurs Res. 2011;43(3):7&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21977723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F, Hunter B, Wheeler AJ. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect. 2015;18(3):312&#x2013;324. doi: 10.1111/hex.12046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.12046</ArticleId><ArticleId IdType="pmc">PMC5060781</ArticleId><ArticleId IdType="pubmed">23363080</ArticleId></ArticleIdList></Reference><Reference><Citation>Beng TS, Guan NC, Jane LE, Chin LE. Health care interactional suffering in palliative care. Am J Hosp Palliat Care. 2014;31(3):307&#x2013;314. doi: 10.1177/1049909113490065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909113490065</ArticleId><ArticleId IdType="pubmed">23689367</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;artolovni A, Stolt M, Scott PA. Suhonen R. Moral injury in healthcare professionals: A scoping review and discussion. Nurs Ethics. 2021. 10.1177/0969733020966776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366182</ArticleId><ArticleId IdType="pubmed">33427020</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradi-Perini C, Beltr&#xe3;o JR, Ribeiro URVCO. Circumstances related to moral distress in palliative care: an integrative review. Am J Hosp Palliat Care. 2020. 10.1177/1049909120978826.</Citation><ArticleIdList><ArticleId IdType="pubmed">33280390</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tol DG, Rietjens JAC, van der Heide A. Empathy and the application of the 'unbearable suffering' criterion in Dutch euthanasia practice. Health Policy. 2012;105(2&#x2013;3):296&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">22417862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlzen R. Suffering, authenticity, and physician assisted suicide. Med Health Care Philos. 2020;23(3):353&#x2013;359. doi: 10.1007/s11019-019-09929-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-019-09929-z</ArticleId><ArticleId IdType="pmc">PMC7426309</ArticleId><ArticleId IdType="pubmed">32661805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, Chirchikova M, Daniel V, Bitzas V, Elmore J, Fortin M-L. Engaging with patients who desire death: interpretation, presence, and constraint. Can Oncol Nurs J. 2017;27(1):56&#x2013;64. doi: 10.5737/236880762715664.</Citation><ArticleIdList><ArticleId IdType="doi">10.5737/236880762715664</ArticleId><ArticleId IdType="pmc">PMC6516379</ArticleId><ArticleId IdType="pubmed">31148812</ArticleId></ArticleIdList></Reference><Reference><Citation>Denier Y, Dierckx de Casterl&#xe9; B, De Bal N, Gastmans C. "It's intense, you know." Nurses' experiences in caring for patients requesting euthanasia. Med Health Care Philos. 2010;13(1):41&#x2013;48. doi: 10.1007/s11019-009-9203-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-009-9203-1</ArticleId><ArticleId IdType="pubmed">19381871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Prat A, van Leeuwen E. Assumptions and moral understandings of the wish to hasten death: a philosophical review of qualitative studies. Med Health Care Philos. 2018;21(1):63&#x2013;75. doi: 10.1007/s11019-017-9785-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-017-9785-y</ArticleId><ArticleId IdType="pubmed">28669129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamondi C, Fusi-Schmidhauser T, Oriani A, Payne S, Preston N. Family members' experiences of assisted dying: a systematic literature review with thematic synthesis. Palliat Med. 2019;33(8):1091&#x2013;1105. doi: 10.1177/0269216319857630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216319857630</ArticleId><ArticleId IdType="pubmed">31244384</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg R, Nissim R, An E, Hales S. Impact of medical assistance in dying (MAiD) on family caregivers. BMJ Support Palliat Care. 2021;11(1):107&#x2013;114. doi: 10.1136/bmjspcare-2018-001686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjspcare-2018-001686</ArticleId><ArticleId IdType="pubmed">30826737</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B, Thorne S, Schiller C, Greig M, Roussel J, Tishelman C. Constructing good nursing practice for Medical Assistance in Dying in Canada: an interpretive descriptive study. Glob Qual Nurs Res. 2020. 10.1177/2333393620938686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377599</ArticleId><ArticleId IdType="pubmed">32743024</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DE, Viens P, Muralidharan O, Kastanias P, Dembo J, Riazantseva E. E-Survey of stressors and protective factors in practicing medical assistance in dying. J Palliat Med. 2021. 10.1089/jpm.2020.0664.</Citation><ArticleIdList><ArticleId IdType="pubmed">33601999</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore J, Wright DK, Paradis M. Nurses&#x2019; moral experiences of assisted death: a meta-synthesis of qualitative research. Nurs Ethics. 2018;25(8):955&#x2013;972. doi: 10.1177/0969733016679468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0969733016679468</ArticleId><ArticleId IdType="pubmed">28027675</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B, Thorne S, Schiller CJ, Greig M, Roussel J. The rocks and hard places of MAiD: a qualitative study of nursing practice in the context of legislated assisted death. BMC Nurs. 2020;19:12. doi: 10.1186/s12912-020-0404-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12912-020-0404-5</ArticleId><ArticleId IdType="pmc">PMC7025406</ArticleId><ArticleId IdType="pubmed">32095114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellens M, Debien E, Claessens F, Gastmans C, Dierckx de Casterle B. &#x201c;It is still intense and not unambiguous.&#x201d; Nurses&#x2019; experiences in the euthanasia care process 15 years after legalisation. J Clin Nurs. 2020;29(3&#x2013;4):492&#x2013;502. doi: 10.1111/jocn.15110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.15110</ArticleId><ArticleId IdType="pubmed">31742806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34736463</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Navigating medical assistance in dying from Bill C-14 to Bill C-7: a qualitative study.</ArticleTitle><Pagination><StartPage>1195</StartPage><MedlinePgn>1195</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1195</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-021-07222-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Even as healthcare providers and systems were settling into the processes required for Medical Assistance in Dying (MAID) under Bill C-14, new legislation was introduced (Bill C-7) that extended assisted death to persons whose natural death is not reasonably foreseeable. The purpose of this paper is to describe the experiences of nurses and nurse practitioners with the implementation and ongoing development of this transition.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This qualitative longitudinal descriptive study gathered data through semi-structured telephone interviews with nurses from across Canada; cross sectional data from 2020 to 2021 is reported here. The study received ethical approval and all participants provided written consent.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Participants included nurses (n&#xa0;= 34) and nurse practitioners (n&#xa0;= 16) with significant experience with MAID. Participants described how MAID had transitioned from a new, secretive, and anxiety-producing procedure to one that was increasingly visible and normalized, although this normalization did not necessarily mitigate the emotional impact. MAID was becoming more accessible, and participants were learning to trust the process. However, the work was becoming increasingly complex, labour intensive, and often poorly remunerated. Although many participants described a degree of integration between MAID and palliative care services, there remained ongoing tensions around equitable access to both. Participants described an evolving gestalt of determining persons' eligibility for MAID that required a high degree of clinical judgement. Deeming someone ineligible was intensely stressful for all involved and so participants had learned to be resourceful in avoiding this possibility. The required 10-day waiting period was difficult emotionally, particularly if persons worried about losing capacity to give final consent. The implementation of C-7 was perceived to be particularly challenging due to the nature of the population that would seek MAID and the resultant complexity of trying to address the origins of their suffering within a resource-strapped system.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Significant social and system calibration must occur to accommodate assisted death as an end-of-life option. The transition to offering MAID for those whose natural death is not reasonably foreseeable will require intensive navigation of a sometimes siloed and inaccessible system. High quality MAID care should be both relational and dialogical and those who provide such care require expert communication skills and knowledge of the healthcare system.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pesut</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Nursing, Principal Research Chair in Palliative and End-of-Life Care, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, BC, V1V 1V7, Kelowna, Canada. barb.pesut@ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia, BC, V6T 2B5, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>David Kenneth</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Ottawa, Ontario, K1H 8M5, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiller</LastName><ForeName>Catharine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Northern British Columbia, 3333 University Way, BC, V2N 4Z9, Prince George, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, BC, V1V 1V7, Kelowna, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puurveen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Nursing, University of British Columbia Okanagan, ARTS 3rd Floor, 1147 Research Road, BC, V1V 1V7, Kelowna, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambaere</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Public Health, Sociology &amp; Ethics of the End of Life, End-of-Life Care Research Group, Ghent University &amp; Vrije Universiteit Brussel (VUB), C. Heymanslaan 10, B-9000, Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJT-148655</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-148655</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-169144</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-148655</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-148655</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008483" MajorTopicYN="N">Medical Assistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017236" MajorTopicYN="Y">Suicide, Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="Y">Terminal Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">End of life</Keyword><Keyword MajorTopicYN="N">Healthcare systems</Keyword><Keyword MajorTopicYN="N">Legislation</Keyword><Keyword MajorTopicYN="N">Medical assistance in dying</Keyword><Keyword MajorTopicYN="N">Nursing</Keyword><Keyword MajorTopicYN="N">Qualitative</Keyword></KeywordList><CoiStatement>The authors declare they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34736463</ArticleId><ArticleId IdType="pmc">PMC8567982</ArticleId><ArticleId IdType="doi">10.1186/s12913-021-07222-5</ArticleId><ArticleId IdType="pii">10.1186/s12913-021-07222-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nicol J, Tiedemann M. Legislative summary: Bill C-14: an act to amend the criminal code and to make related amendments to other acts (Medical Assistance in Dying). 2018. p. 24. Publication No. 42-1-C14-E. Available from: https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/421C14E.</Citation></Reference><Reference><Citation>Downie J, Scallion K. Foreseeably unclear the meaning of the &#x201c;reasonably foreseeable&#x201d; criterion for access to medical assistance in dying in Canada. Dalhousie Law J. 2018;41(1):23&#x2013;57.</Citation></Reference><Reference><Citation>Downie J, Chandler JA. Interpreting Canada&#x2019;s Medical Assistance in Dying legislation. 2018. Institute for Research on Public Policy. Available from: https://on-irpp.org/2I7yQ6p.</Citation></Reference><Reference><Citation>McMorrow T. MAID in Canada: Debating the constitutionality of Canada&#x2019;s new Medical Assistance in Dying law. Queens Law J. 2018;44:69. (CANLIIDocs 11038).</Citation></Reference><Reference><Citation>Council of Canadian Academies. The state of knowledge on Medical Assistance in Dying where a mental disorder is the sole underlying medical condition. 2018. Available from: https://cca-reports.ca/wp-content/uploads/2018/12/The-State-of-Knowledge-on-Medical-Assistance-in-Dying-Where-a-Mental-Disorder-is-the-Sole-Underlying-Medical-Condition.pdf.</Citation></Reference><Reference><Citation>Council of Canadian Academies. The state of knowledge on advance requests for Medical Assistance in Dying. 2018. Available from: https://cca-reports.ca/wp-content/uploads/2019/02/The-State-of-Knowledge-on-Advance-Requests-for-Medical-Assistance-in-Dying.pdf.</Citation></Reference><Reference><Citation>Council of Canadian Academies. The state of knowledge on Medical Assistance in Dying for mature minors. 2018. Available from: https://cca-reports.ca/wp-content/uploads/2018/12/The-State-of-Knowledge-on-Medical-Assistance-in-Dying-for-Mature-Minors.pdf.</Citation></Reference><Reference><Citation>Health Canada. Second annual report on Medical Assistance in Dying in Canada 2020. 2021. Available from: https://www.canada.ca/content/dam/hc-sc/documents/services/medical-assistance-dying/annual-report-2020/annual-report-2020-eng.pdf.</Citation></Reference><Reference><Citation>Robertson WD, Beuthin R. A reveiw of Medical Assistance in Dying on Vancouver Island: the first two years July 2016-July 2018. 2018. Available from: https://www.islandhealth.ca/sites/default/files/2018-11/maid-report-2016-2018.pdf.</Citation></Reference><Reference><Citation>Nicol J, Tiedeman M. Legislative summary of Bill C-7: an act to amend the criminal code (Medical Assistance in Dying). 2020. p. 20. Publication No. 43-2-C7-E. Available from: https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/432C7E.</Citation></Reference><Reference><Citation>Canada Department of Justice. Canadian charter of rights and freedoms. 1982. Available from: https://www.justice.gc.ca/eng/csj-sjc/rfc-dlc/ccrf-ccdl/resources-ressources.html#copy.</Citation></Reference><Reference><Citation>Canada Department of Justice. What we heard report: a public consultation on Medical Assistance in Dying (MAID). 2020. Available from: https://www.justice.gc.ca/eng/cj-jp/ad-am/wwh-cqnae/toc-tdm.html.</Citation></Reference><Reference><Citation>Canadian Society of Palliative Care Physicians. Key messages: palliative care and Medical Assistance in Dying. 2019. Available from: http://www.cspcp.ca/wp-content/uploads/2019/05/CSPCP-Key-Messages-PC-and-MAiD-May-2019-FINAL.pdf.</Citation></Reference><Reference><Citation>Canadian Hospice Palliative Care Association, Canadian Society for Palliative Care Physicians. CHPCA and CSPCP - joint call to action. 2019. Available from: https://www.chpca.ca/news/chpca-and-cspcp-joint-call-to-action/.</Citation></Reference><Reference><Citation>Canadian Institute for Health Information. Access to palliative care in Canada. Ottawa: CIHI; 2018. Available from: https://www.cihi.ca/en/access-to-palliative-care-in-canada.</Citation></Reference><Reference><Citation>Trachtenberg AJ, Manns B. Cost analysis of Medical Assistance in Dying in Canada. CMAJ. 2017;189:E101&#x2013;105. doi: 10.1503/cmaj.160650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.160650</ArticleId><ArticleId IdType="pmc">PMC5250515</ArticleId><ArticleId IdType="pubmed">28246154</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Canada. Framework on palliative care in Canada. 2018. Available from: https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/palliative-care/framework-palliative-care-canada.html.</Citation></Reference><Reference><Citation>Parliamentary Budget Officer. Federal investments in palliative care. 2020. Available from:&#xa0;https://www.pbo-dpb.gc.ca/en/blog/news/BLOG-2021-007--federal-investments-in-palliative-care--investissements-gouvernement-federal-dans-soins-palliatifs#:~:text=Conclusion,today%20C%20specifically%20for%20palliative%20care.</Citation></Reference><Reference><Citation>Pesut B, Thorne S, Schiller CJ, Greig M, Roussel J. The rocks and hard places of MAiD: a qualitative study of nursing practice in the context of legislated assisted death. BMC Nurs. 2020;19:12. Available from: 10.1186/s12912-020-0404-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025406</ArticleId><ArticleId IdType="pubmed">32095114</ArticleId></ArticleIdList></Reference><Reference><Citation>Oczkowski SJW, Crawshaw D, Austin P, Versluis D, Kalles-Chan G, Kekewich M, Curran D, Miller PQ, Kelly M, Wiebe E, et al. How we can improve the quality of care for patients requesting Medical Assistance in Dying: a qualitative study of health care providers. J Pain Symptom Manage. 2021;61(3):513. doi: 10.1016/j.jpainsymman.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2020.08.018</ArticleId><ArticleId IdType="pubmed">32835830</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnood N, Hopwood M-C, Lokuge B, Kurahashi A, Tobin A, Isenberg S, Husain A. Exploring Canadian physicians&#x2019; experiences providing Medical Assistance in Dying: a qualitative study. J Pain Symptom Manage. 2018;56(2):222. doi: 10.1016/j.jpainsymman.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2018.05.006</ArticleId><ArticleId IdType="pubmed">29775692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A, Joolaee S, Jameson K, Ng C. The seismic shift in end-of-life care: palliative care challenges in the era of medical assistance in dying. J Palliat Med. 2021;24(2):189&#x2013;194. doi: 10.1089/jpm.2020.0185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2020.0185</ArticleId><ArticleId IdType="pubmed">32584638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews JJ, Hausner D, Avery J, Hannon B, Zimmermann C, Al-Awamer A. Impact of Medical Assistance in Dying on palliative care: a qualitative study. Palliat Med. 2021;35(2):447&#x2013;454. doi: 10.1177/0269216320968517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216320968517</ArticleId><ArticleId IdType="pubmed">33126842</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DE, Viens P, Muralidharan O, Kastanias P, Dembo J, Riazantseva E. E-Survey of stressors and protective factors in practicing Medical Assistance in Dying. J Palliat Med. 2021. Available from: 10.1089/jpm.2020.0664.</Citation><ArticleIdList><ArticleId IdType="pubmed">33601999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B, Thorne S, Storch J, Chambaere K, Greig M, Burgess M. Riding an elephant: a qualitative study of nurses&#x2019; moral journeys in the context of Medical Assistance in Dying (MAiD). J Clinic Nurs. 2020;29 (19-20):3870&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540490</ArticleId><ArticleId IdType="pubmed">32700402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball IM, Hodge JD, Jansen S, Nickle S, Sibbald RW. A Canadian academic hospital&#x2019;s initial MAiD experience: a health-care systems review. J Palliat Care. 2019;34(2):78&#x2013;84. doi: 10.1177/0825859718812446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0825859718812446</ArticleId><ArticleId IdType="pubmed">30458670</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesut B, Thorne S, Schiller C, Greig M, Roussel J, Tishelman C. Constructing good nursing practice for Medical Assistance in Dying in Canada: an interpretive descriptive study. Glob Qual Nurs Res. 2020. Available from 10.1177/2333393620938686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377599</ArticleId><ArticleId IdType="pubmed">32743024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales BM, Bean S, Isenberg-Grzeda E, Ford B, Deslby D. Improving the Medical Assistance in Dying (MAID) process: a qualitative study of family caregiver perspectives. Palliat Support Care. 2019;17(5):590&#x2013;5. doi: 10.1017/S147895151900004X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S147895151900004X</ArticleId><ArticleId IdType="pubmed">30887936</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Goodridge D, Harrison A, Kemp J, Thorpe L, Weiler R. Care considerations in a patient- and family-centered Medical Assistance in Dying program. J Palliat Care. 2020. Available from: 10.1177/0825859720951661.</Citation><ArticleIdList><ArticleId IdType="pubmed">32854581</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne S. Interpretive description: qualitative research for applied practice. 2. New York: Routledge; 2016.</Citation></Reference><Reference><Citation>Glaser BG, Strauss AL. The discovery of grounded theory: atrategies for qualitative research. Chicago: Aldine Publishing Company; 1967.</Citation></Reference><Reference><Citation>Dierickx S, Deliens L, Cohen J, Chambaere K. Involvement of palliative care in euthanasia practice in a context of legalized euthanasia: a population-based mortality follow-back study. Palliat Med. 2018;32(1):114&#x2013;122. doi: 10.1177/0269216317727158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216317727158</ArticleId><ArticleId IdType="pmc">PMC5758933</ArticleId><ArticleId IdType="pubmed">28849727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dierickx S, Deliens L, Cohen J, Chambaere K. Euthanasia in Belgium: trends in reported cases between 2003 and 2013. CMAJ. 2016;188(16):E407&#x2013;E414. doi: 10.1503/cmaj.160202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.160202</ArticleId><ArticleId IdType="pmc">PMC5088089</ArticleId><ArticleId IdType="pubmed">27620630</ArticleId></ArticleIdList></Reference><Reference><Citation>Onwuteaka-Philipsen BD, Brinkman-Stoppelenburg A, Penning C, de Jong-Krul GJF, van Delden JJM, van der Heide A. Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from 1990 to 2010: a repeated cross-sectional survey. Lancet. 2012;380:908&#x2013;915. doi: 10.1016/S0140-6736(12)61034-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61034-4</ArticleId><ArticleId IdType="pubmed">22789501</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide A, van Delden JJM, BD O-P End-of-life decisions in the Netherlands over 25 years. N Engl J Med. 2017;377(5):492&#x2013;494. doi: 10.1056/NEJMc1705630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1705630</ArticleId><ArticleId IdType="pubmed">28767342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamarat N, Pillonel A, Berthod M-A, Castelli Dransart DA, Lebeer G: Exploring contemporary forms of aid in dying: an ethnography of euthanasia in Belgium and assisted suicide in Switzerland. Death Stud. 2021. Available from: 10.1080/07481187.2021.1926635.</Citation><ArticleIdList><ArticleId IdType="pubmed">34097578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie M, Godin G, Vezina-Im L-A, Blondeau D, Martineau I, Roy L. Psychosocial determinants of nurses&#x2019; intention to practice euthanasia in palliatvie care. Nurs Ethics. 2016;23(1):48&#x2013;60. doi: 10.1177/0969733014557117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0969733014557117</ArticleId><ArticleId IdType="pubmed">25488755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellens M, Debien E, Claessens F, Gastmans C, Dierckx de Casterle B. &#x201c;It is still intense and not unambiguous.&#x201d; Nurses&#x2019; experiences in the euthanasia care process 15 years after legalisation. J Clin Nurs. 2019;29:492&#x2013;502. doi: 10.1111/jocn.15110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.15110</ArticleId><ArticleId IdType="pubmed">31742806</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Blouin S. Ethical judgment in assessing requests for medical assistance in dying in Canada and Quebec: what can we learn from other jurisdictions? Death Stud. 2021. Available from 10.1080/07481187.2021.1926636.</Citation><ArticleIdList><ArticleId IdType="pubmed">34097584</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tol DG, Rietjens JAC, van der Heide A. Empathy and the application of the &#x2018;unbearable suffering&#x2019; criterion in Dutch euthanasia practice. Health Policy. 2012;105(2-3):296&#x2013;302. doi: 10.1016/j.healthpol.2012.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2012.01.014</ArticleId><ArticleId IdType="pubmed">22417862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujioka JK, Mirza RM, McDonald PL, Klinger C. Implementation of medical assistance in dying: a scoping review of health care providers&#x2019; perspectives. J Pain Symptom Manage. 2018;55(6):1564&#x2013;1576. doi: 10.1016/j.jpainsymman.2018.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2018.02.011</ArticleId><ArticleId IdType="pubmed">29477968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemiengre J, Gastmans C, Schotsmans P, Dierckx de Casterle B. Impact of written ethics policy on euthanasia from the perspective of physicians and nurses: a multiple case study in hospitals. AJOB Prim Res. 2010;1(2):49&#x2013;60. doi: 10.1080/21507716.2010.489347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21507716.2010.489347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson SM, Koksvik GH, Richards N, Materstvedt LJ, Clark D. The relationship of palliative care with assisted dying where assisted dying is lawful: a systematic scoping review of the literature. J Pain Symptom Manage. 2020;59(6):1287. doi: 10.1016/j.jpainsymman.2019.12.361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2019.12.361</ArticleId><ArticleId IdType="pmc">PMC8311295</ArticleId><ArticleId IdType="pubmed">31881289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambaere K, Bernheim JL. Does legal physician-assisted dying impede development of palliative care? The Belgian and Benelux experience. J Med Ethics. 2015;41(8):657&#x2013;660. doi: 10.1136/medethics-2014-102116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2014-102116</ArticleId><ArticleId IdType="pubmed">25648645</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34103349</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>373</Volume><Issue>6552</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Senolytics reduce coronavirus-related mortality in old mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabe4832</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.abe4832</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has revealed the pronounced vulnerability of the elderly and chronically ill to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced morbidity and mortality. Cellular senescence contributes to inflammation, multiple chronic diseases, and age-related dysfunction, but effects on responses to viral infection are unclear. Here, we demonstrate that senescent cells (SnCs) become hyper-inflammatory in response to pathogen-associated molecular patterns (PAMPs), including SARS-CoV-2 spike protein-1, increasing expression of viral entry proteins and reducing antiviral gene expression in non-SnCs through a paracrine mechanism. Old mice acutely infected with pathogens that included a SARS-CoV-2-related mouse &#x3b2;-coronavirus experienced increased senescence and inflammation, with nearly 100% mortality. Targeting SnCs by using senolytic drugs before or after pathogen exposure significantly reduced mortality, cellular senescence, and inflammatory markers and increased antiviral antibodies. Thus, reducing the SnC burden in diseased or aged individuals should enhance resilience and reduce mortality after viral infection, including that of SARS-CoV-2.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Camell</LastName><ForeName>Christina D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0001-7847-3543</Identifier><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yousefzadeh</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-2869-1029</Identifier><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3876-3156</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Prata</LastName><ForeName>Larissa G P Langhi</ForeName><Initials>LGPL</Initials><Identifier Source="ORCID">0000-0001-9617-8089</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-2964-8719</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology and Center of Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology and Center of Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Kelly</LastName><ForeName>Ryan D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirtskhalava</LastName><ForeName>Tamar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xun</LastName><ForeName>Pengcheng</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6245-4505</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Indiana University-Bloomington, Bloomington, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ejima</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1185-3987</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Indiana University-Bloomington, Bloomington, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Ailing</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Utkarsh</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-7101-8430</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espindola-Netto</LastName><ForeName>Jair Machado</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giorgadze</LastName><ForeName>Nino</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-1191-3775</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inman</LastName><ForeName>Christina L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kurt O</ForeName><Initials>KO</Initials><Identifier Source="ORCID">0000-0003-0682-4687</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholensky</LastName><ForeName>Stephanie H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>Timothy W</ForeName><Initials>TW</Initials><Identifier Source="ORCID">0000-0001-9756-4192</Identifier><AffiliationInfo><Affiliation>Masonic Cancer Center Comparative Pathology Shared Resource, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeBrasseur</LastName><ForeName>Nathan K</ForeName><Initials>NK</Initials><Identifier Source="ORCID">0000-0002-2002-0418</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosla</LastName><ForeName>Sundeep</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2936-4372</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Sullivan</LastName><ForeName>M Gerard</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-5463-1153</Identifier><AffiliationInfo><Affiliation>Masonic Cancer Center Comparative Pathology Shared Resource, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allison</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0003-3566-9399</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Indiana University-Bloomington, Bloomington, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-9137-1146</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology and Center of Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meves</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7462-8288</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prakash</LastName><ForeName>Y S</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0002-2968-224X</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarella</LastName><ForeName>Sergio E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-0445-4929</Identifier><AffiliationInfo><Affiliation>Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3768-7622</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology and Center of Immunology, University of Minnesota, Minneapolis, MN, USA. probbins@umn.edu kirkland.james@mayo.edu lniedern@umn.edu tchkonia.tamar@mayo.edu hamil062@umn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchkonia</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4623-7145</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA. probbins@umn.edu kirkland.james@mayo.edu lniedern@umn.edu tchkonia.tamar@mayo.edu hamil062@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedernhofer</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0002-1074-1385</Identifier><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA. probbins@umn.edu kirkland.james@mayo.edu lniedern@umn.edu tchkonia.tamar@mayo.edu hamil062@umn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkland</LastName><ForeName>James L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-1676-4905</Identifier><AffiliationInfo><Affiliation>Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA. probbins@umn.edu kirkland.james@mayo.edu lniedern@umn.edu tchkonia.tamar@mayo.edu hamil062@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robbins</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials><Identifier Source="ORCID">0000-0003-1068-7099</Identifier><AffiliationInfo><Affiliation>Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA. probbins@umn.edu kirkland.james@mayo.edu lniedern@umn.edu tchkonia.tamar@mayo.edu hamil062@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 AG058800</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 CA215105</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG013925</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG062413</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 AG056053</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG063543</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG013925</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R33 AG061456</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 AG058800</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG053832</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA077598</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG050886</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG056278</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI116678</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG043376</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044948">Flavonols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069452">Pathogen-Associated Molecular Pattern Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000085064">Receptors, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>OO2ABO9578</RegistryNumber><NameOfSubstance UI="C017875">fisetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>RBZ1571X5H</RegistryNumber><NameOfSubstance UI="D000069439">Dasatinib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2021 Jul 16;373(6552):281-282. doi: 10.1126/science.abi4474.</RefSource><PMID Version="1">34437142</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016922" MajorTopicYN="N">Cellular Senescence</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069439" MajorTopicYN="N">Dasatinib</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044948" MajorTopicYN="N">Flavonols</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069452" MajorTopicYN="N">Pathogen-Associated Molecular Pattern Molecules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085064" MajorTopicYN="N">Receptors, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34103349</ArticleId><ArticleId IdType="mid">NIHMS1727091</ArticleId><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="doi">10.1126/science.abe4832</ArticleId><ArticleId IdType="pii">science.abe4832</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin J. M., Bai P., He W., Wu F., Liu X.-F., Han D.-M., Liu S., Yang J.-K., Gender differences in patients with COVID-19: Focus on severity and mortality. Front. Public Health 8, 152 (2020). 10.3389/fpubh.2020.00152</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H. K., Morgan R., Klein S. L., Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 11, 29 (2020). 10.1186/s13293-020-00304-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L., Kokkinidis D. G., Li W., Karamanis D., Ognibene J., Arora S., Southern W. N., Mantzoros C. S., Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism 108, 154262 (2020). 10.1016/j.metabol.2020.154262</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q., Yang K., Wang W., Jiang L., Song J., Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46, 846&#x2013;848 (2020). 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497&#x2013;506 (2020). 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins P. D., Jurk D., Khosla S., Kirkland J. L., LeBrasseur N. K., Miller J. D., Passos J. F., Pignolo R. J., Tchkonia T., Niedernhofer L. J., Senolytic drugs: Reducing senescent cell viability to extend health span. Annu. Rev. Pharmacol. Toxicol. 61, 779&#x2013;803 (2021). 10.1146/annurev-pharmtox-050120-105018</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-050120-105018</ArticleId><ArticleId IdType="pmc">PMC7790861</ArticleId><ArticleId IdType="pubmed">32997601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgoulis V., Adams P. D., Alimonti A., Bennett D. C., Bischof O., Bishop C., Campisi J., Collado M., Evangelou K., Ferbeyre G., Gil J., Hara E., Krizhanovsky V., Jurk D., Maier A. B., Narita M., Niedernhofer L., Passos J. F., Robbins P. D., Schmitt C. A., Sedivy J., Vougas K., von Zglinicki T., Zhou D., Serrano M., Demaria M., Cellular senescence: Defining a path forward. Cell 179, 813&#x2013;827 (2019). 10.1016/j.cell.2019.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.10.005</ArticleId><ArticleId IdType="pubmed">31675495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkland J. L., Tchkonia T., Cellular senescence: A translational perspective. EBioMedicine 21, 21&#x2013;28 (2017). 10.1016/j.ebiom.2017.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.04.013</ArticleId><ArticleId IdType="pmc">PMC5514381</ArticleId><ArticleId IdType="pubmed">28416161</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J. L., Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J. Clin. Invest. 123, 966&#x2013;972 (2013). 10.1172/JCI64098</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64098</ArticleId><ArticleId IdType="pmc">PMC3582125</ArticleId><ArticleId IdType="pubmed">23454759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkland J. L., Tchkonia T., Zhu Y., Niedernhofer L. J., Robbins P. D., The clinical potential of senolytic drugs. J. Am. Geriatr. Soc. 65, 2297&#x2013;2301 (2017). 10.1111/jgs.14969</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14969</ArticleId><ArticleId IdType="pmc">PMC5641223</ArticleId><ArticleId IdType="pubmed">28869295</ArticleId></ArticleIdList></Reference><Reference><Citation>Prata L. G. P. L., Ovsyannikova I. G., Tchkonia T., Kirkland J. L., Senescent cell clearance by the immune system: Emerging therapeutic opportunities. Semin. Immunol. 40, 101275 (2018). 10.1016/j.smim.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC7061456</ArticleId><ArticleId IdType="pubmed">31088710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Tchkonia T., Pirtskhalava T., Gower A. C., Ding H., Giorgadze N., Palmer A. K., Ikeno Y., Hubbard G. B., Lenburg M., O&#x2019;Hara S. P., LaRusso N. F., Miller J. D., Roos C. M., Verzosa G. C., LeBrasseur N. K., Wren J. D., Farr J. N., Khosla S., Stout M. B., McGowan S. J., Fuhrmann-Stroissnigg H., Gurkar A. U., Zhao J., Colangelo D., Dorronsoro A., Ling Y. Y., Barghouthy A. S., Navarro D. C., Sano T., Robbins P. D., Niedernhofer L. J., Kirkland J. L., The Achilles&#x2019; heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 14, 644&#x2013;658 (2015). 10.1111/acel.12344</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12344</ArticleId><ArticleId IdType="pmc">PMC4531078</ArticleId><ArticleId IdType="pubmed">25754370</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Pirtskhalava T., Farr J. N., Weigand B. M., Palmer A. K., Weivoda M. M., Inman C. L., Ogrodnik M. B., Hachfeld C. M., Fraser D. G., Onken J. L., Johnson K. O., Verzosa G. C., Langhi L. G. P., Weigl M., Giorgadze N., LeBrasseur N. K., Miller J. D., Jurk D., Singh R. J., Allison D. B., Ejima K., Hubbard G. B., Ikeno Y., Cubro H., Garovic V. D., Hou X., Weroha S. J., Robbins P. D., Niedernhofer L. J., Khosla S., Tchkonia T., Kirkland J. L., Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246&#x2013;1256 (2018). 10.1038/s41591-018-0092-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0092-9</ArticleId><ArticleId IdType="pmc">PMC6082705</ArticleId><ArticleId IdType="pubmed">29988130</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefzadeh M. J., Zhu Y., McGowan S. J., Angelini L., Fuhrmann-Stroissnigg H., Xu M., Ling Y. Y., Melos K. I., Pirtskhalava T., Inman C. L., McGuckian C., Wade E. A., Kato J. I., Grassi D., Wentworth M., Burd C. E., Arriaga E. A., Ladiges W. L., Tchkonia T., Kirkland J. L., Robbins P. D., Niedernhofer L. J., Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36, 18&#x2013;28 (2018). 10.1016/j.ebiom.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.09.015</ArticleId><ArticleId IdType="pmc">PMC6197652</ArticleId><ArticleId IdType="pubmed">30279143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D. F., Brown M., Sanchez E., Tattersall R. S., Manson J. J.; HLH Across Speciality Collaboration, UK , COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033&#x2013;1034 (2020). 10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A. G., Lorenc A., Del Molino Del Barrio I., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D. R., Hayday T. S., Francos-Quijorna I., Kamdar S., Joseph M., Davies D., Davis R., Jennings A., Zlatareva I., Vantourout P., Wu Y., Sofra V., Cano F., Greco M., Theodoridis E., Freedman J. D., Gee S., Chan J. N. E., Ryan S., Bugallo-Blanco E., Peterson P., Kisand K., Haljasm&#xe4;gi L., Chadli L., Moingeon P., Martinez L., Merrick B., Bisnauthsing K., Brooks K., Ibrahim M. A. A., Mason J., Lopez Gomez F., Babalola K., Abdul-Jawad S., Cason J., Mant C., Seow J., Graham C., Doores K. J., Di Rosa F., Edgeworth J., Shankar-Hari M., Hayday A. C., A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 26, 1951 (2020). 10.1038/s41591-020-01186-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01186-5</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefzadeh M. J., Zhao J., Bukata C., Wade E. A., McGowan S. J., Angelini L. A., Bank M. P., Gurkar A. U., McGuckian C. A., Calubag M. F., Kato J. I., Burd C. E., Robbins P. D., Niedernhofer L. J., Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell 19, e13094 (2020). 10.1111/acel.13094</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13094</ArticleId><ArticleId IdType="pmc">PMC7059165</ArticleId><ArticleId IdType="pubmed">31981461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F., Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 117, 11727&#x2013;11734 (2020). 10.1073/pnas.2003138117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., P&#xf6;hlmann S., A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78, 779&#x2013;784.e5 (2020). 10.1016/j.molcel.2020.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosch S. F., Mahajan S. D., Collins A. R., SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res. 142, 19&#x2013;27 (2009). 10.1016/j.virusres.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2699111</ArticleId><ArticleId IdType="pubmed">19185596</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., Guignabert C., Humbert M., Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)? Eur. Respir. J. 56, 2001634 (2020). 10.1183/13993003.01634-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K., Kizaki T., SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon 7, e06187 (2021). 10.1016/j.heliyon.2021.e06187</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06187</ArticleId><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Karki R., Williams E. P., Yang D., Fitzpatrick E., Vogel P., Jonsson C. B., Kanneganti T.-D., TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 10.1038/s41590-021-00937-x (2021). 10.1038/s41590-021-00937-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Segura A., de Jong T. V., Melov S., Guryev V., Campisi J., Demaria M., Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27, 2652&#x2013;2660.e4 (2017). 10.1016/j.cub.2017.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.07.033</ArticleId><ArticleId IdType="pmc">PMC5788810</ArticleId><ArticleId IdType="pubmed">28844647</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B. E., Liu W.-C., Uhl S., Hoagland D., M&#xf8;ller R., Jordan T. X., Oishi K., Panis M., Sachs D., Wang T. T., Schwartz R. E., Lim J. K., Albrecht R. A., tenOever B. R., Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036&#x2013;1045.e9 (2020). 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel-Bar&#xf3;n L. A., Morales-Rosales S. L., Aquino-Cruz A. A., Triana-Mart&#xed;nez F., Galv&#xe1;n-Arzate S., Luna-L&#xf3;pez A., Gonz&#xe1;lez-Puertos V. Y., L&#xf3;pez-D&#xed;azguerrero N. E., Torres C., K&#xf6;nigsberg M., Senescence associated secretory phenotype profile from primary lung mice fibroblasts depends on the senescence induction stimuli. Age 38, 26 (2016). 10.1007/s11357-016-9886-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-016-9886-1</ArticleId><ArticleId IdType="pmc">PMC5005892</ArticleId><ArticleId IdType="pubmed">26867806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti M., Castiglioni S., Bernardini D., Maier J. A., Interleukin 1 alpha is a marker of endothelial cellular senescent. Immun. Ageing 3, 4 (2006). 10.1186/1742-4933-3-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-3-4</ArticleId><ArticleId IdType="pmc">PMC1482715</ArticleId><ArticleId IdType="pubmed">16600025</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer M. J., White T. A., Iijima K., Haak A. J., Ligresti G., Atkinson E. J., Oberg A. L., Birch J., Salmonowicz H., Zhu Y., Mazula D. L., Brooks R. W., Fuhrmann-Stroissnigg H., Pirtskhalava T., Prakash Y. S., Tchkonia T., Robbins P. D., Aubry M. C., Passos J. F., Kirkland J. L., Tschumperlin D. J., Kita H., LeBrasseur N. K., Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 8, 14532 (2017). 10.1038/ncomms14532</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14532</ArticleId><ArticleId IdType="pmc">PMC5331226</ArticleId><ArticleId IdType="pubmed">28230051</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D. M., Kim-Schulze S., Huang H.-H., Beckmann N. D., Nirenberg S., Wang B., Lavin Y., Swartz T. H., Madduri D., Stock A., Marron T. U., Xie H., Patel M., Tuballes K., Van Oekelen O., Rahman A., Kovatch P., Aberg J. A., Schadt E., Jagannath S., Mazumdar M., Charney A. W., Firpo-Betancourt A., Mendu D. R., Jhang J., Reich D., Sigel K., Cordon-Cardo C., Feldmann M., Parekh S., Merad M., Gnjatic S., An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636&#x2013;1643 (2020). 10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni V., Sacchi A., Cimini E., Notari S., Grassi G., Tartaglia E., Casetti R., Giancola M. L., Bevilacqua N., Maeurer M., Zumla A., Locatelli F., De Benedetti F., Palmieri F., Marchioni L., Capobianchi M. R., D&#x2019;Offizi G., Petrosillo N., Antinori A., Nicastri E., Ippolito G., Agrati C., An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019. Clin. Infect. Dis. 71, 2272&#x2013;2275 (2020). 10.1093/cid/ciaa577</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa577</ArticleId><ArticleId IdType="pmc">PMC7239202</ArticleId><ArticleId IdType="pubmed">32407466</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. W., Zhang C., Fan X., Meng F.-P., Xu Z., Xia P., Cao W.-J., Yang T., Dai X.-P., Wang S.-Y., Xu R.-N., Jiang T.-J., Li W.-G., Zhang D.-W., Zhao P., Shi M., Agrati C., Ippolito G., Maeurer M., Zumla A., Wang F.-S., Zhang J.-Y., Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun. 11, 3410 (2020). 10.1038/s41467-020-17240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C., Liu G., Luckhardt T., Antony V., Zhou Y., Carter A. B., Thannickal V. J., Liu R.-M., Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease. Aging Cell 16, 1114&#x2013;1124 (2017). 10.1111/acel.12643</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12643</ArticleId><ArticleId IdType="pmc">PMC5595683</ArticleId><ArticleId IdType="pubmed">28722352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Warnock M., Harbaugh A., Yalavarthi S., Gockman K., Zuo M., Madison J. A., Knight J. S., Kanthi Y., Lawrence D. A., Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci. Rep. 11, 1580 (2021). 10.1038/s41598-020-80010-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80010-z</ArticleId><ArticleId IdType="pmc">PMC7810990</ArticleId><ArticleId IdType="pubmed">33452298</ArticleId></ArticleIdList></Reference><Reference><Citation>Orjalo A. V., Bhaumik D., Gengler B. K., Scott G. K., Campisi J., Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U.S.A. 106, 17031&#x2013;17036 (2009). 10.1073/pnas.0905299106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905299106</ArticleId><ArticleId IdType="pmc">PMC2761322</ArticleId><ArticleId IdType="pubmed">19805069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T. B. R., Silva J., Sundaram M., Ellingson M. K., Mao T., Oh J. E., Israelow B., Takahashi T., Tokuyama M., Lu P., Venkataraman A., Park A., Mohanty S., Wang H., Wyllie A. L., Vogels C. B. F., Earnest R., Lapidus S., Ott I. M., Moore A. J., Muenker M. C., Fournier J. B., Campbell M., Odio C. D., Casanovas-Massana A., Herbst R., Shaw A. C., Medzhitov R., Schulz W. L., Grubaugh N. D., Dela Cruz C., Farhadian S., Ko A. I., Omer S. B., Iwasaki A., Yale IMPACT Team , Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463&#x2013;469 (2020). 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins M. A., Sjaastad F. V., Pierson M., Kucaba T. A., Swanson W., Staley C., Weingarden A. R., Jensen I. J., Danahy D. B., Badovinac V. P., Jameson S. C., Vezys V., Masopust D., Khoruts A., Griffith T. S., Hamilton S. E., Microbial exposure enhances immunity to pathogens recognized by TLR2 but increases susceptibility to cytokine storm through TLR4 sensitization. Cell Rep. 28, 1729&#x2013;1743.e5 (2019). 10.1016/j.celrep.2019.07.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.028</ArticleId><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="pubmed">31412243</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins M. A., Jameson S. C., Hamilton S. E., Embracing microbial exposure in mouse research. J. Leukoc. Biol. 105, 73&#x2013;79 (2019). 10.1002/JLB.4RI0718-273R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4RI0718-273R</ArticleId><ArticleId IdType="pmc">PMC6318123</ArticleId><ArticleId IdType="pubmed">30260516</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura L. K., Hamilton S. E., Bi K., Schenkel J. M., Odumade O. A., Casey K. A., Thompson E. A., Fraser K. A., Rosato P. C., Filali-Mouhim A., Sekaly R. P., Jenkins M. K., Vezys V., Haining W. N., Jameson S. C., Masopust D., Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512&#x2013;516 (2016). 10.1038/nature17655</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17655</ArticleId><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N., Syed D. N., Ahmad N., Mukhtar H., Fisetin: A dietary antioxidant for health promotion. Antioxid. Redox Signal. 19, 151&#x2013;162 (2013). 10.1089/ars.2012.4901</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4901</ArticleId><ArticleId IdType="pmc">PMC3689181</ArticleId><ArticleId IdType="pubmed">23121441</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhami V. M., Syed D. N., Khan N., Mukhtar H., Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem. Pharmacol. 84, 1277&#x2013;1281 (2012). 10.1016/j.bcp.2012.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2012.07.012</ArticleId><ArticleId IdType="pmc">PMC3813433</ArticleId><ArticleId IdType="pubmed">22842629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Doornebal E. J., Pirtskhalava T., Giorgadze N., Wentworth M., Fuhrmann-Stroissnigg H., Niedernhofer L. J., Robbins P. D., Tchkonia T., Kirkland J. L., 
New agents that target senescent cells: The flavone, fisetin, and the BCL-X<sub>L</sub> inhibitors, A1331852 and A1155463. Aging
9, 
955&#x2013;963 (2017). 10.18632/aging.101202</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101202</ArticleId><ArticleId IdType="pmc">PMC5391241</ArticleId><ArticleId IdType="pubmed">28273655</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D. J., Wijshake T., Tchkonia T., LeBrasseur N. K., Childs B. G., van de Sluis B., Kirkland J. L., van Deursen J. M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232&#x2013;236 (2011). 10.1038/nature10600</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10600</ArticleId><ArticleId IdType="pmc">PMC3468323</ArticleId><ArticleId IdType="pubmed">22048312</ArticleId></ArticleIdList></Reference><Reference><Citation>Murano I., Rutkowski J. M., Wang Q. A., Cho Y.-R., Scherer P. E., Cinti S., Time course of histomorphological changes in adipose tissue upon acute lipoatrophy. Nutr. Metab. Cardiovasc. Dis. 23, 723&#x2013;731 (2013). 10.1016/j.numecd.2012.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2012.03.005</ArticleId><ArticleId IdType="pmc">PMC3465635</ArticleId><ArticleId IdType="pubmed">22682975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragelle H., Crauste-Manciet S., Seguin J., Brossard D., Scherman D., Arnaud P., Chabot G. G., Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. Int. J. Pharm. 427, 452&#x2013;459 (2012). 10.1016/j.ijpharm.2012.02.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2012.02.025</ArticleId><ArticleId IdType="pubmed">22387278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkland J. L., Tchkonia T., Senolytic drugs: From discovery to translation. J. Intern. Med. 288, 518&#x2013;536 (2020). 10.1111/joim.13141</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13141</ArticleId><ArticleId IdType="pmc">PMC7405395</ArticleId><ArticleId IdType="pubmed">32686219</ArticleId></ArticleIdList></Reference><Reference><Citation>Christy B., Demaria M., Campisi J., Huang J., Jones D., Dodds S. G., Williams C., Hubbard G., Livi C. B., Gao X., Weintraub S., Curiel T., Sharp Z. D., Hasty P., p53 and rapamycin are additive. Oncotarget 6, 15802&#x2013;15813 (2015). 10.18632/oncotarget.4602</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4602</ArticleId><ArticleId IdType="pmc">PMC4599238</ArticleId><ArticleId IdType="pubmed">26158292</ArticleId></ArticleIdList></Reference><Reference><Citation>Laberge R. M., Zhou L., Sarantos M. R., Rodier F., Freund A., de Keizer P. L. J., Liu S., Demaria M., Cong Y.-S., Kapahi P., Desprez P.-Y., Hughes R. E., Campisi J., Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell 11, 569&#x2013;578 (2012). 10.1111/j.1474-9726.2012.00818.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2012.00818.x</ArticleId><ArticleId IdType="pmc">PMC3387333</ArticleId><ArticleId IdType="pubmed">22404905</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren Hooten N., Martin-Montalvo A., Dluzen D. F., Zhang Y., Bernier M., Zonderman A. B., Becker K. G., Gorospe M., de Cabo R., Evans M. K., Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence. Aging Cell 15, 572&#x2013;581 (2016). 10.1111/acel.12469</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12469</ArticleId><ArticleId IdType="pmc">PMC4854919</ArticleId><ArticleId IdType="pubmed">26990999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad A., Robinson A. R., Duensing A., van Drunen E., Beverloo H. B., Weisberg D. B., Hasty P., Hoeijmakers J. H. J., Niedernhofer L. J., ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol. Cell. Biol. 28, 5082&#x2013;5092 (2008). 10.1128/MCB.00293-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00293-08</ArticleId><ArticleId IdType="pmc">PMC2519706</ArticleId><ArticleId IdType="pubmed">18541667</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthold S. W., Smith A. L., Povar M. L., Enterotropic mouse hepatitis virus infection in nude mice. Lab. Anim. Sci. 35, 613&#x2013;618 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">3005764</ArticleId></ArticleIdList></Reference><Reference><Citation>Abcejo A. J., Sathish V., Smelter D. F., Aravamudan B., Thompson M. A., Hartman W. R., Pabelick C. M., Prakash Y. S., Brain-derived neurotrophic factor enhances calcium regulatory mechanisms in human airway smooth muscle. PLOS ONE 7, e44343 (2012). 10.1371/journal.pone.0044343</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044343</ArticleId><ArticleId IdType="pmc">PMC3430656</ArticleId><ArticleId IdType="pubmed">22952960</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash Y. S., Thompson M. A., Vaa B., Matabdin I., Peterson T. E., He T., Pabelick C. M., Caveolins and intracellular calcium regulation in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1118&#x2013;L1126 (2007). 10.1152/ajplung.00136.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00136.2007</ArticleId><ArticleId IdType="pubmed">17704188</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagostino R. B., Belanger A., Dagostino R. B., A suggestion for using powerful and informative tests of normality. Am. Stat. 44, 316&#x2013;321 (1990). 10.2307/2684359</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2684359</ArticleId></ArticleIdList></Reference><Reference><Citation>Box G. E. P., Cox D. R., An analysis of transformations. J. R. Stat. Soc. B 26, 211&#x2013;243 (1964). 10.1111/j.2517-6161.1964.tb00553.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1964.tb00553.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwell M. R., Serlin R. C., A nonparametric test statistic for general linear model. J. Educ. Stat. 14, 351&#x2013;371 (1989). 10.3102/10769986014004351</Citation><ArticleIdList><ArticleId IdType="doi">10.3102/10769986014004351</ArticleId></ArticleIdList></Reference><Reference><Citation>R. G. Miller, <i>Simultaneous Statistical Inference</i> (Springer-Verlag, ed. 2, 1981).</Citation></Reference><Reference><Citation>Tukey J. W., Comparing individual means in the analysis of variance. Biometrics 5, 99&#x2013;114 (1949). 10.2307/3001913</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3001913</ArticleId><ArticleId IdType="pubmed">18151955</ArticleId></ArticleIdList></Reference><Reference><Citation>Einhorn H. J., Hogarth R. M., Unit weighting schemes for decision making. Organ. Behav. Hum. Perform. 13, 171&#x2013;192 (1975). 10.1016/0030-5073(75)90044-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0030-5073(75)90044-6</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33863906</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>16</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Classical MHC expression by DP thymocytes impairs the selection of non-classical MHC restricted innate-like T cells.</ArticleTitle><Pagination><StartPage>2308</StartPage><MedlinePgn>2308</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2308</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-22589-z</ELocationID><Abstract><AbstractText>Conventional T cells are selected by peptide-MHC expressed by cortical epithelial cells in the thymus, and not by cortical thymocytes themselves that do not express MHC I or MHC II. Instead, cortical thymocytes express non-peptide presenting MHC molecules like CD1d and MR1, and promote the selection of PLZF<sup>+</sup> iNKT and MAIT cells, respectively. Here, we report an inducible class-I transactivator mouse that enables the expression of peptide presenting MHC I molecules in different cell types. We show that MHC I expression in DP thymocytes leads to expansion of peptide specific PLZF<sup>+</sup> innate-like (PIL) T cells. Akin to iNKT cells, PIL T cells differentiate into three functional effector subsets in the thymus, and are dependent on SAP signaling. We demonstrate that PIL and NKT cells compete for a narrow niche, suggesting that the absence of peptide-MHC on DP thymocytes facilitates selection of non-peptide specific lymphocytes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georgiev</LastName><ForeName>Hristo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1369-960X</Identifier><AffiliationInfo><Affiliation>Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, D-30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Changwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-9137-1146</Identifier><AffiliationInfo><Affiliation>Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogquist</LastName><ForeName>Kristin A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0001-9963-5687</Identifier><AffiliationInfo><Affiliation>Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, USA. hogqu001@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R37 AI039560</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C549161">NLRC5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075722">Promyelocytic Leukemia Zinc Finger Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C513267">Zbtb16 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072336" MajorTopicYN="N">Mucosal-Associated Invariant T Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055611" MajorTopicYN="N">Natural Killer T-Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075722" MajorTopicYN="N">Promyelocytic Leukemia Zinc Finger Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060168" MajorTopicYN="N">Thymocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013950" MajorTopicYN="N">Thymus Gland</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>17</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33863906</ArticleId><ArticleId IdType="pmc">PMC8052364</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-22589-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-22589-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Edholm ES, Banach M, Robert J. Evolution of innate-like T cells and their selection by MHC class I-like molecules. Immunogenetics. 2016;68:525&#x2013;536. doi: 10.1007/s00251-016-0929-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-016-0929-7</ArticleId><ArticleId IdType="pmc">PMC5695035</ArticleId><ArticleId IdType="pubmed">27368412</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermijlen D, Prinz I. Ontogeny of innate T lymphocytes - some innate lymphocytes are more innate than others. Front. Immunol. 2014;5:1&#x2013;12. doi: 10.3389/fimmu.2014.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00486</ArticleId><ArticleId IdType="pmc">PMC4193329</ArticleId><ArticleId IdType="pubmed">25346734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007;25:297&#x2013;336. doi: 10.1146/annurev.immunol.25.022106.141711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.25.022106.141711</ArticleId><ArticleId IdType="pubmed">17150027</ArticleId></ArticleIdList></Reference><Reference><Citation>Stetson DB, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 2003;198:1069&#x2013;1076. doi: 10.1084/jem.20030630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20030630</ArticleId><ArticleId IdType="pmc">PMC2194220</ArticleId><ArticleId IdType="pubmed">14530376</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe NY, et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 2003;171:4020&#x2013;4027. doi: 10.4049/jimmunol.171.8.4020.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.8.4020</ArticleId><ArticleId IdType="pubmed">14530322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa K, Lin BT, Hardy R. Murine thymic CD4+ T cell subsets: a subset (Thy0) that secretes diverse cytokines and overexpresses the VB8 T cell receptor gene family. J. Exp. Med. 1992;178:269&#x2013;274. doi: 10.1084/jem.176.1.269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.176.1.269</ArticleId><ArticleId IdType="pmc">PMC2119274</ArticleId><ArticleId IdType="pubmed">1351921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lantz O, Bendelac A. An invariant T cell receptor ~x chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4&#x2212; 8&#x2212; T cells in mice and humans. J. Exp. Med. 1994;180:1097&#x2013;1106. doi: 10.1084/jem.180.3.1097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.3.1097</ArticleId><ArticleId IdType="pmc">PMC2191643</ArticleId><ArticleId IdType="pubmed">7520467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 1995;182:2091&#x2013;2096. doi: 10.1084/jem.182.6.2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.182.6.2091</ArticleId><ArticleId IdType="pmc">PMC2192225</ArticleId><ArticleId IdType="pubmed">7500054</ArticleId></ArticleIdList></Reference><Reference><Citation>Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 2005;202:485&#x2013;492. doi: 10.1084/jem.20050456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050456</ArticleId><ArticleId IdType="pmc">PMC2212852</ArticleId><ArticleId IdType="pubmed">16087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat. Immunol. 2010;11:197&#x2013;206. doi: 10.1038/ni.1841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1841</ArticleId><ArticleId IdType="pubmed">20139988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002;2:557&#x2013;568. doi: 10.1038/nri854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri854</ArticleId><ArticleId IdType="pubmed">12154375</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu. Rev. Immunol. 2003;21:139&#x2013;176. doi: 10.1146/annurev.immunol.21.120601.141107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.21.120601.141107</ArticleId><ArticleId IdType="pubmed">12414722</ArticleId></ArticleIdList></Reference><Reference><Citation>Griewank K, et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity. 2007;27:751&#x2013;762. doi: 10.1016/j.immuni.2007.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.08.020</ArticleId><ArticleId IdType="pmc">PMC2170879</ArticleId><ArticleId IdType="pubmed">18031695</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage AK, et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 2008;29:391&#x2013;403. doi: 10.1016/j.immuni.2008.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.07.011</ArticleId><ArticleId IdType="pmc">PMC2613001</ArticleId><ArticleId IdType="pubmed">18703361</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalovsky D, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 2008;9:1055&#x2013;1064. doi: 10.1038/ni.1641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1641</ArticleId><ArticleId IdType="pmc">PMC2662733</ArticleId><ArticleId IdType="pubmed">18660811</ArticleId></ArticleIdList></Reference><Reference><Citation>Seach N, et al. Double positive thymocytes select mucosal-associated invariant T cells. J. Immunol. 2013;191:6002&#x2013;6009. doi: 10.4049/jimmunol.1301212.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301212</ArticleId><ArticleId IdType="pubmed">24244014</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonzo ES, et al. Development of promyelocytic zinc finger and ThPOK-expressing innate &#x3b3;&#x3b4; T cells is controlled by strength of TCR signaling and Id3. J. Immunol. 2010;184:1268&#x2013;1279. doi: 10.4049/jimmunol.0903218.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903218</ArticleId><ArticleId IdType="pmc">PMC3991695</ArticleId><ArticleId IdType="pubmed">20038637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H, Bediako Y, Xu H, Choi HJ, Wang CR. Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells. Proc. Natl Acad. Sci. USA. 2011;108:13241&#x2013;13246. doi: 10.1073/pnas.1105118108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1105118108</ArticleId><ArticleId IdType="pmc">PMC3156174</ArticleId><ArticleId IdType="pubmed">21788511</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y, Wang X, Jameson SC, Hogquist KA. Late stages of T cell maturation in the thymus involve NF-&#x3ba;B and tonic type i interferon signaling. Nat. Immunol. 2016;17:565&#x2013;573. doi: 10.1038/ni.3419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3419</ArticleId><ArticleId IdType="pmc">PMC4837029</ArticleId><ArticleId IdType="pubmed">27043411</ArticleId></ArticleIdList></Reference><Reference><Citation>Scollay R, Jacobs S, Jerabek L, Butcher E, Weissman I. T cell maturation: thymocyte and thymus migrant subpopulations defined with monoclonal antibodies to MHC region antigens. J. Immunol. 1980;124:2845&#x2013;2853.</Citation><ArticleIdList><ArticleId IdType="pubmed">6154739</ArticleId></ArticleIdList></Reference><Reference><Citation>Eun YC, et al. Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity. 2005;23:387&#x2013;396. doi: 10.1016/j.immuni.2005.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.09.005</ArticleId><ArticleId IdType="pubmed">16226504</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity. 2005;23:375&#x2013;386. doi: 10.1016/j.immuni.2005.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.09.002</ArticleId><ArticleId IdType="pubmed">16226503</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Thymic selection pathway regulates the effector function of CD4 T cells. J. Exp. Med. 2007;204:2145&#x2013;2157. doi: 10.1084/jem.20070321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070321</ArticleId><ArticleId IdType="pmc">PMC2118694</ArticleId><ArticleId IdType="pubmed">17724129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, et al. Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans. J. Exp. Med. 2010;207:237&#x2013;246. doi: 10.1084/jem.20091519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091519</ArticleId><ArticleId IdType="pmc">PMC2812550</ArticleId><ArticleId IdType="pubmed">20038602</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner TB, et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl Acad. Sci. USA. 2010;107:13794&#x2013;13799. doi: 10.1073/pnas.1008684107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008684107</ArticleId><ArticleId IdType="pmc">PMC2922274</ArticleId><ArticleId IdType="pubmed">20639463</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner TB, Li A, Kobayashi KS. NLRC5: a newly discovered MHC class I transactivator (CITA) Microbes Infect. 2012;14:477&#x2013;484. doi: 10.1016/j.micinf.2011.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.12.007</ArticleId><ArticleId IdType="pmc">PMC3323719</ArticleId><ArticleId IdType="pubmed">22209772</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongsma MLM, Guarda G, Spaapen RM. The regulatory network behind MHC class I expression. Mol. Immunol. 2019;113:16&#x2013;21. doi: 10.1016/j.molimm.2017.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2017.12.005</ArticleId><ArticleId IdType="pubmed">29224918</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas A, Meissner TB, Kawai T, Kobayashi KS. Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator. J. Immunol. 2012;189:516&#x2013;520. doi: 10.4049/jimmunol.1200064.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200064</ArticleId><ArticleId IdType="pmc">PMC3578426</ArticleId><ArticleId IdType="pubmed">22711889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Jung KC, Park SH. MHC class II-dependent T-T interactions create a diverse, functional and immunoregulatory reaction circle. Immunol. Cell Biol. 2009;87:65&#x2013;71. doi: 10.1038/icb.2008.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2008.85</ArticleId><ArticleId IdType="pubmed">19030015</ArticleId></ArticleIdList></Reference><Reference><Citation>Heng TSP, et al. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 2008;9:1091&#x2013;1094. doi: 10.1038/ni1008-1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1008-1091</ArticleId><ArticleId IdType="pubmed">18800157</ArticleId></ArticleIdList></Reference><Reference><Citation>Min HS, et al. MHC class II-restricted interaction between thymocytes plays an essential role in the production of innate CD8 + T cells. J. Immunol. 2011;186:5749&#x2013;5757. doi: 10.4049/jimmunol.1002825.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002825</ArticleId><ArticleId IdType="pmc">PMC3192403</ArticleId><ArticleId IdType="pubmed">21478404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 2013;14:1146&#x2013;1154. doi: 10.1038/ni.2731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2731</ArticleId><ArticleId IdType="pmc">PMC3824254</ArticleId><ArticleId IdType="pubmed">24097110</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiev H, Ravens I, Benarafa C, F&#xf6;rster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat. Commun. 2016;7:13116. doi: 10.1038/ncomms13116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13116</ArticleId><ArticleId IdType="pmc">PMC5062562</ArticleId><ArticleId IdType="pubmed">27721447</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel I, et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat. Immunol. 2016;17:728&#x2013;739. doi: 10.1038/ni.3437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3437</ArticleId><ArticleId IdType="pmc">PMC4944658</ArticleId><ArticleId IdType="pubmed">27089380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, et al. Lineage-specific effector signatures of invariant NKT cells are shared amongst &#x3b3;&#x3b4; T, innate lymphoid, and Th cells. J. Immunol. 2016;197:1460&#x2013;1470. doi: 10.4049/jimmunol.1600643.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600643</ArticleId><ArticleId IdType="pmc">PMC4976040</ArticleId><ArticleId IdType="pubmed">27385777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle KD, et al. TCR signal strength controls thymic differentiation of iNKT cell subsets. Nat. Commun. 2018;9:2650. doi: 10.1038/s41467-018-05026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05026-6</ArticleId><ArticleId IdType="pmc">PMC6037704</ArticleId><ArticleId IdType="pubmed">29985393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogquist K, Georgiev H. Recent advances in iNKT cell development. F1000Research. 2020;9:127. doi: 10.12688/f1000research.21378.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.21378.1</ArticleId><ArticleId IdType="pmc">PMC7043113</ArticleId><ArticleId IdType="pubmed">32148771</ArticleId></ArticleIdList></Reference><Reference><Citation>Krovi SH, Gapin L. Invariant natural killer T cell subsets&#x2014;more than just developmental intermediates. Front. Immunol. 2018;9:1393. doi: 10.3389/fimmu.2018.01393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01393</ArticleId><ArticleId IdType="pmc">PMC6019445</ArticleId><ArticleId IdType="pubmed">29973936</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, et al. Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. Nat. Commun. 2018;9:2627. doi: 10.1038/s41467-018-05095-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05095-7</ArticleId><ArticleId IdType="pmc">PMC6035278</ArticleId><ArticleId IdType="pubmed">29980684</ArticleId></ArticleIdList></Reference><Reference><Citation>Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. A thymic precursor to the NK T cell lineage. Science. 2002;296:553&#x2013;555. doi: 10.1126/science.1069017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1069017</ArticleId><ArticleId IdType="pubmed">11968185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Jameson SC, Hogquist KA. Alternative memory in the CD8 T cell lineage. Trends Immunol. 2011;32:50&#x2013;56. doi: 10.1016/j.it.2010.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2010.12.004</ArticleId><ArticleId IdType="pmc">PMC3039080</ArticleId><ArticleId IdType="pubmed">21288770</ArticleId></ArticleIdList></Reference><Reference><Citation>Erman B, et al. Coreceptor signal strength regulates positive selection but does not determine CD4/CD8 lineage choice in a physiologic in vivo model. J. Immunol. 2006;177:6613&#x2013;6625. doi: 10.4049/jimmunol.177.10.6613.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.10.6613</ArticleId><ArticleId IdType="pubmed">17082573</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. MHC class II-expressing thymocytes suppress invariant NKT cell development. Immunol. Cell Biol. 2009;87:186&#x2013;189. doi: 10.1038/icb.2008.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2008.78</ArticleId><ArticleId IdType="pmc">PMC2801351</ArticleId><ArticleId IdType="pubmed">18982019</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiev H, Ravens I, Shibuya A, F&#xf6;rster R, Bernhardt G. CD155/CD226-interaction impacts on the generation of innate CD8(+) thymocytes by regulating iNKT-cell differentiation. Eur. J. Immunol. 2016;46:993&#x2013;1003. doi: 10.1002/eji.201546073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546073</ArticleId><ArticleId IdType="pubmed">26689152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang BH, et al. Analyses of the TCR repertoire of MHC class II-restricted innate CD4+ T cells. Exp. Mol. Med. 2015;47:e154. doi: 10.1038/emm.2015.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2015.7</ArticleId><ArticleId IdType="pmc">PMC4351420</ArticleId><ArticleId IdType="pubmed">25813222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurepa Z, Su J, Forman J. Memory phenotype of CD8+ T cells in MHC class Ia-deficient mice. J. Immunol. 2003;170:5414&#x2013;5420. doi: 10.4049/jimmunol.170.11.5414.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.11.5414</ArticleId><ArticleId IdType="pubmed">12759416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bediako Y, et al. SAP is required for the devof innate phenotype in H2-M3&#x2013;restricted CD8+ T cells. J. Immunol. 2012;189:4787&#x2013;4796. doi: 10.4049/jimmunol.1200579.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200579</ArticleId><ArticleId IdType="pmc">PMC3490027</ArticleId><ArticleId IdType="pubmed">23041566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendelac A, Killeen N, Littman DR, Schwartz RH. A subset of CD4+ thymocytes selected by MHC class I molecules. Science. 1994;263:1774&#x2013;1778. doi: 10.1126/science.7907820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7907820</ArticleId><ArticleId IdType="pubmed">7907820</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel I, et al. Co-receptor choice by V&#x3b1;14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection. J. Exp. Med. 2010;207:1015&#x2013;1029. doi: 10.1084/jem.20090557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20090557</ArticleId><ArticleId IdType="pmc">PMC2867285</ArticleId><ArticleId IdType="pubmed">20404101</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashtsoodol N, Bortoluzzi S, Schmidt-Supprian M. T cell receptor expression timing and signal strength in the functional differentiation of invariant natural killer T cells. Front. Immunol. 2019;10:841. doi: 10.3389/fimmu.2019.00841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00841</ArticleId><ArticleId IdType="pmc">PMC6497757</ArticleId><ArticleId IdType="pubmed">31080448</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiest DL, et al. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 1993;178:1701&#x2013;1712. doi: 10.1084/jem.178.5.1701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.178.5.1701</ArticleId><ArticleId IdType="pmc">PMC2191226</ArticleId><ArticleId IdType="pubmed">8228817</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiest DL, Ashe JM, Ryo A, Bolen JB, Singer A. TCR activation of ZAP70 is impaired in CD4+CD8+ thymocytes as a consequence of intrathymic interactions that diminish available P56(lck) Immunity. 1996;4:495&#x2013;504. doi: 10.1016/S1074-7613(00)80415-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)80415-X</ArticleId><ArticleId IdType="pubmed">8630734</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2002;2:309&#x2013;322. doi: 10.1038/nri798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri798</ArticleId><ArticleId IdType="pubmed">12033737</ArticleId></ArticleIdList></Reference><Reference><Citation>Benko S, Kov&#xe1;cs EG, Hezel F, Kufer TA. NLRC5 functions beyond MHC I regulation-What do we know so far? Front. Immunol. 2017;8:1&#x2013;7. doi: 10.3389/fimmu.2017.00150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00150</ArticleId><ArticleId IdType="pmc">PMC5313500</ArticleId><ArticleId IdType="pubmed">28261210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JQ, et al. Emerging roles for NLRC5 in immune diseases. Front. Pharm. 2019;10:1&#x2013;13. doi: 10.3389/fphar.2019.00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00001</ArticleId><ArticleId IdType="pmc">PMC6880621</ArticleId><ArticleId IdType="pubmed">31824312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, et al. NLRC5 Negatively regulates the NF-&#x3ba;B and type I interferon signaling pathways. Cell. 2010;141:483&#x2013;496. doi: 10.1016/j.cell.2010.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.040</ArticleId><ArticleId IdType="pmc">PMC3150216</ArticleId><ArticleId IdType="pubmed">20434986</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Q, et al. Reversible ubiquitination shapes NLRC5 function and modulates NF-&#x3ba;B activation switch. J. Cell Biol. 2015;211:1025&#x2013;1040. doi: 10.1083/jcb.201505091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201505091</ArticleId><ArticleId IdType="pmc">PMC4674279</ArticleId><ArticleId IdType="pubmed">26620909</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Y, et al. Enhanced TLR-induced NF-&#x3ba;B signaling and type I interferon responses in NLRC5 deficient mice. Cell Res. 2012;22:822&#x2013;835. doi: 10.1038/cr.2012.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2012.53</ArticleId><ArticleId IdType="pmc">PMC3343662</ArticleId><ArticleId IdType="pubmed">22473004</ArticleId></ArticleIdList></Reference><Reference><Citation>Long M, Park SG, Strickland I, Hayden MS, Ghosh S. Nuclear factor-&#x3ba;B modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity. 2009;31:921&#x2013;931. doi: 10.1016/j.immuni.2009.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.09.022</ArticleId><ArticleId IdType="pubmed">20064449</ArticleId></ArticleIdList></Reference><Reference><Citation>Isomura I, et al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 2009;206:3001&#x2013;3014. doi: 10.1084/jem.20091411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091411</ArticleId><ArticleId IdType="pmc">PMC2806473</ArticleId><ArticleId IdType="pubmed">19995950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordy LE, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 2011;187:6335&#x2013;6345. doi: 10.4049/jimmunol.1003965.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003965</ArticleId><ArticleId IdType="pmc">PMC3237743</ArticleId><ArticleId IdType="pubmed">22084435</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CN, et al. Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature. 2018;559:627&#x2013;631. doi: 10.1038/s41586-018-0345-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0345-2</ArticleId><ArticleId IdType="pmc">PMC6062473</ArticleId><ArticleId IdType="pubmed">30022164</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda JL, et al. Homeostasis of V&#x3b1;14i NKT cells. Nat. Immunol. 2002;3:966&#x2013;974. doi: 10.1038/ni837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni837</ArticleId><ArticleId IdType="pubmed">12244311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Hogquist KA, How Lipid-Specific T. Cells become effectors: the differentiation of iNKT subsets. Front. Immunol. 2018;9:1450. doi: 10.3389/fimmu.2018.01450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01450</ArticleId><ArticleId IdType="pmc">PMC6028555</ArticleId><ArticleId IdType="pubmed">29997620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat. Protoc. 2006;1:241&#x2013;245. doi: 10.1038/nprot.2006.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.37</ArticleId><ArticleId IdType="pubmed">17406239</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33530930</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Evaluation of an initiative to improve advance care planning for a home-based primary care service.</ArticleTitle><Pagination><StartPage>97</StartPage><MedlinePgn>97</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-021-02035-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Advance care planning (ACP) is a process that enables individuals to describe, in advance, the kind of health care they would want in the future. There is evidence that ACP reduces hospital-based interventions, especially at the end of life. ACP for frail older adults is especially important as this population is more likely to use hospital services but less likely to benefit from resource intensive care. Our study goal was to evaluate whether an approach to ACP developed for frail older adults, known as the Palliative and Therapeutic Harmonization or PATH, demonstrated an improvement in ACP.</AbstractText><AbstractText Label="METHODS">The PATH approach was adapted to a primary care service for homebound older adults in Vancouver, Canada. This retrospective chart review collected surrogate measures related to ACP from 200 randomly selected patients enrolled in the service at baseline (prior to June 22, 2017), and 114 consecutive patients admitted to the program after implementation of the PATH ACP initiative (October 1, 2017 to May 1, 2018). We compared the following surrogate markers of ACP before and after implementation of the PATH model, chart documentation of: frailty stage, substitute decision-maker, resuscitation decision, and hospitalization decision. A composite ACP documentation score that ascribed one point for each of the above four measures (range 0 to 4) was also compared. For those with documented resuscitation and hospitalization decisions, the study examined patient/ substitute decision-maker expressed preferences for do-not-resuscitate and do-not-hospitalize, before and after implementation.</AbstractText><AbstractText Label="RESULTS">We found the following changes in ACP-related documentation before and after implementation: frailty stage (27.0% versus 74.6%, p&#x2009;&lt;&#x2009;.0001); substitute decision-maker (63.5% versus 71.9%, p&#x2009;=&#x2009;0.128); resuscitation decision documented (79.5% versus 67.5%, p&#x2009;=&#x2009;0.018); and hospitalization decision documented (61.5% versus 100.0%, p&#x2009;&lt;&#x2009;.0001); mean (standard deviation) composite ACP documentation score (2.32 (1.16) versus 3.14 (1.11), p&#x2009;&lt;&#x2009;.0001). The adjusted odds ratios (95% confidence intervals) for an expressed preference of do-not-resuscitate and do-not-hospitalize after implementation were 0.87 (0.35, 2.15) and 3.14 (1.78, 5.55), respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Results suggest partial success in implementing the PATH approach to ACP in home-based primary care. Key contextual enablers and barriers are important considerations for successful implementation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Michelle B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, 713-828 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGregor</LastName><ForeName>Margaret J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0553-7240</Identifier><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, 713-828 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada. mrgret@mail.ubc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HomeViVE Program, Vancouver General Hospital, Vancouver, BC, Canada. mrgret@mail.ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, 713-828 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moorhouse</LastName><ForeName>Paige</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallery</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauder</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, 713-828 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032722" MajorTopicYN="Y">Advance Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004282" MajorTopicYN="N">Documentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advance care planning</Keyword><Keyword MajorTopicYN="N">Do-not-hospitalize</Keyword><Keyword MajorTopicYN="N">Do-not-resuscitate</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Home-based primary care</Keyword><Keyword MajorTopicYN="N">Substitute decision-maker</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>3</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33530930</ArticleId><ArticleId IdType="pmc">PMC7852206</ArticleId><ArticleId IdType="doi">10.1186/s12877-021-02035-x</ArticleId><ArticleId IdType="pii">10.1186/s12877-021-02035-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28(8):1000&#x2013;1025. doi: 10.1177/0269216314526272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216314526272</ArticleId><ArticleId IdType="pubmed">24651708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozalo P, Teno JM, Mitchell SL, Skinner J, Bynum J, Tyler D, et al. End-of-life transitions among nursing home residents with cognitive issues. N Engl J Med. 2011;365(13):1212&#x2013;1221. doi: 10.1056/NEJMsa1100347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1100347</ArticleId><ArticleId IdType="pmc">PMC3236369</ArticleId><ArticleId IdType="pubmed">21991894</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel SE, Kiely DK, Mitchell SL. Satisfaction with end-of-life Care for Nursing Home Residents with advanced dementia. J Am Geriatr Soc. 2006;54(10):1567&#x2013;1572. doi: 10.1111/j.1532-5415.2006.00900.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2006.00900.x</ArticleId><ArticleId IdType="pmc">PMC2409052</ArticleId><ArticleId IdType="pubmed">17038076</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay E, Shreve S, Casarett D. Nationwide veterans affairs quality measure for cancer: the family assessment of treatment at end of life. J Clin Oncol. 2008;26(23):3838&#x2013;3844. doi: 10.1200/JCO.2008.16.8534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2008.16.8534</ArticleId><ArticleId IdType="pubmed">18688050</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy DW, Guyatt GH, Russo R, Goeree R, O'Brien BJ, Bedard M, et al. Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA. 2000;283(11):1437&#x2013;1444. doi: 10.1001/jama.283.11.1437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.11.1437</ArticleId><ArticleId IdType="pubmed">10732933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kezirian AC, McGregor MJ, Stead U, Sakaluk T, Spring B, Turgeon S, et al. Advance care planning in the nursing home setting: a practice improvement evaluation. J Soc Work End Life Palliat Care. 2018;14(4):328&#x2013;345. doi: 10.1080/15524256.2018.1547673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15524256.2018.1547673</ArticleId><ArticleId IdType="pubmed">30653404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell SL, Kiely DK, Hamel MB, Park PS, Morris JN, Fries BE. Estimating prognosis for nursing home residents with advanced dementia. JAMA. 2004;291(22):2734&#x2013;2740. doi: 10.1001/jama.291.22.2734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.22.2734</ArticleId><ArticleId IdType="pubmed">15187055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173(5):489&#x2013;495. doi: 10.1503/cmaj.050051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210(6):901&#x2013;908. doi: 10.1016/j.jamcollsurg.2010.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.01.028</ArticleId><ArticleId IdType="pubmed">20510798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastings SN, Purser JL, Johnson KS, Sloane RJ, Whitson HE. Frailty predicts some but not all adverse outcomes in older adults discharged from the emergency department. J Am Geriatr Soc. 2008;56(9):1651&#x2013;1657. doi: 10.1111/j.1532-5415.2008.01840.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.01840.x</ArticleId><ArticleId IdType="pmc">PMC2676906</ArticleId><ArticleId IdType="pubmed">18691282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallery LH, Moorhouse P. Respecting frailty. J Med Ethics. 2011;37(2):126&#x2013;128. doi: 10.1136/jme.2010.040147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jme.2010.040147</ArticleId><ArticleId IdType="pubmed">21097941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapka JG, Carter R, Carter CL, Hennessy W, Kurent JE, DesHarnais S. Care at the end of life: focus on communication and race. J Aging Health. 2006;18(6):791&#x2013;813. doi: 10.1177/0898264306293614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264306293614</ArticleId><ArticleId IdType="pubmed">17099134</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorhouse P, Mallery LH. Palliative and therapeutic harmonization: a model for appropriate decision-making in frail older adults. J Am Geriatr Soc. 2012;60(12):2326&#x2013;2332. doi: 10.1111/j.1532-5415.2012.04210.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.04210.x</ArticleId><ArticleId IdType="pubmed">23110462</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins M, McGregor MJ, Cox MB, Bauder K, Slater J, Yap C, et al. Advance care planning and decision-making in a home-based primary care service in a canadian urban centre. Can Geriatr J. 2019;22(4):8. doi: 10.5770/cgj.22.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.5770/cgj.22.377</ArticleId><ArticleId IdType="pmc">PMC6887142</ArticleId><ArticleId IdType="pubmed">31885758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauder K. An Evaluation of Advance Care Planning Discussions Post-PATH Implementation at HomeViVE. Prepared by Katie Bauder. Vancouver: Practicum Project;&#xa0;2018.</Citation></Reference><Reference><Citation>Dixon J, Karagiannidou M, Knapp M. The effectiveness of advance care planning in improving end-of-life outcomes for people with dementia and their carers: a systematic review and critical discussion. J Pain Symptom Manage. 2018;55(1):132&#x2013;50.e1. doi: 10.1016/j.jpainsymman.2017.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2017.04.009</ArticleId><ArticleId IdType="pubmed">28827062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg T. Acute hospital use, nursing home placement, and mortality in a frail community-dwelling cohort managed with primary integrated interdisciplinary elder Care at Home. J Am Geriatr Soc. 2012;60(7):1340&#x2013;1346. doi: 10.1111/j.1532-5415.2012.03965.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.03965.x</ArticleId><ArticleId IdType="pubmed">22694020</ArticleId></ArticleIdList></Reference><Reference><Citation>Stall N, Nowaczynski M, Sinha SK. Back to the future: home-based primary care for older homebound Canadians: part 1: where we are now. Can Fam Physician. 2013;59(3):237&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3596195</ArticleId><ArticleId IdType="pubmed">23486788</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuchman M, Fain M, Cornwell T. The resurgence of home-based primary care models in the United States. Geriatrics. 2018;3(3):41. doi: 10.3390/geriatrics3030041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics3030041</ArticleId><ArticleId IdType="pmc">PMC6319221</ArticleId><ArticleId IdType="pubmed">31011079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes SL, Weaver FM, Giobbie-Hurder A, Manheim L, Henderson W, Kubal JD, et al. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. JAMA. 2000;284(22):2877&#x2013;2885. doi: 10.1001/jama.284.22.2877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.284.22.2877</ArticleId><ArticleId IdType="pubmed">11147984</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33395288</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5215</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>The journal of physical chemistry. A</Title><ISOAbbreviation>J Phys Chem A</ISOAbbreviation></Journal><ArticleTitle>Predicting Absorption and Emission Maxima of Polycyclic Aromatic Azaborines: Reliable Transition Energies and Character.</ArticleTitle><Pagination><StartPage>3</StartPage><EndPage>12</EndPage><MedlinePgn>3-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jpca.0c05765</ELocationID><Abstract><AbstractText>Polycyclic aromatic azaborines have potential applications as luminophores, novel fluorescent materials, organic light-emitting diodes, and fluorescent sensors. Additionally, their relative structural simplicity should allow the use of computational techniques to design and screen novel compounds in a rapid manner. Herein, the absorption and emission maxima of twelve polycyclic aromatic BN-1,2-azaborine analogues containing the N-BOH moiety were examined to determine a methodology for reliably predicting both the energy and character (local excitation [LE] vs charge transfer [CT]) of the absorption and emission maxima for these compounds. The necessity of implicit solvation models was also investigated. The cam-QTP(01) functional with a small, double-&#x3b6; quality basis set provides reliable data compared to EOM-CCSD/cc-pVDZ single-point computations. Of note, commonly used functionals for these applications (B3LYP and &#x3c9;B97xD) struggle to provide reliable results for both the energy and LE character of the transitions relative to EOM-CCSD computations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0001-6463-3809</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrock</LastName><ForeName>Alan K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida, Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-4429-8668</Identifier><AffiliationInfo><Affiliation>College of Science and Technology, Tarleton State University, Stephenville, Texas 76402, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Charles Edwin</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-6917-2957</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Phys Chem A</MedlineTA><NlmUniqueID>9890903</NlmUniqueID><ISSNLinking>1089-5639</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>4</Day><Hour>17</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33395288</ArticleId><ArticleId IdType="doi">10.1021/acs.jpca.0c05765</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33219552</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Evaluation of A plasma for incompatible patients.</ArticleTitle><Pagination><StartPage>375</StartPage><EndPage>378</EndPage><MedlinePgn>375-378</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.16170</ELocationID><Abstract><AbstractText Label="BACKGROUND">Plasma transfusion is a critical treatment in managing bleeding patients. In an effort to make plasma immediately available in spite of the limited amount of AB plasma, providers have begun using A plasma in life-threatening emergencies. As this practice becomes widely adopted it is important to evaluate safety. Hemolytic transfusions reactions are underreported, and hemolysis may be subclinical.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">A retrospective study was performed at the University of Florida/Shands Hospital of B and AB patients who received 1&#x2009;unit or more of A plasma. Patient charts were reviewed and data collected included age; sex; mortality; intensive care unit (ICU) length of stay; and laboratory tests used in identifying hemolysis including direct antiglobulin test, lactate dehydrogenase, haptoglobin, indirect bilirubin, aspartate aminotransferase, urinalysis, hemoglobin, and hematocrit. The primary end points of the study were immune mediated hemolysis, mortality, and length of ICU stay.</AbstractText><AbstractText Label="RESULTS">Ninety-three patients were identified as eligible for the study. One patient suffered a delayed hemolytic transfusion reaction determined to be due to an anti-Jk<sup>a</sup> . No evidence of hemolysis due to ABO-incompatible plasma transfusion was identified. The volume of A plasma transfused was found to be weakly related to mortality and ICU stay.</AbstractText><AbstractText Label="CONCLUSION">No evidence of ABO immune-mediated hemolysis was observed in the patient population. The results of the study support the safety of A plasma transfusion in B and AB patients. We hypothesize the relationship observed between A plasma volume and mortality/ICU stay may be from collinearity with disease severity.</AbstractText><CopyrightInformation>&#xa9; 2020 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6703-7199</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Laboratory Medicine, and Immunology, University of Florida College of Medicine, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passwater</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Blood Bank Laboratory, UF Health Shands Hospital, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Monique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Blood Bank Laboratory, UF Health Shands Hospital, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhtar</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology, Laboratory Medicine, and Immunology, University of Florida College of Medicine, Gainesville, Florida.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blood Bank Laboratory, UF Health Shands Hospital, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelletier</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathology, Laboratory Medicine, and Immunology, University of Florida College of Medicine, Gainesville, Florida.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blood Bank Laboratory, UF Health Shands Hospital, Gainesville, Florida.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000017">ABO Blood-Group System</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000017" MajorTopicYN="N">ABO Blood-Group System</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016913" MajorTopicYN="N">Blood Component Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001787" MajorTopicYN="N">Blood Group Incompatibility</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003298" MajorTopicYN="N">Coombs Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006461" MajorTopicYN="N">Hemolysis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="Y">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065227" MajorTopicYN="N">Transfusion Reaction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FFP transfusion</Keyword><Keyword MajorTopicYN="N">blood management</Keyword><Keyword MajorTopicYN="N">transfusion practices (adult)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33219552</ArticleId><ArticleId IdType="doi">10.1111/trf.16170</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Holcomb JB, Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks. JAMA Sirg. 2012;148(2):127-136.</Citation></Reference><Reference><Citation>Dunbar N, Yazer M, Biomedical Excellence for Safer Transfusion (BEST) Collaborative, and the STAT. Safety of the use of group A plasma in trauma: The STAT study. Transfusion. 2017;57(8):1879-1884.</Citation></Reference><Reference><Citation>Stevens WT, Morse BC, Bernard A, et al. Incompatible type A plasma transfusion in patients requiring massive transfusion protocol: Outcome of an Eastern association for the surgery of trauma multistudy. J Trauma Acute Care Surg. 2017;83(1):25-29.</Citation></Reference><Reference><Citation>Johnson DJ, Scott AV, Barodka VM, et al. Morbidity and mortality after high-dose transfusion. Anesthesiology. 2016;124(2):387-395.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33122851</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>T cell economics: precursor cells predict inflation.</ArticleTitle><Pagination><StartPage>1482</StartPage><EndPage>1483</EndPage><MedlinePgn>1482-1483</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-020-00819-8</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3768-7622</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, USA. hamil062@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Immunol. 2020 Dec;21(12):1563-1573. doi: 10.1038/s41590-020-00807-y.</RefSource><PMID Version="1">33106669</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="Y">Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007250" MajorTopicYN="N">Inflation, Economic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33122851</ArticleId><ArticleId IdType="doi">10.1038/s41590-020-00819-8</ArticleId><ArticleId IdType="pii">10.1038/s41590-020-00819-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grassmann, S. et al. Nat. Immunol. https://doi.org/10.1038/s41590-020-00807-y (2020).</Citation></Reference><Reference><Citation>Sylwester, A. W. et al. J. Exp. Med. 202, 673&#x2013;685 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050882</ArticleId></ArticleIdList></Reference><Reference><Citation>Klenerman, P. &amp; Oxenius, A. Nat. Rev. Immunol. 16, 367&#x2013;377 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchholz, V. R., Schumacher, T. N. M. &amp; Busch, D. H. Annu. Rev. Immunol. 34, 65&#x2013;92 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032414-112014</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassmann, S. et al. Immunity 50, 1391&#x2013;1400.e4 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.015</ArticleId></ArticleIdList></Reference><Reference><Citation>La Manno, G. et al. Nature 560, 494&#x2013;498 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0414-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, W.-H. W. et al. Cell Rep. 17, 1773&#x2013;1782 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.10.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretschmer, L. et al. Nat. Commun. 11, 113 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13788-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, X. et al. Immunity 33, 229&#x2013;240 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen, S. G. et al. Nature 473, 523&#x2013;527 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32611727</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>205</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>KLRG1<sup>+</sup> Memory CD8 T Cells Combine Properties of Short-Lived Effectors and Long-Lived Memory.</ArticleTitle><Pagination><StartPage>1059</StartPage><EndPage>1069</EndPage><MedlinePgn>1059-1069</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.1901512</ELocationID><Abstract><AbstractText>CD8 effector T cells with a CD127<sup>hi</sup> KLRG1<sup>-</sup> phenotype are considered precursors to the long-lived memory pool, whereas KLRG1<sup>+</sup>CD127<sup>low</sup> cells are viewed as short-lived effectors. Nevertheless, we and others have shown that a KLRG1<sup>+</sup>CD127<sup>low</sup> population persists into the memory phase and that these T cells (termed long-lived effector cells [LLEC]) display robust protective function during acute rechallenge with bacteria or viruses. Whether these T cells represent a true memory population or are instead a remnant effector cell population that failed to undergo initial contraction has remained unclear. In this study, we show that LLEC from mice express a distinct phenotypic and transcriptional signature that shares characteristics of both early effectors and long-lived memory cells. We also find that in contrast to KLRG1<sup>+</sup> effector cells, LLEC undergo homeostatic proliferation and are not critically dependent on IL-15 for their maintenance. Furthermore, we find that LLEC are predominantly derived from KLRG1<sup>+</sup> effector cells when isolated at day 12 of the response. Our work challenges the concept that the KLRG1<sup>+</sup>CD127<sup>low</sup> population is dominated by short-lived cells and shows that KLRG1 downregulation is not a prerequisite to become a long-lived protective memory T cell.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Renkema</LastName><ForeName>Kristin R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges da Silva</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knutson</LastName><ForeName>Todd P</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0001-8431-9964</Identifier><AffiliationInfo><Affiliation>Supercomputing Institute for Advanced Computational Research, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henzler</LastName><ForeName>Christy M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-4566-2211</Identifier><AffiliationInfo><Affiliation>Supercomputing Institute for Advanced Computational Research, University of Minnesota, Minneapolis, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3768-7622</Identifier><AffiliationInfo><Affiliation>Center for Immunology, University of Minnesota, Minneapolis, MN 55455; hamil062@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI116678</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI143828</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA009138</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053699">Interleukin-7 Receptor alpha Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C451496">Klrg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019409" MajorTopicYN="N">Interleukin-15</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053699" MajorTopicYN="N">Interleukin-7 Receptor alpha Subunit</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32611727</ArticleId><ArticleId IdType="mid">NIHMS1602248</ArticleId><ArticleId IdType="pmc">PMC7415731</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1901512</ArticleId><ArticleId IdType="pii">jimmunol.1901512</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, and Kaech SM. 2007. Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor. Immunity 27: 281&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034442</ArticleId><ArticleId IdType="pubmed">17723218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, and Ahmed R. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2275385</ArticleId><ArticleId IdType="pubmed">18316415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, and Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">14625547</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez CX, Amezquita RA, Guan T, Marshall HD, Joshi NS, Kleinstein SH, and Kaech SM. 2015. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212: 2041&#x2013;2056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647261</ArticleId><ArticleId IdType="pubmed">26503446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech SM, and Cui W. 2012. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12: 749&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137483</ArticleId><ArticleId IdType="pubmed">23080391</ArticleId></ArticleIdList></Reference><Reference><Citation>Omilusik KD, Best JA, Yu B, Goossens S, Weidemann A, Nguyen JV, Seuntjens E, Stryjewska A, Zweier C, Roychoudhuri R, Gattinoni L, Bird LM, Higashi Y, Kondoh H, Huylebroeck D, Haigh J, and Goldrath AW. 2015. 
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8 <sup>+</sup> effector and memory T cell populations during infection. J. Exp. Med. 212: 2027&#x2013;2039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647262</ArticleId><ArticleId IdType="pubmed">26503445</ArticleId></ArticleIdList></Reference><Reference><Citation>Omilusik KD, Nadjsombati MS, Shaw LA, Yu B, Milner JJ, and Goldrath AW. 2018. 
Sustained Id2 regulation of E proteins is required for terminal differentiation of effector CD8 <sup>+</sup> T cells. J. Exp. Med. 215: 773&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839762</ArticleId><ArticleId IdType="pubmed">29440362</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SC, and Masopust D. 2018. Understanding Subset Diversity in T Cell Memory. Immunity 48: 214&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JA, McDonald-Hyman C, Jameson SC, and Hamilton SE. 2013. Effector-like CD8+ T Cells in the Memory Population Mediate Potent Protective Immunity. Immunity 38: 1250&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703254</ArticleId><ArticleId IdType="pubmed">23746652</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Nicholas Haining W, Jameson SC, and Masopust D. 2016. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532: 512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, H&#xf6;chst B, Eickhoff S, Rieckmann JC, Russo C, Bauer T, Flecken T, Giesen D, Engel D, Jung S, Busch DH, Protzer U, Thimme R, Mann M, Kurts C, Schultze JL, Kastenm&#xfc;ller W, and Knolle PA. 2015. Functional classification of memory CD8 + T cells by CX 3 CR1 expression. Nat. Commun. 6: 8306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4667439</ArticleId><ArticleId IdType="pubmed">26404698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach C, Moseman EA, Loughhead SM, Garg R, De La Torre JC, Von UH, Correspondence A, Alvarez D, Zwijnenburg AJ, Waanders L, and Von Andrian UH. 2016. The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis Article The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. Immunity 45: 1270&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177508</ArticleId><ArticleId IdType="pubmed">27939671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz AL, Soudja SM, Deceneux C, Lauvau G, and Marie JC. 2014. NK1.1+ CD8+ T cells escape TGF-&#x3b2; control and contribute to early microbial pathogen response. Nat. Commun. 5: 5150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836950</ArticleId><ArticleId IdType="pubmed">25284210</ArticleId></ArticleIdList></Reference><Reference><Citation>Omilusik KD, and Goldrath AW. 2019. Remembering to remember: T cell memory maintenance and plasticity. Curr. Opin. Immunol. 58: 89&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612439</ArticleId><ArticleId IdType="pubmed">31170601</ArticleId></ArticleIdList></Reference><Reference><Citation>Herndler-Brandstetter D, Ishigame H, Shinnakasu R, Plajer V, Stecher C, Zhao J, Lietzenmayer M, Kroehling L, Takumi A, Kometani K, Inoue T, Kluger Y, Kaech SM, Kurosaki T, Okada T, and Flavell RA. 2018. KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity. Immunity 48: 716&#x2013;729.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6465538</ArticleId><ArticleId IdType="pubmed">29625895</ArticleId></ArticleIdList></Reference><Reference><Citation>Haluszczak C, Akue AD, Hamilton SE, Johnson LDS, Pujanauski L, Teodorovic L, Jameson SC, and Kedl RM. 2009. 
The antigen-specific CD8 <sup>+</sup> T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 206: 435&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646575</ArticleId><ArticleId IdType="pubmed">19188498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SC, and Masopust D. 2018. Understanding Subset Diversity in T Cell Memory. Immunity 48: 214&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863745</ArticleId><ArticleId IdType="pubmed">29466754</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnon TI, Horton RM, Grigorova IL, and Cyster JG. 2013. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature 493: 684&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3561487</ArticleId><ArticleId IdType="pubmed">23263181</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL, and Masopust D. 2014. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9: 209&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan T, Dominguez CX, Amezquita RA, Laidlaw BJ, Cheng J, Henao-Mejia J, Williams A, Flavell RA, Lu J, and Kaech SM. 2018. 
ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8 <sup>+</sup> T cell fates. J. Exp. Med. 215: 1153&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881466</ArticleId><ArticleId IdType="pubmed">29449309</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez CX, Amezquita RA, Guan T, Marshall HD, Joshi NS, Kleinstein SH, and Kaech SM. 2015. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212: 2041&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647261</ArticleId><ArticleId IdType="pubmed">26503446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefrancois L 2006. Development, trafficking, and function of memory T-cell subsets. Immunol. Rev. 211: 93&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">16824120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F, Geginat J, and Lanzavecchia A. 2004. Central Memory and Effector Memory T Cell Subsets : Function, Generation, and Maintenance. Annu. Rev. Immunol. 22: 745&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">15032595</ArticleId></ArticleIdList></Reference><Reference><Citation>Best JA, Blair DA, Knell J, Yang E, Mayya V, Doedens A, Dustin ML, Goldrath AW, Monach P, Shinton SA, Hardy RR, Jianu R, Koller D, Collins J, Gazit R, Garrison BS, Rossi DJ, Narayan K, Sylvia K, Kang J, Fletcher A, Elpek K, Bellemare-Pelletier A, Malhotra D, Turley S, Best JA, Jojic V, Koller D, Shay T, Regev A, Cohen N, Brennan P, Brenner M, Kreslavsky T, Bezman NA, Sun JC, Kim CC, Lanier LL, Miller J, Brown B, Merad M, Gautier EL, Jakubzick C, Randolph GJ, Kim F, Rao TN, Wagers A, Heng T, Painter M, Ericson J, Davis S, Ergun A, Mingueneau M, Mathis D, and Benoist C. 2013. Transcriptional insights into the CD8 + T cell response to infection and memory T cell formation. Nat. Immunol. 14: 404&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689652</ArticleId><ArticleId IdType="pubmed">23396170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui G, Staron MM, Gray SM, Ho P-C, Amezquita RA, Wu J, and Kaech SM. 2015. IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity. Cell 161: 750&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704440</ArticleId><ArticleId IdType="pubmed">25957683</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson JM, Zajac AJ, Altman JD, and Ahmed R. 2000. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164: 3950&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754284</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, and Satija R. 2018. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36: 411&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, and Kaech SM. 2007. Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor. Immunity 27: 281&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034442</ArticleId><ArticleId IdType="pubmed">17723218</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsenio J, Kakaradov B, Metz PJ, Kim SH, Yeo GW, and Chang JT. 2014. Early specification of CD8 + T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat. Immunol. Vol. 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968536</ArticleId><ArticleId IdType="pubmed">24584088</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, H&#xf6;chst B, Eickhoff S, Rieckmann JC, Russo C, Bauer T, Flecken T, Giesen D, Engel D, Jung S, Busch DH, Protzer U, Thimme R, Mann M, Kurts C, Schultze JL, Kastenm&#xfc;ller W, and Knolle PA. 2015. Functional classification of memory CD8+ T cells by CX3CR1 expression. Nat. Commun. 6: 8306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4667439</ArticleId><ArticleId IdType="pubmed">26404698</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK, Li HS, Rivera RR, Lind KC, D&#x2019;Cruz LM, Watowich SS, Murre C, and Goldrath AW. 2011. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat. Immunol. 12: 1221&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3872000</ArticleId><ArticleId IdType="pubmed">22057289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Pos Z, Rao M, Klebanoff CA, Yu Z, Sukumar M, Reger RN, Palmer DC, Borman ZA, Muranski P, Wang E, Schrump DS, Marincola FM, Restifo NP, and Gattinoni L. 2011. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat. Immunol. 12: 1230&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226770</ArticleId><ArticleId IdType="pubmed">22057288</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31885758</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1925-8348</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian geriatrics journal : CGJ</Title><ISOAbbreviation>Can Geriatr J</ISOAbbreviation></Journal><ArticleTitle>Advance Care Planning and Decision-Making in a Home-Based Primary Care Service in a Canadian Urban Centre.</ArticleTitle><Pagination><StartPage>182</StartPage><EndPage>189</EndPage><MedlinePgn>182-189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5770/cgj.22.377</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Advance care planning (ACP) is a process that enables individuals to describe, in advance, the kind of health care they would want in the future, and has been shown to reduce hospital-based interventions at the end of life. Our goal was to describe the current state of ACP in a home-based primary care program for frail homebound older people in Vancouver, Canada. We did this by identifying four key elements that should be essential to ACP in this program: frailty stage, documentation of substitute decision-makers, and decision-making with regard to both resuscitation (i.e., do not resuscitate (DNR)) and hospitalization (i.e., do not hospitalize (DNH)). While these elements are an important part of the ACP process, they are often excluded from common practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional, observational study of data abstracted from 200 randomly selected patient electronic medical records between July 1 and September 30, 2017. We describe the association between demographic characteristics, comorbidities, and four key elements of ACP documentation and decision-making as documented in the clinical record using bivariate comparison, a logistic regression model and multiple logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 73% (n=146) of the patient records, there was no explicit documentation of frailty stage. Sixty-four per cent had documentation of a substitute decision-maker. Of those who had their preferences documented, 90.6% (n=144/159) indicated a preference for DNR, and 23.6% (n=29/123) indicated a preference for DNH. In multiple regression modeling, a diagnosis of dementia and older age were associated with documentation of a DNR preference, adjusted odds ratio (AOR) = 4.79 (95% CI 1.37, 16.71) and AOR = 1.14 (95% CI 1.05, 1.24), respectively. Older age, male sex, and English identified as the main language spoken were associated with a DNH preference. AOR = 1.17 (95% CI 1.06, 1.28), AOR = 4.19 (95% CI 1.41, 12.42), and AOR = 3.42 (95% CI 1.14, 10.20), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinician documentation of some elements of ACP, such as identification of a substitute decision-maker and resuscitation status, have been widely adopted, while other elements that should be considered essential components of ACP, such as frailty staging and preferences around hospitalization, are infrequent and provide an opportunity for practice improvement initiatives. The significant association between language and ACP decisions suggests an important role for supporting cross-cultural fluency in the ACP process.</AbstractText><CopyrightInformation>&#xa9; 2019 Author(s). Published by the Canadian Geriatrics Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGregor</LastName><ForeName>Margaret J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Michelle B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauder</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slater</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Clarissa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Home-ViVE Program, Vancouver General Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallery</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moorhouse</LastName><ForeName>Paige</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusnak</LastName><ForeName>Conrad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Geriatr J</MedlineTA><NlmUniqueID>101579189</NlmUniqueID><ISSNLinking>1925-8348</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">advance care planning</Keyword><Keyword MajorTopicYN="N">do not hospitalize</Keyword><Keyword MajorTopicYN="N">do not resuscitate</Keyword><Keyword MajorTopicYN="N">frailty staging</Keyword><Keyword MajorTopicYN="N">homebased primary care</Keyword><Keyword MajorTopicYN="N">substitute decision-maker</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST DISCLOSURES The authors declare that no conflicts of interest exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31885758</ArticleId><ArticleId IdType="pmc">PMC6887142</ArticleId><ArticleId IdType="doi">10.5770/cgj.22.377</ArticleId><ArticleId IdType="pii">cgj-22-182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173(5):489&#x2013;95. doi: 10.1503/cmaj.050051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487&#x2013;92. doi: 10.1111/j.1532-5415.2012.04054.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.04054.x</ArticleId><ArticleId IdType="pubmed">22881367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HS, Watts JN, Peel NM, et al. Frailty and post-operative outcomes in older surgical patients: a systematic review. BMC Geriatr. 2016;16(1):157. doi: 10.1186/s12877-016-0329-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-016-0329-8</ArticleId><ArticleId IdType="pmc">PMC5007853</ArticleId><ArticleId IdType="pubmed">27580947</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans SJ, Sayers M, Mitnitski A, et al. The risk of adverse outcomes in hospitalized older patients in relation to a frailty index based on a comprehensive geriatric assessment. Age Ageing. 2014;43(1):127&#x2013;32. doi: 10.1093/ageing/aft156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/aft156</ArticleId><ArticleId IdType="pubmed">24171946</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor M, Pare D, Wong A, et al. Correlates of a &#x201c;do not hospitalize&#x201d; designation: In a sample of frail nursing home residents in Vancouver. Can Fam Physician. 2010;56(11):1158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2980437</ArticleId><ArticleId IdType="pubmed">21075999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallery LH, Moorhouse P. Respecting frailty. J Med Ethics. 2011;37(2):126&#x2013;28. doi: 10.1136/jme.2010.040147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jme.2010.040147</ArticleId><ArticleId IdType="pubmed">21097941</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson M, Attree M, Jones I, et al. Diagnosis, prognosis and awareness of dying in nursing homes: towards the Gold Standard? Int J Older People Nurs. 2014;9(2):95&#x2013;105. doi: 10.1111/opn.12024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/opn.12024</ArticleId><ArticleId IdType="pubmed">23437805</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorhouse P, Koller K, Mallery L. End of life care in frailty. Interdiscip Top Gerontol Geriatr. 2015;41:151&#x2013;60. doi: 10.1159/000381232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381232</ArticleId><ArticleId IdType="pubmed">26301987</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone MJ, Kanitsaki O. Ethics and advance care planning in a culturally diverse society. J Transcult Nurs. 2009;20(4):405&#x2013;16. doi: 10.1177/1043659609340803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1043659609340803</ArticleId><ArticleId IdType="pubmed">19597187</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorhouse P, Mallery LH. Palliative and therapeutic harmonization: a model for appropriate decision-making in frail older adults. J Am Geriatr Soc. 2012;60(12):2326&#x2013;32. doi: 10.1111/j.1532-5415.2012.04210.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.04210.x</ArticleId><ArticleId IdType="pubmed">23110462</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor M, Cox MB, Slater J, et al. A before-after study of hospital use in two frail populations receiving different homebased services over the same time in Vancouver, Canada. BMC Health Serv Res. 2018;18(1):248. doi: 10.1186/s12913-018-3040-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-018-3040-y</ArticleId><ArticleId IdType="pmc">PMC5887263</ArticleId><ArticleId IdType="pubmed">29622006</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew MK. Social vulnerability in old age, Chap. 33. In: Fillit HM, Rockwood K, Woodhouse K, editors. Brocklehurst&#x2019;s Textbook of Geriatric Medicine and Gerontology. 7th edition. Philadelphia, PA: Saunders Elsevier; 2010. pp. 198&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-1-4160-6231-8.10033-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C, Jackson SS, Bullman TA, et al. Impact of home-based primary care program in an urban Veterans Affairs medical center. J Am Med Dir Assoc. 2009;10(2):133&#x2013;37. doi: 10.1016/j.jamda.2008.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2008.08.002</ArticleId><ArticleId IdType="pubmed">19187882</ArticleId></ArticleIdList></Reference><Reference><Citation>Trarieux-Signol S, Moreau S, Gourin MP, et al. Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies. BMC Palliative Care. 2014;13(1):57. doi: 10.1186/1472-684X-13-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-684X-13-57</ArticleId><ArticleId IdType="pmc">PMC4391307</ArticleId><ArticleId IdType="pubmed">25859160</ArticleId></ArticleIdList></Reference><Reference><Citation>Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. The BMJ. 2010;340:1345. doi: 10.1136/bmj.c1345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c1345</ArticleId><ArticleId IdType="pmc">PMC2844949</ArticleId><ArticleId IdType="pubmed">20332506</ArticleId></ArticleIdList></Reference><Reference><Citation>Teno J, Gruneir A, Schwartz Z, et al. Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc. 2007;55(2):189&#x2013;94. doi: 10.1111/j.1532-5415.2007.01045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2007.01045.x</ArticleId><ArticleId IdType="pubmed">17302654</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S, Lawand C. A snapshot of advance directives in long-term care: how often is &#x201c;do not&#x201d; done? Healthcare Q. 2017;19(4):10&#x2013;12. doi: 10.12927/hcq.2017.25018.</Citation><ArticleIdList><ArticleId IdType="doi">10.12927/hcq.2017.25018</ArticleId><ArticleId IdType="pubmed">28130945</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institute for Health, Quick Stats. Access Data &amp; Reports. Table I: Number of facilities and residents in continuing care facilities submitting to CCRS by province/territory 2017&#x2013;2018.   https://www.cihi.ca/en/quick-stats.</Citation></Reference><Reference><Citation>Howard M, Bernard C, Klein D, et al. Barriers to and enablers of advance care planning with patients in primary care: survey of health care providers. Can Fam Physician. 2018;64(4):e190&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897087</ArticleId><ArticleId IdType="pubmed">29650621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HWB. Advance care planning in Chinese seniors: cultural perspective. J Palliative Care. 2018;33(4):242&#x2013;46. doi: 10.1177/0825859718763644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0825859718763644</ArticleId><ArticleId IdType="pubmed">29569520</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell A, Morris J, Park P, et al. Terminal care for persons with advanced dementia in the nursing home and home care settings. J Palliative Med. 2004;7(6):808&#x2013;16. doi: 10.1089/jpm.2004.7.808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2004.7.808</ArticleId><ArticleId IdType="pubmed">15684848</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Jawahari A, Podgurski L, Eichler A, et al. Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial. J Clin Oncol. 2010;28(2):305&#x2013;10. doi: 10.1200/JCO.2009.24.7502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2009.24.7502</ArticleId><ArticleId IdType="pmc">PMC3040012</ArticleId><ArticleId IdType="pubmed">19949010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried T, Van Ness P, Byers A, et al. Changes in preferences for life-sustaining treatment among older persons with advanced illness. J Gen Intern Med. 2007;22(4):495&#x2013;501. doi: 10.1007/s11606-007-0104-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-007-0104-9</ArticleId><ArticleId IdType="pmc">PMC1839865</ArticleId><ArticleId IdType="pubmed">17372799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried T, O&#x2019;leary J, Van Ness P, et al. Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc. 2007;55(7):1007&#x2013;14. doi: 10.1111/j.1532-5415.2007.01232.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2007.01232.x</ArticleId><ArticleId IdType="pmc">PMC1948955</ArticleId><ArticleId IdType="pubmed">17608872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonashiro-Cho J, Cote S, Enguidanos S. Knowledge about and perceptions of advance care planning and communication of Chinese-American older adults. J Am Geriatr Soc. 2016;64(9):1884&#x2013;89. doi: 10.1111/jgs.14261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14261</ArticleId><ArticleId IdType="pubmed">27584825</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S, Wong ST, Katz A, et al. The influence of patient-clinician ethnocultural and language concordance on continuity and quality of care: a cross-sectional analysis. CMAJ Open. 2018;6(3):e276&#x2013;84. doi: 10.9778/cmajo.20170160.</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20170160</ArticleId><ArticleId IdType="pmc">PMC6182102</ArticleId><ArticleId IdType="pubmed">30026191</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31511640</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2042-0226</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cellular &amp; molecular immunology</Title><ISOAbbreviation>Cell Mol Immunol</ISOAbbreviation></Journal><ArticleTitle>Deubiquitinase Otub1 negatively regulates IL-15 signaling in CD8 T cells and NK cells.</ArticleTitle><Pagination><StartPage>846</StartPage><EndPage>847</EndPage><MedlinePgn>846-847</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41423-019-0283-4</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, 55414, USA. hamil062@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA077598</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cell Mol Immunol</MedlineTA><NlmUniqueID>101242872</NlmUniqueID><ISSNLinking>1672-7681</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000072017">Deubiquitinating Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Immunol. 2019 Jul;20(7):879-889. doi: 10.1038/s41590-019-0405-2.</RefSource><PMID Version="1">31182807</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072017" MajorTopicYN="Y">Deubiquitinating Enzymes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019409" MajorTopicYN="Y">Interleukin-15</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31511640</ArticleId><ArticleId IdType="pmc">PMC6828713</ArticleId><ArticleId IdType="doi">10.1038/s41423-019-0283-4</ArticleId><ArticleId IdType="pii">10.1038/s41423-019-0283-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leonard, W. J., Lin, J. X. &amp; O&#x2019;Shea, J. J. <i>Immunity</i>. 10.1016/j.immuni.2019.03.028 (2009).</Citation></Reference><Reference><Citation>Zhou, X. et al. <i>Nat. Immunol.</i><b>20</b>, 879&#x2013;889 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588407</ArticleId><ArticleId IdType="pubmed">31182807</ArticleId></ArticleIdList></Reference><Reference><Citation>Rautela, J. &amp; Huntington, N. D. <i>Curr. Opin. Immunol.</i><b>44</b>, 1&#x2013;6 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27835762</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmann, T. A. &amp; Tagaya, Y. <i>Annu. Rev. Immunol.</i><b>17</b>, 19&#x2013;49 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10358752</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31412243</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization.</ArticleTitle><Pagination><StartPage>1729</StartPage><EndPage>1743.e5</EndPage><MedlinePgn>1729-1743.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2019.07.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(19)30925-8</ELocationID><Abstract><AbstractText>Microbial exposures can define an individual's basal immune state. Cohousing specific pathogen-free (SPF) mice with pet store mice, which harbor numerous infectious microbes, results in global changes to the&#xa0;immune system, including increased circulating phagocytes and elevated inflammatory cytokines. How these differences in the basal immune state influence the acute response to systemic infection is unclear. Cohoused mice exhibit enhanced protection from virulent Listeria monocytogenes (LM) infection, but increased morbidity and mortality to polymicrobial sepsis. Cohoused mice have more TLR2<sup>+</sup> and TLR4<sup>+</sup> phagocytes, enhancing recognition of microbes through pattern-recognition receptors. However, the response to a TLR2 ligand is muted in cohoused mice, whereas the response to a TLR4 ligand is greatly amplified, suggesting a basis for the distinct response to Listeria monocytogenes and sepsis. Our data illustrate how microbial exposure can enhance the immune response to unrelated challenges but also increase the risk of immunopathology from a severe cytokine storm.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sjaastad</LastName><ForeName>Frances V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucaba</LastName><ForeName>Tamara A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swanson</LastName><ForeName>Whitney</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staley</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weingarden</LastName><ForeName>Alexa R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Soil, Water, and Climate and The BioTechnology Institute, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Isaac J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danahy</LastName><ForeName>Derek B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badovinac</LastName><ForeName>Vladimir P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA; Department of Pathology, University of Iowa, Iowa City, IA, USA; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vezys</LastName><ForeName>Vaiva</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masopust</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoruts</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffith</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Department of Urology, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Minneapolis VA Health Care System, Minneapolis, MN, USA. Electronic address: tgriffit@umn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA; Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Electronic address: hamil062@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007485</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX001324</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA009138</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM115462</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM113961</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007511</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI143828</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI116678</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007313</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA077598</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493486">Tlr2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493487">Tlr4 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008089" MajorTopicYN="N">Listeria monocytogenes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008088" MajorTopicYN="N">Listeriosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010586" MajorTopicYN="N">Phagocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051195" MajorTopicYN="N">Toll-Like Receptor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Listeria monocytogenes</Keyword><Keyword MajorTopicYN="N">Toll-like receptors</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">physiological microbial exposure</Keyword><Keyword MajorTopicYN="N">polymicrobial sepsis</Keyword></KeywordList><CoiStatement>DECLARATION OF INTERESTS. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31412243</ArticleId><ArticleId IdType="mid">NIHMS1537427</ArticleId><ArticleId IdType="pmc">PMC6703181</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2019.07.028</ArticleId><ArticleId IdType="pii">S2211-1247(19)30925-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akira S, Takeda K, and Kaisho T (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol 2, 675&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">11477402</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Uematsu S, and Takeuchi O (2006). Pathogen recognition and innate immunity. Cell 724, 783&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MJ, and Willis TJ (2003). Canonical analysis of principal coordinates: A useful method of constrained ordination for ecology. Ecology 84, 511&#x2013;525.</Citation></Reference><Reference><Citation>Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, and Virgin HW 4th. (2007). Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">17507983</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, and Hand TW (2014). Role of the microbiota in immunity and inflammation. Cell 157, 121&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg RE, Crossley E, Murray S, and Forman J (2003). Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med 198, 1583&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592647</ArticleId><ArticleId IdType="pubmed">14623912</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg RE, Crossley E, Murray S, and Forman J (2005). Relative contributions of NK and CD8Tcellsto IFN-gamma mediated innate immune protection against Listeria monocytogenes. J. Immunol 175, 1751&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1615713</ArticleId><ArticleId IdType="pubmed">16034116</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, et al. (2016). Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler BA (2009). TLRs and innate immunity. Blood 113, 1399&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644070</ArticleId><ArticleId IdType="pubmed">18757776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray JR, and Curtis JT (1957). An ordination of the upland forest communities of southern Wisconsin. Ecol. Monogr. 27, 325&#x2013;349.</Citation></Reference><Reference><Citation>Cabrera-Perez J, Condotta SA, Badovinac VP, and Griffith TS (2014). Impact of sepsis on CD4 T cell immunity. J. Leukoc. Biol 96, 767&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197564</ArticleId><ArticleId IdType="pubmed">24791959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Perez J, Condotta SA, James BR, Kashem SW, Brincks EL, Rai D, Kucaba TA, Badovinac VP, and Griffith TS (2015). Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J. Immunol 194, 1609&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4412277</ArticleId><ArticleId IdType="pubmed">25595784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Perez J, Babcock JC, Dileepan T, Murphy KA, Kucaba TA, Badovinac VP, and Griffith TS (2016). Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after Sepsis. J. Immunol 197, 1692&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4992581</ArticleId><ArticleId IdType="pubmed">27448587</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Perez J, Badovinac VP, and Griffith TS (2017). Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease. Exp. Biol. Med. (Maywood) 242, 127&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5167116</ArticleId><ArticleId IdType="pubmed">27633573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipeta J, Komada Y, Zhang XL, Deguchi T, Sugiyama K, Azuma E, and Sakurai M (1998). CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. Cell. Immunol 183, 149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">9606999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chousterman BG, Swirski FK, and Weber GF (2017). Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 39, 517&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">28555385</ArticleId></ArticleIdList></Reference><Reference><Citation>Claesson MJ, Wang Q, O&#x2019;Sullivan O, Greene-Diniz R, Cole JR, Ross RP, and O&#x2019;Toole PW (2010). Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res. 38, e200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001100</ArticleId><ArticleId IdType="pubmed">20880993</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke KR (1993). Non-parametric multivariate analyses of changes in community structure. Aust. J. Ecol 18, 117&#x2013;143.</Citation></Reference><Reference><Citation>Condotta SA, Rai D, James BR, Griffith TS, and Badovinac VP (2013). Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J. Immunol 190, 1991&#x2013;2000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578009</ArticleId><ArticleId IdType="pubmed">23355736</ArticleId></ArticleIdList></Reference><Reference><Citation>Condotta SA, Khan SH, Rai D, Griffith TS, and Badovinac VP (2015). Polymicrobial sepsis increases susceptibility to chronic viral infection and exacerbates CD8+ T cell exhaustion. J. Immunol 195, 116&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4475506</ArticleId><ArticleId IdType="pubmed">25980007</ArticleId></ArticleIdList></Reference><Reference><Citation>Danahy DB, Anthony SM, Jensen IJ, Hartwig SM, Shan Q, Xue HH, Harty JT, Griffith TS, and Badovinac VP (2017). Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 13, e1006569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599054</ArticleId><ArticleId IdType="pubmed">28910403</ArticleId></ArticleIdList></Reference><Reference><Citation>Danahy DB, Jensen IJ, Griffith TS, and Badovinac VP (2019). Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host Survival. J. Immunol 202, 2843&#x2013;2848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6504616</ArticleId><ArticleId IdType="pubmed">30971442</ArticleId></ArticleIdList></Reference><Reference><Citation>Doudna JA, and Charpentier E (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096.</Citation><ArticleIdList><ArticleId IdType="pubmed">25430774</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong S, Condotta SA, Rai D, Martin MD, Griffith TS, and Badovinac VP (2014). Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions. J. Immunol 192, 3618&#x2013;3625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001259</ArticleId><ArticleId IdType="pubmed">24646738</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RC, Haas BJ, Clemente JC, Quince C, and Knight R (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150044</ArticleId><ArticleId IdType="pubmed">21700674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink MP (2014). Animal models of sepsis. Virulence 5, 143&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3916368</ArticleId><ArticleId IdType="pubmed">24022070</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster HL (1959). Housing of disease-free vertebrates. Ann. N Y Acad. Sci 78, 80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">13824112</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster SL, Hargreaves DC, and Medzhitov R (2007). Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">17538624</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin BS, Parroche P, Ataide MA, Lauw F, Ropert C, de Oliveira RB, Pereira D, Tada MS, Nogueira P, da Silva LH, et al. (2009). Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc. Natl. Acad. Sci. USA 106, 5789&#x2013;5794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2657593</ArticleId><ArticleId IdType="pubmed">19297619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparoni A, Ciardelli L, Avanzini A, Castellazzi AM, Carini R, Rondini G, and Chirico G (2003). Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol. Neonate 84, 297&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">14593240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung P, Rai D, Condotta SA, Babcock JC, Badovinac VP, and Griffith TS (2011). Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent. J. Immunol 187, 2148&#x2013;2154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3159846</ArticleId><ArticleId IdType="pubmed">21788440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hack CE, DeGroot ER, Felt-Bersma RJ, Nuijens JH, StrackVan Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, and Aarden LA (1989). Increased plasma levels of interleukin-6 in sepsis. Blood 74, 1704&#x2013;1710.</Citation><ArticleIdList><ArticleId IdType="pubmed">2790194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Wolkers MC, Schoenberger SP, and Jameson SC (2006). The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat. Immunol 7, 475&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">16604076</ArticleId></ArticleIdList></Reference><Reference><Citation>Haring JS, Badovinac VP, and Harty JT (2006). Inflaming the CD8+ T cell response. Immunity 25, 19&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">16860754</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rtel C, Adam N, Strunk T, Temming P, M&#xfc;ller-Steinhardt M, and Schultz C (2005). Cytokine responses correlate differentially with age in infancy and early childhood. Clin. Exp. Immunol 142, 446&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1809539</ArticleId><ArticleId IdType="pubmed">16297156</ArticleId></ArticleIdList></Reference><Reference><Citation>Harty JT, and Bevan MJ (1995). Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 3, 109&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">7621071</ArticleId></ArticleIdList></Reference><Reference><Citation>Heipertz EL, Harper J, Lopez CA, Fikrig E, Hughes ME, and Walker WE (2018). Circadian Rhythms Influence the Severity of Sepsis in Mice via a TLR2-Dependent, Leukocyte-Intrinsic Mechanism. J. Immunol 201, 193&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9351006</ArticleId><ArticleId IdType="pubmed">29760192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbert T, Steinhagen F, Senzig S, Cramer N, Bekeredjian-Ding I, Parcina M, Baumgarten G, Hoeft A, Frede S, Boehm O, and Klaschik S (2017). Vendor effects on murine gut microbiota influence experimental abdominal sepsis. J. Surg. Res 211, 126&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, and Karl IE (2003). The pathophysiology and treatment of sepsis. N. Engl. J. Med 348, 138&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12519925</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Jameson SC, and Hamilton SE (2019). Embracing microbial exposure in mouse research. J. Leukoc. Biol 105, 73&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318123</ArticleId><ArticleId IdType="pubmed">30260516</ArticleId></ArticleIdList></Reference><Reference><Citation>Huse SM, Welch DM, Morrison HG, and Sogin ML (2010). Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ. Microbiol 12, 1889&#x2013;1898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2909393</ArticleId><ArticleId IdType="pubmed">20236171</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G, and Brinster C (2009). Isolation of dendritic cells. Curr Protoc Immunol. Chapter 3, Unit 3.7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19653207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen IJ, Sjaastad FV, Griffith TS, and Badovinac VP (2018a). Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. J. Immunol 200, 1543&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826615</ArticleId><ArticleId IdType="pubmed">29463691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen IJ, Winborn CS, Fosdick MG, Shao P, Tremblay MM, Shan Q, Tripathy SK, Snyder CM, Xue HH, Griffith TS, et al. (2018b). Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 14, e1007405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231673</ArticleId><ArticleId IdType="pubmed">30379932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada N, Seo SU, Chen GY, and N&#xfa;&#xf1;ez G (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol 13, 321&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">23618829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, and Akira S (2011).Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T, and Kawai T (2014). Toll-like receptor signaling pathways. Front. Immunol 5, 461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4174766</ArticleId><ArticleId IdType="pubmed">25309543</ArticleId></ArticleIdList></Reference><Reference><Citation>Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC, Collman RG, Bushman FD, Knight R, and Kelley ST (2011). Bayesian community-wide culture-independent microbial source tracking. Nat. Methods 8, 761&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791591</ArticleId><ArticleId IdType="pubmed">21765408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, Lavoie PM, Furlong J, Fortuno ES 3rd, Hajjar AM, et al. (2009). Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol 183, 7150&#x2013;7160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556237</ArticleId><ArticleId IdType="pubmed">19917677</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinonen R, Sugawara H, and Shumway M; International Nucleotide Sequence Database Collaboration (2011). The sequence read archive. Nucleic Acids Res. 39, D19&#x2013;D21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3013647</ArticleId><ArticleId IdType="pubmed">21062823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lertmemongkolchai G, Cai G, Hunter CA, and Bancroft GJ (2001). Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J. Immunol 166, 1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">11145690</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, Vincent JL, Townsend S, Lemeshow S, and Dellinger RP (2012). Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect. Dis 12, 919&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima CX, Souza DG, Amaral FA, Fagundes CT, Rodrigues IP, Alves-Filho JC, Kosco-Vilbois M, Ferlin W, Shang L, Elson G, and Teixeira MM (2015). Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis. PLoS ONE 10, e0132336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492955</ArticleId><ArticleId IdType="pubmed">26147469</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai V, Torrazza RM, Ukhanova M, Wang X, Sun Y, Li N, Shuster J, Sharma R, Hudak ML, and Neu J (2013). Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLoS ONE 8, e52876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3544792</ArticleId><ArticleId IdType="pubmed">23341915</ArticleId></ArticleIdList></Reference><Reference><Citation>Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Wei-gel C, Bauer M, Griffith TS, F&#xf6;rster M, Brunkhorst FM, et al. (2014). Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of na&#xef;ve T-cells but no enduring cell-autonomous defects in T-cell function. PLoS ONE 9, e115094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4277344</ArticleId><ArticleId IdType="pubmed">25541945</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Sivula CP, and Jameson SC (2017). Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology. J. Immunol 199, 383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512602</ArticleId><ArticleId IdType="pubmed">28696328</ArticleId></ArticleIdList></Reference><Reference><Citation>McCall MB, Netea MG, Hermsen CC, Jansen T, Jacobs L, Golenbock D, van der Ven AJ, and Sauerwein RW (2007). Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J. Immunol 179, 162&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">17579034</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller B, and Grossniklaus U (2010). Model organisms-A historical perspective. J. Proteomics 73, 2054&#x2013;2063.</Citation><ArticleIdList><ArticleId IdType="pubmed">20727995</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O&#x2019;Neill LA, and Xavier RJ (2016).Trained immunity: A program of innate immune memory in health and disease. Science 352, aaf1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5087274</ArticleId><ArticleId IdType="pubmed">27102489</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira-Nascimento L, Massari P, and Wetzler LM (2012). The Role of TLR2 in Infection and Immunity. Front. Immunol 3, 79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342043</ArticleId><ArticleId IdType="pubmed">22566960</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JA, McDonald-Hyman C, Jameson SC, and Hamilton SE (2013). Effector-like CD8<sup>+</sup> T cells in the memory population mediate potent protective immunity. Immunity
38, 1250&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703254</ArticleId><ArticleId IdType="pubmed">23746652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedraza-S&#xe1;nchez S, Hise AG, Ramachandra L, Arechavaleta-Velasco F, and King CL (2013). Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns. Clin. Vaccine Immunol 20, 962&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3697450</ArticleId><ArticleId IdType="pubmed">23595503</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, et al. (2012). Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3864037</ArticleId><ArticleId IdType="pubmed">22901542</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese TA, Bi K, Kambal A, Filali-Mouhim A, Be&#xfc;ra LK, B&#xfc;rger MC, Pulendran B, Sekaly RP, Jameson SC, Masopust D, et al. (2016). Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response. Cell Host Microbe 19, 713&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896745</ArticleId><ArticleId IdType="pubmed">27107939</ArticleId></ArticleIdList></Reference><Reference><Citation>Remick DG, Newcomb DE, Bolgos GL, and Call DR (2000). Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">10670840</ArticleId></ArticleIdList></Reference><Reference><Citation>Remick DG, Bolgos GR, Siddiqui J, Shin J, and Nemzek JA (2002). Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17, 463&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12069181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittirsch D, Huber-Lang MS, Flierl MA, and Ward PA (2009). Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754226</ArticleId><ArticleId IdType="pubmed">19131954</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, Hickman HD, McCulloch JA, Badger JH, Ajami NJ, et al. (2017). Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. Cell 171, 1015&#x2013;1028.e1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887100</ArticleId><ArticleId IdType="pubmed">29056339</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. (2009). Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol 75, 7537&#x2013;7541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786419</ArticleId><ArticleId IdType="pubmed">19801464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo Y, Unsinger J, Burnham CA, Green JM, and Hotchkiss RS (2015). Interleukin-7 and anti-programmed cell death 1 antibody havediffering effects to reverse sepsis-induced immunosuppression. Shock 43, 334&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4359667</ArticleId><ArticleId IdType="pubmed">25565644</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo Y, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CD, Green JM, Morre M, Bochicchio GV, and Hotchkiss RS (2017). Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. J. Leukoc. Biol 101, 543&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5235902</ArticleId><ArticleId IdType="pubmed">27630218</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons MP, Moore JM, Kemp TJ, and Griffith TS (2007). Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils. Infect. Immun 75, 1265&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1828584</ArticleId><ArticleId IdType="pubmed">17194806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjaastad FV, Condotta SA, Kotov JA, Pape KA, Dail C, Danahy DB, Kucaba TA, Tygrett LT, Murphy KA, Cabrera-Perez J,et al. (2018). Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell Responses. Front. Immunol 9, 2532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220049</ArticleId><ArticleId IdType="pubmed">30429857</ArticleId></ArticleIdList></Reference><Reference><Citation>Spec A, Shindo Y, Burnham CA, Wilson S, Ablordeppey EA, Beiter ER, Chang K, Drewry AM, and Hotchkiss RS (2016). T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit. Care 20, 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719210</ArticleId><ArticleId IdType="pubmed">26786705</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley C, Kaiser T, Vaughn BP, Graiziger CT, Hamilton MJ, Rehman TU, Song K, Khoruts A, and Sadowsky MJ (2018). Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation. Microbiome 6, 166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6145197</ArticleId><ArticleId IdType="pubmed">30227892</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman RM, Kaplan G, Witmer MD, and Cohn ZA (1979). Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med 749, 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2184752</ArticleId><ArticleId IdType="pubmed">762493</ArticleId></ArticleIdList></Reference><Reference><Citation>Stortz JA, Raymond SL, Mira JC, Moldawer LL, Mohr AM, and Efron PA (2017). Murine Models of Sepsis and Trauma: Can We Bridge the Gap? ILARJ. 58, 90&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886315</ArticleId><ArticleId IdType="pubmed">28444204</ArticleId></ArticleIdList></Reference><Reference><Citation>Strother RK, Danahy DB, Kotov DI, Kucaba TA, Zacharias ZR, Griffith TS, Legge KL, and Badovinac VP (2016). Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo. J. Immunol 197, 4301&#x2013;4311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123856</ArticleId><ArticleId IdType="pubmed">27798171</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, and Akira S (2001a). Regulation of innate immune responses by Toll-like receptors. Jpn. J. Infect. Dis 54, 209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">11862002</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, and Akira S (2001b). Roles ofToll-like receptors in innate immune responses. Genes Cells 6, 733&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">11554921</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Kaisho T, and Akira S (2003). Toll-like receptors. Annu. Rev. Immunol 21, 335&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12524386</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiemann S, Smit N, Roy U, Lesker TR, Galvez EJC, Helmecke J, Basic M, Bleich A, Goodman AL, Kalinke U, et al. (2017). Enhancement of IFNgamma Production by Distinct Commensals Ameliorates Salmonella-Induced Disease. Cell Host Microbe 21, 682&#x2013;694.e685.</Citation><ArticleIdList><ArticleId IdType="pubmed">28618267</ArticleId></ArticleIdList></Reference><Reference><Citation>Unsinger J, Kazama H, McDonough JS, Hotchkiss RS, and Ferguson TA (2009). Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J. Leukoc. Biol 85, 382&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653946</ArticleId><ArticleId IdType="pubmed">19088177</ArticleId></ArticleIdList></Reference><Reference><Citation>Venet F, Foray A-P, Villars-M&#xe9;chin A, Malcus C, Poitevin-Later F, Lepape A, and Monneret G (2012). IL-7 restores lymphocyte functions in septic patients. J. Immunol 189, 5073&#x2013;5081.</Citation><ArticleIdList><ArticleId IdType="pubmed">23053510</ArticleId></ArticleIdList></Reference><Reference><Citation>Venet F, Demaret J, Blaise BJ, Rouget C, Girardot T, Idealisoa E, Rimmel&#xe9; T, Mallet F, Lepape A, Textoris J, and Monneret G (2017). IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. J. Immunol 199, 1606&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pubmed">28724580</ArticleId></ArticleIdList></Reference><Reference><Citation>Waage A, Brandtzaeg P, Halstensen A, Kierulf P, and Espevik T (1989). The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med 169, 333&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189201</ArticleId><ArticleId IdType="pubmed">2783334</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, and Cavaillon JM (2010). Resilience to bacterial infection: difference between species could be due to proteins in serum. J. Infect. Dis 201, 223&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798011</ArticleId><ArticleId IdType="pubmed">20001600</ArticleId></ArticleIdList></Reference><Reference><Citation>West EE, Jin H-T, Rasheed A-U, Penaloza-Macmaster P, Ha S-J, Tan WG, Youngblood B, Freeman GJ, Smith KA, and Ahmed R (2013). PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest 123, 2604&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668811</ArticleId><ArticleId IdType="pubmed">23676462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry EJ, Teichgr&#xe4;ber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, and Ahmed R (2003). Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol 4, 225&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">12563257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanotti S, Kumar A, and Kumar A (2002). Cytokine modulation in sepsis and septic shock. Expert Opin. Investig. Drugs 11, 1061&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">12150702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30940709</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>02</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>Respiratory Heterogeneity Shapes Biofilm Formation and Host Colonization in Uropathogenic Escherichia coli.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02400-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.02400-18</ELocationID><Abstract><AbstractText>Biofilms are multicellular bacterial communities encased in a self-secreted extracellular matrix comprised of polysaccharides, proteinaceous fibers, and DNA. Organization of these components lends spatial organization to the biofilm community such that biofilm residents can benefit from the production of common goods while being protected from exogenous insults. Spatial organization is driven by the presence of chemical gradients, such as oxygen. Here we show that two quinol oxidases found in <i>Escherichia coli</i> and other bacteria organize along the biofilm oxygen gradient and that this spatially coordinated expression controls architectural integrity. Cytochrome <i>bd</i>, a high-affinity quinol oxidase required for aerobic respiration under hypoxic conditions, is the most abundantly expressed respiratory complex in the biofilm community. Depletion of the cytochrome <i>bd-</i>expressing subpopulation compromises biofilm complexity by reducing the abundance of secreted extracellular matrix as well as increasing cellular sensitivity to exogenous stresses. Interrogation of the distribution of quinol oxidases in the planktonic state revealed that &#x223c;15% of the population expresses cytochrome <i>bd</i> at atmospheric oxygen concentration, and this population dominates during acute urinary tract infection. These data point toward a bet-hedging mechanism in which heterogeneous expression of respiratory complexes ensures respiratory plasticity of <i>E. coli</i> across diverse host niches.<b>IMPORTANCE</b> Biofilms are multicellular bacterial communities encased in a self-secreted extracellular matrix comprised of polysaccharides, proteinaceous fibers, and DNA. Organization of these components lends spatial organization in the biofilm community. Here we demonstrate that oxygen gradients in uropathogenic <i>Escherichia coli</i> (UPEC) biofilms lead to spatially distinct expression programs for quinol oxidases-components of the terminal electron transport chain. Our studies reveal that the cytochrome <i>bd</i>-expressing subpopulation is critical for biofilm development and matrix production. In addition, we show that quinol oxidases are heterogeneously expressed in planktonic populations and that this respiratory heterogeneity provides a fitness advantage during infection. These studies define the contributions of quinol oxidases to biofilm physiology and suggest the presence of respiratory bet-hedging behavior in UPEC.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Beebout et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beebout</LastName><ForeName>Connor J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eberly</LastName><ForeName>Allison R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werby</LastName><ForeName>Sabrina H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reasoner</LastName><ForeName>Seth A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brannon</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De</LastName><ForeName>Shuvro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pediatric Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Madison J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marissa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clayton</LastName><ForeName>Douglass B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Division of Pediatric Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cegelski</LastName><ForeName>Lynette</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjifrangiskou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA maria.hadjifrangiskou@vumc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 DK106472</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI107052</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007347</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 DK076169</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.-</RegistryNumber><NameOfSubstance UI="C020094">duroquinol oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000332" MajorTopicYN="N">Aerobiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000693" MajorTopicYN="N">Anaerobiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018441" MajorTopicYN="N">Biofilms</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073537" MajorTopicYN="Y">Biological Variation, Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018740" MajorTopicYN="Y">Genetic Heterogeneity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056689" MajorTopicYN="N">Uropathogenic Escherichia coli</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Escherichia coli</Keyword><Keyword MajorTopicYN="N">biofilms</Keyword><Keyword MajorTopicYN="N">heterogeneity</Keyword><Keyword MajorTopicYN="N">oxygen gradients</Keyword><Keyword MajorTopicYN="N">respiration</Keyword><Keyword MajorTopicYN="N">urinary tract infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30940709</ArticleId><ArticleId IdType="pmc">PMC6445943</ArticleId><ArticleId IdType="doi">10.1128/mBio.02400-18</ArticleId><ArticleId IdType="pii">mBio.02400-18</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kostakioti M, Hadjifrangiskou M, Hultgren SJ. 2013. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 3:a010306. doi: 10.1101/cshperspect.a010306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a010306</ArticleId><ArticleId IdType="pmc">PMC3683961</ArticleId><ArticleId IdType="pubmed">23545571</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199&#x2013;210. doi: 10.1038/nrmicro1838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1838</ArticleId><ArticleId IdType="pubmed">18264116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadell CD, Drescher K, Foster KR. 2016. Spatial structure, cooperation and competition in biofilms. Nat Rev Microbiol 14:589&#x2013;600. doi: 10.1038/nrmicro.2016.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.84</ArticleId><ArticleId IdType="pubmed">27452230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlamakis H, Aguilar C, Losick R, Kolter R. 2008. Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev 22:945&#x2013;953. doi: 10.1101/gad.1645008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1645008</ArticleId><ArticleId IdType="pmc">PMC2279205</ArticleId><ArticleId IdType="pubmed">18381896</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gestel J, Vlamakis H, Kolter R. 2015. Division of labor in biofilms: the ecology of cell differentiation. Microbiol Spectr 3:MB-0002-2014. doi: 10.1128/microbiolspec.MB-0002-2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.MB-0002-2014</ArticleId><ArticleId IdType="pubmed">26104716</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago&#x161; A, Kiesewalter H, Martin M, Hsu CY, Hartmann R, Wechsler T, Eriksen C, Brix S, Drescher K, Stanley-Wall N, K&#xfc;mmerli R, Kov&#xe1;cs &#xc1;. 2018. Division of labor during biofilm matrix production. Curr Biol 28:1903&#x2013;1913.e5. doi: 10.1016/j.cub.2018.04.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.04.046</ArticleId><ArticleId IdType="pmc">PMC6331042</ArticleId><ArticleId IdType="pubmed">29887307</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich LE, Okegbe C, Price-Whelan A, Sakhtah H, Hunter RC, Newman DK. 2013. Bacterial community morphogenesis is intimately linked to the intracellular redox state. J Bacteriol 195:1371&#x2013;1380. doi: 10.1128/JB.02273-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.02273-12</ArticleId><ArticleId IdType="pmc">PMC3624522</ArticleId><ArticleId IdType="pubmed">23292774</ArticleId></ArticleIdList></Reference><Reference><Citation>DePas WH, Hufnagel DA, Lee JS, Blanco LP, Bernstein HC, Fisher ST, James GA, Stewart PS, Chapman MR. 2013. Iron induces bimodal population development by Escherichia coli. Proc Natl Acad Sci U S A 110:2629&#x2013;2634. doi: 10.1073/pnas.1218703110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218703110</ArticleId><ArticleId IdType="pmc">PMC3574911</ArticleId><ArticleId IdType="pubmed">23359678</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd KA, Moore JL, Eberly AR, Good JA, Shaffer CL, Zaver H, Almqvist F, Skaar EP, Caprioli RM, Hadjifrangiskou M. 2015. Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLoS Pathog 11:e1004697. doi: 10.1371/journal.ppat.1004697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004697</ArticleId><ArticleId IdType="pmc">PMC4349694</ArticleId><ArticleId IdType="pubmed">25738819</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo J, Cortez KL, Cornell WC, Price-Whelan A, Dietrich LE. 
2017. 
An orphan <i>cbb</i><sub>3</sub>-type cytochrome oxidase subunit supports <i>Pseudomonas aeruginosa</i> biofilm growth and virulence. Elife
6:30205. doi: 10.7554/eLife.30205.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30205</ArticleId><ArticleId IdType="pmc">PMC5697931</ArticleId><ArticleId IdType="pubmed">29160206</ArticleId></ArticleIdList></Reference><Reference><Citation>Unden G, Bongaerts J. 1997. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta 1320:217&#x2013;234. doi: 10.1016/S0005-2728(97)00034-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0005-2728(97)00034-0</ArticleId><ArticleId IdType="pubmed">9230919</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov VB, Verkhovsky MI. 2015. Oxygen as acceptor. EcoSal Plus 6(2). doi: 10.1128/ecosalplus.ESP-0012-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/ecosalplus.ESP-0012-2015</ArticleId><ArticleId IdType="pmc">PMC11575855</ArticleId><ArticleId IdType="pubmed">26734697</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov VB, Gennis RB, Hemp J, Verkhovsky MI. 2011. The cytochrome bd respiratory oxygen reductases. Biochim Biophys Acta 1807:1398&#x2013;1413. doi: 10.1016/j.bbabio.2011.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2011.06.016</ArticleId><ArticleId IdType="pmc">PMC3171616</ArticleId><ArticleId IdType="pubmed">21756872</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris RL, Schmidt TM. 2013. Shallow breathing: bacterial life at low O(2). Nat Rev Microbiol 11:205&#x2013;212. doi: 10.1038/nrmicro2970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2970</ArticleId><ArticleId IdType="pmc">PMC3969821</ArticleId><ArticleId IdType="pubmed">23411864</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov VB, Murali R, Verkhovskaya ML, Bloch DA, Han H, Gennis RB, Verkhovsky MI. 2011. Aerobic respiratory chain of Escherichia coli is not allowed to work in fully uncoupled mode. Proc Natl Acad Sci U S A 108:17320&#x2013;17324. doi: 10.1073/pnas.1108217108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1108217108</ArticleId><ArticleId IdType="pmc">PMC3198357</ArticleId><ArticleId IdType="pubmed">21987791</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5:913&#x2013;919. doi: 10.1038/nchembio.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.242</ArticleId><ArticleId IdType="pmc">PMC2838449</ArticleId><ArticleId IdType="pubmed">19915538</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurcisek JA, Brockman KL, Novotny LA, Goodman SD, Bakaletz LO. 
2017. 
Nontypeable <i>Haemophilus influenzae</i> releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery. Proc Natl Acad Sci U S A
114:E6632&#x2013;E6641. doi: 10.1073/pnas.1705508114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705508114</ArticleId><ArticleId IdType="pmc">PMC5559034</ArticleId><ArticleId IdType="pubmed">28696280</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapsinski GJ, Wynosky-Dolfi MA, Oppong GO, Tursi SA, Wilson RP, Brodsky IE, T&#xfc;kel &#xc7;. 2015. Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curli. Infect Immun 83:693&#x2013;701. doi: 10.1128/IAI.02370-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.02370-14</ArticleId><ArticleId IdType="pmc">PMC4294241</ArticleId><ArticleId IdType="pubmed">25422268</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M. 2017. Biofilm formation by uropathogenic Escherichia coli is favored under oxygen conditions that mimic the bladder environment. Int J Mol Sci 18:E2077. doi: 10.3390/ijms18102077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102077</ArticleId><ArticleId IdType="pmc">PMC5666759</ArticleId><ArticleId IdType="pubmed">28973965</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd KA, Mitchell CA, Eberly AR, Colling SJ, Zhang EW, DePas W, Chapman MR, Conover M, Rogers BR, Hultgren SJ, Hadjifrangiskou M. 
2016. 
The UbiI (VisC) aerobic ubiquinone synthase is required for expression of type 1 pili, biofilm formation, and pathogenesis in uropathogenic <i>Escherichia coli</i>. J Bacteriol
198:2662&#x2013;2672. doi: 10.1128/JB.00030-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00030-16</ArticleId><ArticleId IdType="pmc">PMC5019064</ArticleId><ArticleId IdType="pubmed">27161114</ArticleId></ArticleIdList></Reference><Reference><Citation>Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 5:e1000448. doi: 10.1371/journal.ppat.1000448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000448</ArticleId><ArticleId IdType="pmc">PMC2680622</ArticleId><ArticleId IdType="pubmed">19478872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80:1516&#x2013;1529. doi: 10.1111/j.1365-2958.2011.07660.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2958.2011.07660.x</ArticleId><ArticleId IdType="pmc">PMC3643513</ArticleId><ArticleId IdType="pubmed">21542868</ArticleId></ArticleIdList></Reference><Reference><Citation>Klauck G, Serra DO, Possling A, Hengge R. 2018. Spatial organization of different sigma factor activities and c-di-GMP signalling within the three-dimensional landscape of a bacterial biofilm. Open Biol 8:180066. doi: 10.1098/rsob.180066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180066</ArticleId><ArticleId IdType="pmc">PMC6119863</ArticleId><ArticleId IdType="pubmed">30135237</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra DO, Klauck G, Hengge R. 2015. Vertical stratification of matrix production is essential for physical integrity and architecture of macrocolony biofilms of Escherichia coli. Environ Microbiol 17:5073&#x2013;5088. doi: 10.1111/1462-2920.12991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.12991</ArticleId><ArticleId IdType="pmc">PMC5014196</ArticleId><ArticleId IdType="pubmed">26234179</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra DO, Richter AM, Hengge R. 2013. Cellulose as an architectural element in spatially structured Escherichia coli biofilms. J Bacteriol 195:5540&#x2013;5554. doi: 10.1128/JB.00946-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00946-13</ArticleId><ArticleId IdType="pmc">PMC3889604</ArticleId><ArticleId IdType="pubmed">24097954</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd M, Sanguinetti G, Cook GM, Poole RK. 2010. Compensations for diminished terminal oxidase activity in Escherichia coli: cytochrome bd-II-mediated respiration and glutamate metabolism. J Biol Chem 285:18464&#x2013;18472. doi: 10.1074/jbc.M110.118448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.118448</ArticleId><ArticleId IdType="pmc">PMC2881772</ArticleId><ArticleId IdType="pubmed">20392690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Sekedat MD, Cornell WC, Silva GM, Okegbe C, Price-Whelan A, Vogel C, Dietrich LEP. 
2018. 
Phenazines regulate Nap-dependent denitrification in <i>Pseudomonas aeruginosa</i> biofilms. J Bacteriol
200:e00031-18. doi: 10.1128/JB.00031-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00031-18</ArticleId><ArticleId IdType="pmc">PMC5892114</ArticleId><ArticleId IdType="pubmed">29463605</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrate OA, Zhou X, Reichhardt C, Cegelski L. 2013. Sum of the parts: composition and architecture of the bacterial extracellular matrix. J Mol Biol 425:4286&#x2013;4294. doi: 10.1016/j.jmb.2013.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.06.022</ArticleId><ArticleId IdType="pmc">PMC3812305</ArticleId><ArticleId IdType="pubmed">23827139</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongsomboon W, Serra DO, Possling A, Hadjineophytou C, Hengge R, Cegelski L. 2018. Phosphoethanolamine cellulose: a naturally produced chemically modified cellulose. Science 359:334&#x2013;338. doi: 10.1126/science.aao4096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao4096</ArticleId><ArticleId IdType="pubmed">29348238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hufnagel DA, Depas WH, Chapman MR. 
2015. 
The biology of the <i>Escherichia coli</i> extracellular matrix. Microbiol Spectr
3:MB-0014-2014. doi: 10.1128/microbiolspec.MB-0014-2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.MB-0014-2014</ArticleId><ArticleId IdType="pmc">PMC4507285</ArticleId><ArticleId IdType="pubmed">26185090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobley L, Ostrowski A, Rao FV, Bromley KM, Porter M, Prescott AR, MacPhee CE, van Aalten DM, Stanley-Wall NR. 2013. BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm. Proc Natl Acad Sci U S A 110:13600&#x2013;13605. doi: 10.1073/pnas.1306390110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1306390110</ArticleId><ArticleId IdType="pmc">PMC3746881</ArticleId><ArticleId IdType="pubmed">23904481</ArticleId></ArticleIdList></Reference><Reference><Citation>Asally M, Kittisopikul M, Rue P, Du Y, Hu Z, Cagatay T, Robinson AB, Lu H, Garcia-Ojalvo J, Suel GM. 2012. Localized cell death focuses mechanical forces during 3D patterning in a biofilm. Proc Natl Acad Sci U S A 109:18891&#x2013;18896. doi: 10.1073/pnas.1212429109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1212429109</ArticleId><ArticleId IdType="pmc">PMC3503208</ArticleId><ArticleId IdType="pubmed">23012477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutruzzol&#xe0; F, Frankenberg-Dinkel N. 
2016. 
Origin and impact of nitric oxide in <i>Pseudomonas aeruginosa</i> biofilms. J Bacteriol
198:55&#x2013;65. doi: 10.1128/JB.00371-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00371-15</ArticleId><ArticleId IdType="pmc">PMC4686190</ArticleId><ArticleId IdType="pubmed">26260455</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuffr&#xe8; A, Borisov VB, Arese M, Sarti P, Forte E. 2014. Cytochrome bd oxidase and bacterial tolerance to oxidative and nitrosative stress. Biochim Biophys Acta 1837:1178&#x2013;1187. doi: 10.1016/j.bbabio.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2014.01.016</ArticleId><ArticleId IdType="pubmed">24486503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason MG, Shepherd M, Nicholls P, Dobbin PS, Dodsworth KS, Poole RK, Cooper CE. 2009. Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nat Chem Biol 5:94&#x2013;96. doi: 10.1038/nchembio.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.135</ArticleId><ArticleId IdType="pubmed">19109594</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd M, Achard ME, Idris A, Totsika M, Phan MD, Peters KM, Sarkar S, Ribeiro CA, Holyoake LV, Ladakis D, Ulett GC, Sweet MJ, Poole RK, McEwan AG, Schembri MA. 2016. The cytochrome bd-I respiratory oxidase augments survival of multidrug-resistant Escherichia coli during infection. Sci Rep 6:35285. doi: 10.1038/srep35285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35285</ArticleId><ArticleId IdType="pmc">PMC5073308</ArticleId><ArticleId IdType="pubmed">27767067</ArticleId></ArticleIdList></Reference><Reference><Citation>Borisov VB, Forte E, Davletshin A, Mastronicola D, Sarti P, Giuffr&#xe8; A. 2013. Cytochrome bd oxidase from Escherichia coli displays high catalase activity: an additional defense against oxidative stress. FEBS Lett 587:2214&#x2013;2218. doi: 10.1016/j.febslet.2013.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.05.047</ArticleId><ArticleId IdType="pubmed">23727202</ArticleId></ArticleIdList></Reference><Reference><Citation>Safarian S, Rajendran C, M&#xfc;ller H, Preu J, Langer JD, Ovchinnikov S, Hirose T, Kusumoto T, Sakamoto J, Michel H. 2016. Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases. Science 352:583&#x2013;586. doi: 10.1126/science.aaf2477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf2477</ArticleId><ArticleId IdType="pmc">PMC5515584</ArticleId><ArticleId IdType="pubmed">27126043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindqvist A, Membrillo-Herna&#x144;dez J, Poole RK, Cook GM. 2000. Roles of respiratory oxidases in protecting Escherichia coli K12 from oxidative stress. Antonie Van Leeuwenhoek 78:23&#x2013;31. doi: 10.1023/A:1002779201379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1002779201379</ArticleId><ArticleId IdType="pubmed">11016692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZJ, Joe BN, Coakley FV, Zaharchuk G, Busse R, Yeh BM. 2008. Urinary oxygen tension measurement in humans using magnetic resonance imaging. Acad Radiol 15:1467&#x2013;1473. doi: 10.1016/j.acra.2008.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2008.04.013</ArticleId><ArticleId IdType="pmc">PMC2605795</ArticleId><ArticleId IdType="pubmed">18995198</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269&#x2013;284. doi: 10.1038/nrmicro3432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3432</ArticleId><ArticleId IdType="pmc">PMC4457377</ArticleId><ArticleId IdType="pubmed">25853778</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi Y, Choi PJ, Li GW, Chen H, Babu M, Hearn J, Emili A, Xie XS. 2010. Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science 329:533&#x2013;538. doi: 10.1126/science.1188308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1188308</ArticleId><ArticleId IdType="pmc">PMC2922915</ArticleId><ArticleId IdType="pubmed">20671182</ArticleId></ArticleIdList></Reference><Reference><Citation>Silander OK, Nikolic N, Zaslaver A, Bren A, Kikoin I, Alon U, Ackermann M. 2012. A genome-wide analysis of promoter-mediated phenotypic noise in Escherichia coli. PLoS Genet 8:e1002443. doi: 10.1371/journal.pgen.1002443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002443</ArticleId><ArticleId IdType="pmc">PMC3261926</ArticleId><ArticleId IdType="pubmed">22275871</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh D, Paulsson J. 2011. Non-genetic heterogeneity from stochastic partitioning at cell division. Nat Genet 43:95&#x2013;100. doi: 10.1038/ng.729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.729</ArticleId><ArticleId IdType="pmc">PMC3208402</ArticleId><ArticleId IdType="pubmed">21186354</ArticleId></ArticleIdList></Reference><Reference><Citation>Barraud N, Schleheck D, Klebensberger J, Webb JS, Hassett DJ, Rice SA, Kjelleberg S. 
2009. 
Nitric oxide signaling in <i>Pseudomonas aeruginosa</i> biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol
191:7333&#x2013;7342. doi: 10.1128/JB.00975-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00975-09</ArticleId><ArticleId IdType="pmc">PMC2786556</ArticleId><ArticleId IdType="pubmed">19801410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hengge R. 2009. Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol 7:263&#x2013;273. doi: 10.1038/nrmicro2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2109</ArticleId><ArticleId IdType="pubmed">19287449</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572&#x2013;4579. doi: 10.1128/IAI.69.7.4572-4579.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.69.7.4572-4579.2001</ArticleId><ArticleId IdType="pmc">PMC98534</ArticleId><ArticleId IdType="pubmed">11402001</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy KC, Campellone KG. 2003. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol 4:11. doi: 10.1186/1471-2199-4-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2199-4-11</ArticleId><ArticleId IdType="pmc">PMC317293</ArticleId><ArticleId IdType="pubmed">14672541</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer CL, Zhang EW, Dudley AG, Dixon BR, Guckes KR, Breland EJ, Floyd KA, Casella DP, Algood HM, Clayton DB, Hadjifrangiskou M. 
2017. 
Purine biosynthesis metabolically constrains intracellular survival of uropathogenic <i>Escherichia coli</i>. Infect Immun
85:e00471-16. doi: 10.1128/IAI.00471-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00471-16</ArticleId><ArticleId IdType="pmc">PMC5203662</ArticleId><ArticleId IdType="pubmed">27795353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. doi: 10.1093/nar/29.9.e45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.9.e45</ArticleId><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida C, Azevedo NF, Santos S, Keevil CW, Vieira MJ. 2011. Discriminating multi-species populations in biofilms with peptide nucleic acid fluorescence in situ hybridization (PNA FISH). PLoS One 6:e14786. doi: 10.1371/journal.pone.0014786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014786</ArticleId><ArticleId IdType="pmc">PMC3066202</ArticleId><ArticleId IdType="pubmed">21479268</ArticleId></ArticleIdList></Reference><Reference><Citation>Okegbe C, Fields BL, Cole SJ, Beierschmitt C, Morgan CJ, Price-Whelan A, Stewart RC, Lee VT, Dietrich LEP. 2017. Electron-shuttling antibiotics structure bacterial communities by modulating cellular levels of c-di-GMP. Proc Natl Acad Sci U S A 114:E5236&#x2013;E5245. doi: 10.1073/pnas.1700264114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1700264114</ArticleId><ArticleId IdType="pmc">PMC5495239</ArticleId><ArticleId IdType="pubmed">28607054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CS, Dodson KW, Hultgren SJ. 2009. A murine model of urinary tract infection. Nat Protoc 4:1230&#x2013;1243. doi: 10.1038/nprot.2009.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.116</ArticleId><ArticleId IdType="pmc">PMC2963178</ArticleId><ArticleId IdType="pubmed">19644462</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed National Academies Press, Washington, DC.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30260516</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-3673</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of leukocyte biology</Title><ISOAbbreviation>J Leukoc Biol</ISOAbbreviation></Journal><ArticleTitle>Embracing microbial exposure in mouse research.</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>79</EndPage><MedlinePgn>73-79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/JLB.4RI0718-273R</ELocationID><Abstract><AbstractText>Research using mouse models have contributed essential knowledge toward our current understanding of how the human immune system functions. One key difference between humans and typical laboratory mice, however, is exposure to pathogens in their respective environments. Several recent studies have highlighted that these microbial encounters shape the development and functional status of the immune system. For humans, such numerous and unavoidable encounters with viruses, bacteria, and parasites may be a defining factor in generating a healthy and robust immune system, poised to respond to new infections and to vaccination. Additionally, the commensal organisms that make up the host microbiome also change with environment and impact the immune response. Hence, there is a pressing need to generate more faithful mouse models that reflect the natural state of the human immune system. This review explores the use of new experimental mouse models designed to better understand how host-microbial interactions shape the immune response. By embracing these technologies to complement traditional mouse models, researchers can remove a significant barrier that has long separated murine and human immunologists.</AbstractText><CopyrightInformation>&#xa9;2018 Society for Leukocyte Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mathew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI116678</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI143828</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI116678</GrantID><Agency>National Institutes of Health (United States)</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Leukoc Biol</MedlineTA><NlmUniqueID>8405628</NlmUniqueID><ISSNLinking>0741-5400</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032761" MajorTopicYN="Y">Animal Experimentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">host-pathogen interactions</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30260516</ArticleId><ArticleId IdType="mid">NIHMS1001891</ArticleId><ArticleId IdType="pmc">PMC6318123</ArticleId><ArticleId IdType="doi">10.1002/JLB.4RI0718-273R</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346 10.1126/science.1258096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258096</ArticleId><ArticleId IdType="pubmed">25430774</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013;110:3507&#x2013;3512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587220</ArticleId><ArticleId IdType="pubmed">23401516</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Herrath MG, Nepom GT. Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity. J Exp Med 2005;202:1159&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213225</ArticleId><ArticleId IdType="pubmed">16275758</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust D, Sivula CP, Jameson SC. Of mice, dirty mice, and men: using mice to understand human immunology. J Immunol 2017;199:383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512602</ArticleId><ArticleId IdType="pubmed">28696328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172:2731&#x2013;2738.</Citation><ArticleIdList><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>Beura LK, Hamilton SE, Bi K, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 2016;532:512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871315</ArticleId><ArticleId IdType="pubmed">27096360</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese TA, Bi K, Kambal A, et al. Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response. Cell Host Microbe 2016;19:713&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896745</ArticleId><ArticleId IdType="pubmed">27107939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosshart SP, Vassallo BG, Angeletti D, et al. Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell 2017;171:1015&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887100</ArticleId><ArticleId IdType="pubmed">29056339</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Budischak SA, The HC, et al. Rapid environmental effects on gut nematode susceptibility in rewilded mice. PLoS Biol 2018;16:e2004108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5843147</ArticleId><ArticleId IdType="pubmed">29518091</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster HL. Housing of disease-free vertebrates. Ann N Y Acad Sci 1959;78:80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">13824112</ArticleId></ArticleIdList></Reference><Reference><Citation>Festing MFW, Blackmore DK. Life span of specified-pathogen-free (MRC category 4) mice and rats. Lab Anim 1971;5:179&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">5166568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K, Handa H, Umehara K, Sasaki S. Germfree mice reared on an &#x2018;antigen-free&#x2019; diet. Lab Anim Sci 1978;28:38&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">633838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard M Germfree animals and biological research. Science 1964;145:247&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">14171565</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao L, Reese TA. Making mouse models that reflect human immune responses. Trends Immunol 2017;38:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">28161189</ArticleId></ArticleIdList></Reference><Reference><Citation>Viney M, Riley EM. The immunology of wild rodents: current status and future prospects. Front Immunol 2017;8:1481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5694458</ArticleId><ArticleId IdType="pubmed">29184549</ArticleId></ArticleIdList></Reference><Reference><Citation>Abolins S, King EC, Lazarou L, et al. The comparative immunology of wild and laboratory mice, Mus musculus domesticus. Nat Commun 2017;8:14811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418598</ArticleId><ArticleId IdType="pubmed">28466840</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JA, McDonald-Hyman C, Jameson SC, Hamilton SE. Effector-like CD8+ T cells in the memory population mediate potent protective immunity. Immunity 2013;38:1250&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703254</ArticleId><ArticleId IdType="pubmed">23746652</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O&#x2019;Garra A. Type I interferons in infectious disease. Nat Publ Gr 2015;15:87&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauvau G, Goriely S. Memory CD8+ T cells: orchestrators and key players of innate immunity? PLoS Pathog 2016;12:e1005722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008753</ArticleId><ArticleId IdType="pubmed">27584152</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg RE, Crossley E, Murray S, Forman J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med 2003;198:1583&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592647</ArticleId><ArticleId IdType="pubmed">14623912</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014;157:121&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight R, Callewaert C, Marotz C, et al. The microbiome and human biology. Annu Rev Genomics Hum Genet 2017;18:65&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">28375652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796826</ArticleId><ArticleId IdType="pubmed">19836068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci 2011;108:4615&#x2013;4622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063590</ArticleId><ArticleId IdType="pubmed">20660719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 2011;108:11548&#x2013;11553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136249</ArticleId><ArticleId IdType="pubmed">21709219</ArticleId></ArticleIdList></Reference><Reference><Citation>Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969237</ArticleId><ArticleId IdType="pubmed">21205640</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbert T, Steinhagen F, Senzig S, et al. Vendor effects on murine gut microbiota influence experimental abdominal sepsis. J Surg Res 2017;211:126&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501108</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmore JR, Gaudette BT, Gomez Atria D, et al. Commensal microbes induce serum IgA responses that protect against polymicrobial sepsis. Cell Host Microbe 2018;23:302&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350773</ArticleId><ArticleId IdType="pubmed">29478774</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach J-F. Six questions about the hygiene hypothesis. Cell Immunol 2005;233:158&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">15963966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach J-F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 2017;18:105&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">29034905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham NL, Badovinac VP, Harty JT. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation. J Immunol 2009;183:2337&#x2013;2348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786780</ArticleId><ArticleId IdType="pubmed">19635915</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelekati E, Wherry EJ. Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe 2012;12:458&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617576</ArticleId><ArticleId IdType="pubmed">23084915</ArticleId></ArticleIdList></Reference><Reference><Citation>Arama C, Troye-Blomberg M. The path of malaria vaccine development: challenges and perspectives. J Intern Med 2014;275: 456&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635625</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher HA, Schrager L. TB vaccine development and the end TB strategy: importance and current status. Trans R Soc Trop Med Hyg 2016;110:212&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830404</ArticleId><ArticleId IdType="pubmed">27076508</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Hesran J-Y, Akiana J, Ndiaye el HM, Dia M, Senghor P, Konate L. Severe malaria attack is associated with high prevalence of Ascaris lum-bricoides infection among children in rural Senegal. Trans R Soc Trop Med Hyg 2004;98:397&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">15138075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacher M, Singhasivanon P, Yimsamran S, et al. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J Parasitol 2002;88:55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12053980</ArticleId></ArticleIdList></Reference><Reference><Citation>Briand V, Watier L, LE Hesran J-Y, Garcia A, Cot M. Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children?. Am J Trop Med Hyg 2005;72:702&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">15964953</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, Segura M, Stevenson MM. Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection. Infect Immun 2006;74:2138&#x2013;2144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1418908</ArticleId><ArticleId IdType="pubmed">16552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xf3;rido M, Grima MA, Gillis CM, et al. Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection. J Immunol 2013;191:302&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">23698750</ArticleId></ArticleIdList></Reference><Reference><Citation>Redford PS, Mayer-Barber KD, McNab FW, et al. Influenza A virus impairs control of mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis 2014;209:270&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3873785</ArticleId><ArticleId IdType="pubmed">23935205</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29625893</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.</ArticleTitle><Pagination><StartPage>760</StartPage><EndPage>772.e4</EndPage><MedlinePgn>760-772.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2018.03.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(18)30088-8</ELocationID><Abstract><AbstractText>Cerebral malaria is a deadly complication of Plasmodium infection and involves blood brain barrier (BBB) disruption following infiltration of white blood cells. During experimental cerebral malaria (ECM), mice inoculated with Plasmodium berghei ANKA-infected red blood cells develop a fatal CM-like disease caused by CD8<sup>+</sup> T&#xa0;cell-mediated pathology. We found that treatment with interleukin-15 complex (IL-15C) prevented ECM, whereas IL-2C treatment had no effect. IL-15C-expanded natural killer (NK) cells were necessary and sufficient for protection against ECM. IL-15C treatment also decreased CD8<sup>+</sup> T&#xa0;cell activation in the brain and prevented BBB breakdown without influencing parasite load. IL-15C induced NK cells to express IL-10, which was required for IL-15C-mediated protection against ECM. Finally, we show that ALT-803, a modified human IL-15C, mediates similar induction of IL-10 in NK cells and protection against ECM. These data identify a regulatory role for cytokine-stimulated NK cells in the prevention of a pathogenic immune response.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burrack</LastName><ForeName>Kristina S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55414, USA; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taras</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dougherty</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henzler</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Supercomputing Institute for Advanced Computational Research, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Rendong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Supercomputing Institute for Advanced Computational Research, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Altor BioScience Corporation, Miramar, FL 33025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeng</LastName><ForeName>Emily K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Altor BioScience Corporation, Miramar, FL 33025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Hing C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Altor BioScience Corporation, Miramar, FL 33025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felices</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cichocki</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>Geoffrey T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Sara E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55414, USA. Electronic address: hamil062@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 NS094150</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 AI120312</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI038903</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI100088</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007425</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C582303">ALT-803</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C556062">IL10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019409">Interleukin-15</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019409" MajorTopicYN="N">Interleukin-15</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016779" MajorTopicYN="N">Malaria, Cerebral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010962" MajorTopicYN="N">Plasmodium berghei</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8(+) T&#xa0;cells</Keyword><Keyword MajorTopicYN="N">IL-10</Keyword><Keyword MajorTopicYN="N">IL-15</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword><Keyword MajorTopicYN="N">cerebral malaria</Keyword><Keyword MajorTopicYN="N">cytokine complexes</Keyword><Keyword MajorTopicYN="N">immunopathology</Keyword></KeywordList><CoiStatement><b>DECLARATION OF INTERESTS</b>. S.A., E.K.J., and H.C.W. are employees and stockholders of Altor Bioscience Corporation. H.C.W. holds a patent on ALT-803 (US Patent No. 8,507,222). No other competing interests were declared by the other authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29625893</ArticleId><ArticleId IdType="mid">NIHMS950131</ArticleId><ArticleId IdType="pmc">PMC5906161</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2018.03.012</ArticleId><ArticleId IdType="pii">S1074-7613(18)30088-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basher F, Jeng EK, Wong H, Wu J. Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC. Oncotarget. 2016;7:814&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4808035</ArticleId><ArticleId IdType="pubmed">26625316</ArticleId></ArticleIdList></Reference><Reference><Citation>Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, Snounou G, R&#xe9;nia L. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002;169:6369&#x2013;6375.</Citation><ArticleIdList><ArticleId IdType="pubmed">12444144</ArticleId></ArticleIdList></Reference><Reference><Citation>Biron CA. Yet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence. Proc Natl Acad Sci USA. 2012;109:1814&#x2013;1815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277572</ArticleId><ArticleId IdType="pubmed">22308452</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 2006;311:1924&#x2013;1927.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009;113:5488&#x2013;5496.</Citation><ArticleIdList><ArticleId IdType="pubmed">19234143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cichocki F, Miller JS. In vitro development of human killer-immunoglobulin receptor-positive NK cells. Methods Mol Biol. 2010;612:15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">20033631</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL. Bacterial manipulation of NK cell regulatory activity increases susceptibility to Listeria monocytogenes infection. PLoS Pathog. 2016;12:e1005708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4905663</ArticleId><ArticleId IdType="pubmed">27295349</ArticleId></ArticleIdList></Reference><Reference><Citation>Claser C, De Souza JB, Thorburn SG, Grau GE, Riley EM, R&#xe9;nia L, Hafalla JCR. Host Resistance to Plasmodium-induced acute immune pathology is regulated by interleukin-10 receptor signaling. Infect Immun. 2017;85:85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5442633</ArticleId><ArticleId IdType="pubmed">28396319</ArticleId></ArticleIdList></Reference><Reference><Citation>Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013;34:342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">23601842</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouse J, Xu HC, Lang PA, Oxenius A. NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol. 2015;36:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25432489</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P, Congia S, Mingari MC, Moretta L. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol. 2007;37:445&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">17273991</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oca MM, Engwerda C, Haque A. Plasmodium berghei ANKA (PbA) infection of C57BL/6J mice: a model of severe malaria. Methods Mol Biol. 2013;1031:203&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dende C, Meena J, Nagarajan P, Panda AK, Rangarajan PN, Padmanaban G. Simultaneously targeting inflammatory response and parasite sequestration in brain to treat experimental cerebral malaria. Sci Rep. 2015;5:12671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521148</ArticleId><ArticleId IdType="pubmed">26227888</ArticleId></ArticleIdList></Reference><Reference><Citation>Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA, Goldrath AW, Turley SJ. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res. 2008;68:2972&#x2013;2983.</Citation><ArticleIdList><ArticleId IdType="pubmed">18413767</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauconnier M, Palomo J, Bourigault ML, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, et al. IL-12R&#x3b2;2 is essential for the development of experimental cerebral malaria. J Immunol. 2012;188:1905&#x2013;1914.</Citation><ArticleIdList><ArticleId IdType="pubmed">22238458</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol. 2008;214:224&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">18161757</ArticleId></ArticleIdList></Reference><Reference><Citation>Floros T, Tarhini AA. Anticancer cytokines: biology and clinical effects of interferon-&#x3b1;2, interleukin (IL)-2, IL-15, IL-21, and IL-12. Semin Oncol. 2015;42:539&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557618</ArticleId><ArticleId IdType="pubmed">26320059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleissner CA, Zastrow A, Klingenberg R, Kluger MS, Konstandin M, Celik S, Haemmerling S, Shankar V, Giese T, Katus HA, Dengler TJ. IL-10 inhibits endothelium-dependent T cell costimulation by up-regulation of ILT3/4 in human vascular endothelial cells. Eur J Immunol. 2007;37:177&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">17163451</ArticleId></ArticleIdList></Reference><Reference><Citation>Goff L, Trapnell C, Kelley D. CummeRbund: visualization and exploration of cufflinks high-throughput sequencing data. 2014  https://www.bioconductor.org/packages/3.7/bioc/vignettes/cummeRbund/inst/doc/cummeRbund-manual.pdf.</Citation></Reference><Reference><Citation>Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Kim AS, Hamilton SE, Pena M, Yazew T, Qi CF, et al. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proc Natl Acad Sci USA. 2015;112:13075&#x2013;13080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4620853</ArticleId><ArticleId IdType="pubmed">26438846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Schenkel JM, Akue AD, Jameson SC. IL-2 complex treatment can protect naive mice from bacterial and viral infection. J Immunol. 2010;185:6584&#x2013;6590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3016939</ArticleId><ArticleId IdType="pubmed">21037095</ArticleId></ArticleIdList></Reference><Reference><Citation>Han KP, Zhu X, Liu B, Jeng E, Kong L, Yovandich JL, Vyas VV, Marcus WD, Chavaillaz PA, Romero CA, et al. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine. 2011;56:804&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221918</ArticleId><ArticleId IdType="pubmed">22019703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen DS, Bernard NJ, Nie CQ, Schofield L. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol. 2007;178:5779&#x2013;5788.</Citation><ArticleIdList><ArticleId IdType="pubmed">17442962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hora R, Kapoor P, Thind KK, Mishra PC. Cerebral malaria&#x2013;clinical manifestations and pathogenesis. Metab Brain Dis. 2016;31:225&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746434</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, R&#xe9;nia L. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med. 2013;5:984&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3721469</ArticleId><ArticleId IdType="pubmed">23681698</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland SW, Claser C, Poh CM, Gun SY, R&#xe9;nia L. Pathogenic CD8+ T cells in experimental cerebral malaria. Semin Immunopathol. 2015a;37:221&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">25772948</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland SW, Poh CM, R&#xe9;nia L. Activated brain endothelial cells cross-present malaria antigen. PLoS Pathog. 2015b;11:e1004963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457820</ArticleId><ArticleId IdType="pubmed">26046849</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins MA, Johnson HL, Jin F, Songo NA, Hanson LM, LaFrance SJ, Butler NS, Harty JT, Johnson AJ. Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria. Infect Immun. 2017;85:85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400849</ArticleId><ArticleId IdType="pubmed">28264905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24:491&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">12967673</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson HL, Chen Y, Jin F, Hanson LM, Gamez JD, Pirko I, Johnson AJ. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol. 2012;189:1937&#x2013;1945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3411871</ArticleId><ArticleId IdType="pubmed">22772449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamimura D, Sawa Y, Sato M, Agung E, Hirano T, Murakami M. IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb. J Immunol. 2006;177:306&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">16785526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053844</ArticleId><ArticleId IdType="pubmed">23618408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim PS, Kwilas AR, Xu W, Alter S, Jeng EK, Wong HC, Schlom J, Hodge JW. IL-15 superagonist/IL-15R&#x3b1;Sushi-Fc fusion complex (IL-15SA/IL-15R&#x3b1;Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas. Oncotarget. 2016;7:16130&#x2013;16145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941302</ArticleId><ArticleId IdType="pubmed">26910920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology. 1997;91:536&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1363872</ArticleId><ArticleId IdType="pubmed">9378491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Kim KS, Fodil-Cornu N, Vidal SM, Biron CA. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med. 2009;206:2235&#x2013;2251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757878</ArticleId><ArticleId IdType="pubmed">19720840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, et al. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc Natl Acad Sci USA. 2008;105:14509&#x2013;14514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2567226</ArticleId><ArticleId IdType="pubmed">18799734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551262</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, Trompette A, Yogev N, Gu Y, Khodoun M, Hildeman D, et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol. 2009;183:2312&#x2013;2320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772089</ArticleId><ArticleId IdType="pubmed">19620304</ArticleId></ArticleIdList></Reference><Reference><Citation>Malleret B, Claser C, Ong ASM, Suwanarusk R, Sriprawat K, Howland SW, Russell B, Nosten F, R&#xe9;nia L. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep. 2011;1:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216599</ArticleId><ArticleId IdType="pubmed">22355635</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, Kaye PM. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity. 2008;29:295&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656759</ArticleId><ArticleId IdType="pubmed">18701085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathios D, Park CK, Marcus WD, Alter S, Rhode PR, Jeng EK, Wong HC, Pardoll DM, Lim M. Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model. Int J Cancer. 2016;138:187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4696021</ArticleId><ArticleId IdType="pubmed">26174883</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, Hogquist KA. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. 2011;208:1279&#x2013;1289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173240</ArticleId><ArticleId IdType="pubmed">21606508</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikura M, Inoue S, Kobayashi F. Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J Biomed Biotechnol. 2011;2011:383962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228686</ArticleId><ArticleId IdType="pubmed">22190849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol. 2003;170:2221&#x2013;2228.</Citation><ArticleIdList><ArticleId IdType="pubmed">12574396</ArticleId></ArticleIdList></Reference><Reference><Citation>Onkoba WN, Chimbari MJ, Kamau JM, Mukaratirwa S. Differential immune responses in mice infected with the tissue-dwelling nematode Trichinella zimbabwensis. J Helminthol. 2016;90:547&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">26294082</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Lee SH, Yoon SR, Park YJ, Jung H, Kim TD, Choi I. IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells. Mol Cells. 2011;32:265&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887627</ArticleId><ArticleId IdType="pubmed">21809216</ArticleId></ArticleIdList></Reference><Reference><Citation>Penet MF, Viola A, Confort-Gouny S, Le Fur Y, Duhamel G, Kober F, Ibarrola D, Izquierdo M, Coltel N, Gharib B, et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci. 2005;25:7352&#x2013;7358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725296</ArticleId><ArticleId IdType="pubmed">16093385</ArticleId></ArticleIdList></Reference><Reference><Citation>Perona-Wright G, Mohrs K, Szaba FM, Kummer LW, Madan R, Karp CL, Johnson LL, Smiley ST, Mohrs M. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe. 2009;6:503&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796259</ArticleId><ArticleId IdType="pubmed">20006839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope C, Kim SK, Marzo A, Masopust D, Williams K, Jiang J, Shen H, Lefran&#xe7;ois L. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol. 2001;166:3402&#x2013;3409.</Citation><ArticleIdList><ArticleId IdType="pubmed">11207297</ArticleId></ArticleIdList></Reference><Reference><Citation>Potchen MJ, Kampondeni SD, Seydel KB, Birbeck GL, Hammond CA, Bradley WG, DeMarco JK, Glover SJ, Ugorji JO, Latourette MT, et al. Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol. 2012;33:1740&#x2013;1746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779545</ArticleId><ArticleId IdType="pubmed">22517285</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt RL, Liang HE, Locksley RM. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol. 2009;10:385&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714053</ArticleId><ArticleId IdType="pubmed">19252490</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;nia L, Potter SM. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol. 2006;28:589&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">17042930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosario M, Liu B, Kong L, Collins LI, Schneider SE, Chen X, Han K, Jeng EK, Rhode PR, Leong JW, et al. The IL-15-based ALT-803 complex enhances Fc&#x3b3;RIIIa-triggered NK cell responses and in vivo clearance of B cell lymphomas. Clin Cancer Res. 2016;22:596&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738096</ArticleId><ArticleId IdType="pubmed">26423796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha. Proc Natl Acad Sci USA. 2006;103:9166&#x2013;9171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1482584</ArticleId><ArticleId IdType="pubmed">16757567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryg-Cornejo V, Nie CQ, Bernard NJ, Lundie RJ, Evans KJ, Crabb BS, Schofield L, Hansen DS. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection. Immunobiology. 2013;218:263&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">22704523</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw TN, Stewart-Hutchinson PJ, Strangward P, Dandamudi DB, Coles JA, Villegas-Mendez A, Gallego-Delgado J, van Rooijen N, Zindy E, Rodriguez A, et al. Perivascular arrest of CD8+ T cells is a signature of experimental cerebral malaria. PLoS Pathog. 2015;11:e1005210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643016</ArticleId><ArticleId IdType="pubmed">26562533</ArticleId></ArticleIdList></Reference><Reference><Citation>Specht S, Ruiz DF, Dubben B, Deininger S, Hoerauf A. Filaria-induced IL-10 suppresses murine cerebral malaria. Microbes Infect. 2010;12:635&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">20420933</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklasek TA, Schluns KS, Lefran&#xe7;ois L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol. 2006;177:6072&#x2013;6080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847275</ArticleId><ArticleId IdType="pubmed">17056533</ArticleId></ArticleIdList></Reference><Reference><Citation>Storm J, Craig AG. Pathogenesis of cerebral malaria&#x2013;inflammation and cytoadherence. Front Cell Infect Microbiol. 2014;4:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114466</ArticleId><ArticleId IdType="pubmed">25120958</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson PA, 2nd, Hart GT, Russo MV, Nayak D, Yazew T, Pe&#xf1;a M, Khan SM, Janse CJ, Pierce SK, McGavern DB. CD8+ T cells induce fatal brainstem pathology during cerebral malaria via luminal antigen-specific engagement of brain vasculature. PLoS Pathog. 2016;12:e1006022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131904</ArticleId><ArticleId IdType="pubmed">27907215</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarrio ML, Lee SH, Fragoso MF, Sun HW, Kanno Y, O&#x2019;Shea JJ, Biron CA. Proliferation conditions promote intrinsic changes in NK cells for an IL-10 response. J Immunol. 2014;193:354&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065839</ArticleId><ArticleId IdType="pubmed">24907347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomala J, Chmelova H, Mrkvan T, Rihova B, Kovar M. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy. J Immunol. 2009;183:4904&#x2013;4912.</Citation><ArticleIdList><ArticleId IdType="pubmed">19801515</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146043</ArticleId><ArticleId IdType="pubmed">20436464</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31:46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869392</ArticleId><ArticleId IdType="pubmed">23222703</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdeil G, Marquardt K, Surh CD, Sherman LA. Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy. Proc Natl Acad Sci USA. 2008;105:16683&#x2013;16688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575480</ArticleId><ArticleId IdType="pubmed">18936481</ArticleId></ArticleIdList></Reference><Reference><Citation>Votavova P, Tomala J, Kovar M. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15R&#x3b1;-Fc chimera. Immunol Lett. 2014;159:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">24512738</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh RM, Waggoner SN. NK cells controlling virus-specific T cells: rheostats for acute vs. persistent infections. Virology. 2013;435:37&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521501</ArticleId><ArticleId IdType="pubmed">23217614</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. World Malaria Report 2016. Geneva: World Health Organization); 2016.   http://apps.who.int/iris/bitstream/10665/252038/1/9789241511711-eng.pdf?ua=1.</Citation></Reference><Reference><Citation>Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD, et al. Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor &#x3b1;Su/Fc fusion complex in syngeneic murine models of multiple myeloma. Cancer Res. 2013;73:3075&#x2013;3086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3914673</ArticleId><ArticleId IdType="pubmed">23644531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ya&#xf1;ez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol. 1996;157:1620&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pubmed">8759747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Aoshi T, Kawai S, Mori Y, Konishi A, Ozkan M, Fujita Y, Haseda Y, Shimizu M, Kohyama M, et al. Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria. Cell Host Microbe. 2014;15:551&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">24832450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29434238</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 <sup>+</sup> T cell responses.</ArticleTitle><Pagination><StartPage>633</StartPage><MedlinePgn>633</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">633</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-018-03037-x</ELocationID><Abstract><AbstractText>The contribution of antigen-presenting cell (APC) types in generating CD8<sup>+</sup> T&#xa0;cell responses in the central nervous system (CNS) is not fully defined, limiting the development of vaccines and understanding of immune-mediated neuropathology. Here, we generate a transgenic mouse that enables cell-specific deletion of the H-2Kb MHC class I molecule. By deleting H-2K<sup>b</sup> on dendritic cells and macrophages, we compare the effect of each APC in three distinct models of neuroinflammation: picornavirus infection, experimental cerebral malaria, and a syngeneic glioma. Dendritic cells and macrophages both activate CD8<sup>+</sup> T&#xa0;cell responses in response to these CNS immunological challenges. However, the extent to which each of these APCs contributes to CD8<sup>+</sup> T&#xa0;cell priming varies. These findings reveal distinct functions for dendritic cells and macrophages in generating CD8<sup>+</sup> T&#xa0;cell responses to neurological disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malo</LastName><ForeName>Courtney S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0001-9674-3826</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goddery</LastName><ForeName>Emma N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolcher</LastName><ForeName>Heather M A</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renner</LastName><ForeName>Danielle N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology of Disease Graduate Program, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pease</LastName><ForeName>Larry R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavelko</LastName><ForeName>Kevin D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Johnson.Aaron2@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Johnson.Aaron2@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS103212</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS094150</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 CA186976</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007425</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS094765</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017951" MajorTopicYN="Y">Antigen Presentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000938" MajorTopicYN="N">Antigen-Presenting Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="N">Glioma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016779" MajorTopicYN="N">Malaria, Cerebral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434238</ArticleId><ArticleId IdType="pmc">PMC5809416</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-03037-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-018-03037-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borrow P, Tonks P, Welsh CJ, Nash AA. The role of CD8+T cells in the acute and chronic phases of Theiler&#x2019;s murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 1992;73:1861&#x2013;1865. doi: 10.1099/0022-1317-73-7-1861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-73-7-1861</ArticleId><ArticleId IdType="pubmed">1629706</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts MT, Richards MH, Miller SD. A critical role for virus-specific CD8(+) CTLs in protection from Theiler&#x2019;s virus-induced demyelination in disease-susceptible SJL mice. Virology. 2010;402:102&#x2013;111. doi: 10.1016/j.virol.2010.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.02.031</ArticleId><ArticleId IdType="pmc">PMC2872027</ArticleId><ArticleId IdType="pubmed">20381109</ArticleId></ArticleIdList></Reference><Reference><Citation>Herz J, Johnson KR, McGavern DB. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J. Exp. Med. 2015;212:1153&#x2013;1169. doi: 10.1084/jem.20142047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20142047</ArticleId><ArticleId IdType="pmc">PMC4516789</ArticleId><ArticleId IdType="pubmed">26122661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear HM, et al. Pattern recognition receptor MDA5 modulates CD8+T cell-dependent clearance of West Nile virus from the central nervous system. J. Virol. 2013;87:11401&#x2013;11415. doi: 10.1128/JVI.01403-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01403-13</ArticleId><ArticleId IdType="pmc">PMC3807324</ArticleId><ArticleId IdType="pubmed">23966390</ArticleId></ArticleIdList></Reference><Reference><Citation>Malo CS, et al. The effect of vector silencing during Picornavirus vaccination against experimental melanoma and glioma. PLoS ONE. 2016;11:e0162064. doi: 10.1371/journal.pone.0162064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162064</ArticleId><ArticleId IdType="pmc">PMC4999064</ArticleId><ArticleId IdType="pubmed">27560502</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner DN, et al. Effective treatment of established GL261 murine gliomas through Picornavirus vaccination-enhanced tumor antigen-specific CD8+T cell responses. PLoS ONE. 2015;10:e0125565. doi: 10.1371/journal.pone.0125565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125565</ArticleId><ArticleId IdType="pmc">PMC4416934</ArticleId><ArticleId IdType="pubmed">25933216</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner DN, et al. Improved treatment efficacy of antiangiogenic therapy when combined with Picornavirus vaccination in the GL261 glioma model. Neurotherapeutics. 2016;13:226&#x2013;236. doi: 10.1007/s13311-015-0407-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0407-1</ArticleId><ArticleId IdType="pmc">PMC4720676</ArticleId><ArticleId IdType="pubmed">26620211</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26:485&#x2013;495. doi: 10.1016/j.it.2005.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2005.07.004</ArticleId><ArticleId IdType="pubmed">16039904</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33:579&#x2013;589. doi: 10.1016/j.it.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2012.07.004</ArticleId><ArticleId IdType="pubmed">22926201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012;12:623&#x2013;635. doi: 10.1038/nri3265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3265</ArticleId><ArticleId IdType="pubmed">22903150</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggins M, et al. Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria. Infect. Immun. 2017;6:00985&#x2013;00916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400849</ArticleId><ArticleId IdType="pubmed">28264905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Fernandez YV, Johnson AJ, Rodriguez M, Pease LR. Clearance of Theiler&#x2019;s virus infection depends on the ability to generate a CD8+T&#x2004;cell response against a single immunodominant viral peptide. Eur. J. Immunol. 2003;33:2501&#x2013;2510. doi: 10.1002/eji.200324007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200324007</ArticleId><ArticleId IdType="pubmed">12938226</ArticleId></ArticleIdList></Reference><Reference><Citation>Almolda B, Gonzalez B, Castellano B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front. Biosci. 2011;16:1157&#x2013;1171. doi: 10.2741/3781.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3781</ArticleId><ArticleId IdType="pubmed">21196224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart MN, Fabry Z. CNS antigen presentation. Trends Neurosci. 1995;18:475&#x2013;481. doi: 10.1016/0166-2236(95)92767-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(95)92767-K</ArticleId><ArticleId IdType="pubmed">8592751</ArticleId></ArticleIdList></Reference><Reference><Citation>Karman J, Ling C, Sandor M, Fabry Z. Dendritic cells in the initiation of immune responses against central nervous system-derived antigens. Immunol. Lett. 2004;92:107&#x2013;115. doi: 10.1016/j.imlet.2003.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2003.10.017</ArticleId><ArticleId IdType="pubmed">15081534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach H, Zuniga EI, Truong P, Oldstone MBA, McGavern DB. Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J. Exp. Med. 2006;203:1963&#x2013;1975. doi: 10.1084/jem.20060039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060039</ArticleId><ArticleId IdType="pmc">PMC2118382</ArticleId><ArticleId IdType="pubmed">16847068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PE. Recent advances in antigen processing and presentation. Nat. Immunol. 2007;8:1041&#x2013;1048. doi: 10.1038/ni1516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1516</ArticleId><ArticleId IdType="pubmed">17878914</ArticleId></ArticleIdList></Reference><Reference><Citation>Perarnau B, et al. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 1999;29:1243&#x2013;1252. doi: 10.1002/(SICI)1521-4141(199904)29:04&lt;1243::AID-IMMU1243&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-4141(199904)29:04&lt;1243::AID-IMMU1243&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10229092</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarry U, et al. Efficiently stimulated adult microglia cross-prime naive CD8+T cells injected in the brain. Eur. J. Immunol. 2013;43:1173&#x2013;1184. doi: 10.1002/eji.201243040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201243040</ArticleId><ArticleId IdType="pubmed">23529826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper M, et al. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J. Immunol. 2008;180:6229&#x2013;6236. doi: 10.4049/jimmunol.180.9.6229.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.9.6229</ArticleId><ArticleId IdType="pmc">PMC6157020</ArticleId><ArticleId IdType="pubmed">18424745</ArticleId></ArticleIdList></Reference><Reference><Citation>John B, et al. Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog. 2009;5:3. doi: 10.1371/journal.ppat.1000505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000505</ArticleId><ArticleId IdType="pmc">PMC2700268</ArticleId><ArticleId IdType="pubmed">19578440</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008;8:607&#x2013;618. doi: 10.1038/nri2368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2368</ArticleId><ArticleId IdType="pmc">PMC2735460</ArticleId><ArticleId IdType="pubmed">18641646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi LAM, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 2005;175:2071. doi: 10.4049/jimmunol.175.4.2071.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.4.2071</ArticleId><ArticleId IdType="pubmed">16081773</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter L, Albert ML. Cutting edge: cross-presented intracranial antigen primes CD8+T cells. J. Immunol. 2007;178:6038&#x2013;6042. doi: 10.4049/jimmunol.178.10.6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.10.6038</ArticleId><ArticleId IdType="pubmed">17475827</ArticleId></ArticleIdList></Reference><Reference><Citation>Karman J, Ling C, Sandor M, Fabry Z. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 2004;173:2353&#x2013;2361. doi: 10.4049/jimmunol.173.4.2353.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.4.2353</ArticleId><ArticleId IdType="pubmed">15294948</ArticleId></ArticleIdList></Reference><Reference><Citation>Abram CL, Roberge GL, Hu Y, Lowell CA. Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice. J. Immunol. Methods. 2014;408:89&#x2013;100. doi: 10.1016/j.jim.2014.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2014.05.009</ArticleId><ArticleId IdType="pmc">PMC4105345</ArticleId><ArticleId IdType="pubmed">24857755</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic. Res. 1999;8:265&#x2013;277. doi: 10.1023/A:1008942828960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1008942828960</ArticleId><ArticleId IdType="pubmed">10621974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermsen C, van de Wiel T, Mommers E, Sauerwein R, Eling W. Depletion of CD4+or CD8+T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology. 1997;114:7&#x2013;12. doi: 10.1017/S0031182096008293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0031182096008293</ArticleId><ArticleId IdType="pubmed">9011069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavelko KD, et al. Theiler&#x2019;s murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS ONE. 2011;6:e20217. doi: 10.1371/journal.pone.0020217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020217</ArticleId><ArticleId IdType="pmc">PMC3098865</ArticleId><ArticleId IdType="pubmed">21625449</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavelko KD, et al. The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine. Mol. Ther. 2013;21:1087&#x2013;1095. doi: 10.1038/mt.2013.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.52</ArticleId><ArticleId IdType="pmc">PMC3666639</ArticleId><ArticleId IdType="pubmed">23568262</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh T, et al. Immunocompetent murine models for the study of glioblastoma immunotherapy. J. Transl. Med. 2014;12:1479&#x2013;5876. doi: 10.1186/1479-5876-12-107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-107</ArticleId><ArticleId IdType="pmc">PMC4012243</ArticleId><ArticleId IdType="pubmed">24779345</ArticleId></ArticleIdList></Reference><Reference><Citation>Szatmari T, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 2006;97:546&#x2013;553. doi: 10.1111/j.1349-7006.2006.00208.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1349-7006.2006.00208.x</ArticleId><ArticleId IdType="pmc">PMC11159227</ArticleId><ArticleId IdType="pubmed">16734735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MP, Renner DN, Johnson AJ, Pavelko KD. A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen. Viral Immunol. 2014;27:361&#x2013;366. doi: 10.1089/vim.2014.0045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2014.0045</ArticleId><ArticleId IdType="pmc">PMC4150375</ArticleId><ArticleId IdType="pubmed">25025983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, Katzmarski N, Haas CA, Prinz M. Bone marrow cell recruitment to the brain in the absence of irradiation or Parabiosis Bias. PLoS ONE. 2013;8:e58544. doi: 10.1371/journal.pone.0058544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058544</ArticleId><ArticleId IdType="pmc">PMC3592806</ArticleId><ArticleId IdType="pubmed">23526995</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012;12:557&#x2013;569. doi: 10.1038/nri3254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3254</ArticleId><ArticleId IdType="pubmed">22790179</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Shin JS. The role of dendritic cells in central tolerance. Immune Netw. 2015;15:111&#x2013;120. doi: 10.4110/in.2015.15.3.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2015.15.3.111</ArticleId><ArticleId IdType="pmc">PMC4486773</ArticleId><ArticleId IdType="pubmed">26140042</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerri L, et al. Analysis of APC types involved in CD4 tolerance and regulatory T cell generation using reaggregated thymic organ cultures. J. Immunol. 2013;190:2102&#x2013;2110. doi: 10.4049/jimmunol.1202883.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202883</ArticleId><ArticleId IdType="pubmed">23365074</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietto AI, van Dommelen S, Wu L. The impact of circulating dendritic cells on the development and differentiation of thymocytes. Immunol. Cell Biol. 2009;87:39&#x2013;45. doi: 10.1038/icb.2008.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2008.86</ArticleId><ArticleId IdType="pubmed">19048018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannarile MA, Decanis N, van Meerwijk JP, Brocker T. The role of dendritic cells in selection of classical and nonclassical CD8+T cells in vivo. J. Immunol. 2004;173:4799&#x2013;4805. doi: 10.4049/jimmunol.173.8.4799.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.8.4799</ArticleId><ArticleId IdType="pubmed">15470019</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon B, Lores P, Pioche C, Racz P, Jami J, Klatzmann D. Conditional ablation of dendritic cells in transgenic mice. J. Immunol. 1994;152:537&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">8283035</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyes KW, et al. Genetically engineered macrophages: a potential platform for cancer immunotherapy. Hum. Gene. Ther. 2017;28:200&#x2013;215. doi: 10.1089/hum.2016.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2016.060</ArticleId><ArticleId IdType="pubmed">27758144</ArticleId></ArticleIdList></Reference><Reference><Citation>Galarneau H, Villeneuve J, Gowing G, Julien JP, Vallieres L. Increased glioma growth in mice depleted of macrophages. Cancer Res. 2007;67:8874&#x2013;8881. doi: 10.1158/0008-5472.CAN-07-0177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-0177</ArticleId><ArticleId IdType="pubmed">17875729</ArticleId></ArticleIdList></Reference><Reference><Citation>Diefenbach A, Raulet DH. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev. 2002;188:9&#x2013;21. doi: 10.1034/j.1600-065X.2002.18802.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-065X.2002.18802.x</ArticleId><ArticleId IdType="pubmed">12445277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 2004;5:678&#x2013;684. doi: 10.1038/ni1082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1082</ArticleId><ArticleId IdType="pubmed">15224093</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AA, et al. Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. Cancer Immunol. Immunother. 2017;66:379&#x2013;389. doi: 10.1007/s00262-016-1941-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-016-1941-3</ArticleId><ArticleId IdType="pmc">PMC11028819</ArticleId><ArticleId IdType="pubmed">27942839</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyns B, Tosoni A, Hwu WJ, Reardon DA. Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects. Cancer. 2010;116:2868&#x2013;2877. doi: 10.1002/cncr.25035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.25035</ArticleId><ArticleId IdType="pubmed">20564393</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337&#x2013;341. doi: 10.1038/nature14432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14432</ArticleId><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarkson BD, et al. Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. Adv. Exp. Med. Biol. 2012;946:309&#x2013;333. doi: 10.1007/978-1-4614-0106-3_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-0106-3_18</ArticleId><ArticleId IdType="pmc">PMC3666851</ArticleId><ArticleId IdType="pubmed">21948376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumba Garcia LM, Huseby Kelcher AM, Malo CS, Johnson AJ. Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique. J. Immunol. Methods. 2016;10:30195&#x2013;30198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310589</ArticleId><ArticleId IdType="pubmed">27623324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29170787</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1477-0539</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>48</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>Organic &amp; biomolecular chemistry</Title><ISOAbbreviation>Org Biomol Chem</ISOAbbreviation></Journal><ArticleTitle>Synthesis, computational, and spectroscopic analysis of tunable highly fluorescent BN-1,2-azaborine derivatives containing the N-BOH moiety.</ArticleTitle><Pagination><StartPage>10172</StartPage><EndPage>10183</EndPage><MedlinePgn>10172-10183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c7ob02415k</ELocationID><Abstract><AbstractText>Nine new polycyclic aromatic BN-1,2-azaborine analogues containing the N-BOH moiety were synthesized using a convenient two-step, one-pot procedure. Characterization of the prepared compounds show the luminescence wavelength and the quantum yields of the azaborines were tunable by controlling the power and location of the donor and acceptor substituents on the chromophore. UV-visible spectroscopy and density functional theory (DFT) computations revealed that the addition of electron-donating moieties to the isoindolinone hemisphere raised the energy of the HOMO, resulting in the reduction of the HOMO-LUMO gap. The addition of an electron-accepting moiety to the isoindolinone hemisphere and an electron-donating group to the boronic acid hemisphere decreased the HOMO-LUMO gap considerably, leading to emission properties from partial intramolecular charge transfer (ICT) states. The combined effect of an acceptor on the isoindolinone side and a donor on the boronic acid side (strong acceptor-&#x3c0;-donor) gave the most red-shifted absorption. The polycyclic aromatic BN-1,2-azaborines emitted strong fluorescence in solution and in the solid-state with the largest red-shifted emission at 640 nm and a Stokes shift of &#x394;&#x3bb; = 218 nm, or &#x394;&#x3bd; = 8070 cm<sup>-1</sup>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saint-Louis</LastName><ForeName>Carl Jacky</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida, Pensacola, Florida 32514, USA. aschrock@uwf.edu mhuggins@uwf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shavnore</LastName><ForeName>Ren&#xe9;e N</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>McClinton</LastName><ForeName>Caleb D C</ForeName><Initials>CDC</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Magill</LastName><ForeName>Lacey L</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Breanna M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Charles Edwin</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Schrock</LastName><ForeName>Alan K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Org Biomol Chem</MedlineTA><NlmUniqueID>101154995</NlmUniqueID><ISSNLinking>1477-0520</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29170787</ArticleId><ArticleId IdType="doi">10.1039/c7ob02415k</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28264905</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5522</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Infection and immunity</Title><ISOAbbreviation>Infect Immun</ISOAbbreviation></Journal><ArticleTitle>Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00985-16</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/IAI.00985-16</ELocationID><Abstract><AbstractText>Human cerebral malaria (HCM) is a serious complication of <i>Plasmodium falciparum</i> infection. The most severe outcomes for patients include coma, permanent neurological deficits, and death. Recently, a large-scale magnetic resonance imaging (MRI) study in humans identified brain swelling as the most prominent predictor of fatal HCM. Therefore, in this study, we sought to define the mechanism controlling brain edema through the use of the murine experimental cerebral malaria (ECM) model. Specifically, we investigated the ability of CD8 T cells to initiate brain edema during ECM. We determined that areas of blood-brain barrier (BBB) permeability colocalized with a reduction of the cerebral endothelial cell tight-junction proteins claudin-5 and occludin. Furthermore, through small-animal MRI, we analyzed edema and vascular leakage. Using gadolinium-enhanced T1-weighted MRI, we determined that vascular permeability is not homogeneous but rather confined to specific regions of the brain. Our findings show that BBB permeability was localized within the brainstem, olfactory bulb, and lateral ventricle. Concurrently with the initiation of vascular permeability, T2-weighted MRI revealed edema and brain swelling. Importantly, ablation of the cytolytic effector molecule perforin fully protected against vascular permeability and edema. Furthermore, perforin production specifically by CD8 T cells was required to cause fatal edema during ECM. We propose that CD8 T cells initiate BBB breakdown through perforin-mediated disruption of tight junctions. In turn, leakage from the vasculature into the parenchyma causes brain swelling and edema. This results in a breakdown of homeostatic maintenance that likely contributes to ECM pathology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Immunology Program, Mayo Graduate School, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Holly L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Neurobiology of Disease Program, Mayo Graduate School, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N Songo</LastName><ForeName>Aurelie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurobiology of Disease Program, Mayo Graduate School, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaFrance</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Noah S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harty</LastName><ForeName>John T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Department of Pathology, and Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA Johnson.Aaron2@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS103212</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS094150</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007425</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Immun</MedlineTA><NlmUniqueID>0246127</NlmUniqueID><ISSNLinking>0019-9567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052899">Pore Forming Cytotoxic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C483886">perforin, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001929" MajorTopicYN="N">Brain Edema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="Y">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016779" MajorTopicYN="N">Malaria, Cerebral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052899" MajorTopicYN="N">Pore Forming Cytotoxic Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8 T cell</Keyword><Keyword MajorTopicYN="N">blood-brain barrier</Keyword><Keyword MajorTopicYN="N">experimental cerebral malaria</Keyword><Keyword MajorTopicYN="N">perforin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28264905</ArticleId><ArticleId IdType="pmc">PMC5400849</ArticleId><ArticleId IdType="doi">10.1128/IAI.00985-16</ArticleId><ArticleId IdType="pii">IAI.00985-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. 2015. World malaria report: 2015. WHO Global Malaria Program, Geneva, Switzerland.</Citation></Reference><Reference><Citation>WHO. 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1):S1&#x2013;S90.</Citation><ArticleIdList><ArticleId IdType="pubmed">11103309</ArticleId></ArticleIdList></Reference><Reference><Citation>Idro R, Jenkins NE, Newton CR. 2005. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 4:827&#x2013;840. doi: 10.1016/S1474-4422(05)70247-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70247-7</ArticleId><ArticleId IdType="pubmed">16297841</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando SD, Rodrigo C, Rajapakse S. 2010. The &#x2018;hidden&#x2019; burden of malaria: cognitive impairment following infection. Malar J 9:366. doi: 10.1186/1475-2875-9-366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2875-9-366</ArticleId><ArticleId IdType="pmc">PMC3018393</ArticleId><ArticleId IdType="pubmed">21171998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihara M, Carter JA, Newton CR. 2006. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Health 11:386&#x2013;397. doi: 10.1111/j.1365-3156.2006.01579.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2006.01579.x</ArticleId><ArticleId IdType="pubmed">16553922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra SK, Newton CR. 2009. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 5:189&#x2013;198. doi: 10.1038/nrneurol.2009.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.23</ArticleId><ArticleId IdType="pmc">PMC2859240</ArticleId><ArticleId IdType="pubmed">19347024</ArticleId></ArticleIdList></Reference><Reference><Citation>Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW, Birbeck GL, Bradley WG, Fox LL, Glover SJ, Hammond CA, Heyderman RS, Chilingulo CA, Molyneux ME, Taylor TE. 2015. Brain swelling and death in children with cerebral malaria. N Engl J Med 372:1126&#x2013;1137. doi: 10.1056/NEJMoa1400116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1400116</ArticleId><ArticleId IdType="pmc">PMC4450675</ArticleId><ArticleId IdType="pubmed">25785970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rest JR. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg 76:410&#x2013;415. doi: 10.1016/0035-9203(82)90203-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0035-9203(82)90203-6</ArticleId><ArticleId IdType="pubmed">7051459</ArticleId></ArticleIdList></Reference><Reference><Citation>Amani V, Boubou MI, Pied S, Marussig M, Walliker D, Mazier D, Renia L. 1998. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun 66:4093&#x2013;4099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC108491</ArticleId><ArticleId IdType="pubmed">9712753</ArticleId></ArticleIdList></Reference><Reference><Citation>Neill AL, Hunt NH. 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105:165&#x2013;175. doi: 10.1017/S0031182000074072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0031182000074072</ArticleId><ArticleId IdType="pubmed">1280805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J, Lucas R, Grau GE. 2001. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 14:810&#x2013;820. doi: 10.1128/CMR.14.4.810-820.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.14.4.810-820.2001</ArticleId><ArticleId IdType="pmc">PMC89004</ArticleId><ArticleId IdType="pubmed">11585786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacer A, Movila A, Sohet F, Girgis NM, Gundra UM, Loke P, Daneman R, Frevert U. 2014. Experimental cerebral malaria pathogenesis&#x2013;hemodynamics at the blood brain barrier. PLoS Pathog 10:e1004528. doi: 10.1371/journal.ppat.1004528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004528</ArticleId><ArticleId IdType="pmc">PMC4256476</ArticleId><ArticleId IdType="pubmed">25474413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ. 2011. Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis 203:1454&#x2013;1463. doi: 10.1093/infdis/jir058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir058</ArticleId><ArticleId IdType="pmc">PMC3080888</ArticleId><ArticleId IdType="pubmed">21415018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini GM, Martins YC, Cabrales P, Frangos JA, Carvalho LJ. 2012. S-nitrosoglutathione prevents experimental cerebral malaria. J Neuroimmune Pharmacol 7:477&#x2013;487. doi: 10.1007/s11481-012-9343-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9343-6</ArticleId><ArticleId IdType="pmc">PMC3354027</ArticleId><ArticleId IdType="pubmed">22391863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong PK, Melchior B, Martins YC, Hofer A, Orjuela-Sanchez P, Cabrales P, Zanini GM, Frangos JA, Carvalho LJ. 2013. Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria. PLoS Pathog 9:e1003444. doi: 10.1371/journal.ppat.1003444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003444</ArticleId><ArticleId IdType="pmc">PMC3688552</ArticleId><ArticleId IdType="pubmed">23818850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ya&#xf1;ez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 157:1620&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pubmed">8759747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermsen C, van de Wiel T, Mommers E, Sauerwein R, Eling W. 
1997. 
Depletion of CD4<sup>+</sup> or CD8<sup>+</sup> T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology
114:7&#x2013;12. doi: 10.1017/S0031182096008293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0031182096008293</ArticleId><ArticleId IdType="pubmed">9011069</ArticleId></ArticleIdList></Reference><Reference><Citation>Boubou MI, Collette A, Voegtle D, Mazier D, Cazenave PA, Pied S. 1999. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria. Int Immunol 11:1553&#x2013;1562. doi: 10.1093/intimm/11.9.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/11.9.1553</ArticleId><ArticleId IdType="pubmed">10464176</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley RW, Mackey LJ, Lambert PH. 1982. Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J Immunol 129:2213&#x2013;2218.</Citation><ArticleIdList><ArticleId IdType="pubmed">6749988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B. 
2003. 
Perforin-dependent brain-infiltrating cytotoxic CD8<sup>+</sup> T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol
170:2221&#x2013;2228. doi: 10.4049/jimmunol.170.4.2221.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.4.2221</ArticleId><ArticleId IdType="pubmed">12574396</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH. 2006. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol 36:485&#x2013;496. doi: 10.1016/j.ijpara.2005.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpara.2005.12.005</ArticleId><ArticleId IdType="pubmed">16500656</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque A, Best SE, Unosson K, Amante FH, de Labastida F, Anstey NM, Karupiah G, Smyth MJ, Heath WR, Engwerda CR. 
2011. 
Granzyme B expression by CD8<sup>+</sup> T cells is required for the development of experimental cerebral malaria. J Immunol
186:6148&#x2013;6156. doi: 10.4049/jimmunol.1003955.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003955</ArticleId><ArticleId IdType="pubmed">21525386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, Villadangos JA, Crabb BS, Heath WR. 
2008. 
Blood-stage Plasmodium infection induces CD8<sup>+</sup> T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha<sup>+</sup> dendritic cells. Proc Natl Acad Sci U S A
105:14509&#x2013;14514. doi: 10.1073/pnas.0806727105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806727105</ArticleId><ArticleId IdType="pmc">PMC2567226</ArticleId><ArticleId IdType="pubmed">18799734</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakoda M, Kimura D, Yuda M, Chinzei Y, Shibata Y, Honma K, Yui K. 
2008. 
Malaria-specific and nonspecific activation of CD8<sup>+</sup> T cells during blood stage of Plasmodium berghei infection. J Immunol
181:1420&#x2013;1428. doi: 10.4049/jimmunol.181.2.1420.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.2.1420</ArticleId><ArticleId IdType="pubmed">18606696</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, Renia L. 2013. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med 5:984&#x2013;999. doi: 10.1002/emmm.201202273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202273</ArticleId><ArticleId IdType="pmc">PMC3721469</ArticleId><ArticleId IdType="pubmed">23681698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 38:323&#x2013;337. doi: 10.1016/S1537-1891(02)00200-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1537-1891(02)00200-8</ArticleId><ArticleId IdType="pubmed">12529927</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott NJ, Ronnback L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41&#x2013;53. doi: 10.1038/nrn1824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1824</ArticleId><ArticleId IdType="pubmed">16371949</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. 1993. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777&#x2013;1788. doi: 10.1083/jcb.123.6.1777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.123.6.1777</ArticleId><ArticleId IdType="pmc">PMC2290891</ArticleId><ArticleId IdType="pubmed">8276896</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, Sasaki H, Furuse M, Tsukita S. 1999. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185&#x2013;194. doi: 10.1083/jcb.147.1.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.147.1.185</ArticleId><ArticleId IdType="pmc">PMC2164984</ArticleId><ArticleId IdType="pubmed">10508865</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson PA II, Hart GT, Russo MV, Nayak D, Yazew T, Pena M, Khan SM, Janse CJ, Pierce SK, McGavern DB. 
2016. 
CD8<sup>+</sup> T cells induce fatal brainstem pathology during cerebral malaria via luminal antigen-specific engagement of brain vasculature. PLoS Pathog
12:e1006022. doi: 10.1371/journal.ppat.1006022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006022</ArticleId><ArticleId IdType="pmc">PMC5131904</ArticleId><ArticleId IdType="pubmed">27907215</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland SW, Poh CM, Renia L. 2015. Activated brain endothelial cells cross-present malaria antigen. PLoS Pathog 11:e1004963. doi: 10.1371/journal.ppat.1004963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004963</ArticleId><ArticleId IdType="pmc">PMC4457820</ArticleId><ArticleId IdType="pubmed">26046849</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw TN, Stewart-Hutchinson PJ, Strangward P, Dandamudi DB, Coles JA, Villegas-Mendez A, Gallego-Delgado J, van Rooijen N, Zindy E, Rodriguez A, Brewer JM, Couper KN, Dustin ML. 
2015. 
Perivascular arrest of CD8<sup>+</sup> T cells is a signature of experimental cerebral malaria. PLoS Pathog
11:e1005210. doi: 10.1371/journal.ppat.1005210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005210</ArticleId><ArticleId IdType="pmc">PMC4643016</ArticleId><ArticleId IdType="pubmed">26562533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacer A, Movila A, Baer K, Mikolajczak SA, Kappe SH, Frevert U. 2012. Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog 8:e1002982. doi: 10.1371/journal.ppat.1002982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002982</ArticleId><ArticleId IdType="pmc">PMC3486917</ArticleId><ArticleId IdType="pubmed">23133375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassmer SC, de Souza JB, Frere C, Candal FJ, Juhan-Vague I, Grau GE. 2006. TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol 176:1180&#x2013;1184. doi: 10.4049/jimmunol.176.2.1180.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.2.1180</ArticleId><ArticleId IdType="pubmed">16394007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau LS, Fernandez Ruiz D, Davey GM, de Koning-Ward TF, Papenfuss AT, Carbone FR, Brooks AG, Crabb BS, Heath WR. 
2011. 
Blood-stage Plasmodium berghei infection generates a potent, specific CD8<sup>+</sup> T-cell response despite residence largely in cells lacking MHC I processing machinery. J Infect Dis
204:1989&#x2013;1996. doi: 10.1093/infdis/jir656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir656</ArticleId><ArticleId IdType="pubmed">21998471</ArticleId></ArticleIdList></Reference><Reference><Citation>Poh CM, Howland SW, Grotenbreg GM, Renia L. 
2014. 
Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8<sup>+</sup> T cells with different specificities. Infect Immun
82:4854&#x2013;4864. doi: 10.1128/IAI.02180-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.02180-14</ArticleId><ArticleId IdType="pmc">PMC4249313</ArticleId><ArticleId IdType="pubmed">25156726</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash MD, Munoz MA, Jain R, Tong PL, Koskinen A, Regner M, Kleifeld O, Ho B, Olson M, Turner SJ, Mrass P, Weninger W, Bird PI. 2014. Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling. Immunity 41:960&#x2013;972. doi: 10.1016/j.immuni.2014.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.11.012</ArticleId><ArticleId IdType="pubmed">25526309</ArticleId></ArticleIdList></Reference><Reference><Citation>Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL. 
2008. 
Noncytotoxic lytic granule-mediated CD8<sup>+</sup> T cell inhibition of HSV-1 reactivation from neuronal latency. Science
322:268&#x2013;271. doi: 10.1126/science.1164164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1164164</ArticleId><ArticleId IdType="pmc">PMC2680315</ArticleId><ArticleId IdType="pubmed">18845757</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL. 2000. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459&#x2013;1466. doi: 10.1084/jem.191.9.1459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.9.1459</ArticleId><ArticleId IdType="pmc">PMC2213436</ArticleId><ArticleId IdType="pubmed">10790421</ArticleId></ArticleIdList></Reference><Reference><Citation>Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. 2008. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 3:e3037. doi: 10.1371/journal.pone.0003037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003037</ArticleId><ArticleId IdType="pmc">PMC2516328</ArticleId><ArticleId IdType="pubmed">18725947</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson HL, Chen Y, Suidan GL, McDole JR, Lohrey AK, Hanson LM, Jin F, Pirko I, Johnson AJ. 2012. A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption. J Neuroinflammation 9:60. doi: 10.1186/1742-2094-9-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-60</ArticleId><ArticleId IdType="pmc">PMC3350446</ArticleId><ArticleId IdType="pubmed">22452799</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson HL, Jin F, Pirko I, Johnson AJ. 2013. Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. J Neurovirol 20:107&#x2013;112. doi: 10.1007/s13365-013-0187-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-013-0187-5</ArticleId><ArticleId IdType="pmc">PMC3894260</ArticleId><ArticleId IdType="pubmed">23857332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hearn J, Rayment N, Landon DN, Katz DR, de Souza JB. 2000. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun 68:5364&#x2013;5376. doi: 10.1128/IAI.68.9.5364-5376.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.68.9.5364-5376.2000</ArticleId><ArticleId IdType="pmc">PMC101800</ArticleId><ArticleId IdType="pubmed">10948166</ArticleId></ArticleIdList></Reference><Reference><Citation>Purves D, Augustine GJ, Fitzpatrick D, Hall WC, LaMantia A-S, White LE. 2012. Neuroscience, 5th ed Sinauer Associates, Sunderland, Mass.</Citation></Reference><Reference><Citation>Allen GI, Tsukahara N. 1974. Cerebrocerebellar communication systems. Physiol Rev 54:957&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">4370744</ArticleId></ArticleIdList></Reference><Reference><Citation>Aird WC. 2007. Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ Res 100:158&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">17272818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Aoshi T, Kawai S, Mori Y, Konishi A, Ozkan M, Fujita Y, Haseda Y, Shimizu M, Kohyama M, Kobiyama K, Eto K, Nabekura J, Horii T, Ishino T, Yuda M, Hemmi H, Kaisho T, Akira S, Kinoshita M, Tohyama K, Yoshioka Y, Ishii KJ, Coban C. 2014. Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria. Cell Host Microbe 15:551&#x2013;563. doi: 10.1016/j.chom.2014.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.04.008</ArticleId><ArticleId IdType="pubmed">24832450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann A, Pfeil J, Alfonso J, Kurz FT, Sahm F, Heiland S, Monyer H, Bendszus M, Mueller AK, Helluy X, Pham M. 2016. Experimental cerebral malaria spreads along the rostral migratory stream. PLoS Pathog 12:e1005470. doi: 10.1371/journal.ppat.1005470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005470</ArticleId><ArticleId IdType="pmc">PMC4786214</ArticleId><ArticleId IdType="pubmed">26964100</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J, participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria. 2012. The role of animal models for research on severe malaria. PLoS Pathog 8:e1002401. doi: 10.1371/journal.ppat.1002401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002401</ArticleId><ArticleId IdType="pmc">PMC3271056</ArticleId><ArticleId IdType="pubmed">22319438</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson HL, Chen Y, Jin F, Hanson LM, Gamez JD, Pirko I, Johnson AJ. 2012. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol 189:1937&#x2013;1945. doi: 10.4049/jimmunol.1200658.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200658</ArticleId><ArticleId IdType="pmc">PMC3411871</ArticleId><ArticleId IdType="pubmed">22772449</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner DN, Jin F, Litterman AJ, Balgeman AJ, Hanson LM, Gamez JD, Chae M, Carlson BL, Sarkaria JN, Parney IF, Ohlfest JR, Pirko I, Pavelko KD, Johnson AJ. 
2015. 
Effective treatment of established GL261 murine gliomas through picornavirus vaccination-enhanced tumor antigen-specific CD8<sup>+</sup> T cell responses. PLoS One
10:e0125565. doi: 10.1371/journal.pone.0125565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125565</ArticleId><ArticleId IdType="pmc">PMC4416934</ArticleId><ArticleId IdType="pubmed">25933216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28196601</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-9777</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month><Day>04</Day></PubDate></JournalIssue><Title>Cell stem cell</Title><ISOAbbreviation>Cell Stem Cell</ISOAbbreviation></Journal><ArticleTitle>Cholinergic Signals from the CNS Regulate G-CSF-Mediated HSC Mobilization from Bone Marrow via a Glucocorticoid Signaling Relay.</ArticleTitle><Pagination><StartPage>648</StartPage><EndPage>658.e4</EndPage><MedlinePgn>648-658.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stem.2017.01.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1934-5909(17)30002-4</ELocationID><Abstract><AbstractText>Hematopoietic stem cells (HSCs) are mobilized from niches in the bone marrow (BM) to the blood circulation by the cytokine granulocyte colony-stimulating factor (G-CSF) through complex mechanisms. Among these, signals from the sympathetic nervous system regulate HSC egress via its niche, but how the brain communicates with the BM remains largely unknown. Here we show that muscarinic receptor type-1 (Chrm1) signaling in the hypothalamus promotes G-CSF-elicited HSC mobilization via hormonal priming of the hypothalamic-pituitary-adrenal (HPA) axis. Blockade of Chrm1 in the CNS, but not the periphery, reduces HSC mobilization. Mobilization is impaired in Chrm1<sup>-&#x2215;-</sup> mice and rescued by parabiosis with wild-type mice, suggesting a relay by a blood-borne factor. We have identified the glucocorticoid (GC) hormones as critical for optimal mobilization. Physiological levels of corticosterone promote HSC migration via the GC receptor Nr3c1-dependent signaling and upregulation of actin-organizing molecules. These results uncover long-range regulation of HSC migration emerging from the brain.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Halley</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dachuan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnon</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christin</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Gary J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA; Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenette</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA. Electronic address: paul.frenette@einstein.yu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK105441</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL069438</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL097700</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007491</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK026687</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK056638</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Stem Cell</MedlineTA><NlmUniqueID>101311472</NlmUniqueID><ISSNLinking>1875-9777</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086088">CHRM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043643">Receptor, Muscarinic M1</NameOfSubstance></Chemical><Chemical><RegistryNumber>143011-72-7</RegistryNumber><NameOfSubstance UI="D016179">Granulocyte Colony-Stimulating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001854" MajorTopicYN="N">Bone Marrow Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016179" MajorTopicYN="N">Granulocyte Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019650" MajorTopicYN="N">Hematopoietic Stem Cell Mobilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017403" MajorTopicYN="N">In Situ Hybridization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043643" MajorTopicYN="N">Receptor, Muscarinic M1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hematopoietic stem cell mobilization</Keyword><Keyword MajorTopicYN="N">hyphothalamic-pituitary-adrenal axis</Keyword><Keyword MajorTopicYN="N">muscarinic receptor type-1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28196601</ArticleId><ArticleId IdType="mid">NIHMS849976</ArticleId><ArticleId IdType="pmc">PMC5467872</ArticleId><ArticleId IdType="doi">10.1016/j.stem.2017.01.002</ArticleId><ArticleId IdType="pii">S1934-5909(17)30002-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Albiero M, Poncina N, Ciciliot S, Cappellari R, Menegazzo L, Ferraro F, Bolego C, Cignarella A, Avogaro A, Fadini GP. Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M. Diabetes. 2015;64:2957&#x2013;2968.</Citation><ArticleIdList><ArticleId IdType="pubmed">25804939</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schutz G, Beug H. The glucocorticoid receptor is required for stress erythropoiesis. Genes &amp; development. 1999;13:2996&#x2013;3002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC317156</ArticleId><ArticleId IdType="pubmed">10580006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendall LJ, Bradstock KF. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine &amp; growth factor reviews. 2014;25:355&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">25131807</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood. 1993;81:3158&#x2013;3163.</Citation><ArticleIdList><ArticleId IdType="pubmed">7684625</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner S, Zaruba MM, Huber B, David R, Vallaster M, Assmann G, Mueller-Hoecker J, Franz WM. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Experimental hematology. 2008;36:1157&#x2013;1166.</Citation><ArticleIdList><ArticleId IdType="pubmed">18504066</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">14574413</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo FA, Ali SF, Wolff GL, Scallet AC. Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice. Pharmacology, biochemistry, and behavior. 1996;53:425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">8808153</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellino F, Heuser J, Marchetti S, Bruno B, Luini A. Glucocorticoid stabilization of actin filaments: a possible mechanism for inhibition of corticotropin release. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:3775&#x2013;3779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC525573</ArticleId><ArticleId IdType="pubmed">1315038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208:261&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039855</ArticleId><ArticleId IdType="pubmed">21282381</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med. 2011;208:251&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039862</ArticleId><ArticleId IdType="pubmed">21282380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes &amp; development. 1995;9:1608&#x2013;1621.</Citation><ArticleIdList><ArticleId IdType="pubmed">7628695</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kloet ER, Fitzsimons CP, Datson NA, Meijer OC, Vreugdenhil E. Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors, transcription machinery and microRNA. Brain research. 2009;1293:129&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">19332027</ArticleId></ArticleIdList></Reference><Reference><Citation>Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988;72:2074&#x2013;2081.</Citation><ArticleIdList><ArticleId IdType="pubmed">3264199</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:15312&#x2013;15317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC65026</ArticleId><ArticleId IdType="pubmed">11752469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gireesh G, Kaimal SB, Kumar TP, Paulose CS. Decreased muscarinic M1 receptor gene expression in the hypothalamus, brainstem, and pancreatic islets of streptozotocin-induced diabetic rats. J Neurosci Res. 2008;86:947&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">17960828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordijn MS, Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. The Cochrane database of systematic reviews. 2015;8:CD008727.</Citation><ArticleIdList><ArticleId IdType="pubmed">26282194</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto K, Oue N, Hayashi T, Shinmei S, Sakamoto N, Sentani K, Teishima J, Matsubara A, Yasui W. Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer. Pathobiology. 2014;81:190&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">25170626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y, Lacombe J, Armstrong SA, Duhrsen U, Frenette PS. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell. 2014;15:365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156919</ArticleId><ArticleId IdType="pubmed">25017722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays SJ, Tobes MC, Gildersleeve DL, Wieland DM, Beierwaltes WH. Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues. Journal of medicinal chemistry. 1984;27:15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">6606707</ArticleId></ArticleIdList></Reference><Reference><Citation>Heintz N. Gene expression nervous system atlas (GENSAT) Nat Neurosci. 2004;7:483.</Citation><ArticleIdList><ArticleId IdType="pubmed">15114362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillhouse EW, Milton NG. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. The Journal of endocrinology. 1989;122:713&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">2572662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoggatt J, Speth JM, Pelus LM. Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization. Stem cells. 2013;31:2599&#x2013;2606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947455</ArticleId><ArticleId IdType="pubmed">24123398</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari M, Seese RR, Babayan AH, Gall CM, Lauterborn JC. Glucocorticoid receptors are localized to dendritic spines and influence local actin signaling. Mol Neurobiol. 2012;46:304&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3973133</ArticleId><ArticleId IdType="pubmed">22717988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaup BH, Blomstrand C. Cerebro-spinal fluid concentrations of pirenzepine after therapeutic dosage. Scandinavian journal of gastroenterology Supplement. 1980;66:35&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">6941375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends in pharmacological sciences. 2013;34:518&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951203</ArticleId><ArticleId IdType="pubmed">23953592</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124:407&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">16439213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamori Y, Katayama Y, Asada N, Minagawa K, Sato M, Okamura A, Shimoyama M, Nakagawa K, Okano T, Tanimoto M, et al. Role for vitamin D receptor in the neuronal control of the hematopoietic stem cell niche. Blood. 2010;116:5528&#x2013;5535.</Citation><ArticleIdList><ArticleId IdType="pubmed">20813899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollet O, Vagima Y, D&#x2019;Uva G, Golan K, Canaani J, Itkin T, Gur-Cohen S, Kalinkovich A, Caglio G, Medaglia C, et al. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. Leukemia. 2013;27:2006&#x2013;2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">23680895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:637&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3821873</ArticleId><ArticleId IdType="pubmed">24107994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan W, Cortes M, Frost I, Esain V, Theodore LN, Liu SY, Budrow N, Goessling W, North TE. The Central Nervous System Regulates Embryonic HSPC Production via Stress-Responsive Glucocorticoid Receptor Signaling. Cell Stem Cell. 2016;19:370&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181112</ArticleId><ArticleId IdType="pubmed">27424782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LW, Hardwick A, Moubayed M, et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood. 1995;85:275&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">7528570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapidot T, Kollet O. The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2010;2010:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21239763</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque JP, Winkler IG. Mobilization of hematopoietic stem cells: state of the art. Curr Opin Organ Transplant. 2008;13:53&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">18660707</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wu X, Camacho R, Schwartz GJ, LeRoith D. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PloS one. 2011;6:e17058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3040739</ArticleId><ArticleId IdType="pubmed">21379576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Poursine-Laurent J, Link DC. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood. 2000;95:3025&#x2013;3031.</Citation><ArticleIdList><ArticleId IdType="pubmed">10807765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas D, Bruns I, Battista M, Mendez-Ferrer S, Magnon C, Kunisaki Y, Frenette PS. Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields. Blood. 2012;119:3962&#x2013;3965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3350363</ArticleId><ArticleId IdType="pubmed">22422821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med. 2013;19:695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964478</ArticleId><ArticleId IdType="pubmed">23644514</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnon C, Frenette PS. Hematopoietic stem cell trafficking. StemBook; Cambridge (MA): 2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">20614595</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361.</Citation><ArticleIdList><ArticleId IdType="pubmed">23846904</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayanagi T, Morita T, Hayashi K, Fukumoto K, Sobue K. Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton. The Journal of biological chemistry. 2008;283:31183&#x2013;31196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2662183</ArticleId><ArticleId IdType="pubmed">18772142</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008;452:442&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">18256599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma&#x2019;ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146551</ArticleId><ArticleId IdType="pubmed">20703299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercier FE, Sykes DB, Scadden DT. Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1(STEM) Mouse. Stem cell reports. 2016;6:985&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4911492</ArticleId><ArticleId IdType="pubmed">27185283</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J Comp Neurol. 2004;469:311&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">14730584</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel M, Font L, Sanchis-Segura C, Aragon CM. Neonatal administration of monosodium glutamate prevents the development of ethanol-but not psychostimulant-induced sensitization: a putative role of the arcuate nucleus. The European journal of neuroscience. 2003;17:2163&#x2013;2170.</Citation><ArticleIdList><ArticleId IdType="pubmed">12786983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng AC, Kumar SK, Russell SJ, Rajkumar SV, Drake MT. Dexamethasone and the risk for adrenal suppression in multiple myeloma. Leukemia. 2009;23:1009&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893349</ArticleId><ArticleId IdType="pubmed">19151775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmori N, Itoi K, Tozawa F, Sakai Y, Sakai K, Horiba N, Demura H, Suda T. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology. 1995;136:4858&#x2013;4863.</Citation><ArticleIdList><ArticleId IdType="pubmed">7588217</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxtoby E, Jowett T. Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development. Nucleic acids research. 1993;21:1087&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC309267</ArticleId><ArticleId IdType="pubmed">8464695</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CK, Miller C, Lawrence G. Addison&#x2019;s disease from non-Hodgkin&#x2019;s lymphoma with normal-size adrenal glands. J Clin Oncol. 2007;25:2322&#x2013;2324.</Citation><ArticleIdList><ArticleId IdType="pubmed">17538179</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">12068293</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. The New England journal of medicine. 2005;353:1711&#x2013;1723.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236742</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiermann C, Kunisaki Y, Lucas D, Chow A, Jang JE, Zhang D, Hashimoto D, Merad M, Frenette PS. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity. 2012;37:290&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428436</ArticleId><ArticleId IdType="pubmed">22863835</ArticleId></ArticleIdList></Reference><Reference><Citation>To LB, Levesque JP, Herbert KE. How I treat patients who mobilize hematopoietic stem cells poorly. Blood. 2011;118:4530&#x2013;4540.</Citation><ArticleIdList><ArticleId IdType="pubmed">21832280</ArticleId></ArticleIdList></Reference><Reference><Citation>Udelsman R, Ramp J, Gallucci WT, Gordon A, Lipford E, Norton JA, Loriaux DL, Chrousos GP. Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. The Journal of clinical investigation. 1986;77:1377&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC424500</ArticleId><ArticleId IdType="pubmed">3958189</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasco-Hernandez T, Sawen P, Bryder D, Cammenga J. Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis. Stem cell reports. 2016;7:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945592</ArticleId><ArticleId IdType="pubmed">27373927</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterstrat A, Liang Y, Swiderski CF, Shelton BJ, Van Zant G. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood. 2010;115:408&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808161</ArticleId><ArticleId IdType="pubmed">19901263</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, Helwani F, Poulton IJ, van Rooijen N, Alexander KA, Raggatt LJ, et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010;116:4815&#x2013;4828.</Citation><ArticleIdList><ArticleId IdType="pubmed">20713966</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science. 2001;294:1933&#x2013;1936.</Citation><ArticleIdList><ArticleId IdType="pubmed">11729320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Hu Z, Wang Z, Tao J, Lu T, Yang C, Lee B, Ye Z. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014;17:119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020276</ArticleId><ArticleId IdType="pubmed">24418912</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27704820</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-6904</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>22</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of organic chemistry</Title><ISOAbbreviation>J Org Chem</ISOAbbreviation></Journal><ArticleTitle>The Synthesis and Characterization of Highly Fluorescent Polycyclic Azaborine Chromophores.</ArticleTitle><Pagination><StartPage>10955</StartPage><EndPage>10963</EndPage><MedlinePgn>10955-10963</MedlinePgn></Pagination><Abstract><AbstractText>Six new heteroaromatic polycyclic azaborine chromophores were designed, synthesized, and investigated as easily tunable high-luminescent organic materials. The impact of the nitrogen-boron-hydroxy (N-BOH) unit in the azaborines was investigated by comparison with their N-carbonyl analogs. Insertion of the N-B(OH)-C unit into heteroaromatic polycyclic compounds resulted in strong visible absorption and sharp fluorescence with efficient quantum yields. The solid-state fluorescence of the heteroaromatic polycyclic compounds displayed a large Stokes shift compared to being in solution. The large Stokes shifts observed offset the self-quench effect in the solid state.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saint-Louis</LastName><ForeName>Carl Jacky</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magill</LastName><ForeName>Lacey L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Alabama , 1825 University Boulevard, Birmingham, Alabama 35294, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrell</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Nicolle S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trindell</LastName><ForeName>Jamie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Texas-Austin , 120 Inner Campus Dr., Austin, Texas 78712, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Saraphina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisch</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Tennessee , 1420 Circle Dr., Knoxville, Tennessee 37996, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munro</LastName><ForeName>Lyndsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Nevada, Reno , Reno, Nevada 89557, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalano</LastName><ForeName>Vincent J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Nevada, Reno , Reno, Nevada 89557, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Charles Edwin</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Mississippi State University , Mississippi State, Mississippi 39762, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughan</LastName><ForeName>Pamela P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molek</LastName><ForeName>Karen S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrock</LastName><ForeName>Alan K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida , Pensacola, Florida 32514, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Org Chem</MedlineTA><NlmUniqueID>2985193R</NlmUniqueID><ISSNLinking>0022-3263</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27704820</ArticleId><ArticleId IdType="doi">10.1021/acs.joc.6b01998</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25616042</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-8652</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>American journal of hematology</Title><ISOAbbreviation>Am J Hematol</ISOAbbreviation></Journal><ArticleTitle>Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>385</EndPage><MedlinePgn>381-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajh.23956</ELocationID><Abstract><AbstractText>Intravenous immunoglobulin (IVIG) decreases neutrophil adhesion to endothelium and red blood cell-neutrophil interactions in sickle cell mice undergoing vaso-occlusion. In this Phase I clinical trial of sickle cell anemia (SCA) patients admitted with pain crisis, we evaluated the status of adhesion molecules on neutrophils in control and IVIG-treated subjects pre- and post-infusion up to 800 mg/kg, the same dose used in murine studies. Mac-1 function significantly decreased from baseline in the low-dose IVIG (200-400 mg/kg) cohorts. IVIG-related adverse events may have occurred in the high-dose (600-800 mg/kg) cohorts. There were no significant increases in neutrophil and leukocyte counts, suggesting that IVIG may more selectively inhibit Mac-1 function as opposed to neutrophil adhesion. This study provides the first in-human validation of pre-clinical murine studies that IVIG can decrease Mac-1 function.</AbstractText><CopyrightInformation>&#xa9; 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manwani</LastName><ForeName>Deepa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carullo</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serban</LastName><ForeName>Stelian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mount Sinai School of Medicine, New York, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olowokure</LastName><ForeName>Olugbenga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mount Sinai School of Medicine, New York, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jungeun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Hillel W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billett</LastName><ForeName>Henny</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atweh</LastName><ForeName>George F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mount Sinai School of Medicine, New York, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenette</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Mount Sinai School of Medicine, New York, New York</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mount Sinai School of Medicine, New York, New York</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Albert Einstein College of Medicine, Bronx, New York</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York Blood Center, New York, New York</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL089217</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR001072</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL069438</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1 TL1 TR00107 2-01</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001071</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23HL089217</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01FD003447</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 FD003447</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1 KL2 TR001071 -01</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001073</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1 UL1 TR0010 73-01</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hematol</MedlineTA><NlmUniqueID>7610369</NlmUniqueID><ISSNLinking>0361-8609</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016177">Macrophage-1 Antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D056586" MajorTopicYN="N">Acute Chest Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000755" MajorTopicYN="N">Anemia, Sickle Cell</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016177" MajorTopicYN="N">Macrophage-1 Antigen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018375" MajorTopicYN="N">Neutrophil Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no relevant conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25616042</ArticleId><ArticleId IdType="mid">NIHMS659240</ArticleId><ArticleId IdType="pmc">PMC4409477</ArticleId><ArticleId IdType="doi">10.1002/ajh.23956</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turhan A, Jenab P, Bruhns P, et al. Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. Blood. 2004;103:2397&#x2013;2400.</Citation><ArticleIdList><ArticleId IdType="pubmed">14630831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Shi PA, Chiang EY, et al. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood. 2008;111:915&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2200843</ArticleId><ArticleId IdType="pubmed">17932253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo A, Chang J, Jang JE, et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nature medicine. 2009;15:384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772164</ArticleId><ArticleId IdType="pubmed">19305412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JE, Hidalgo A, Frenette PS. Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcgammaRIII and SHP-1. Circulation research. 2012;110:1057&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3351009</ArticleId><ArticleId IdType="pubmed">22415018</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon SICS, 1, Thackray H, Magnani JL, Wun T. Inhibition of E-Selectin Inflammatory Function by the Glycomimetic GMI-1070. Blood: The American Society of Hematology. 2011</Citation></Reference><Reference><Citation>Magnani JLKF, Patton JT, Larkin SK, Styles L, DeCastro LM, Telen MJ, Wun T, Thackray H. Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State. Blood: The American Society of Hematology. 2012</Citation></Reference><Reference><Citation>Telen MJWT, McCavit TL, DeCastro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR, Rhee S, Magnani JL, Thackray H. GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease. Blood: The American Society of Hematology. 2013</Citation></Reference><Reference><Citation>Lin RY, Rodriguez-Baez G, Bhargave GA, et al. Intravenous gammaglobulin-associated renal impairment reported to the FDA: 2004 &#x2013; 2009. Clinical nephrology. 2011;76:365&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">22000556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Ahmed I, Nissel-Horowitz S, et al. Intravenous gammglobulin-associated acute renal failure. American journal of hematology. 2001;66:151&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">11421298</ArticleId></ArticleIdList></Reference><Reference><Citation>Turhan A, Weiss LA, Mohandas N, et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:3047&#x2013;3051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122470</ArticleId><ArticleId IdType="pubmed">11880644</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama Y, Hidalgo A, Chang J, et al. CD44 is a physiological E-selectin ligand on neutrophils. The Journal of experimental medicine. 2005;201:1183&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213157</ArticleId><ArticleId IdType="pubmed">15824084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nature reviews Immunology. 2013;13:159&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">23435331</ArticleId></ArticleIdList></Reference><Reference><Citation>Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc. 2000;75:83&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630762</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk MB, Gross N, Gross S, et al. Thromboembolic events associated with immunoglobulin treatment. Vox Sang. 2013;105:54&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">23398249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382:311&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">23697825</ArticleId></ArticleIdList></Reference><Reference><Citation>Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855&#x2013;1865.</Citation><ArticleIdList><ArticleId IdType="pubmed">10861320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobota A, Graham DA, Neufeld EJ, et al. Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Pediatric blood &amp; cancer. 2012;58:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581528</ArticleId><ArticleId IdType="pubmed">21674766</ArticleId></ArticleIdList></Reference><Reference><Citation>Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. Jama. 2010;303:1288&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pubmed">20371788</ArticleId></ArticleIdList></Reference><Reference><Citation>Casulli S, Topcu S, Fattoum L, et al. A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms. PloS one. 2011;6:e26469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3204983</ArticleId><ArticleId IdType="pubmed">22065996</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnegan EM, Turhan A, Golan DE, et al. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. American journal of hematology. 2007;82:266&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">17094094</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida CB, Scheiermann C, Jang JE, et al. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. Blood. 2012;120:2879&#x2013;2888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466969</ArticleId><ArticleId IdType="pubmed">22833547</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkerrou M, Delarche C, Brahimi L, et al. Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood. 2002;99:2297&#x2013;2303.</Citation><ArticleIdList><ArticleId IdType="pubmed">11895759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill V, Doig C, Knight D, et al. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation. 2005;112:2031&#x2013;2039.</Citation><ArticleIdList><ArticleId IdType="pubmed">16172269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigal D, Vermot-Desroches C, Heitz S, et al. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules. Clinical immunology and immunopathology. 1994;71:309&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7515337</ArticleId></ArticleIdList></Reference><Reference><Citation>Hidalgo A, Peired AJ, Wild MK, et al. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity. 2007;26:477&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4080624</ArticleId><ArticleId IdType="pubmed">17442598</ArticleId></ArticleIdList></Reference><Reference><Citation>Wun T, Styles L, DeCastro L, et al. Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia. PloS one. 2014;9:e101301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079300</ArticleId><ArticleId IdType="pubmed">24988449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Patton JT, Sarkar A, et al. GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood. 2010;116:1779&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2947397</ArticleId><ArticleId IdType="pubmed">20508165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25358664</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1749-4486</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery</Title><ISOAbbreviation>Clin Otolaryngol</ISOAbbreviation></Journal><ArticleTitle>Can nurse practitioners provide a safe and effective ENT emergency service? Our experience.</ArticleTitle><Pagination><StartPage>148</StartPage><EndPage>153</EndPage><MedlinePgn>148-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/coa.12349</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vijendren</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ENT Department, Ipswich Hospital Trust, Ipswich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Otolaryngol</MedlineTA><NlmUniqueID>101247023</NlmUniqueID><ISSNLinking>1749-4478</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D039602" MajorTopicYN="N">After-Hours Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009722" MajorTopicYN="Y">Nurse Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010036" MajorTopicYN="Y">Otolaryngology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25358664</ArticleId><ArticleId IdType="doi">10.1111/coa.12349</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23813913</PMID><DateCompleted><Year>2013</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN><JournalIssue CitedMedium="Internet"><Volume>161A</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>American journal of medical genetics. Part A</Title><ISOAbbreviation>Am J Med Genet A</ISOAbbreviation></Journal><ArticleTitle>The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes.</ArticleTitle><Pagination><StartPage>1833</StartPage><EndPage>1852</EndPage><MedlinePgn>1833-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.35996</ELocationID><Abstract><AbstractText>Chromosome 17p13.3 is a gene rich region that when deleted is associated with the well-known Miller-Dieker syndrome. A recently described duplication syndrome involving this region has been associated with intellectual impairment, autism and occasional brain MRI abnormalities. We report 34 additional patients from 21 families to further delineate the clinical, neurological, behavioral, and brain imaging findings. We found a highly diverse phenotype with inter- and intrafamilial variability, especially in cognitive development. The most specific phenotype occurred in individuals with large duplications that include both the YWHAE and LIS1 genes. These patients had a relatively distinct facial phenotype and frequent structural brain abnormalities involving the corpus callosum, cerebellar vermis, and cranial base. Autism spectrum disorders were seen in a third of duplication probands, most commonly in those with duplications of YWHAE and flanking genes such as CRK. The typical neurobehavioral phenotype was usually seen in those with the larger duplications. We did not confirm the association of early overgrowth with involvement of YWHAE and CRK, or growth failure with duplications of LIS1. Older patients were often overweight. Three variant phenotypes included cleft lip/palate (CLP), split hand/foot with long bone deficiency (SHFLD), and a connective tissue phenotype resembling Marfan syndrome. The duplications in patients with clefts appear to disrupt ABR, while the SHFLD phenotype was associated with duplication of BHLHA9 as noted in two recent reports. The connective tissue phenotype did not have a convincing critical region. Our experience with this large cohort expands knowledge of this diverse duplication syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curry</LastName><ForeName>Cynthia J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Genetic Medicine Central California, Fresno, CA 93701, USA. ccurry@fresno.ucsf.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Jill A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gripp</LastName><ForeName>Karen W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Aylsworth</LastName><ForeName>Arthur S</ForeName><Initials>AS</Initials></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Taha Ben</ForeName><Initials>TB</Initials></Author><Author ValidYN="Y"><LastName>Chizhikov</LastName><ForeName>Victor V</ForeName><Initials>VV</Initials></Author><Author ValidYN="Y"><LastName>Dybose</LastName><ForeName>Giedre</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fagerberg</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Falco</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fels</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Fichera</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Graakjaer</LastName><ForeName>Jesper</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Donatella</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hair</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ladda</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chumei</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Moeschler</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Nowaczyk</LastName><ForeName>Malgorzata J M</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Ozmore</LastName><ForeName>Jillian R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Reitano</LastName><ForeName>Santina</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Corrado</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Roos</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Schnur</LastName><ForeName>Rhonda E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Sell</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Suwannarat</LastName><ForeName>Pim</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Svaneby</LastName><ForeName>Dea</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Szybowska</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tarnopolsky</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tervo</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Anne Chun-Hui</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Tucker</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Vallee</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>Ferrin C</ForeName><Initials>FC</Initials></Author><Author ValidYN="Y"><LastName>Zand</LastName><ForeName>Dina J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Barkovich</LastName><ForeName>A James</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Aradhya</LastName><ForeName>Swaroop</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Lisa G</ForeName><Initials>LG</Initials></Author><Author ValidYN="Y"><LastName>Dobyns</LastName><ForeName>William B</ForeName><Initials>WB</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS050375</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS058721</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS077163</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS058721</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet A</MedlineTA><NlmUniqueID>101235741</NlmUniqueID><ISSNLinking>1552-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048948">14-3-3 Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C482983">YWHAE protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.47</RegistryNumber><NameOfSubstance UI="D043203">1-Alkyl-2-acetylglycerophosphocholine Esterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.47</RegistryNumber><NameOfSubstance UI="C084102">PAFAH1B1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D043203" MajorTopicYN="N">1-Alkyl-2-acetylglycerophosphocholine Esterase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048948" MajorTopicYN="N">14-3-3 Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002653" MajorTopicYN="N">Child Behavior Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002659" MajorTopicYN="N">Child Development Disorders, Pervasive</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002886" MajorTopicYN="N">Chromosomes, Human, Pair 17</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020440" MajorTopicYN="Y">Gene Duplication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">17p13.3</Keyword><Keyword MajorTopicYN="N">ABR</Keyword><Keyword MajorTopicYN="N">BHLHA9</Keyword><Keyword MajorTopicYN="N">LIS1</Keyword><Keyword MajorTopicYN="N">YWHAE</Keyword><Keyword MajorTopicYN="N">autism</Keyword><Keyword MajorTopicYN="N">cleft lip/palate</Keyword><Keyword MajorTopicYN="N">marfanoid habitus</Keyword><Keyword MajorTopicYN="N">microarray</Keyword><Keyword MajorTopicYN="N">split hand foot long bone deficiency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23813913</ArticleId><ArticleId IdType="mid">NIHMS467264</ArticleId><ArticleId IdType="pmc">PMC5517092</ArticleId><ArticleId IdType="doi">10.1002/ajmg.a.35996</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adamek N, Geeves MA, Coluccio LM. Myo1c mutations associated with hearing loss cause defects in the interaction with nucleotide and actin. Cell Mol Life Sci. 2011;68(1):139&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014424</ArticleId><ArticleId IdType="pubmed">20640478</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldinger KA, Lehmann OJ, Hudgins L, Chizhikov VV, Bassuk AG, Ades LC, Krantz ID, Dobyns WB, Millen KJ. FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation. Nat Genet. 2009;41(9):1037&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843139</ArticleId><ArticleId IdType="pubmed">19668217</ArticleId></ArticleIdList></Reference><Reference><Citation>Armour CM, Bulman DE, Jarinova O, Rogers RC, Clarkson KB, DuPont BR, Dwivedi A, Bartel FO, McDonell L, Schwartz CE, Boycott KM, Everman DB, Graham GE. 17p13.3 microduplications are associated with split-hand/foot malformation and long-bone deficiency (SHFLD) Eur J Hum Genet. 2011;19(11):1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198152</ArticleId><ArticleId IdType="pubmed">21629300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi W, Sapir T, Shchelochkov OA, Zhang F, Withers MA, Hunter JV, Levy T, Shinder V, Peiffer DA, Gunderson KL, Nezarati MM, Shotts VA, Amato SS, Savage SK, Harris DJ, Day-Salvatore DL, Horner M, Lu XY, Sahoo T, Yanagawa Y, Beaudet AL, Cheung SW, Martinez S, Lupski JR, Reiner O. Increased LIS1 expression affects human and mouse brain development. Nat Genet. 2009;41(2):168&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4396744</ArticleId><ArticleId IdType="pubmed">19136950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno DL, Anderlid BM, Lindstrand A, van Ravenswaaij-Arts C, Ganesamoorthy D, Lundin J, Martin CL, Douglas J, Nowak C, Adam MP, Kooy RF, Van der Aa N, Reyniers E, Vandeweyer G, Stolte-Dijkstra I, Dijkhuizen T, Yeung A, Delatycki M, Borgstrom B, Thelin L, Cardoso C, van Bon B, Pfundt R, de Vries BB, Wallin A, Amor DJ, James PA, Slater HR, Schoumans J. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet. 2010;47(5):299&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">20452996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso C, Leventer RJ, Ward HL, Toyo-Oka K, Chung J, Gross A, Martin CL, Allanson J, Pilz DT, Olney AH, Mutchinick OM, Hirotsune S, Wynshaw-Boris A, Dobyns WB, Ledbetter DH. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet. 2003;72(4):918&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1180354</ArticleId><ArticleId IdType="pubmed">12621583</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM, Baylin SB. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum Mol Genet. 2000;9(3):413&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655551</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobyns WB, Curry CJR, Hoyme HE, Turlington L, Ledbetter DH. Clinical and molecular diagnosis of Miller-Dieker syndrome. Am J Hum Genet. 1991;48:584&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1682996</ArticleId><ArticleId IdType="pubmed">1671808</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobyns WB, Stratton RF, Parke JT, Greenberg F, Nussbaum RL, Ledbetter DH. Miller-Dieker syndrome and monosomy 17p. J Pediatr. 1983;102:552&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">6834189</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm C, Sporle R, Schmid TE, Adler ID, Adamski J, Schughart K, Graw J. Isolation and embryonic expression of the novel mouse gene hic1, the homologue of HIC1, a candidate gene for the miller-dieker syndrome [In Process Citation] Hum Mol Genet. 1999;8(4):697&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">10072440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannes FD, Sharp AJ, Mefford HC, de Ravel T, Ruivenkamp CA, Breuning MH, Fryns JP, Devriendt K, Van Buggenhout G, Vogels A, Stewart H, Hennekam RC, Cooper GM, Regan R, Knight SJ, Eichler EE, Vermeesch JR. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet. 2009;46(4):223&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658752</ArticleId><ArticleId IdType="pubmed">18550696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokanson DE, Laakso JM, Lin T, Sept D, Ostap EM. Myo1c binds phosphoinositides through a putative pleckstrin homology domain. Mol Biol Cell. 2006;17(11):4856&#x2013;4865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1635404</ArticleId><ArticleId IdType="pubmed">16971510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppman-Chaney N, Wain K, Seger P, Superneau D, Hodge J. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin Genet 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22775350</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyon C, Marlin S, Chantot-Bastaraud S, Mabboux P, Beaujard MP, Al Ageeli E, Vazquez MP, Picard A, Siffroi JP, Portnoi MF. A new 17p13.3 microduplication including the PAFAH1B1 and YWHAE genes resulting from an unbalanced X;17 translocation. Eur J Med Genet. 2011;54(3):287&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietilainen OP, Buizer-Voskamp JE, Strengman E, Francks C, Muglia P, Gylfason A, Gustafsson O, Olason PI, Steinberg S, Hansen T, Jakobsen KD, Rasmussen HB, Giegling I, Moller HJ, Hartmann A, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Bramon E, Kiemeney LA, Franke B, Murray R, Vassos E, Toulopoulou T, Muhleisen TW, Tosato S, Ruggeri M, Djurovic S, Andreassen OA, Zhang Z, Werge T, Ophoff RA, Rietschel M, Nothen MM, Petursson H, Stefansson H, Peltonen L, Collier D, Stefansson K, St Clair DM. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry. 2011;16(1):17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3330746</ArticleId><ArticleId IdType="pubmed">19786961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaartinen V, Gonzalez-Gomez I, Voncken JW, Haataja L, Faure E, Nagy A, Groffen J, Heisterkamp N. Abnormal function of astroglia lacking Abr and Bcr RacGAPs. Development. 2001;128(21):4217&#x2013;4227.</Citation><ArticleIdList><ArticleId IdType="pubmed">11684658</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopocki E, Lohan S, Doelken SC, Stricker S, Ockeloen CW, Soares Thiele de Aguiar R, Lezirovitz K, Mingroni Netto RC, Jamsheer A, Shah H, Kurth I, Habenicht R, Warman M, Devriendt K, Kordass U, Hempel M, Rajab A, Makitie O, Naveed M, Radhakrishna U, Antonarakis SE, Horn D, Mundlos S. Duplications of BHLHA9 are associated with ectrodactyly and tibia hemimelia inherited in non-Mendelian fashion. J Med Genet. 2012;49(2):119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">22147889</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignon-Ravix C, Cacciagli P, El-Waly B, Moncla A, Milh M, Girard N, Chabrol B, Philip N, Villard L. Deletion of YWHAE in a patient with periventricular heterotopias and pronounced corpus callosum hypoplasia. J Med Genet. 2010;47(2):132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">19635726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagamani SC, Zhang F, Shchelochkov OA, Bi W, Ou Z, Scaglia F, Probst FJ, Shinawi M, Eng C, Hunter JV, Sparagana S, Lagoe E, Fong CT, Pearson M, Doco-Fenzy M, Landais E, Mozelle M, Chinault AC, Patel A, Bacino CA, Sahoo T, Kang SH, Cheung SW, Lupski JR, Stankiewicz P. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet. 2009;46(12):825&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostergaard JR, Graakjaer J, Brandt C, Birkebaek NH. Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatment. Eur J Med Genet. 2012;55(1):22&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">22085993</ArticleId></ArticleIdList></Reference><Reference><Citation>Pernot E, Terryn S, Cheong SC, Markadieu N, Janas S, Blockmans M, Jacoby M, Pouillon V, Gayral S, Rossier BC, Beauwens R, Erneux C, Devuyst O, Schurmans S. The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system. Pflugers Arch. 2011;462(6):871&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">21938401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramalingam A, Zhou XG, Fiedler SD, Brawner SJ, Joyce JM, Liu HY, Yu S. 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet. 2011;56(7):541&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">21614007</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos L, Jonch AE, Kjaergaard S, Taudorf K, Simonsen H, Hamborg-Petersen B, Brondum-Nielsen K, Kirchhoff M. A new microduplication syndrome encompassing the region of the Miller-Dieker (17p13 deletion) syndrome. J Med Genet. 2009;46(10):703&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">19520700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchelochkov OA, Cheung SW, Lupski JR. Genomic and clinical characteristics of microduplications in chromosome 17. Am J Med Genet A. 2010;152A(5):1101&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">20425816</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojima K, Sugiura C, Takahashi H, Ikegami M, Takahashi Y, Ohno K, Matsuo M, Saito K, Yamamoto T. Genomic copy number variations at 17p13.3 and epileptogenesis. Epilepsy Res. 2010;89(2&#x2013;3):303&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">20227246</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeesch JR, Balikova I, Schrander-Stumpel C, Fryns JP, Devriendt K. The causality of de novo copy number variants is overestimated. Eur J Hum Genet. 2011;19(11):1112&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198146</ArticleId><ArticleId IdType="pubmed">21587321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenden JA, Watson CJ. Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Breast Cancer Res. 2010;12(2):202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879565</ArticleId><ArticleId IdType="pubmed">20398329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23502962</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>CD169&#x207a; macrophages provide a niche promoting erythropoiesis under homeostasis and stress.</ArticleTitle><Pagination><StartPage>429</StartPage><EndPage>436</EndPage><MedlinePgn>429-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.3057</ELocationID><Abstract><AbstractText>A role for macrophages in erythropoiesis was suggested several decades ago when erythroblastic islands in the bone marrow, composed of a central macrophage surrounded by developing erythroblasts, were described. However, the in vivo role of macrophages in erythropoiesis under homeostatic conditions or in disease remains unclear. We found that specific depletion of CD169(+) macrophages markedly reduced the number of erythroblasts in the bone marrow but did not result in overt anemia under homeostatic conditions, probably because of concomitant alterations in red blood cell clearance. However, CD169(+) macrophage depletion significantly impaired erythropoietic recovery from hemolytic anemia, acute blood loss and myeloablation. Furthermore, macrophage depletion normalized the erythroid compartment in a JAK2(V617F)-driven mouse model of polycythemia vera, suggesting that erythropoiesis in polycythemia vera remains under the control of macrophages in the bone marrow and splenic microenvironments. These results indicate that CD169(+) macrophages promote late erythroid maturation and that modulation of the macrophage compartment may be a new strategy to treat erythropoietic disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Jalal</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Daigo</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kunisaki</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Pinho</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Leboeuf</LastName><ForeName>Marylene</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Noizat</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>van Rooijen</LastName><ForeName>Nico</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Masato</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhizhuang Joe</ForeName><Initials>ZJ</Initials></Author><Author ValidYN="Y"><LastName>Bergman</LastName><ForeName>Aviv</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Merad</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Frenette</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL069438</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01CA112100</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL097700</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL116340</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32GM062754</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA112100</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL097700</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK056638</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL116340</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM062754</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL097819</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5F30HL099028</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 HL099028</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI095611</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063267">Sialic Acid Binding Ig-like Lectin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C571167">Siglec1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019010">Vascular Cell Adhesion Molecule-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Med. 2013 Apr;19(4):399-401. doi: 10.1038/nm.3156.</RefSource><PMID Version="1">23558622</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Immunol. 2013 May;13(5):307. doi: 10.1038/nri3448.</RefSource><PMID Version="1">23558888</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000743" MajorTopicYN="N">Anemia, Hemolytic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004900" MajorTopicYN="N">Erythroblasts</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004920" MajorTopicYN="N">Erythropoiesis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011087" MajorTopicYN="N">Polycythemia Vera</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063267" MajorTopicYN="N">Sialic Acid Binding Ig-like Lectin 1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019010" MajorTopicYN="N">Vascular Cell Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23502962</ArticleId><ArticleId IdType="mid">NIHMS427552</ArticleId><ArticleId IdType="pmc">PMC3983996</ArticleId><ArticleId IdType="doi">10.1038/nm.3057</ArticleId><ArticleId IdType="pii">nm.3057</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bessis M. L&#x2019; &#xee;lot &#xe9;rythroblastique, unit&#xe9; fonctionnelle de la moelle osseuse. Rev Hematol. 1958;13:8&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">13555228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas N, Prenant M. Three-dimensional model of bone marrow. Blood. 1978;51:633&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">630113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G, et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood. 2006;108:2064&#x2013;2071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1895542</ArticleId><ArticleId IdType="pubmed">16690966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes MM, Kopsombut P, Bondurant MC, Price JO, Koury MJ. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood. 2008;111:1700&#x2013;1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2214751</ArticleId><ArticleId IdType="pubmed">17993612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanspal M, Smockova Y, Uong Q. Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood. 1998;92:2940&#x2013;2950.</Citation><ArticleIdList><ArticleId IdType="pubmed">9763581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112:470&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2481536</ArticleId><ArticleId IdType="pubmed">18650462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow A, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. The Journal of experimental medicine. 2011;208:261&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039855</ArticleId><ArticleId IdType="pubmed">21282381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow A, Brown BD, Merad M. Studying the mononuclear phagocyte system in the molecular age. Nature reviews Immunology. 2011;11:788&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">22025056</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake Y, et al. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest. 2007;117:2268&#x2013;2278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1924497</ArticleId><ArticleId IdType="pubmed">17657313</ArticleId></ArticleIdList></Reference><Reference><Citation>Crocker PR, Werb Z, Gordon S, Bainton DF. Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters. Blood. 1990;76:1131&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">2205308</ArticleId></ArticleIdList></Reference><Reference><Citation>Manwani D, Bieker JJ. The erythroblastic island. Current topics in developmental biology. 2008;82:23&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3234703</ArticleId><ArticleId IdType="pubmed">18282516</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbe E, Huitinga I, Dopp EA, Bauer J, Dijkstra CD. A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding. Journal of cell science. 1996;109 ( Pt 12):2937&#x2013;2945.</Citation><ArticleIdList><ArticleId IdType="pubmed">9013341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos P, et al. Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood. 2011;117:1379&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056475</ArticleId><ArticleId IdType="pubmed">21059897</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. The Journal of biological chemistry. 1985;260:5131&#x2013;5138.</Citation><ArticleIdList><ArticleId IdType="pubmed">3988747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadahira Y, et al. Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: an experimental model for studying the role of stromal macrophages in erythropoiesis. J Leukoc Biol. 2000;68:464&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">11037966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessis M. Erythroblastic island functional unity of bone marrow. Rev Hematol. 1958;13:8&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">13555228</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends in immunology. 2011;32:241&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">21514223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood. 2011;118:1912&#x2013;1922.</Citation><ArticleIdList><ArticleId IdType="pubmed">21705499</ArticleId></ArticleIdList></Reference><Reference><Citation>Harandi OF, Hedge S, Wu DC, McKeone D, Paulson RF. Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors. J Clin Invest. 2010;120:4507&#x2013;4519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993581</ArticleId><ArticleId IdType="pubmed">21060151</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson RF, Shi L, Wu DC. Stress erythropoiesis: new signals and new stress progenitor cells. Curr Opin Hematol. 2011;18:139&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099455</ArticleId><ArticleId IdType="pubmed">21372709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto D, et al. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. The Journal of experimental medicine. 2011;208:1069&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3092347</ArticleId><ArticleId IdType="pubmed">21536742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadahira Y, Mori M, Kimoto T. Participation of radioresistant Forssman antigen-bearing macrophages in the formation of stromal elements of erythroid spleen colonies. Br J Haematol. 1989;71:469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">2653405</ArticleId></ArticleIdList></Reference><Reference><Citation>Millot S, et al. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood. 2010;116:6072&#x2013;6081.</Citation><ArticleIdList><ArticleId IdType="pubmed">20844235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadahira Y, Yoshino T, Monobe Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. The Journal of experimental medicine. 1995;181:411&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191848</ArticleId><ArticleId IdType="pubmed">7528776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohyama M, et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature. 2009;457:318&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756102</ArticleId><ArticleId IdType="pubmed">19037245</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooi HC, et al. Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur J Immunol. 1983;13:306&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">6189722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tippett E, et al. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. Plos One. 2011;6:e19968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098854</ArticleId><ArticleId IdType="pubmed">21625498</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing S, et al. Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood. 2008;111:5109&#x2013;5117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2384138</ArticleId><ArticleId IdType="pubmed">18334677</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefferi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">17488875</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LM, Priestley GV, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol. 2003;23:9349&#x2013;9360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC309677</ArticleId><ArticleId IdType="pubmed">14645544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulyanova T, Jiang Y, Padilla S, Nakamoto B, Papayannopoulou T. Combinatorial and distinct roles of alpha and alpha integrins in stress erythropoiesis in mice. Blood. 2011;117:975&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035084</ArticleId><ArticleId IdType="pubmed">20956802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungartz G, et al. Adult murine hematopoiesis can proceed without beta1 and beta7 integrins. Blood. 2006;108:1857&#x2013;1864.</Citation><ArticleIdList><ArticleId IdType="pubmed">16735603</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele J, et al. Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia. Virchows Archiv : an international journal of pathology. 2000;437:160&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">10993276</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele J, et al. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation. Leukemia. 2000;14:1378&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">10942232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartnell A, et al. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood. 2001;97:288&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">11133773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood. 2005;105:2741&#x2013;2748.</Citation><ArticleIdList><ArticleId IdType="pubmed">15591122</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman DL, Russell ES, Levin EY. Enzymatic studies of the hemopoietic defect in flexed mice. Genetics. 1969;61:631&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1212230</ArticleId><ArticleId IdType="pubmed">5393940</ArticleId></ArticleIdList></Reference><Reference><Citation>Seggewiss R, Einsele H. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation. Semin Hematol. 2007;44:203&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">17631184</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CB, et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood. 1992;80:2677&#x2013;2682.</Citation><ArticleIdList><ArticleId IdType="pubmed">1421381</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuser M, Ganser A. Recombinant human erythropoietin in the treatment of nonrenal anemia. Ann Hematol. 2006;85:69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">16078035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan H, Spivak JL. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era. Clinical advances in hematology &amp; oncology : H&amp;O. 2009;7:334&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">19521323</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy MM, Deshpande A, Sattler M. Targeting JAK2 in the therapy of myeloproliferative neoplasms. Expert opinion on therapeutic targets. 2012;16:313&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4051134</ArticleId><ArticleId IdType="pubmed">22339244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood. 2012;119:1810&#x2013;1820.</Citation><ArticleIdList><ArticleId IdType="pubmed">22186992</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito M, et al. Diphtheria toxin receptor-mediated conditionaland targeted cell ablation in transgenic mice. Nature biotechnology. 2001;19:746&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">11479567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009;106:17413&#x2013;17418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762680</ArticleId><ArticleId IdType="pubmed">19805084</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves JP, Reeves PA, Chin LT. Survival surgery: removal of the spleen or thymus. Current protocols in immunology/edited by John E Coligan [et al] 2001;Chapter 1(Unit 1):10.</Citation><ArticleIdList><ArticleId IdType="pubmed">18432668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann-Fezer G, et al. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Annals of Hematology. 1993;67:81&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8347734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22657995</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2012</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-228X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinics in sports medicine</Title><ISOAbbreviation>Clin Sports Med</ISOAbbreviation></Journal><ArticleTitle>The young adult spine in sports.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>472</EndPage><MedlinePgn>453-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.csm.2012.03.007</ELocationID><Abstract><AbstractText>In summary, LBP is a common problem for the young adult athlete, with discogenic pain being the most common of all etiologies. Although rare, more serious etiologies such as tumor or infection should be included in the differential diagnosis until effectively ruled out. Regardless of the cause, nonoperative and conservative strategies should be the cornerstone of treatment, owing to the favorable natural history of most LBP etiologies. Short-term non-narcotic medications are helpful, and avoidance of bed rest is critical for the athletic population. Rehabilitation should focus on stabilization and strengthening of the core and pelvic muscle groups, and biomechanical imbalances should be addressed. Surgical intervention ought to be utilized as a last resort in this population. Return to play should be considered only when the athlete is pain free with full range of motion and daily medications have been discontinued. Careful monitoring of the training regimen should always be undertaken,especially with chronic pain or recurrent injuries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mautner</LastName><ForeName>Ken R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Department of Orthopedics, Emory University, Atlanta, GA 30329, USA. kmautne@emory.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mandy J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Sports Med</MedlineTA><NlmUniqueID>8112473</NlmUniqueID><ISSNLinking>0278-5919</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001265" MajorTopicYN="N">Athletic Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055959" MajorTopicYN="N">Intervertebral Disc Degeneration</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011843" MajorTopicYN="N">Radiculopathy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013124" MajorTopicYN="N">Spinal Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22657995</ArticleId><ArticleId IdType="doi">10.1016/j.csm.2012.03.007</ArticleId><ArticleId IdType="pii">S0278-5919(12)00023-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22594956</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-7052</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Organic letters</Title><ISOAbbreviation>Org Lett</ISOAbbreviation></Journal><ArticleTitle>A fluorescent dipyrrinone oxime for the detection of pesticides and other organophosphates.</ArticleTitle><Pagination><StartPage>2686</StartPage><EndPage>2689</EndPage><MedlinePgn>2686-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/ol300799f</ELocationID><Abstract><AbstractText>An N,N-carbonyl-bridged dipyrrinone oxime has been synthesized and studied as a potential sensor for organophosphates. The molecular sensor underwent a drastic colorimetric response upon formation of the adduct. The pesticide dimethoate was found to produce the biggest spectral response, with a limit of detection equal to 4.0 ppm using UV-visible spectroscopy. Minimal fluorescence "turn on" via a PET mechanism was seen, and molecular modeling studies were used to explain the lower than expected PET response. The X-ray crystal structure of the fluorescent dipyrrinone oxime was also obtained.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida, 11000 University Parkway, Pensacola, Florida 32514, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Marauo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Munro</LastName><ForeName>Lyndsay</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Catalano</LastName><ForeName>Vincent J</ForeName><Initials>VJ</Initials></Author><Author ValidYN="Y"><LastName>Cragg</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Karl J</ForeName><Initials>KJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Org Lett</MedlineTA><NlmUniqueID>100890393</NlmUniqueID><ISSNLinking>1523-7052</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010755">Organophosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010091">Oximes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010575">Pesticides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="Y">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010755" MajorTopicYN="N">Organophosphates</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010091" MajorTopicYN="N">Oximes</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010575" MajorTopicYN="N">Pesticides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22594956</ArticleId><ArticleId IdType="doi">10.1021/ol300799f</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="HMD" IndexingMethod="Manual"><PMID Version="1">22400156</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0013-2586</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>Eighteenth-century studies</Title><ISOAbbreviation>Eighteenth Century Stud</ISOAbbreviation></Journal><ArticleTitle>Popular culture and sporting life in the rural margins of late eighteenth-century England: the world of Robert Anderson, "The Cumberland Bard".</ArticleTitle><Pagination><StartPage>189</StartPage><EndPage>205</EndPage><MedlinePgn>189-205</MedlinePgn></Pagination><Abstract><AbstractText>This study sets out to extend and challenge existing historiography on late eighteenth century British popular culture, customary sports, class and cultural identity, focusing upon the rural geo-political borderland of England. It suggests that prevailing class-based and more London-biased studies need to be balanced with more regionalist-based work, and shows the importance of northern regional leisure variants. The textual and historical analysis draws largely on the published works of a neglected working-class dialect poet, Robert Anderson, living and working in Cumberland, arguing that he represented a strain of ''bardic regionalism,'' a variant of Katie Trumpener&#x2019;s ''bardic nationalism.''</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Eighteenth Century Stud</MedlineTA><NlmUniqueID>100967184</NlmUniqueID><ISSNLinking>0013-2586</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="Y">Activities of Daily Living</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003466" MajorTopicYN="Y">Cultural Characteristics</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006663" MajorTopicYN="Y">Historiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049671" MajorTopicYN="N">History, 18th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012423" MajorTopicYN="N">Rural Health</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="Y">Rural Population</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012923" MajorTopicYN="Y">Social Class</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013177" MajorTopicYN="Y">Sports</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22400156</ArticleId><ArticleId IdType="doi">10.1353/ecs.2012.0006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22371396</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>188</Volume><Issue>7</Issue><PubDate><Year>2012</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells.</ArticleTitle><Pagination><StartPage>3371</StartPage><EndPage>3381</EndPage><MedlinePgn>3371-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.1100573</ELocationID><Abstract><AbstractText>Asthma is a chronic inflammatory disease in which airway epithelial cells are the first line of defense against exposure of the airway to infectious agents. Src homology protein (SHP)-1, a protein tyrosine phosphatase, is a negative regulator of signaling pathways that are critical to the development of asthma and host defense. We hypothesize that SHP-1 function is defective in asthma, contributing to the increased inflammatory response induced by Mycoplasma pneumoniae, a pathogen known to exacerbate asthma. M. pneumoniae significantly activated SHP-1 in airway epithelial cells collected from nonasthmatic subjects by bronchoscopy with airway brushing but not in cells from asthmatic subjects. In asthmatic airway epithelial cells, M. pneumoniae induced significant PI3K/Akt phosphorylation, NF-&#x3ba;B activation, and IL-8 production compared with nonasthmatic cells, which were reversed by SHP-1 overexpression. Conversely, SHP-1 knockdown significantly increased IL-8 production and PI3K/Akt and NF-&#x3ba;B activation in the setting of M. pneumoniae infection in nonasthmatic cells, but it did not exacerbate these three parameters already activated in asthmatic cells. Thus, SHP-1 plays a critical role in abrogating M. pneumoniae-induced IL-8 production in nonasthmatic airway epithelial cells through inhibition of PI3K/Akt and NF-&#x3ba;B activity, but it is defective in asthma, resulting in an enhanced inflammatory response to infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. ying.wang5@duke.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>Tony D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Lugogo</LastName><ForeName>Njira L</ForeName><Initials>NL</Initials></Author><Author ValidYN="Y"><LastName>Que</LastName><ForeName>Loretta G</ForeName><Initials>LG</Initials></Author><Author ValidYN="Y"><LastName>Francisco</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ingram</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Molly</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Beaver</LastName><ForeName>Denise M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Jo Rae</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI081672</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494918">AKT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="C509249">PTPN6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="D053824">Protein Tyrosine Phosphatase, Non-Receptor Type 6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053824" MajorTopicYN="N">Protein Tyrosine Phosphatase, Non-Receptor Type 6</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22371396</ArticleId><ArticleId IdType="mid">NIHMS514007</ArticleId><ArticleId IdType="pmc">PMC3880785</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1100573</ArticleId><ArticleId IdType="pii">jimmunol.1100573</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Djukanovi&#x107; R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992;145:669&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">1546849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pubmed">9856949</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegra L, Blasi F, Centanni S, Cosentini R, Denti F, Raccanelli R, Tarsia P, Valenti V. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J. 1994;7:2165&#x2013;2168.</Citation><ArticleIdList><ArticleId IdType="pubmed">7713198</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkovich S, Millian SJ, Snyder RD. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy. 1970;28:43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">4341456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991;266:225&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">2056624</ArticleId></ArticleIdList></Reference><Reference><Citation>Huhti E, Mokka T, Nikoskelainen J, Halonen P. Association of viral and mycoplasma infections with exacerbations of asthma. Ann Allergy. 1974;33:145&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">4368435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelaia G, Vatrella A, Gallelli L, Renda T, Cazzola M, Maselli R, Marsico SA. Respiratory infections and asthma. Respir Med. 2006;100:775&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135443</ArticleId><ArticleId IdType="pubmed">16289785</ArticleId></ArticleIdList></Reference><Reference><Citation>Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, Iniguez JL, Chaussain M, Nicand E, Raymond J, Gendrel D. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis. 2004;38:1341&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">15156467</ArticleId></ArticleIdList></Reference><Reference><Citation>Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol. 2007;120:1279&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2810155</ArticleId><ArticleId IdType="pubmed">17949801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213100</ArticleId><ArticleId IdType="pubmed">15781584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft M, Adler KB, Ingram JL, Crews AL, Atkinson TP, Cairns CB, Krause DC, Chu HW. Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J. 2008;31:43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">18166592</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, &#xfc;hlradt PFM, Akira S. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol. 2000;164:554&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">10623793</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, Harbeck RJ, Martin RJ. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol. 2005;174:5713&#x2013;5719.</Citation><ArticleIdList><ArticleId IdType="pubmed">15843573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers MA, Whelan AO, Spallek R, Singh M, Coddeville B, Guerardel Y, Elass E. Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9. Biochem Biophys Res Commun. 2010;400:403&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurokawa K, Lee H, Roh KB, Asanuma M, Kim YS, Nakayama H, Shiratsuchi A, Choi Y, Takeuchi O, Kang HJ, et al. The Triacylated ATP Binding Cluster Transporter Substrate-binding Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for the Toll-like Receptor 2. J Biol Chem. 2009;284:8406&#x2013;8411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2659198</ArticleId><ArticleId IdType="pubmed">19139093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiguchi M, Matsumoto M, Takao T, Hoshino M, Shimonishi Y, Tsuji S, Begum NA, Takeuchi O, Akira S, Toyoshima K, Seya T. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J Immunol. 2001;166:2610&#x2013;2616.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160323</ArticleId></ArticleIdList></Reference><Reference><Citation>Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int J Biochem Cell Biol. 2002;34:901&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007626</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Kida Y, Kuwano K. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2. Immunology. 2007;121:473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265974</ArticleId><ArticleId IdType="pubmed">17433078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, Kuronuma K, Mitsuzawa H, Voelker DR, Chan ED. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol. 2008;295:L220&#x2013;L230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2494795</ArticleId><ArticleId IdType="pubmed">18487355</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen SH, Bastien L, Posner BI, Chr&#xe9;tien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature. 1991;352:736&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">1652101</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol. 1992;12:2396&#x2013;2405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC364412</ArticleId><ArticleId IdType="pubmed">1373816</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman RM, Jr, Plutzky J, Neel BG. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci USA. 1992;89:11239&#x2013;11243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC50525</ArticleId><ArticleId IdType="pubmed">1280823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi TL, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol. 1992;12:836&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC364317</ArticleId><ArticleId IdType="pubmed">1732748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashiwada M, Giallourakis CC, Pan PY, Rothman PB. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol. 2001;167:6382&#x2013;6387.</Citation><ArticleIdList><ArticleId IdType="pubmed">11714803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson EM, Dickensheets H, Qu CK, Donnelly RP, Keegan AD. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J Biol Chem. 2003;278:3903&#x2013;3911.</Citation><ArticleIdList><ArticleId IdType="pubmed">12459556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity. 1995;2:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">7600299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci USA. 1996;93:9624&#x2013;9629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC38478</ArticleId><ArticleId IdType="pubmed">8790380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Somani AK, Yuen D, Yang Y, Love PE, Siminovitch KA. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol. 1999;163:3012&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477564</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BR. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem. 1998;273:33893&#x2013;33896.</Citation><ArticleIdList><ArticleId IdType="pubmed">9852037</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raghunath PN, Vonderheid E, Odum N, Wasik MA. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am J Pathol. 2000;157:1137&#x2013;1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850163</ArticleId><ArticleId IdType="pubmed">11021818</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury JD, Rassidakis GZ, Medeiros LJ, Amin HM, Lai R. Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma. Blood. 2004;104:1580&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType="pubmed">15317731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA. 2005;102:6948&#x2013;6953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1100783</ArticleId><ArticleId IdType="pubmed">15870198</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, Mejico LJ, Jubelt B, Massa PT. SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest. 2008;88:243&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883308</ArticleId><ArticleId IdType="pubmed">18209728</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophi GP, Hudson CA, Panos M, Gruber RC, Massa PT. Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J Virol. 2009;83:522&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2612370</ArticleId><ArticleId IdType="pubmed">18987138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamata T, Yamashita M, Kimura M, Murata K, Inami M, Shimizu C, Sugaya K, Wang CR, Taniguchi M, Nakayama T. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest. 2003;111:109&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151831</ArticleId><ArticleId IdType="pubmed">12511594</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SY, Zheng T, Kim YK, Cohn L, Homer RJ, McKenzie AN, Zhu Z. A critical role of SHP-1 in regulation of type 2 inflammation in the lung. Am J Respir Cell Mol Biol. 2009;40:568&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677436</ArticleId><ArticleId IdType="pubmed">18952567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YS, Oh SY, Zhu Z. Tyrosine phosphatase SHP-1 in oxidative stress and development of allergic airway inflammation. Am J Respir Cell Mol Biol. 2008;39:412&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2551702</ArticleId><ArticleId IdType="pubmed">18441283</ArticleId></ArticleIdList></Reference><Reference><Citation>National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(5, Suppl.):S94&#x2013;S138. Published erratum appears in 2008 J. Allergy Clin. Immunol. 121: 1330.</Citation><ArticleIdList><ArticleId IdType="pubmed">17983880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xu L, Duan H, Pasek DA, Eu JP, Meissner G. Knocking down type 2 but not type 1 calsequestrin reduces calcium sequestration and release in C2C12 skeletal muscle myotubes. J Biol Chem. 2006;281:15572&#x2013;15581.</Citation><ArticleIdList><ArticleId IdType="pubmed">16595676</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Samulski RJ, Xiao X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol. 1997;71:5236&#x2013;5243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191759</ArticleId><ArticleId IdType="pubmed">9188591</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998;72:2224&#x2013;2232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109519</ArticleId><ArticleId IdType="pubmed">9499080</ArticleId></ArticleIdList></Reference><Reference><Citation>Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, Remacle J. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res. 2001;29:E21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29628</ArticleId><ArticleId IdType="pubmed">11160941</ArticleId></ArticleIdList></Reference><Reference><Citation>Massa PT, Wu C. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res. 1998;18:499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">9712366</ArticleId></ArticleIdList></Reference><Reference><Citation>Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA. 1992;89:1123&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC48398</ArticleId><ArticleId IdType="pubmed">1736296</ArticleId></ArticleIdList></Reference><Reference><Citation>Craggs G, Kellie S. A functional nuclear localization sequence in the C-terminal domain of SHP-1. J Biol Chem. 2001;276:23719&#x2013;23725.</Citation><ArticleIdList><ArticleId IdType="pubmed">11323437</ArticleId></ArticleIdList></Reference><Reference><Citation>Slevogt H, Zabel S, Opitz B, Hocke A, Eitel J, N'guessan PD, Lucka L, Riesbeck K, Zimmermann W, Zweigner J, et al. CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat Immunol. 2008;9:1270&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">18836450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, Siminovitch KA, Mills GB. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem. 1999;274:27583&#x2013;27589.</Citation><ArticleIdList><ArticleId IdType="pubmed">10488096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol. 2002;22:5962&#x2013;5974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC133991</ArticleId><ArticleId IdType="pubmed">12138205</ArticleId></ArticleIdList></Reference><Reference><Citation>Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999;401:86&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999;401:82&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485710</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaled AR, Butfiloski EJ, Sobel ES, Schiffenbauer J. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B. Cell Immunol. 1998;185:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">9636682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Jimi E, Bothwell AL. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J Immunol. 2003;171:3620&#x2013;3626.</Citation><ArticleIdList><ArticleId IdType="pubmed">14500659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Brooks DM, Lurie DI. Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-alpha, and IL-1beta. Glia. 2006;53:304&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">16265671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, Chu HW, Church TD, Kandasamy P, Fertel D, et al. Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol. 2011;301:L598&#x2013;L606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3191759</ArticleId><ArticleId IdType="pubmed">21784968</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yoshida Y, Yamashita U. DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase. Mol Immunol. 2008;45:3984&#x2013;3989.</Citation><ArticleIdList><ArticleId IdType="pubmed">18657320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol. 1999;19:4798&#x2013;4805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84278</ArticleId><ArticleId IdType="pubmed">10373529</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandan D, Lo R, Reiner NE. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun. 1999;67:4055&#x2013;4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC96702</ArticleId><ArticleId IdType="pubmed">10417174</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake A, Murata Y, Okazawa H, Ikeda H, Niwayama Y, Ohnishi H, Hirata Y, Matozaki T. Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages. Genes Cells. 2008;13:209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">18233962</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Hou J, Zhou J, Zhao W, Xu H, Zheng Y, Yu Y, Liu S, Cao X. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol. 2008;9:542&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">18391954</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125:1178&#x2013;1187. quiz 1188&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172767</ArticleId><ArticleId IdType="pubmed">20513517</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22059989</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2249</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>3</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical and experimental immunology</Title><ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation></Journal><ArticleTitle>2&#x3b1;-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.</ArticleTitle><Pagination><StartPage>325</StartPage><EndPage>332</EndPage><MedlinePgn>325-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2249.2011.04481.x</ELocationID><Abstract><AbstractText>Type 1 diabetes (T1D) is an autoimmune disease that destroys the insulin-producing beta-islet cells of the pancreas. Currently, there are no treatment modalities for prevention of T1D, and the mechanisms influencing disease inception and early progression are not well understood. We have used the insulin 2(-/-) non-obese diabetic (Ins2(-/-) NOD) model to study stages of T1D and to examine the protective effects of a potent analogue of 1&#x3b1;,25-dihydroxyvitamin D(3), 2&#x3b1;-methyl-19-nor-(20S)-1&#x3b1;,25-dihydroxyvitamin D(3) (2AMD). Pancreatic tissues from control and 2AMD-treated Ins2(-/-) NOD mice were obtained weekly from 5 to 16 weeks of age. Using immunohistochemical (IHC) analysis, samples were analysed for changes in beta cell survival, islet structure and T cell invasion. Weekly intraperitoneal glucose tolerance tests (IPGTT) were performed to assess comparative beta cell function in control and treated animals. IHC demonstrated progressive beta cell destruction in control mice. In contrast, 2AMD treatment preserved islet cell architecture, arrested intra-islet T cell invasion and prevented the transition from insulitis to diabetes. IPGTT results revealed progressive impairment of beta cell function with increasing age in control mice, while 2AMD treatment resulted in normal beta function throughout the study. These results demonstrate that the Ins2(-/-) NOD model provides a rapid and effective method for studying T1D and for assessing efficacy of anti-diabetic agents.</AbstractText><CopyrightInformation>&#xa9; 2011 The Authors. Clinical and Experimental Immunology &#xa9; 2011 British Society for Immunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiekhaefer</LastName><ForeName>C M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gorichanaz</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Nehring</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>DeLuca</LastName><ForeName>H F</ForeName><Initials>HF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569114">2-methyl-19-nor-1,25-dihydroxyvitamin D3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>FXC9231JVH</RegistryNumber><NameOfSubstance UI="D002117">Calcitriol</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002117" MajorTopicYN="N">Calcitriol</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005951" MajorTopicYN="N">Glucose Tolerance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050417" MajorTopicYN="N">Insulin-Secreting Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="N">Islets of Langerhans</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22059989</ArticleId><ArticleId IdType="pmc">PMC3232379</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04481.x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pearl-Yafe M, Kaminitz A, Yolcu ES, Yaniv I, Stein J, Askenasy N. Pancreatic islets under attack: cellular and molecular effectors. Curr Pharm Des. 2007;13:749&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17346189</ArticleId></ArticleIdList></Reference><Reference><Citation>McDevitt HO, Unanue ER. Autoimmune diabetes mellitus &#x2013; much progress, but many challenges. Adv Immunol. 2008;100:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19111161</ArticleId></ArticleIdList></Reference><Reference><Citation>Azam A, Eisenbarth GS. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes. Exp Opin Biol Ther. 2004;4:1569&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15461568</ArticleId></ArticleIdList></Reference><Reference><Citation>Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes. Ann NY Acad Sci. 2005;1051:194&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">16126959</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arq Bras Endocrinol Metabol. 2008;52:146&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18438525</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai EB, Sherry NA, Palmer JP, Herold KC, Grp D-S. The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia. 2006;49:261&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16404554</ArticleId></ArticleIdList></Reference><Reference><Citation>Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes. Ann NY Acad Sci. 2005;1051:194&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">16126959</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E, Eisenbarth GS. Type 1A diabetes mellitus-associated autoimmunity. Endocrinol Metab Clin North Am. 2002;31:391&#x2013;410. vii&#x2013;viii.</Citation><ArticleIdList><ArticleId IdType="pubmed">12092457</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev. 2005;204:232&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">15790362</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11476858</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med. 1999;5:601&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371488</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005;23:447&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15771578</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME. NOD mice and autoimmunity. Autoimmun Rev. 2005;4:373&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081028</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter EH. Nonobese diabetic mice and the genetics of diabetes susceptibility. Curr Diab Rep. 2005;5:141&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15794919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Santamaria P. Lessons on autoimmune diabetes from animal models. Clin Sci (Lond) 2006;110:627&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">16689681</ArticleId></ArticleIdList></Reference><Reference><Citation>Giarratana N, Penna G, Adorini L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol. 2007;380:285&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">17876100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicker LS, Clark J, Fraser HI, et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun. 2005;25:29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">16257508</ArticleId></ArticleIdList></Reference><Reference><Citation>von Herrath M, Chan A. How can we improve the translational landscape for a faster cure of type 1 diabetes? J Clin Invest. 2009;119:1061&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673858</ArticleId><ArticleId IdType="pubmed">19422092</ArticleId></ArticleIdList></Reference><Reference><Citation>von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol. 2009;10:129&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19148193</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois-Lafforgue D, Mogenet L, Thebault K, Jami J, Krief P, Boitard C. Proinsulin 2 knockout NOD mice &#x2013; a model for genetic variation of insulin gene expression in type 1 diabetes. Diabetes. 2002;51:S489&#x2013;S493.</Citation><ArticleIdList><ArticleId IdType="pubmed">12475795</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath VL, Moore NC, Parnell SM, Mason DW. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun. 1998;11:309&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">9776708</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleau JM, Esling A, Geutkens S, Dardenne M, Homo-Delarche F. Pancreatic hormone and glutamic acid decarboxylase expression in the mouse thymus: a real-time PCR study. Biochem Biophys Res Commun. 2001;283:843&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11350061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 2002;51:1383&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">11978634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliese A, Zeller M, Fernandez A, Jr, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 1997;15:293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vafiadis P, Bennett ST, Todd JA, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 1997;15:289&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054944</ArticleId></ArticleIdList></Reference><Reference><Citation>Thebault-Baumont K, Dubois-Laforgue D, Krief P, et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest. 2003;111:851&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153768</ArticleId><ArticleId IdType="pubmed">12639991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sicinski RR, Prahl JM, Smith CM, DeLuca HF. New 1&#x3b1;,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. J Med Chem. 1998;41:4662&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">9804706</ArticleId></ArticleIdList></Reference><Reference><Citation>Suda T, DeLuca HF, Tanaka Y. Biological activity of 25-hydroxyergocalciferol in rats. J Nutr. 1970;100:1049&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">4318536</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Levy NS, Hayes CE. Impaired immunity in vitamin D-deficient mice. J Nutr. 1987;117:857&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">3495650</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="HMD" IndexingMethod="Manual"><PMID Version="1">21949942</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0952-3367</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>8-9</Issue><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>The International journal of the history of sport</Title><ISOAbbreviation>Int J Hist Sport</ISOAbbreviation></Journal><ArticleTitle>Prologue: extending study of the visual in the history of sport.</ArticleTitle><Pagination><StartPage>1089</StartPage><EndPage>1104</EndPage><MedlinePgn>1089-1104</MedlinePgn></Pagination><Abstract><AbstractText>This paper highlights the value of images and materiality associated with sport in the past, and explores the range of sociocultural practices associated with them. It provides a critique of the neglect of such sources by many historians and notes that interest is now substantially growing in visuality and visual material. It emphasises the huge breadth and depth of sports-related evidence that can now be accessed, from stamps to stadiums and from posters to sports paraphernalia. It then examines the multiplicity of methodologies that can potentially be used to exploit the visual, its sites of production and sites of reception and seeing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Cumbria, Ambleside, Cumbria, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahony</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Hist Sport</MedlineTA><NlmUniqueID>100968205</NlmUniqueID><ISSNLinking>0952-3367</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001109" MajorTopicYN="N">Archives</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003466" MajorTopicYN="Y">Cultural Characteristics</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018864" MajorTopicYN="N">Cultural Diversity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010781" MajorTopicYN="Y">Photography</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012924" MajorTopicYN="Y">Social Conditions</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013177" MajorTopicYN="Y">Sports</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21949942</ArticleId><ArticleId IdType="doi">10.1080/09523367.2011.567765</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21471104</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>183</Volume><Issue>12</Issue><PubDate><Year>2011</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Airway fibroblasts in asthma manifest an invasive phenotype.</ArticleTitle><Pagination><StartPage>1625</StartPage><EndPage>1632</EndPage><MedlinePgn>1625-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201009-1452OC</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Invasive cell phenotypes have been demonstrated in malignant transformation, but not in other diseases, such as asthma. Cellular invasiveness is thought to be mediated by transforming growth factor (TGF)-&#x3b2;1 and matrix metalloproteinases (MMPs). IL-13 is a key T(H)2 cytokine that directs many features of airway remodeling through TGF-&#x3b2;1 and MMPs.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We hypothesized that, in human asthma, IL-13 stimulates increased airway fibroblast invasiveness via TGF-&#x3b2;1 and MMPs in asthma compared with normal controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fibroblasts were cultured from endobronchial biopsies in 20 subjects with mild asthma (FEV(1): 90 &#xb1; 3.6% pred) and 17 normal control subjects (FEV(1): 102 &#xb1; 2.9% pred) who underwent bronchoscopy. Airway fibroblast invasiveness was investigated using Matrigel chambers. IL-13 or IL-13 with TGF-&#x3b2;1 neutralizing antibody or pan-MMP inhibitor (GM6001) was added to the lower chamber as a chemoattractant. Flow cytometry and immunohistochemistry were performed in a subset of subjects to evaluate IL-13 receptor levels.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">IL-13 significantly stimulated invasion in asthmatic airway fibroblasts, compared with normal control subjects. Inhibitors of both TGF-&#x3b2;1 and MMPs blocked IL-13-induced invasion in asthma, but had no effect in normal control subjects. At baseline, in airway tissue, IL-13 receptors were expressed in significantly higher levels in asthma, compared with normal control subjects. In airway fibroblasts, baseline IL-13R&#x3b1;2 was reduced in asthma compared with normal control subjects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">IL-13 potentiates airway fibroblast invasion through a mechanism involving TGF-&#x3b2;1 and MMPs. IL-13 receptor subunits are differentially expressed in asthma. These effects may result in IL-13-directed airway remodeling in asthma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ingram</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, 201 MSRB 1, Research Drive, Box 2641, Durham, NC 27710, USA. jennifer.ingram@duke.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Molly J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>Tony D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuejuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Francisco</LastName><ForeName>Dave C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Degan</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Firszt</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Beaver</LastName><ForeName>Denise M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Lugogo</LastName><ForeName>Njira L</ForeName><Initials>NL</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Sunday</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Noble</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 HL084917</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL060539</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL-05-009</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018793">Interleukin-13</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053660">Receptors, Interleukin-13</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D020782">Matrix Metalloproteinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056151" MajorTopicYN="N">Airway Remodeling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018793" MajorTopicYN="N">Interleukin-13</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020782" MajorTopicYN="N">Matrix Metalloproteinases</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053660" MajorTopicYN="N">Receptors, Interleukin-13</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21471104</ArticleId><ArticleId IdType="pmc">PMC3136991</ArticleId><ArticleId IdType="doi">10.1164/rccm.201009-1452OC</ArticleId><ArticleId IdType="pii">201009-1452OC</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC408149</ArticleId><ArticleId IdType="pubmed">10079098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, <i>et al.</i> Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med
2001;194:809&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195954</ArticleId><ArticleId IdType="pubmed">11560996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram JL, Antao-Menezes A, Mangum JB, Lyght O, Lee PJ, Elias JA, Bonner JC. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J Immunol 2006;177:4141&#x2013;4148.</Citation><ArticleIdList><ArticleId IdType="pubmed">16951379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft M, Lewis C, Pham D, Chu HW. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol 2001;107:602&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">11295646</ArticleId></ArticleIdList></Reference><Reference><Citation>LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008;132:259&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265076</ArticleId><ArticleId IdType="pubmed">18243101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng T, Liu W, Oh SY, Zhu Z, Hu B, Homer RJ, Cohn L, Grusby MJ, Elias JA. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J Immunol 2008;180:522&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">18097054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz B, Phan SH, Thannickal VH, Galli A, Bochaton-Piallat ML, Gabbani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007;170:1807&#x2013;1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899462</ArticleId><ArticleId IdType="pubmed">17525249</ArticleId></ArticleIdList></Reference><Reference><Citation>Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38:872&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">18498538</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreen N, Mohammed KA, Mubarak KK, Baz MA, Akindipe OA, Fernandez-Bussy S, Antony VB. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-{beta}1 <i>in vitro</i>. Am J Physiol Lung Cell Mol Physiol
2009;297:L115&#x2013;L124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711818</ArticleId><ArticleId IdType="pubmed">19411308</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008;123:2229&#x2013;2238.</Citation><ArticleIdList><ArticleId IdType="pubmed">18777559</ArticleId></ArticleIdList></Reference><Reference><Citation>Denys H, Derycke L, Hendrix A, Westbroek W, Gheldof A, Narine K, Pauwels P, Gespach C, Bracke M, De Wever O. Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion. Cancer Lett 2008;266:263&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">18423981</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H, <i>et al.</i> Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat
2008;110:39&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">17674196</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 2010;70:2224&#x2013;2234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840052</ArticleId><ArticleId IdType="pubmed">20215503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe RG, Weiss SJ. Breaching the basement membrane: who, when and how? Trends Cell Biol 2008;18:560&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">18848450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins-Port CE, Higgins PJ. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 2007;185:116&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">17587817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota I, Li XY, Hu Y, Weiss SJ. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc Natl Acad Sci USA 2009;106:20318&#x2013;20323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787166</ArticleId><ArticleId IdType="pubmed">19915148</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239&#x2013;3245.</Citation><ArticleIdList><ArticleId IdType="pubmed">2438036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram JL, Huggins MJ, Church TD, Francisco D, Beaver DM, Kraft M. Dexamethasone modulates IL-13 and IL-4 receptor subunit expression in airway fibroblasts in asthma [abstract]. Am J Respir Crit Care Med 2009;179:A4270.</Citation></Reference><Reference><Citation>Ingram JL, Huggins MJ, Church TD, Francisco D, Firszt R, Degan S, Noble PW, Beaver DM, Sunday ME, Kraft M. Interleukin-13 induces airway fibroblast invasion in asthma: implications for a mechanism dependent on MMPs and TGF-beta [abstract]. Am J Respir Crit Care Med 2010;181:A1072.</Citation></Reference><Reference><Citation>American Thoracic Society Board of Directors. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">3605835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward C, Johns DP, Bish R, Pais M, Reid DW, Ingram C, Feltis B, Walters EH. Reduced airway distensibilty, fixed airflow limitation, and airway wall remodeling in asthma. Am J Respir Crit Care Med 2001;164:1718&#x2013;1721.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719315</ArticleId></ArticleIdList></Reference><Reference><Citation>Benayoun L, Druihle A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:1360&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531777</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010;298:L715&#x2013;L731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2886606</ArticleId><ArticleId IdType="pubmed">20363851</ArticleId></ArticleIdList></Reference><Reference><Citation>Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105:193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">10669837</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipps S, Benyahia F, Ou T-T, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 2004;31:626&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">15333330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997;16:664&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">9191468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Oliveri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">9106559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, Strober W. IL-13 signaling via IL-13R&#x3b1;2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008;135:2003&#x2013;2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">18938165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioi M, Seetharam S, Puri RK. N-linked glycosylation of IL-13R&#x3b1;2 is essential for optimal IL-13 inhibitory activity. FASEB J 2006;20:E1670&#x2013;E1680.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023392</ArticleId></ArticleIdList></Reference><Reference><Citation>Townley RG, Gendapodi PR, Qutna N, Evans J, Romero FA, Abel P. Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of &#x3b2;-adrenergic bronchodilators and corticosteroids. Ann Allergy Asthma Immunol 2009;102:190&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">19354064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo L, Fulkerson PC, Finkelman FD, Mingler M, Fischetti CA, Blanchard C, Rothenberg ME. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R&#x3b1;2-inhibited pathway. J Immunol 2010;185:660&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746758</ArticleId><ArticleId IdType="pubmed">20543112</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T, Bharat J, Nakajima A, Puri RK. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res 2009;69:8678&#x2013;8685.</Citation><ArticleIdList><ArticleId IdType="pubmed">19887609</ArticleId></ArticleIdList></Reference><Reference><Citation>Themsche CV, Alain T, Kossakowska AE, Urbanski S, Potworowski EF, St-Pierre Y. Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors <i>in vivo</i>. J Immunol
2004;173:3605&#x2013;3611.</Citation><ArticleIdList><ArticleId IdType="pubmed">15356104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito W, Tanimoto M, Ono K, Mizuno S, Yoshida A, Koga H, Fuchimoto Y, Kondo N, Tanimoto Y, Kiura K, <i>et al.</i> Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice. Int Arch Allergy Immunol
2008;145:324&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004075</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID, <i>et al.</i> Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol
2008;121:685&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992379</ArticleId><ArticleId IdType="pubmed">18328894</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto J, Lensmar C, Roquet A, van der Ploeg I, Gigliotti D, Eklund A, Grunewald J. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000;94:806&#x2013;814.</Citation><ArticleIdList><ArticleId IdType="pubmed">10955758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang H, Yang H, Zhang L, Chen X, Zheng X, He S. Induction of T-helper 2 cytokine release and up-regulated expression of protease-activated receptors on mast cells by recombinant American cockroach allergen Per a 7. Clin Exp Allergy 2008;38:1160&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">18691294</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Li Z, Xue L, Jiang X, Liu F. SUMF2 interacts with interleukin-13 and inhibits interleukin-13 secretion in bronchial smooth muscle cells. J Cell Biochem 2009;108:1076&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">19739097</ArticleId></ArticleIdList></Reference><Reference><Citation>Temann UA, Laouar Y, Eynon EE, Homer R, Flavell RA. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 2007;19:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med 2007;175:896&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">17272787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CC, Chu HW, Westcott JY, Tucker A, Langmack EL, Sutherland ER, Kraft M. Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J Allergy Clin Immunol 2005;115:534&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">15753901</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21400587</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2011</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-458X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Magnetic resonance in chemistry : MRC</Title><ISOAbbreviation>Magn Reson Chem</ISOAbbreviation></Journal><ArticleTitle>Conformational and configurational analysis of an N,N carbonyl dipyrrinone-derived oximate and nitrone by NMR and quantum chemical calculations.</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>212</EndPage><MedlinePgn>205-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mrc.2728</ELocationID><Abstract><AbstractText>The geometries and relative energies of new N,N carbonyl dipyrrinone-derived oxime molecules (E/Z-s-cis 4a and E/Z-s-cis 4b) have been investigated. The calculated energies, molecular geometries, and (1) H/(13) C NMR chemical shifts agree with experimental data, and the results are presented herein. The E-s-cis conformations of 4a and 4b and the Z-s-cis conformation of 5b were found to be the thermodynamically most stable isomers with the oxime hydrogen atom or the methyl functional group adopting an anti-orientation with respect to the dipyrrinone group. This conformation was unambiguously supported by a number of 2D NMR experiments.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida, Pensacola, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Marauo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liu</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tillman</LastName><ForeName>Destin</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Jarrett</LastName><ForeName>William L</ForeName><Initials>WL</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Karl J</ForeName><Initials>KJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Magn Reson Chem</MedlineTA><NlmUniqueID>9882600</NlmUniqueID><ISSNLinking>0749-1581</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000931">Antidotes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002801">Cholinesterase Reactivators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009589">Nitrogen Oxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010091">Oximes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011726">Pyridinium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C015388">nitrones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000931" MajorTopicYN="N">Antidotes</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="N">Biosensing Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002801" MajorTopicYN="N">Cholinesterase Reactivators</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009589" MajorTopicYN="N">Nitrogen Oxides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010091" MajorTopicYN="N">Oximes</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011726" MajorTopicYN="N">Pyridinium Compounds</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011789" MajorTopicYN="N">Quantum Theory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013237" MajorTopicYN="N">Stereoisomerism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21400587</ArticleId><ArticleId IdType="doi">10.1002/mrc.2728</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20635404</PMID><DateCompleted><Year>2010</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN><JournalIssue CitedMedium="Internet"><Volume>152A</Volume><Issue>8</Issue><PubDate><Year>2010</Year><Month>Aug</Month></PubDate></JournalIssue><Title>American journal of medical genetics. Part A</Title><ISOAbbreviation>Am J Med Genet A</ISOAbbreviation></Journal><ArticleTitle>Femoral-facial syndrome: Prenatal diagnosis and clinical features. Report of three cases.</ArticleTitle><Pagination><StartPage>2029</StartPage><EndPage>2033</EndPage><MedlinePgn>2029-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.33543</ELocationID><Abstract><AbstractText>The objective of our article is to illustrate the earliest prenatal sonographic diagnosis of femoral-facial syndrome (FFS) and to illustrate the spectrum of clinical manifestations of this condition. We present serial sonographic evaluation with 3D evaluation in two fetuses diagnosed prenatally with FFS and the postnatal findings in three patients (one fetus following pregnancy interruption and two newborns one of whom was diagnosed prenatally) with FFS. The two patients with prenatally diagnosed FFS were found to have femoral shortening and characteristic facial features, one 12 weeks of gestation, and one at 15 weeks of gestation. The sonographic findings in the two prenatally diagnosed patients were confirmed after delivery. We also present a third patient who was diagnosed at delivery in whom the diagnosis was missed at a routine prenatal sonogram at 19 weeks of gestation. The patients reported herein expand the clinical spectrum of FFS. The utility of sonographic evaluation in diagnosis of the facial appearance and of the bony abnormalities in this condition is emphasized.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nowaczyk</LastName><ForeName>M J M</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. nowaczyk@hhsc.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mohide</LastName><ForeName>P T</ForeName><Initials>PT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet A</MedlineTA><NlmUniqueID>101235741</NlmUniqueID><ISSNLinking>1552-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000015" MajorTopicYN="Y">Abnormalities, Multiple</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019465" MajorTopicYN="N">Craniofacial Abnormalities</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005269" MajorTopicYN="N">Femur</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011296" MajorTopicYN="Y">Prenatal Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20635404</ArticleId><ArticleId IdType="doi">10.1002/ajmg.a.33543</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20351044</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-7793</ISSN><JournalIssue CitedMedium="Internet"><Volume>588</Volume><Issue>Pt 11</Issue><PubDate><Year>2010</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of physiology</Title><ISOAbbreviation>J Physiol</ISOAbbreviation></Journal><ArticleTitle>AMPA receptor subunits define properties of state-dependent synaptic plasticity.</ArticleTitle><Pagination><StartPage>1929</StartPage><EndPage>1946</EndPage><MedlinePgn>1929-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1113/jphysiol.2010.187229</ELocationID><Abstract><AbstractText>Many synapses undergo immediate and persistent activity-dependent changes in strength via processes that fall under the umbrella of synaptic plasticity. It is known that this type of synaptic plasticity exhibits an underlying state dependence; that is, as synapses change in strength they move into distinct 'states' that are defined by the mechanism and ability to undergo future plasticity. In this study, we have investigated the molecular mechanisms that underlie state-dependent synaptic plasticity. Using intracellular application of peptides that mimic the C-terminal tail sequences of GluR1 and GluR2 AMPA receptor subtypes, combined with paired recordings of minimal synaptic connections, we have shown that AMPA receptor subtypes present in the membrane at a given time confer some properties of plasticity states. These data show that during synaptic plasticity, AMPA receptor subtypes are differentially stabilized by postsynaptic density proteins in or out of the postsynaptic membrane, and this differential synaptic expression of different AMPA receptor subtypes defines distinct synaptic states.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emond</LastName><ForeName>Michelle R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Johanna M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Jesse E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Lifang</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Huganir</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Madison</LastName><ForeName>Daniel V</ForeName><Initials>DV</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH065541</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH065541</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Physiol</MedlineTA><NlmUniqueID>0266262</NlmUniqueID><ISSNLinking>0022-3751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009479">Neuropeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018091">Receptors, AMPA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491308">Grip1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>P6W5IXV8V9</RegistryNumber><NameOfSubstance UI="C104722">glutamate receptor ionotropic, AMPA 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056654" MajorTopicYN="N">CA3 Region, Hippocampal</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004594" MajorTopicYN="N">Electrophysiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008845" MajorTopicYN="N">Microinjections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009479" MajorTopicYN="N">Neuropeptides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018091" MajorTopicYN="N">Receptors, AMPA</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20351044</ArticleId><ArticleId IdType="pmc">PMC2901981</ArticleId><ArticleId IdType="doi">10.1113/jphysiol.2010.187229</ArticleId><ArticleId IdType="pii">jphysiol.2010.187229</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adesnik H, Nicoll RA, England PM. Photoinactivation of native AMPA receptors reveals their real-time trafficking. Neuron. 2005;48:977&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashby MC, Maier SR, Nishimune A, Henley JM. Lateral diffusion drives constitutive exchange of AMPA receptors at dendritic spines and is regulated by spine morphology. J Neurosci. 2006;26:7046&#x2013;7055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673929</ArticleId><ArticleId IdType="pubmed">16807334</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta F, Sala C, Saglietti L, Hirling H, Sheng M, Passafaro M. NSF interaction is important for direct insertion of GluR2 at synaptic sites. Mol Cell Neurosci. 2005;28:650&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">15797712</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RC, Beattie EC, von Zastrow M, Malenka RC. Role of AMPA receptor endocytosis in synaptic plasticity. Nat Rev Neurosci. 2001;2:315&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11331915</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RC, Beattie EC, Xia H, L&#xfc;scher C, Altschuler Y, Nicoll RA, Malenka RC, von Zastrow M. Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci U S A. 1999a;96:14112&#x2013;14117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24199</ArticleId><ArticleId IdType="pubmed">10570207</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RC, Lissin DV, von Zastrow M, Nicoll RA, Malenka RC. Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat Neurosci. 1999b;2:454&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">10321250</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HJ, Steinberg JP, Huganir RL, Linden DJ. Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression. Science. 2003;300:1751&#x2013;1755.</Citation><ArticleIdList><ArticleId IdType="pubmed">12805550</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HJ, Xia J, Scannevin RH, Zhang X, Huganir RL. Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci. 2000;20:7258&#x2013;7267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772789</ArticleId><ArticleId IdType="pubmed">11007883</ArticleId></ArticleIdList></Reference><Reference><Citation>Citri A, Malenka RC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology. 2008;33:18&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17728696</ArticleId></ArticleIdList></Reference><Reference><Citation>Daw MI, Chittajallu R, Bortolotto ZA, Dev KK, Duprat F, Henley JM, Collingridge GL, Isaac JT. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron. 2000;28:873&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">11163273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H, O&#x2019;Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature. 1997;386:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">9069286</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond GB. Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol. 2008;587:713&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2669962</ArticleId><ArticleId IdType="pubmed">19218620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlers MD. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron. 2000;28:511&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">11144360</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner CC, Nash J, Huganir RL. PDZ domains in synapse assembly and signalling. Trends Cell Biol. 2000;10:274&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">10856930</ArticleId></ArticleIdList></Reference><Reference><Citation>Goslin K, Asmussen H, Banker G, editors. Rat Hippocampal Neurons in Low-density Culture. Cambridge, MA, USA: MIT Press; 1998.</Citation></Reference><Reference><Citation>Groc L, Choquet D. Measurement and characteristics of neurotransmitter receptor surface trafficking. Mol Membr Biol. 2008;25:344&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">18446620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson JE, Emond MR, Madison DV. Blocking polysynaptic inhibition via opioid receptor activation isolates excitatory synaptic currents without triggering epileptiform activity in organotypic hippocampal slices. J Neurosci Methods. 2006;150:8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science. 2000;287:2262&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">10731148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">8210177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci. 2007;8:844&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">17948030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH, Chung HJ, Lee HK, Huganir RL. Interaction of the AMPA receptor subunit GluR2/3 with PDZ domains regulates hippocampal long-term depression. Proc Natl Acad Sci U S A. 2001;98:11725&#x2013;11730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC58797</ArticleId><ArticleId IdType="pubmed">11573007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH, Takamiya K, Petralia RS, Sattler R, Yu S, Zhou W, Kalb R, Wenthold R, Huganir R. Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1. Nat Neurosci. 2005;8:985&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pubmed">16007085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornau HC, Seeburg PH, Kennedy MB. Interaction of ion channels and receptors with PDZ domain proteins. Curr Opin Neurobiol. 1997;7:368&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">9232802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature. 2000;405:955&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">10879537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Liu L, Wang YT, Sheng M. Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD. Neuron. 2002;36:661&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">12441055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao D, Zhang X, O&#x2019;Brien R, Ehlers MD, Huganir RL. Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons. Nat Neurosci. 1999;2:37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195178</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;scher C, Xia H, Beattie EC, Carroll RC, von Zastrow M, Malenka RC, Nicoll RA. Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron. 1999;24:649&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">10595516</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita M, Tomizawa K, Moriwaki A, Li ST, Terada H, Matsui H. A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci. 2001;21:6000&#x2013;6007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763134</ArticleId><ArticleId IdType="pubmed">11487623</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Madison DV. State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron. 2002;33:765&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">11879653</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Madison DV. Discrete synaptic states define a major mechanism of synapse plasticity. Trends Neurosci. 2004;27:744&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">15541515</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Pavlidis P, Madison DV. Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation. Neuron. 2001;29:691&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">11301028</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Selcher JC, Hanson JE, Madison DV. Dynamin-dependent NMDAR endocytosis during LTD and its dependence on synaptic state. BMC Neurosci. 2005;6:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1187896</ArticleId><ArticleId IdType="pubmed">16042781</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulkey RM, Malenka RC. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron. 1992;9:967&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pubmed">1419003</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves G, Cooke SF, Bliss TV. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci. 2008;9:65&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">18094707</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll RA. Expression mechanisms underlying long-term potentiation: a postsynaptic view. Philos Trans R Soc Lond B Biol Sci. 2003;358:721&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1693172</ArticleId><ArticleId IdType="pubmed">12740118</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll RA, Tomita S, Bredt DS. Auxiliary subunits assist AMPA-type glutamate receptors. Science. 2006;311:1253&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">16513974</ArticleId></ArticleIdList></Reference><Reference><Citation>Osten P, Khatri L, Perez JL, Kohr G, Giese G, Daly C, Schulz TW, Wensky A, Lee LM, Ziff EB. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron. 2000;27:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">10985351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa S, Iino M. Two distinct types of AMPA responses in cultured rat hippocampal neurons. Neurosci Lett. 1993;155:187&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">7690918</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer CL, Cotton L, Henley JM. The molecular pharmacology and cell biology of &#x3b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev. 2005;57:253&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314513</ArticleId><ArticleId IdType="pubmed">15914469</ArticleId></ArticleIdList></Reference><Reference><Citation>Panicker S, Brown K, Nicoll RA. Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse. Proc Natl Acad Sci U S A. 2008;105:1032&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2242677</ArticleId><ArticleId IdType="pubmed">18195349</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Penick EC, Edwards JG, Kauer JA, Ehlers MD. Recycling endosomes supply AMPA receptors for LTP. Science. 2004;305:1972&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448273</ArticleId></ArticleIdList></Reference><Reference><Citation>Passafaro M, Piech V, Sheng M. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci. 2001;4:917&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">11528423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlidis P, Madison DV. Synaptic transmission in pair recordings from CA3 pyramidal cells in organotypic culture. J Neurophysiol. 1999;81:2787&#x2013;2797.</Citation><ArticleIdList><ArticleId IdType="pubmed">10368397</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlidis P, Montgomery J, Madison DV. Presynaptic protein kinase activity supports long-term potentiation at synapses between individual hippocampal neurons. J Neurosci. 2000;20:4497&#x2013;4505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772468</ArticleId><ArticleId IdType="pubmed">10844019</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccini A, Malinow R. Critical postsynaptic density 95/disc large/zonula occludens-1 interactions by glutamate receptor 1 (GluR1) and GluR2 required at different subcellular sites. J Neurosci. 2002;22:5387&#x2013;5392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758183</ArticleId><ArticleId IdType="pubmed">12097490</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant K, Pelkey KA, Bortolotto ZA, Morita D, Terashima A, McBain CJ, Collingridge GL, Isaac JT. Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci. 2006;9:602&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">16582904</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthenveedu MA, Yudowski GA, von Zastrow M. Endocytosis of neurotransmitter receptors: location matters. Cell. 2007;130:988&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">17889644</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche KW, O&#x2019;Brien RJ, Mammen AL, Bernhardt J, Huganir RL. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron. 1996;16:1179&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">8663994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenmund C. The tetrameric structure of a glutamate receptor channel. Science. 1998;280:1596&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">9616121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sans N, Vissel B, Petralia RS, Wang YX, Chang K, Royle GA, Wang CY, O&#x2019;Gorman S, Heinemann SF, Wenthold RJ. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci. 2003;23:9367&#x2013;9373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6740562</ArticleId><ArticleId IdType="pubmed">14561864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol. 2007;23:613&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">17506699</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S-H, Hayashi Y, Esteban JA, Malinow R. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell. 2001;105:331&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11348590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S-H, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science. 1999;284:1811&#x2013;1816.</Citation><ArticleIdList><ArticleId IdType="pubmed">10364548</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991;37:173&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">1715499</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita S, Fukata M, Nicoll RA, Bredt DS. Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science. 2004;303:1508&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">15001777</ArticleId></ArticleIdList></Reference><Reference><Citation>Waites CL, Specht CG, H&#xe4;rtel K, Leal-Ortiz S, Genoux D, Li D, Drisdel RC, Jeyifous O, Cheyne JE, Green WN, Montgomery JM, Garner CC. Synaptic SAP97 isoforms regulate AMPA receptor dynamics and access to presynaptic glutamate. J Neurosci. 2009;29:4332&#x2013;4345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230533</ArticleId><ArticleId IdType="pubmed">19357261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenthold RJ, Petralia RS, Blahos J, II, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci. 1996;16:1982&#x2013;1989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578515</ArticleId><ArticleId IdType="pubmed">8604042</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao MY, Zhou Q, Nicoll RA. Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors. Neuropharmacology. 2001;41:664&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">11640920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudowski GA, Puthenveedu MA, Leonoudakis D, Panicker S, Thorn KS, Beattie EC, von Zastrow M. Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors. J Neurosci. 2007;27:11112&#x2013;11121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3249441</ArticleId><ArticleId IdType="pubmed">17928453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff EB. TARPs and the AMPA receptor trafficking paradox. Neuron. 2007;53:627&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">17329203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19707637</PMID><DateCompleted><Year>2009</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2009</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-548X</ISSN><JournalIssue CitedMedium="Internet"><Issue>35</Issue><PubDate><Year>2009</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Chemical communications (Cambridge, England)</Title><ISOAbbreviation>Chem Commun (Camb)</ISOAbbreviation></Journal><ArticleTitle>Synthesis and molecular recognition studies of pyrrole sulfonamides.</ArticleTitle><Pagination><StartPage>5254</StartPage><EndPage>5256</EndPage><MedlinePgn>5254-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/b911985j</ELocationID><Abstract><AbstractText>We report the synthesis and characterization of the pyrrole sulfonamide as a new class of potential molecular receptors, including conformational analysis and molecular recognition studies for four pyrrole sulfonamide derivatives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of West Florida, 11000 University Parkway, Pensacola, FL 32514, USA. mhuggins@uwf.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Tyler</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Hunt</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Commun (Camb)</MedlineTA><NlmUniqueID>9610838</NlmUniqueID><ISSNLinking>1359-7345</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19707637</ArticleId><ArticleId IdType="doi">10.1039/b911985j</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19103465</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2009</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>1-2</Issue><PubDate><Year>2009</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Alexithymia determines the anxiety experienced in skydiving.</ArticleTitle><Pagination><StartPage>134</StartPage><EndPage>138</EndPage><MedlinePgn>134-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2008.11.022</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High-risk activities have typically been explored within a sensation seeking framework. They may, however, allow those with emotional difficulties to experience and regulate their emotions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Skydivers (n=87) completed anxiety and heart rate data four times on a single day before and after a skydive.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A 2 (group: alexithymic; non alexithymic) x 4 (time) ANOVA with repeated measures on the second factor revealed a significant alexithymia x time interaction, F(2.27, 192.60)=45.48, p&lt;.001, eta(2)=.35. Anxiety fluctuated significantly more for alexithymic skydivers than it did for their non alexithymic counterparts. This interaction was not mirrored by heart rate. The relationship between alexithymia and anxiety remained significant when accounting for sensation seeking.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The results leave open interpretations that are based on anhedonia, which was not controlled for.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Alexithymic individuals may find, in the high-risk domain, an environment that satisfies their emotion regulation needs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woodman</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Sport, Health, and Exercise Sciences, Bangor University, Gwynedd LL57 2DG, UK. t.woodman@bangor.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Le Scanff</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Cazenave</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000342" MajorTopicYN="N">Affective Symptoms</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001359" MajorTopicYN="Y">Aviation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010555" MajorTopicYN="N">Personality Inventory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013177" MajorTopicYN="Y">Sports</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19103465</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2008.11.022</ArticleId><ArticleId IdType="pii">S0165-0327(08)00474-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18484053</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2008</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>1998</Year></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>The use of virus isolation, histopathology and immunoperoxidase techniques to study the dissemination of a chicken isolate of avian pneumovirus in chickens.</ArticleTitle><Pagination><StartPage>632</StartPage><EndPage>640</EndPage><MedlinePgn>632-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079459808419395</ELocationID><Abstract><AbstractText>A subgroup B isolate of turkey rhinotracheitis virus (TRTV) or avian pneumovirus (APV), obtained from a flock of commercial breeding chickens experiencing poor egg production, mortality and swollen head syndrome, was shown to cause substantial respiratory signs in both young SPF chickens and chicks with high levels of maternally derived TRT antibodies. This isolate replicated to high titre in the respiratory tract of experimentally inoculated SPF chickens for approximately 5 days after inoculation, but was recovered only occasionally after that time. It was never recovered from non-respiratory tract tissues. A detailed, sequential histological and immunoperoxidase study was performed. This revealed that, whilst TRT virus could be demonstrated consistently in the epithelium of upper respiratory tract tissue, although only for a short time after inoculation, the damage which it caused was minimal and recovery was rapid. This study, using a pathogenic TRT isolate obtained from diseased chickens, provides clear evidence that TRT virus can cause damage to the respiratory tract of chickens and that this damage is both localized and short lived.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catelli</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento di Sanita Pubblica Veterinaria e Patologia Animale-Sezione di Patologia Aviare, Facolta di Medicina Veterinaria, Universite di Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Chesher</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Baxendale</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18484053</ArticleId><ArticleId IdType="doi">10.1080/03079459808419395</ArticleId><ArticleId IdType="pii">784700431</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="HMD" IndexingMethod="Manual"><PMID Version="1">18459239</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0707-5332</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2001</Year></PubDate></JournalIssue><Title>The International history review</Title><ISOAbbreviation>Int Hist Rev</ISOAbbreviation></Journal><ArticleTitle>Athleticism in the Victorian and Edwardian public school.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>155</EndPage><MedlinePgn>149-55</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int Hist Rev</MedlineTA><NlmUniqueID>100968196</NlmUniqueID><ISSNLinking>0707-5332</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000884" MajorTopicYN="N">Anthropology, Cultural</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000885" MajorTopicYN="N">Anthropology, Physical</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001265" MajorTopicYN="N">Athletic Injuries</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054874" MajorTopicYN="Y">Athletic Performance</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003466" MajorTopicYN="Y">Cultural Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004493" MajorTopicYN="N">Education</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010806" MajorTopicYN="Y">Physical Education and Training</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010809" MajorTopicYN="N">Physical Fitness</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017150" MajorTopicYN="N">Public Sector</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012574" MajorTopicYN="Y">Schools</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013177" MajorTopicYN="N">Sports</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>5</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>7</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>5</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18459239</ArticleId><ArticleId IdType="doi">10.1080/714001663</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18203180</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN><JournalIssue CitedMedium="Internet"><Volume>146A</Volume><Issue>3</Issue><PubDate><Year>2008</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of medical genetics. Part A</Title><ISOAbbreviation>Am J Med Genet A</ISOAbbreviation></Journal><ArticleTitle>Paternal deletion 6q24.3: a new congenital anomaly syndrome associated with intrauterine growth failure, early developmental delay and characteristic facial appearance.</ArticleTitle><Pagination><StartPage>354</StartPage><EndPage>360</EndPage><MedlinePgn>354-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.32144</ELocationID><Abstract><AbstractText>Deletions of the long arm of chromosome 6 are relatively uncommon and to date minimal genotype-phenotype correlations have been observed. We report on three unrelated patients with de novo paternal interstitial deletions of 6q24.3. FISH mapping was used to delineate the minimal region of overlap between these three patients. Although all three patients had different size deletions and different breakpoints, two of the patients shared a 2.5 Mb region of overlap and strikingly similar facial features including a triangular face, frontal bossing with metopic prominence, short and upward-slanting palpebral fissures, asymmetry of upper eyelids, hooded eyelids, shallow orbits, prominent inferior orbital crease, wide mouth, and long and flat philtrum. They also had redundant skin, joint laxity, a small thorax, and early developmental delay. The smallest region of overlap between all three patients was a region of deletion less than 1 Mb; all had a history of IUGR and postnatal short stature without overt radiologic skeletal anomalies. The dysmorphic features, early developmental and growth delay may be due to the hemizygous state for one of the genes in the deleted region of two of the patients or to a long range effect of the deletion on expression of other genes. In addition, since imprinted genes have been reported in this region, paternal deletion of an imprinted gene in all three patients may contribute to the growth phenotype. We propose that this is a new congenital malformation syndrome associated with a paternal deletion of 6q24.3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nowaczyk</LastName><ForeName>Ma&#x142;gorzata J M</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Melissa T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Raca</LastName><ForeName>Gordana</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Soma</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Christa Lese</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rosenfield</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Waggoner</LastName><ForeName>Darrel J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet A</MedlineTA><NlmUniqueID>101235741</NlmUniqueID><ISSNLinking>1552-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002872" MajorTopicYN="Y">Chromosome Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025063" MajorTopicYN="N">Chromosome Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002896" MajorTopicYN="N">Chromosomes, Human, Pair 6</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020732" MajorTopicYN="N">Cytogenetic Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002658" MajorTopicYN="N">Developmental Disabilities</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019066" MajorTopicYN="Y">Facies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005220" MajorTopicYN="Y">Fathers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005317" MajorTopicYN="N">Fetal Growth Retardation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>6</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18203180</ArticleId><ArticleId IdType="doi">10.1002/ajmg.a.32144</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17626490</PMID><DateCompleted><Year>2007</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2007</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0005-2086</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Avian diseases</Title><ISOAbbreviation>Avian Dis</ISOAbbreviation></Journal><ArticleTitle>The efficacy of an avian metapneumovirus vaccine applied simultaneously with infectious bronchitis and Newcastle disease virus vaccines to specific-pathogen-free chickens.</ArticleTitle><Pagination><StartPage>594</StartPage><EndPage>596</EndPage><MedlinePgn>594-6</MedlinePgn></Pagination><Abstract><AbstractText>Avian metapneumovirus (aMPV), Newcastle disease virus (NDV), and infectious bronchitis virus (IBV) are important respiratory pathogens of chickens. To achieve early posthatch protection against all three diseases it would be helpful to deliver live aMPV, IBV, and NDV vaccines simultaneously at 1 day of age. However, previous work has indicated that the efficacy of aMPV vaccines may be affected when codelivered with IBV or NDV vaccines. The efficacy of an aMPV vaccine when codelivered to chickens in a trivalent combination with an NDV and an IBV vaccine was examined. The serological antibody response to the aMPV vaccine given with the IBV and NDV vaccine was significantly lower than when the aMPV vaccine was given alone. However, the aMPV vaccine did not affect the serological response to the IBV and NDV vaccines. Irrespective, the efficacy of the aMPV vaccine was not affected based on clinical signs postchallenge. This is the first report showing aMPV, IBV, and NDV vaccines can be codelivered without affecting the efficacy of the aMPV vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarpey</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Intervet UK, Walton Manor, Walton, Milton Keynes, Bucks MK7 7AJ, United Kingdom. ian.tarpey@intervet.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Avian Dis</MedlineTA><NlmUniqueID>0370617</NlmUniqueID><ISSNLinking>0005-2086</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="N">Metapneumovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009521" MajorTopicYN="N">Newcastle Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>7</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>7</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17626490</ArticleId><ArticleId IdType="doi">10.1637/0005-2086(2007)51[594:TEOAAM]2.0.CO;2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17462834</PMID><DateCompleted><Year>2007</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2007</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0378-1135</ISSN><JournalIssue CitedMedium="Print"><Volume>124</Volume><Issue>1-2</Issue><PubDate><Year>2007</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Veterinary microbiology</Title><ISOAbbreviation>Vet Microbiol</ISOAbbreviation></Journal><ArticleTitle>Onset of immunity following in ovo delivery of avian metapneumovirus vaccines.</ArticleTitle><Pagination><StartPage>134</StartPage><EndPage>139</EndPage><MedlinePgn>134-9</MedlinePgn></Pagination><Abstract><AbstractText>Avian metapneumovirus (aMPV) is an important cause of disease in chickens and turkeys. As infection can occur early in life and spread of the virus throughout a flock is rapid, an early onset of immunity post-vaccination would be advantageous. We have studied the serological immune response and the onset of protective immunity of an aMPV vaccine delivered to chickens via the in ovo route compared to oculonasal delivery at day old. A 1000-fold lower dose delivered in ovo to chicken specific pathogen free (SPF) embryos, than vaccination at day old, provided a significantly higher antibody response. In the presence of maternally derived antibody (MDA), there was no significant difference in antibody response between the vaccination routes. However, the onset of immunity (OOI) for the vaccine delivered to MDA positive chicken embryos was 5 days post-hatch in comparison to 8 days post-hatch for the same dose of vaccine given at day old indicating that chicks would be protected against disease earlier in the field if vaccinated by the in ovo route. In further experiments the OOI for a turkey vaccine delivered to MDA positive turkey embryos was shown to be 8 days post-hatch.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarpey</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Intervet UK, Walton Manor, Walton, Milton Keynes, Bucks MK7 7AJ, UK. ian.tarpey@intervet.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vet Microbiol</MedlineTA><NlmUniqueID>7705469</NlmUniqueID><ISSNLinking>0378-1135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="Y">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004531" MajorTopicYN="N">Eggs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="N">Metapneumovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014422" MajorTopicYN="Y">Turkeys</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>4</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>12</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>4</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17462834</ArticleId><ArticleId IdType="doi">10.1016/j.vetmic.2007.03.018</ArticleId><ArticleId IdType="pii">S0378-1135(07)00155-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16218009</PMID><DateCompleted><Year>2005</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-0124</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2005</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Journal of continuing education in nursing</Title><ISOAbbreviation>J Contin Educ Nurs</ISOAbbreviation></Journal><ArticleTitle>Registered nurse refresher course as an adjunct in nurse recruitment.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>217</EndPage><MedlinePgn>213-7</MedlinePgn></Pagination><Abstract><AbstractText>A registered nurse refresher course in the east central region of Missouri has offered a singular opportunity for nurses wishing to re-enter the nursing profession. By offering both didactic instruction and clinical experience with a nurse mentor in the medical center, nurses who have been out of nursing or in a non-clinical role have had the chance to begin to reorient themselves to professional practice before committing to a permanent position. This article describes one institution's experience and process for those who might be considering developing a re-entry program of their own.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marilyn E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Missouri Baptist Medical Center, St Louis, MO 63131, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Contin Educ Nurs</MedlineTA><NlmUniqueID>0262321</NlmUniqueID><ISSNLinking>0022-0124</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004509" MajorTopicYN="N">Education, Nursing, Continuing</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004518" MajorTopicYN="N">Education, Professional, Retraining</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008611" MajorTopicYN="Y">Mentors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008923" MajorTopicYN="N" Type="Geographic">Missouri</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010560" MajorTopicYN="Y">Personnel Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016730" MajorTopicYN="N">Program Development</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>11</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16218009</ArticleId><ArticleId IdType="doi">10.3928/0022-0124-20050901-07</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16141764</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1040-872X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Current opinion in obstetrics &amp; gynecology</Title><ISOAbbreviation>Curr Opin Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Newer pharmacologic options in management of overactive bladder syndrome.</ArticleTitle><Pagination><StartPage>495</StartPage><EndPage>506</EndPage><MedlinePgn>495-506</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Urinary incontinence is an under-reported epidemic that currently affects an estimated 13 million people in the United States, of whom about 11 million are women, according to the National Institute of Diabetes and Digestive and Kidney Diseases (Publication No. 02-4132). Because many patients are unaware of curative options and perceive it to be an inevitable outcome of advancing age, they fail to report their symptoms and increase their risk of developing associated co-morbid disease. Failure to diagnose and treat this condition increases financial burdens on individuals, their families and health care organizations.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Pharmacologic therapy of urge incontinence previously had limited treatment success because efficacious drugs were poorly tolerated, resulting in low patient compliance. Tolerance and effectiveness continue to be improved due to innovative new drugs and alternative delivery systems.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">The goal of this review is to update the clinician on the efficacy and the tolerability of established and investigational pharmacologic modalities of therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Tam H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>University of California, Irvine College of Medicine, Orange, California, USA. bsgini@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostergard</LastName><ForeName>Donald R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Narender N</ForeName><Initials>NN</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Melissa E</ForeName><Initials>ME</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Obstet Gynecol</MedlineTA><NlmUniqueID>9007264</NlmUniqueID><ISSNLinking>1040-872X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018680" MajorTopicYN="N">Cholinergic Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004333" MajorTopicYN="N">Drug Administration Routes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001745" MajorTopicYN="N">Urinary Bladder Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014549" MajorTopicYN="N">Urinary Incontinence</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>102</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16141764</ArticleId><ArticleId IdType="doi">10.1097/01.gco.0000180157.02998.9a</ArticleId><ArticleId IdType="pii">00001703-200510000-00010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15763725</PMID><DateCompleted><Year>2005</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2005</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2004</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Hatchability, serology and virus excretion following in ovo vaccination of chickens with an avian metapneumovirus vaccine.</ArticleTitle><Pagination><StartPage>576</StartPage><EndPage>580</EndPage><MedlinePgn>576-80</MedlinePgn></Pagination><Abstract><AbstractText>The present investigation describes for the first time the effect of an avian metapneumovirus vaccine administered in ovo to 18-day-old chicken embryos. The application of the vaccine had no adverse effect on the hatchability or the health of the chicks post hatch. The antibody titres achieved were higher than those determined for birds vaccinated at 1 day old. Not only were the mean titres in the in ovo vaccinated groups higher, but many more birds developed a measurable antibody response than birds vaccinated at 1 day old. Variation of the vaccine dose used in ovo had little effect on the serological responses that peaked 21 to 28 days post hatch. Re-isolation of the vaccine virus was much more successful from birds vaccinated in ovo than from birds vaccinated at 1 day old, and detection of the nucleic acid by polymerase chain reaction correlated with the results of live virus isolation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intervet, UK, Houghton, Huntingdon, UK. michael.hess@vu-wien.ac.at</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Heincz</LastName><ForeName>U</ForeName><Initials>U</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="N">Metapneumovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010063" MajorTopicYN="N">Ovum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>3</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>3</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15763725</ArticleId><ArticleId IdType="doi">10.1080/03079450400013220</ArticleId><ArticleId IdType="pii">NTPWQHNAN9YYLUBW</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15334481</PMID><DateCompleted><Year>2004</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0004-3591</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>8</Issue><PubDate><Year>2004</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Arthritis and rheumatism</Title><ISOAbbreviation>Arthritis Rheum</ISOAbbreviation></Journal><ArticleTitle>Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.</ArticleTitle><Pagination><StartPage>2651</StartPage><EndPage>2659</EndPage><MedlinePgn>2651-9</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the effect of mutations in tumor necrosis factor receptor superfamily 1A (TNFRSF1A) on the ability of the receptors to be cleaved from the cell surface upon stimulation. The mutations we studied are associated with clinically distinct forms of TNF receptor-associated periodic syndrome (TRAPS). We also investigated different cell types within the same form of TRAPS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The shedding of TNFRSF1A in response to stimulation with phorbol myristate acetate was assessed in leukocytes and dermal fibroblasts from patients with C33Y TRAPS, and in HEK 293 cell lines stably transfected with constructs containing wild-type TNFRSF1A and/or TNFRSF1A mutants identified in TRAPS patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The shedding of TNFRSF1A differed between cell types within the same form of TRAPS. In particular, dermal fibroblasts, but not leukocytes, from C33Y TRAPS patients demonstrated reduced shedding of TNFRSF1A. Shedding of both wild-type and mutant TNFRSF1A from the transfected HEK 293 cells showed minor differences, but was in all cases induced to a substantial extent.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Differences in TNFRSF1A shedding are not purely a function of the TNFRSF1A structure, but are also influenced by other features of genetic makeup and/or cellular differentiation. It is unlikely that a defect in TNFRSF1A shedding per se can fully explain the clinical features that are common to TRAPS patients with different TNFRSF1A mutations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Immunology, Queen's Medical Centre, University of Nottingham, Nottingham, UK. mary.huggins@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>McIntosh</LastName><ForeName>Richard S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Bainbridge</LastName><ForeName>Susan E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Dickinson</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Draper-Morgan</LastName><ForeName>Kelly-Ann</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Tighe</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheum</MedlineTA><NlmUniqueID>0370605</NlmUniqueID><ISSNLinking>0004-3591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018124">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047888">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010505" MajorTopicYN="N">Familial Mediterranean Fever</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018124" MajorTopicYN="N">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047888" MajorTopicYN="N">Receptors, Tumor Necrosis Factor, Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>9</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15334481</ArticleId><ArticleId IdType="doi">10.1002/art.20380</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15316120</PMID><DateCompleted><Year>2004</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1462-0324</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2004</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Rheumatology (Oxford, England)</Title><ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation></Journal><ArticleTitle>Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.</ArticleTitle><Pagination><StartPage>1405</StartPage><EndPage>1408</EndPage><MedlinePgn>1405-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the effect of Etanercept treatment in systemic AA amyloidosis in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Etanercept therapy was given to a 27 year old woman, with systemic amyloidosis and nephrotic syndrome, and to her 51 year old father, also affected by TRAPS, who had previously undergone renal transplant for amyloidosis. Serum SAA levels, plasma cytokines, glomerular filtration rate and serum amyloid P scanning were monitored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Etanercept treatment resulted in initial clinical resolution of nephrotic syndrome in the 27 year old female. Both subjects demonstrated improvements in GFR and initial reduction or stabilisation of amyloid deposits on SAP scanning.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Etanercept may reverse or slow the progression of systemic AA amyloidosis in subjects with C33Y TNFRSF1A mutation. Treatment may however need to be continuous and life-long to prevent progression to end stage disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drewe</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical and Molecular Immunology, University Hospital, Nottingham NG7 2UH, UK. liz.drewe@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Cassidy</LastName><ForeName>M J D</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rheumatology (Oxford)</MedlineTA><NlmUniqueID>100883501</NlmUniqueID><ISSNLinking>1462-0324</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018124">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047888">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000685">Serum Amyloid A Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>OP401G7OJC</RegistryNumber><NameOfSubstance UI="D000068800">Etanercept</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068800" MajorTopicYN="N">Etanercept</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010505" MajorTopicYN="N">Familial Mediterranean Fever</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009404" MajorTopicYN="N">Nephrotic Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018124" MajorTopicYN="N">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047888" MajorTopicYN="N">Receptors, Tumor Necrosis Factor, Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000685" MajorTopicYN="N">Serum Amyloid A Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>12</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15316120</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keh357</ArticleId><ArticleId IdType="pii">keh357</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15312137</PMID><DateCompleted><Year>2004</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-2805</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Immunology</Title><ISOAbbreviation>Immunology</ISOAbbreviation></Journal><ArticleTitle>Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>79</EndPage><MedlinePgn>65-79</MedlinePgn></Pagination><Abstract><AbstractText>Tumour necrosis factor (TNF)-receptor-associated periodic syndrome (TRAPS) is a hereditary autoinflammatory disorder involving autosomal-dominant missense mutations in TNF receptor superfamily 1A (TNFRSF1A) ectodomains. To elucidate the molecular effects of TRAPS-related mutations, we transfected HEK-293 cells to produce lines stably expressing high levels of either wild-type (WT) or single mutant recombinant forms of TNFRSF1A. Mutants with single amino acid substitutions in the first cysteine-rich domain (CRD1) were produced both as full-length receptor proteins and as truncated forms lacking the cytoplasmic signalling domain (deltasig). High-level expression of either WT or mutant full-length TNFRSF1A spontaneously induced apoptosis and interleukin-8 production, indicating that the mutations in CRD1 did not abrogate signalling. Consistent with this, WT and mutant full-length TNFRSF1A formed cytoplasmic aggregates that co-localized with ubiquitin and chaperones, and with the signal transducer TRADD, but not with the inhibitor, silencer of death domain (SODD). Furthermore, as expected, WT and mutant deltasig forms of TNFRSF1A did not induce apoptosis or interleukin-8 production. However, whereas the WT full-length TNFRSF1A was expressed both in the cytoplasm and on the cell surface, the mutant receptors showed strong cytoplasmic expression but reduced cell-surface expression. The WT and mutant deltasig forms of TNFRSF1A were all expressed at the cell surface, but a proportion of the mutant receptors were also retained in the cytoplasm and co-localized with BiP. Furthermore, the mutant forms of surface-expressed deltasig TNFRSF1A were defective in binding TNF-alpha. We conclude that TRAPS-related CRD1 mutants of TNFRSF1A possess signalling properties associated with the cytoplasmic death domain, but other behavioural features of the mutant receptors are abnormal, including intracellular trafficking and TNF binding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Infection, Immunity and Inflammation, Division of Immunology, School of Molecular Medical Sciences, University of Nottingham, UK. ian.todd@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Draper-Morgan</LastName><ForeName>Kelly-Ann</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>McIntosh</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bainbridge</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Dickinson</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jamhawi</LastName><ForeName>Lama</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sansaridis</LastName><ForeName>Marios</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Tighe</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunology</MedlineTA><NlmUniqueID>0374672</NlmUniqueID><ISSNLinking>0019-2805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018124">Receptors, Tumor Necrosis Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047888">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010505" MajorTopicYN="N">Familial Mediterranean Fever</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018124" MajorTopicYN="N">Receptors, Tumor Necrosis Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047888" MajorTopicYN="N">Receptors, Tumor Necrosis Factor, Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2005</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15312137</ArticleId><ArticleId IdType="pmc">PMC1782552</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2567.2004.01942.x</ArticleId><ArticleId IdType="pii">IMM1942</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996;334:1717&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">8637518</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian Fever. Quart J Med. 1982;51:469&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">7156325</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of Familial Hibernian Fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc. 1997;72:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">9294526</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFRSF1A, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">10199409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull KM, Drewe E, Aksentijevich I, Dean IJ, Singh H, Powell RJ, Kastner DL. TNF receptor-associated periodic syndrome: emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 2002;81:349&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">12352631</ArticleId></ArticleIdList></Reference><Reference><Citation>MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signalling. 2002;14:477&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11897488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan FKM, Chun HJ, Zheng L, Siegel R, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand independent receptor assembly and signalling. Science. 2000;288:2351&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10875917</ArticleId></ArticleIdList></Reference><Reference><Citation>Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld H-J, Broger C, Loetscher H, Lesslauer W. Crystal structure of the soluble human 55kD TNF receptor-TNF&#x3b2; complex: implications for TNF receptor activation. Cell. 1993;73:431&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">8387891</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksentijevich I, Galon J, Soares M, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype&#x2013;phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001;69:301&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1235304</ArticleId><ArticleId IdType="pubmed">11443543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dode C, Papo T, Fieschi C, et al. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a french family. Arthitis Rheum. 2000;43:1535&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">10902757</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadoul M, Dode C, Cosyns J-P, Abramowicz D, Georges B, Delpech M, Pirson Y. Autosomal-dominant periodic fever with AA amyloidosis: novel mutation in tumor necrosis factor receptor 1 gene. Kidney Int. 2001;59:1677&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11318938</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A, Dode C, van der Meer JWM, Drenth JPH. Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene. Am J Med. 2001;110:313&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239851</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A, van Deuren M, Tighe PJ, van der Meer JWM, Drenth JPH. Genetic analysis as a valuable key to diagnosis and treatment of periodic fever. Arch Intern Med. 2001;161:2491&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen Wolff A, Kreth HW, Hofmann S, et al. Periodic fever (TRAPS) caused by mutations in the TNF alpha receptor 1 (TNFRSF1A) gene of three German patients. Eur J Haematol. 2001;67:105&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11722598</ArticleId></ArticleIdList></Reference><Reference><Citation>Aganna E, Zeharia A, Hitman GA, et al. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46:245&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11817598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevala H, Karenko L, Stjernberg S, et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever. Arthritis Rheum. 2002;46:1061&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11953985</ArticleId></ArticleIdList></Reference><Reference><Citation>Dode C, Andre M, Bienvenu T, et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46:2181&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dode C, Hazenberg BP, Pecheux C, et al. Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. Nephrol Dial Transplant. 2002;17:1212&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12105243</ArticleId></ArticleIdList></Reference><Reference><Citation>Stjernberg S, Pettersson T, Karenko L, Pitkanen S, Peterson P, Ranki A. A novel mutation in exon 3 of the TNFRSF1A gene in a Finnish family with TRAPS. Clin Exp Rheumatol. 2002;20(Suppl. 26):S&#x2013;72.</Citation></Reference><Reference><Citation>Frenkel J, Ploos van Amstel JK, Smith B, Lasham C, Gaiser N, Rijkers GT. Non-cysteine TNFRSF1A mutation in Dutch family with periodic fever. Clin Exp Rheumatol. 2002;20(Suppl. 26):S&#x2013;73.</Citation></Reference><Reference><Citation>Obici L, Palladini G, Marciano S, Massa M, Zoppo M, Merlini G. Molecular characterisation of tumor necrosis factor receptor associated periodic syndrome (TRAPS) in Italy: identification of novel and recurrent mutations and evidence for a high frequency of the R92Q allele in the Italian population. Clin Exp Rheumatol. 2002;20(Suppl. 26):S&#x2013;76.</Citation></Reference><Reference><Citation>Aganna E, Hammond L, Hawkins PN, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">13130484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegel MA, Huffmeier U, Scherb E, Scheidig C, Geiler T, Kalden JR, Reis A, Lorenz H-M. Tumour necrosis factor receptor-associated periodic syndrome characterised by a mutation affecting the cleavage site of the receptor: implications for pathogenesis. Arthritis Rheum. 2003;48:2386&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12905494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopito RR, Ron D. Conformational disease. Nat Cell Biol. 2000;2:E207&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11056553</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrell RW. Lomas DA. Alpha1-antitrypsin deficiency &#x2013; a model for conformational diseases. N Engl J Med. 2002;346:45&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11778003</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarlane SM, Pashmi G, Connell MC, Littlejohn AF, Tucker SJ, Vandenabeele P, MacEwan DJ. Differential activation of nuclear factor-kB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett. 2002;515:119&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11943206</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse NJ, Finucane DM, Green DR, et al. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 1998;5:1051&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9894612</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH, Wallach D. Self association of the &#x2018;Death Domains&#x2019; of the p55 tumour necrosis factor (TNF) receptor and Fas/APO1 prompts signalling for TNF and Fas/Apo1 effects. J Biol Chem. 1995;270:387&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">7529234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaeta ML, Johnson DR, Kluger MS, Pober JS. The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Lab Invest. 2000;80:1185&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10950109</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143:1883&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Mata R, Bebok Z, Sorscher EJ, Sztul ES. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol. 1999;146:1239&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2156127</ArticleId><ArticleId IdType="pubmed">10491388</ArticleId></ArticleIdList></Reference><Reference><Citation>Teckman JH, Perlmutter DH. Retention of mutant &#x3b1;1-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol. 2000;279:G961&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">11052993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B, Duden R, Rubinsztein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Human Mol Genet. 2002;11:1107&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">11978769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan FK-M, Siegel RM, Lenardo MJ. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity. 2000;13:419&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">11070160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley JR, Thiru S, Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol. 1995;146:27&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1870772</ArticleId><ArticleId IdType="pubmed">7856733</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SR, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol. 1999;162:1042&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9916731</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey H, Stewart A, Vandenabeele P, Luzio JP. The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. Biochem J. 2002;366:15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222747</ArticleId><ArticleId IdType="pubmed">11985495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders CR, Nagy JK. Misfolding of membrane proteins in health and disease: the lady or the tiger? Curr Opin Struct Biol. 2000;10:438&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">10981632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Al-Lamki RS, Zhang H, Kirkiles-Smith N, Gaeta ML, Thiru S, Pober JS, Bradley JR. Histamine antagonizes tumor necrosis factor (TNF) signalling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool. J Biol Chem. 2003;278:21751&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12646554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Schmidt B, Teckman J, Perlmutter DH. A naturally occurring nonpolymerogenic mutant of &#x3b1;1-antitrypsin characterised by prolonged retention in the endoplasmic reticulum. J Biol Chem. 2001;276:33893&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11427540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen MM, Jensen ON, Holst HU, Hansen JJ, Corydon TJ, Bross P, Bolund L, Gregersen N. Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum. J Biol Chem. 2000;275:33861&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10906332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjaer S, Ibanez CF. Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet. 2003;12:2133&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12915470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">12667444</ArticleId></ArticleIdList></Reference><Reference><Citation>Houten SM, Frenkel J, Rijkers GT, Wanders RJA, Kuis W, Waterham HR. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet. 2002;11:3115&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">12444096</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993;73:457&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">8387893</ArticleId></ArticleIdList></Reference><Reference><Citation>Peschon JJ, Torrance DS, Stocking KL, et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol. 1998;160:943&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9551933</ArticleId></ArticleIdList></Reference><Reference><Citation>Penuel E, Akita RW, Sliwkowski MX. Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association. J Biol Chem. 2002;277:28468&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12000754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Hawari F, Alsaaty S, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest. 2002;110:515&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC150410</ArticleId><ArticleId IdType="pubmed">12189246</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in umour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology. 2003;42:235&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12595616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14982944</PMID><DateCompleted><Year>2004</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2007</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0741-5400</ISSN><JournalIssue CitedMedium="Print"><Volume>75</Volume><Issue>5</Issue><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of leukocyte biology</Title><ISOAbbreviation>J Leukoc Biol</ISOAbbreviation></Journal><ArticleTitle>Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.</ArticleTitle><Pagination><StartPage>772</StartPage><EndPage>776</EndPage><MedlinePgn>772-6</MedlinePgn></Pagination><Abstract><AbstractText>The novel, proinflammatory cytokine endothelial monocyte-activating polypeptide-II (EMAP-II) was first found in tumor cell supernatants. EMAP-II is closely related or identical to the p43 auxiliary protein of the multisynthase complex, which is involved in protein synthesis. In vitro, EMAP-II induces procoagulant activity, increased expression of E- and P-selectins and tumor necrosis factor receptor-1, and ultimately, programmed cell death (apoptosis) in cultured endothelial cells. EMAP-II is also chemotactic for monocytes and neutrophils. However, the role of the p43/EMAP-II cytokine form in tumors is not understood. We hypothesized an immune-regulatory role within neoplastic tissues and investigated its effects on lymphocytes. EMAP-II causes a dose-dependent inhibition of proliferation and apoptosis in Jurkat T cells and mitogen-activated peripheral blood mononuclear cells. Coculture with DLD-1 colorectal cancer cells or media conditioned by these cells induces apoptosis in Jurkat cells, which is partially reversed by antibodies against EMAP-II. Our data suggest that EMAP-II constitutes a component of a novel, immunosuppressive pathway in solid tumors, which is not normally expressed outside the cell but in tumors, may be subject to abnormal processing and released from tumor cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Wolfson Digestive Disease Centre, University Hospital, University of Nottingham, Nottingham, UK. cliff.murray@nott.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heng</LastName><ForeName>Y M</ForeName><Initials>YM</Initials></Author><Author ValidYN="Y"><LastName>Symonds</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Leukoc Biol</MedlineTA><NlmUniqueID>8405628</NlmUniqueID><ISSNLinking>0741-5400</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C077219">small inducible cytokine subfamily E, member 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009363" MajorTopicYN="N">Neoplasm Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14982944</ArticleId><ArticleId IdType="doi">10.1189/jlb.1003487</ArticleId><ArticleId IdType="pii">jlb.1003487</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14688335</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1767</ISSN><JournalIssue CitedMedium="Print"><Volume>172</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>281</EndPage><MedlinePgn>274-81</MedlinePgn></Pagination><Abstract><AbstractText>Endothelial monocyte-activating polypeptide-II (EMAP-II) was first isolated from cell growth medium conditioned by tumor cells, and is closely related or identical with the p43 component of the mammalian multisynthase complex. In its secreted form, EMAP-II has multiple cytokine-like activities in vitro, inducing procoagulant activity on the surface of endothelial cells, increasing expression of E- and P-selectins and TNF-R1, and directing migration of monocytes and neutrophils. EMAP-II has also been shown to induce apoptosis in endothelial cells, leading to the suggestion that it is a proinflammatory polypeptide with antiangiogenic activity. The role of secreted EMAP-II in tumors remains poorly understood, and we hypothesized that EMAP-II may play a role in immune evasion by tumor cells. We investigated its effects on lymphocytes, using recombinant protein, or colorectal cancer cell lines, as a source of native EMAP-II. Recombinant EMAP-II inhibits DNA synthesis and cell division, and induces apoptosis in mitogen-activated lymphocytes in PBMC preparations, and in Jurkat T cells. Native EMAP-II, released by or expressed on the surface of colorectal carcinoma cells, also induces activation of caspase 8 and apoptosis of PBLs and Jurkat cells, which are partially blocked by addition of Abs against EMAP-II. Thus, activated lymphocytes, along with proliferating endothelial cells, are targets for the cytotoxic activity of EMAP-II. Membrane-bound and soluble EMAP-II appear to play multiple roles in the tumor microenvironment, one of which is to assist in immune evasion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>J Clifford</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Wolfson Digestive Diseases Centre, University Hospital, School of Molecular Medical Sciences, University of Nottingham, Nottingham NG7 2UH, United Kingdom. cliff.murray@nott.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Symonds</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Wynne</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tiga</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Heng</LastName><ForeName>Yee M</ForeName><Initials>YM</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>R Adrian</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006131">Growth Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C077219">small inducible cytokine subfamily E, member 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505530">CASP8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053181">Caspase 8</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053181" MajorTopicYN="N">Caspase 8</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006131" MajorTopicYN="N">Growth Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019073" MajorTopicYN="N">HT29 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016131" MajorTopicYN="N">Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009363" MajorTopicYN="N">Neoplasm Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14688335</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.172.1.274</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14681066</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2003</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Avian metapneumovirus excretion in vaccinated and non-vaccinated specified pathogen free laying chickens.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>40</EndPage><MedlinePgn>35-40</MedlinePgn></Pagination><Abstract><AbstractText>Vaccinated and non-vaccinated specified pathogen-free White Leghorn laying chickens were challenged at peak of lay by the intravenous or oculonasal route with a virulent avian metapneumovirus (aMPV) subtype B chicken strain. Severe clinical signs and a drop in egg production were induced in the non-vaccinated intravenously challenged birds whereas the vaccinates were not affected. Live virus excretion was demonstrated in the faeces and respiratory tract of non-vaccinated hens for up to 7 days post intravenous challenge. After oculonasal challenge, virus excretion could only be demonstrated in the respiratory tract for up to 5 days. No live virus excretion was found in either the faeces or the respiratory tract of vaccinated birds. Concurrent with live virus isolation, the presence of viral RNA was demonstrated by single reverse transcription-polymerase chain reaction (RT-PCR). Nested RT-PCR was more sensitive and viral RNA could be detected in non-vaccinated birds up to 28 days post either intravenous or oculonasal challenge, at which time the experiment was terminated. Viral RNA was detected for up to 12 days in vaccinated birds. This is the first study investigating excretion of aMPV and viral RNA in vaccinated and non-vaccinated laying hens challenged under experimental conditions. The results are of importance with regard to the persistence of aMPV and the appropriate diagnostic detection method in laying birds.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intervet, UK, The Elms, Houghton, Huntingdon, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Mudzamiri</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Heincz</LastName><ForeName>U</ForeName><Initials>U</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="Y">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="N">Metapneumovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010058" MajorTopicYN="N">Oviposition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017201" MajorTopicYN="N">Virus Shedding</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14681066</ArticleId><ArticleId IdType="doi">10.1080/0307945031000163273</ArticleId><ArticleId IdType="pii">BM2Y669QPA094FPJ</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14666378</PMID><DateCompleted><Year>2006</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0172-8172</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>183</StartPage><EndPage>187</EndPage><MedlinePgn>183-7</MedlinePgn></Pagination><Abstract><AbstractText>A link between Epstein-Barr Virus (EBV) and systemic lupus erythematosus (SLE) has been suggested. However, recent advances in molecular technology now permit more detailed analysis. Sera from SLE patients were tested for antibodies to several EBV antigens and had a significantly higher prevalence of immunoglobulin G antibodies against EBV early antigens than in normal or disease controls. This suggests that recent EBV infection or virus reactivation was occurring in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Immunology, School of Molecular Medical Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK. mary.huggins@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019309">Epstein-Barr Virus Nuclear Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="N">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019309" MajorTopicYN="N">Epstein-Barr Virus Nuclear Antigens</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>6</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14666378</ArticleId><ArticleId IdType="doi">10.1007/s00296-003-0420-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 1971 Jan 23;1(7691):167-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4102189</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 1997 Jan;11(1):98-111</Citation><ArticleIdList><ArticleId IdType="pubmed">8990095</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1999 Aug;42(8):1782-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10446885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2001 Feb;20(2):148-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11224832</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2001 Sep;17(2):155-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11591124</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1998 Nov;28(11):3488-98</Citation><ArticleIdList><ArticleId IdType="pubmed">9842891</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1997 Dec 15;100(12):3019-26</Citation><ArticleIdList><ArticleId IdType="pubmed">9399948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2003;12(5):356-63</Citation><ArticleIdList><ArticleId IdType="pubmed">12765298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14581095</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3999</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of psychosomatic research</Title><ISOAbbreviation>J Psychosom Res</ISOAbbreviation></Journal><ArticleTitle>Symptomatic distress, hopelessness, and the desire for hastened death in hospitalized cancer patients.</ArticleTitle><Pagination><StartPage>411</StartPage><EndPage>418</EndPage><MedlinePgn>411-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study evaluated the desire for hastened death (DHD) in cancer patients at varying stages of disease to determine its frequency and relationship to physical and psychological distress.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred twenty-four inpatients at Princess Margaret Hospital completed questionnaires assessing pain, physical symptoms, depression, hopelessness, and DHD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was significant physical and psychological distress in this sample with a mean of nine physical symptoms reported by each subject. Seven percent reported moderate DHD on the Schedule of Attitudes Towards Hastened Death (SAHD) and 2% reported high DHD. Hopelessness and stage of disease were the only significant independent predictors of DHD and their interaction was associated with increased DHD. Hopelessness and, less so, depression both mediated the pathways between illness-related factors and DHD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings suggest that DHD is significantly related to hopelessness and advancing disease. Assessment of this phenomenon prior to the end of life may provide opportunities for intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Psychosocial Oncology and Palliative Care, Princess Margaret Hospital, University Health Network, 610 University Avenue, 5th Floor, Room 605, M5G 2M9 Toronto, ON, Canada. jennifer.jones@uhn.on.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary Anne</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Rydall</LastName><ForeName>Anne C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Rodin</LastName><ForeName>Gary M</ForeName><Initials>GM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Psychosom Res</MedlineTA><NlmUniqueID>0376333</NlmUniqueID><ISSNLinking>0022-3999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001293" MajorTopicYN="Y">Attitude to Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="Y">Stress, Psychological</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14581095</ArticleId><ArticleId IdType="doi">10.1016/s0022-3999(03)00526-9</ArticleId><ArticleId IdType="pii">S0022399903005269</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14501246</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1040-872X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Current opinion in obstetrics &amp; gynecology</Title><ISOAbbreviation>Curr Opin Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Urinary incontinence: newer pharmacotherapeutic trends.</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>427</EndPage><MedlinePgn>419-27</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Urinary incontinence is an under-reported epidemic with profound effects on quality of life. With recent pharmacologic advances, the belief that incontinence is an inevitable part of aging should be abandoned. Because many patients are unaware of curative options, they fail to report their symptoms and increase their risk of developing associated comorbid disease. Failure to diagnose and treat this disease in a timely manner increases society's economic burden associated with incontinence.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Pharmacologic treatment of urge incontinence previously had limited treatment success because efficacious drugs were poorly tolerated, resulting in low patient compliance. Tolerance continues to be improved due to innovative new drugs and alternative delivery systems. While previous pharmacologic management of mild stress incontinence consisted of off-label agents with limited effectiveness, newly introduced drug therapy adds a viable, nonsurgical option for women with stress incontinence.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">The goal of this review is to update the clinician on the efficacy and tolerability of established and investigational pharmacologic modalities of therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Melissa E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>University of California, Irvine College of Medicine, Irvine, California, USA. mehuggins@cox.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Narender N</ForeName><Initials>NN</Initials></Author><Author ValidYN="Y"><LastName>Ostergard</LastName><ForeName>Donald R</ForeName><Initials>DR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Obstet Gynecol</MedlineTA><NlmUniqueID>9007264</NlmUniqueID><ISSNLinking>1040-872X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014550" MajorTopicYN="N">Urinary Incontinence, Stress</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014551" MajorTopicYN="N">Urinary Tract</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>57</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14501246</ArticleId><ArticleId IdType="doi">10.1097/00001703-200310000-00011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12765298</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0961-2033</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>363</EndPage><MedlinePgn>356-63</MedlinePgn></Pagination><Abstract><AbstractText>Recent studies indicate that normal B cells can be primed to differentiate into two distinct cytokine-secreting effector subsets, Be1 and Be2. The aim of this study was to analyse, for the first time, Be1 and Be2 cells at the single cell level in SLE patients using the recently developed technique of flow cytometry for intracellular cytokines. Peripheral blood mononuclear cells (PBMC) from SLE patients and age- and sex-matched normal controls were cultured for 24 h in the presence or absence of phorbal myristate acetate and ionomycin (PMA/I) or lipopolysaccharide (LPS). The production of type I (IFN-gamma, IL-2) and type 2 (IL-4, IL-5, IL-6, IL-10, IL-13) cytokines by B cells (and IL-10 production by fractionated CD5+ and CD5- B cells) was investigated using an intracellular cytokine staining technique and flow cytometry. In the absence of PMA/I stimulation, the percentage of B cells from SLE patients was significantly lower than those of normal subjects and significantly more SLE B cells spontaneously produced IL-10 than controls. Moreover, CD5+ B cells from SLE patients were enriched for cells with signs of previous in vivo activation and for high levels of IL-10 production. A significant positive correlation was observed between the percentage of IL-10- and IL-6-producing PMA/I-stimulated B cells in SLE patients, but not in controls. There were no significant differences in the production of other cytokines by B cells of SLE patients and normal subjects. In conclusion, a general alteration of type 1 and type 2 cytokine production by B cells is not observed in SLE patients. The role of B cell cytokines in the pathogenesis of SLE appears to be exerted by elevated secretion of in vivo IL-10, which may play an important role in the immune dysregulation observed in SLE patients. Moreover, the cross regulation of IL-10 and IL-6 is disrupted in SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amel Kashipaz</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Molecular and Clinical Immunology, School of Clinical Laboratory Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lanyon</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018956">CD5 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018956" MajorTopicYN="N">CD5 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018418" MajorTopicYN="N">Th2 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12765298</ArticleId><ArticleId IdType="doi">10.1191/0961203303lu338oa</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12423312</PMID><DateCompleted><Year>2002</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-2805</ISSN><JournalIssue CitedMedium="Print"><Volume>107</Volume><Issue>3</Issue><PubDate><Year>2002</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Immunology</Title><ISOAbbreviation>Immunology</ISOAbbreviation></Journal><ArticleTitle>Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens.</ArticleTitle><Pagination><StartPage>358</StartPage><EndPage>365</EndPage><MedlinePgn>358-65</MedlinePgn></Pagination><Abstract><AbstractText>Recent studies have indicated that cells undergoing apoptosis are the source of autoantigens which drive autoimmune responses in systemic lupus erythematosus (SLE). It has been recognized for many years that in vitro stimulation of T cells with irradiated major histocompatibility complex (MHC) class II-bearing autologous cells results in T-cell proliferation with immunological specificity and memory, namely the autologous mixed lymphocyte reaction (AMLR). The nature of the major stimulants in the AMLR is still unclear. We investigated whether apoptotic fragments from irradiated cells act as antigenic stimulators for AMLR or nucleohistone-primed T cells. T-cell proliferation in the primary AMLR was significantly suppressed by the presence of a caspase inhibitor Z-Val-Ala-Asp-CH2F (Z-VAD.fmk), indicating that apoptotic antigens released from irradiated autologous feeder cells act as stimulators of AMLR T cells. This inhibitory effect of Z-VAD was not caused by toxic effects, because the T-cell response to the mitogen phytohaemagglutinin (PHA) was not inhibited by Z-VAD. A nucleohistone preparation was shown to contain antigens that are important in the AMLR, as culture with nucleohistone (but not with thyroglobulin or hen-egg lysozyme) primed T cells to respond with secondary kinetics in a subsequent AMLR that was also suppressed by Z-VAD. Our data provide evidence that the AMLR constitutes a model for the evaluation of cellular and molecular mechanisms that may be relevant to the pathogenesis of SLE and similar autoimmune diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amel Kashipaz</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Molecular and Clinical Immunology, School of Clinical Laboratory Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunology</MedlineTA><NlmUniqueID>0374672</NlmUniqueID><ISSNLinking>0019-2805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000590">Amino Acid Chloromethyl Ketones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061945">Caspase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015853">Cysteine Proteinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C096713">benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000590" MajorTopicYN="N">Amino Acid Chloromethyl Ketones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061945" MajorTopicYN="N">Caspase Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015853" MajorTopicYN="N">Cysteine Proteinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005720" MajorTopicYN="N">Gamma Rays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007959" MajorTopicYN="N">Lymphocyte Culture Test, Mixed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018448" MajorTopicYN="Y">Models, Immunological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>11</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>12</Month><Day>17</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>11</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12423312</ArticleId><ArticleId IdType="pmc">PMC1782802</ArticleId><ArticleId IdType="doi">10.1046/j.1365-2567.2002.01516.x</ArticleId><ArticleId IdType="pii">1516</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999;58:309&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1752888</ArticleId><ArticleId IdType="pubmed">10225817</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoura Z, Piette JC, Chabre H, Cacoub P, Papo T, Wechsler B, Bach JF, Koutouzov S. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 1997;40:2217&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416860</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman CR. Circulating DNA in systemic lupus erythematosus. Isolation and characterisation. J Clin Invest. 1984;73:832&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC425087</ArticleId><ArticleId IdType="pubmed">6323528</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine JS, Koh JS. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant. Semin Nephrol. 1999;19:34&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9952279</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1241&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9663482</ArticleId></ArticleIdList></Reference><Reference><Citation>Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosis. J Immunol. 1994;152:3685&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8144943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen A, Casciola Rosen L. Clearing the way to mechanisms of autoimmunity. Nat Med. 2001;7:664&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11385500</ArticleId></ArticleIdList></Reference><Reference><Citation>Walport MJ. Lupus, DNAse and defective disposal of cellular debris. Nat Genet. 2000;25:135&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10835621</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomea are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 2000;43:2307&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11037891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993;183:1367&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191002</ArticleId><ArticleId IdType="pubmed">8478612</ArticleId></ArticleIdList></Reference><Reference><Citation>Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 1997;40:2162&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaliyaperumal A, Mohan C, Wu W, Datta SK. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med. 1996;183:2459&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192594</ArticleId><ArticleId IdType="pubmed">8676066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach ML, Bach FH, Joo P. Leukemia-associated antigens in the mixed leukocyte culture test. Science. 1969;166:1520&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17655047</ArticleId></ArticleIdList></Reference><Reference><Citation>Romain PL, Schlossman SF, Reinherz EL. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction. J Immunol. 1984;133:1093&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">6235279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagan J, Choi YS. Failure of the human autologous mixed lymphocyte reaction in the absence of foreign antigens. Eur J Immunol. 1983;13:1031&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">6229407</ArticleId></ArticleIdList></Reference><Reference><Citation>Damle NK, Gupta S. Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR. Scand J Immunol. 1982;16:59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">6214846</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA, and DNA in polyacrylamide gel. Electrophoresis. 1987;8:93&#x2013;9.</Citation></Reference><Reference><Citation>Opelz G, Kiuchi M, Takasugi M, Terasaki PI. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975;142:1327&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189968</ArticleId><ArticleId IdType="pubmed">127826</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse NJ, Finucane DM, Green DR, et al. Calpain activation is upstream of caspases in radiation-induce apoptosis. Cell Death Differ. 1998;5:1051&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9894612</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994;179:1317&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191465</ArticleId><ArticleId IdType="pubmed">7511686</ArticleId></ArticleIdList></Reference><Reference><Citation>Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 1998;33:1152&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9663470</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med. 1995;182:1625&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192237</ArticleId><ArticleId IdType="pubmed">7500007</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implication for initiation of autoimmunity. J Exp Med. 1999;190:815&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195625</ArticleId><ArticleId IdType="pubmed">10499920</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinecker C, Machold KP, Majdic O, Hocker P, Knapp W, Smolen JS. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J Immunol. 1998;161:3966&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9780165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez LA, Macsween JM. The suppressive effects of monocytes in the autologous mixed lymphocyte reaction. Immunology. 1981;44:653&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1554996</ArticleId><ArticleId IdType="pubmed">6459291</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyashita T, Kralewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">8183579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastan M. On the TRAIL from p53 to apoptosis? Nat Genet. 1997;17:1317&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">9326922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallan E, Blomhoff HK, Smeland EB, Lomo J. Involvement of ICE (caspase) family in &#x3b3;-radiation-induced apoptosis of normal B lymphocytes. Scand J Immunol. 1997;46:601&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9420624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell DA, Morrison B, VandenBygaart B. Immunogenic DNA-related factors: nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest. 1990;85:1487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296596</ArticleId><ArticleId IdType="pubmed">2332503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11921325</PMID><DateCompleted><Year>2002</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1057-9249</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2002</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Psycho-oncology</Title><ISOAbbreviation>Psychooncology</ISOAbbreviation></Journal><ArticleTitle>The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment.</ArticleTitle><Pagination><StartPage>93</StartPage><EndPage>102</EndPage><MedlinePgn>93-102</MedlinePgn></Pagination><Abstract><AbstractText>Given the marked individual variability in psychological adjustment in response to breast cancer, it is important to specify factors contributing to adaptive survivorship. This longitudinal study of 70 women with Stage I or II breast cancer tested the ability of situation-specific coping strategies and a more stable attribute, hope, to predict adjustment prospectively from the point shortly following diagnosis through the first year. Consonant with previous studies, coping through active acceptance at diagnosis predicted more positive adjustment across time, and avoidance-oriented coping predicted greater fear of cancer recurrence, over and above participant age and initial status on dependent variables. The hypothesis that coping through turning to religion would be more effective for less hopeful women was supported, and mixed support emerged for the hypothesis that approach-oriented coping strategies would yield greater adaptational benefits for women high in hope. Findings suggest that risk and protective factors for adjustment across the first year of survivorship can be identified even prior to definitive surgery for breast cancer, particularly when both dispositional characteristics such as hope and situation-specific coping strategies are considered.</AbstractText><CopyrightInformation>Copyright 2002 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stanton</LastName><ForeName>Annette L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Kansas, Lawrence, KS 66045-2160, USA. astanton@ku.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danoff-Burg</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Melissa E</ForeName><Initials>ME</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychooncology</MedlineTA><NlmUniqueID>9214524</NlmUniqueID><ISSNLinking>1057-9249</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003674" MajorTopicYN="N">Defense Mechanisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012803" MajorTopicYN="Y">Sick Role</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013534" MajorTopicYN="N">Survival</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>3</Month><Day>29</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>5</Month><Day>15</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>3</Month><Day>29</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11921325</ArticleId><ArticleId IdType="doi">10.1002/pon.574</ArticleId><ArticleId IdType="pii">10.1002/pon.574</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11810661</PMID><DateCompleted><Year>2002</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0197-3851</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2002</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Prenatal diagnosis</Title><ISOAbbreviation>Prenat Diagn</ISOAbbreviation></Journal><ArticleTitle>Fluorescence in situ hybridization of uncultured lymphocytes from cystic hygroma fluid: a potential approach for rapid prenatal diagnosis.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>82</EndPage><MedlinePgn>81-2</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Viola</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Prenat Diagn</MedlineTA><NlmUniqueID>8106540</NlmUniqueID><ISSNLinking>0197-3851</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002887" MajorTopicYN="Y">Chromosomes, Human, Pair 18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005313" MajorTopicYN="N">Fetal Death</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017404" MajorTopicYN="Y">In Situ Hybridization, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018191" MajorTopicYN="N">Lymphangioma, Cystic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011296" MajorTopicYN="N">Prenatal Diagnosis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014314" MajorTopicYN="Y">Trisomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>1</Month><Day>26</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>4</Month><Day>16</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>1</Month><Day>26</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11810661</ArticleId><ArticleId IdType="doi">10.1002/pd.240</ArticleId><ArticleId IdType="pii">10.1002/pd.240</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="HMD" IndexingMethod="Manual"><PMID Version="1">20690230</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1462-1495</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><PubDate><Year>2002</Year></PubDate></JournalIssue><Title>The European sports history review</Title><ISOAbbreviation>Eur Sport Hist Rev</ISOAbbreviation></Journal><ArticleTitle>A tranquil transformation: middle-class racing "revolutionaries" in nineteenth-century England.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>57</EndPage><MedlinePgn>35-57</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Sport Hist Rev</MedlineTA><NlmUniqueID>101533745</NlmUniqueID><ISSNLinking>1462-1495</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005191" MajorTopicYN="N">Family Characteristics</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005195" MajorTopicYN="N">Family Relations</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005715" MajorTopicYN="Y">Gambling</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006608" MajorTopicYN="Y">Hierarchy, Social</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006736" MajorTopicYN="N">Horses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007899" MajorTopicYN="Y">Leisure Activities</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012924" MajorTopicYN="Y">Social Conditions</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012927" MajorTopicYN="N">Social Control, Informal</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013177" MajorTopicYN="Y">Sports</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20690230</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11735518</PMID><DateCompleted><Year>2002</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3263</ISSN><JournalIssue CitedMedium="Print"><Volume>66</Volume><Issue>25</Issue><PubDate><Year>2001</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>The Journal of organic chemistry</Title><ISOAbbreviation>J Org Chem</ISOAbbreviation></Journal><ArticleTitle>A C-H...O=C hydrogen bond? Intramolecular hydrogen bonding in a novel semirubin.</ArticleTitle><Pagination><StartPage>8402</StartPage><EndPage>8410</EndPage><MedlinePgn>8402-10</MedlinePgn></Pagination><Abstract><AbstractText>(4Z)-8-(5-Carboxypentyl)-9-butyl-2,3-diethyl-dipyrrin-1-one (1), a new analogue of xanthobilirubic acid, (4Z)-8-(carboxyethyl)-2,7,9-dimethyl-3-ethyl-dipyrrin-1-one, was synthesized in four steps from the known 2,3-diethyl-dipyrrin-1-one. Whereas xanthobilirubic acid (which is a model for one-half of bilirubin, the yellow pigment of jaundice) and its homologues with hexanoic and longer acid chains at C-8 engage only in intermolecular hydrogen bonding, 1 is found to engage in intramolecular hydrogen bonding. In CDCl(3) solution, dipyrrinone 1 adopts an anti-Z conformation, and its hexanoic acid COOH is hydrogen-bonded to the lactam H-N-C=O and to the pyrrole C(7)-H but not to the pyrrole NH. The latter constitutes an example of a hydrogen bond of the type C-H...O=C, weak and detected typically in crystals. Dipyrrinone 1 is found by vapor pressure osmometry to be monomeric in CHCl(3), but its methyl ester (2) tends toward being dimeric, like that of methyl xanthobilirubinate, which is dimeric.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Nevada, Reno, Nevada 89557-0020, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightner</LastName><ForeName>D A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD-17779</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Org Chem</MedlineTA><NlmUniqueID>2985193R</NlmUniqueID><ISSNLinking>0022-3263</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002208">Caproates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012997">Solvents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C415191">semirubin</NameOfSubstance></Chemical><Chemical><RegistryNumber>1F8SN134MX</RegistryNumber><NameOfSubstance UI="C037652">hexanoic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V31YC746X</RegistryNumber><NameOfSubstance UI="D002725">Chloroform</NameOfSubstance></Chemical><Chemical><RegistryNumber>RFM9X3LJ49</RegistryNumber><NameOfSubstance UI="D001663">Bilirubin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001663" MajorTopicYN="N">Bilirubin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002208" MajorTopicYN="N">Caproates</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002725" MajorTopicYN="N">Chloroform</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012997" MajorTopicYN="N">Solvents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013055" MajorTopicYN="N">Spectrophotometry, Infrared</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014835" MajorTopicYN="N">Volatilization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>12</Month><Day>12</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>18</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>12</Month><Day>12</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11735518</ArticleId><ArticleId IdType="doi">10.1021/jo010525p</ArticleId><ArticleId IdType="pii">jo010525p</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11732858</PMID><DateCompleted><Year>2002</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0172-8172</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2001</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Retroviral activity in Beh&#xe7;et's syndrome and systemic lupus erythematosus detected by a PCR-based reverse transcriptase assay.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>57</EndPage><MedlinePgn>53-7</MedlinePgn></Pagination><Abstract><AbstractText>The objective of this study was to assess retroviral activity in Beh&#xe7;et's syndrome (BS) and systemic lupus erythematosus (SLE) patients. Serum and peripheral blood mononuclear cells (PBMC) were obtained from patients and normal volunteers and PBMC cultured with and without phytohaemagglutinin stimulation. Reverse transcriptase (RT) activity in serum and culture supernatants was measured using a sensitive polymerase chain reaction-based assay. An RT activity above the levels in normal controls was detected in a minority of patients with BS (2/15) and SLE (1/13) and was typically present in all three types of sample. Elevated levels of RT activity were not detected in follow-up samples from the two BS patients. Our findings indicate that elevated RT activity is present in only a minority of patients with BS and SLE. Simultaneously elevated activity in all three sample types implicates PBMC as the source of this retroviral activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIntosh</LastName><ForeName>R S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Immunology, University of Nottingham, Queen's Medical Centre, UK. richard.mcintosh@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Kontogiannis</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Tighe</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001528" MajorTopicYN="N">Behcet Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012190" MajorTopicYN="N">Retroviridae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="Y">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012494" MajorTopicYN="N">Sampling Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>12</Month><Day>6</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>2</Month><Day>22</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>12</Month><Day>6</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11732858</ArticleId><ArticleId IdType="doi">10.1007/s00296-001-0140-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11709043</PMID><DateCompleted><Year>2002</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0261-1929</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2001</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Alternatives to laboratory animals : ATLA</Title><ISOAbbreviation>Altern Lab Anim</ISOAbbreviation></Journal><ArticleTitle>Electrical stimulation of transforming growth factor-beta 1 secretion by human dermal fibroblasts and the U937 human monocytic cell line.</ArticleTitle><Pagination><StartPage>693</StartPage><EndPage>701</EndPage><MedlinePgn>693-701</MedlinePgn></Pagination><Abstract><AbstractText>The in vitro effects on human dermal fibroblasts and the U937 human monocytic cell line of three phases of electrical microcurrents generated by the ACE Stimulator were investigated. The growth and viability of growing and confluent dermal fibroblasts were not directly influenced by the separate microcurrent phases. One form of microcurrent (designated phase 1) stimulated both dermal fibroblasts and U937 cells to secrete transforming growth factor-beta 1 (TGF-beta 1), which is an important regulator of cell-mediated inflammation and tissue regeneration, but none of the three phases stimulated secretion of the pro-inflammatory cytokine interleukin-6 by U937 cells. The stimulation of TGF-beta 1 secretion in these experiments was not dramatic (a median increase over control levels of 20-30%), although it could be biologically significant.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Molecular and Clinical Immunology, School of Clinical Laboratory Sciences, University of Nottingham Faculty of Medicine and Health Sciences, Queen's Medical Centre, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clothier</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Searle</LastName><ForeName>K C</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Jeyarajah</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Pradel</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lacey</LastName><ForeName>K L</ForeName><Initials>KL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Altern Lab Anim</MedlineTA><NlmUniqueID>8110074</NlmUniqueID><ISSNLinking>0261-1929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508960">TGFB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000826" MajorTopicYN="Y">Animal Testing Alternatives</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020405" MajorTopicYN="N">Dermis</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020298" MajorTopicYN="N">U937 Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>11</Month><Day>16</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>5</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>11</Month><Day>16</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11709043</ArticleId><ArticleId IdType="doi">10.1177/026119290102900611</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="KIE" IndexingMethod="Manual"><PMID Version="1">11644972</PMID><DateCompleted><Year>1999</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>61</Volume><Issue>4</Issue><PubDate><Year>1997</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>The duty to recontact: attitudes of genetics service providers.</ArticleTitle><Pagination><StartPage>A57</StartPage><MedlinePgn>A57</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="Y">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030881" MajorTopicYN="Y">Disclosure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033002" MajorTopicYN="Y">Duty to Recontact</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005817" MajorTopicYN="Y">Genetic Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036281" MajorTopicYN="N">Genetic Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033142" MajorTopicYN="Y">Genetic Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005823" MajorTopicYN="N">Genetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007603" MajorTopicYN="N">Jurisprudence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028681" MajorTopicYN="N">Moral Obligations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027724" MajorTopicYN="Y">Reproductive Techniques, Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012941" MajorTopicYN="N">Social Responsibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">59392</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword></KeywordList><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic counseling</GeneralNote><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic services</GeneralNote><GeneralNote Owner="KIE">Abstract</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>20</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>11</Month><Day>2</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>20</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11644972</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11591124</PMID><DateCompleted><Year>2001</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-8411</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2001</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of autoimmunity</Title><ISOAbbreviation>J Autoimmun</ISOAbbreviation></Journal><ArticleTitle>Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>163</EndPage><MedlinePgn>155-63</MedlinePgn></Pagination><Abstract><AbstractText>The production of type 1 (IFN-gamma, IL-2) and type 2 (IL-4, IL-5, IL-10, IL-13) cytokines by CD8(-) and CD8(+) T cells from systemic lupus erythematosus (SLE) patients and normal subjects was investigated using an intracellular cytokine-staining technique. This flow cytometric method facilitates analysis of both surface markers and cytoplasmic cytokines, after a short term (6 h) culture with or without phorbol myristate acetate and ionomycin (PMA/I) stimulation. In SLE patients, more unstimulated T cells produced IL-10 in comparison with controls; other cytokines were not detected in unstimulated cells. The percentage of IL-10-secreting T cells did not significantly increase after PMA/I stimulation of cells from SLE patients. The mean intensity of fluorescence (MIF) of intracellular IL-4 staining was significantly higher in CD8(-) T cells of SLE patients than controls. Significantly fewer CD8(-) and CD8(+) T cells from SLE patients secreted IFN-gamma after PMA/I stimulation compared with controls. The MIF and percentage of IL-2, IL-5, and IL-13-secreting cell subsets were not significantly different between SLE patients and controls. These findings indicate that T cells of SLE patients are already stimulated to produce IL-10 in vivo, which may result in downregulation of IFN-gamma secreting CD8(-) and CD8(+) T cells observed following PMA/I stimulation. Thus, the population size of Th1 and Tc1 cells are reduced in SLE patients whereas the effector function of Th2 cells, with respect to IL-4 production, is enhanced in SLE patients. Furthermore, although the balance between Th1/Th2 and between Tc1/Tc2 is disrupted in SLE patients, it is significantly biased in favour of the Th2 subset only.</AbstractText><CopyrightInformation>Copyright 2001 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amel-Kashipaz</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Molecular and Clinical Immunology, School of Clinical Laboratory Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. nixmra@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lanyon</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Autoimmun</MedlineTA><NlmUniqueID>8812164</NlmUniqueID><ISSNLinking>0896-8411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016827">CD8 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018793">Interleukin-13</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015848">Interleukin-5</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016827" MajorTopicYN="N">CD8 Antigens</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019085" MajorTopicYN="N">Fluorescent Antibody Technique, Direct</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018793" MajorTopicYN="N">Interleukin-13</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007376" MajorTopicYN="N">Interleukin-2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015848" MajorTopicYN="N">Interleukin-5</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013194" MajorTopicYN="N">Staining and Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018418" MajorTopicYN="N">Th2 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>5</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11591124</ArticleId><ArticleId IdType="doi">10.1006/jaut.2001.0525</ArticleId><ArticleId IdType="pii">S0896-8411(01)90525-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19184935</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2009</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3338</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2001</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Cloning, expression and immunogenicity of the avian pneumovirus (Colorado isolate) F protein.</ArticleTitle><Pagination><StartPage>471</StartPage><EndPage>474</EndPage><MedlinePgn>471-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079450120078653</ELocationID><Abstract><AbstractText>The F protein of the Colorado isolate of avian pneumovirus (APV), expressed from a DNA plasmid, was recognized by antiserum to both A and B subgroup APVs. After two intramuscular injections of turkeys with this plasmid, a homologous antibody response was detected by enzyme-linked immunosorbent assay. This antibody also recognized subgroup A APV. However, there was no neutralization of the Colorado isolate or of subgroup A or B viruses. Although no significant clinical protection was detected following homologous challenge of poults, an anamnestic serological response was seen, suggesting that a systemic antibody response but no local mucosal immunity was induced.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarpey</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Shilleto</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19184935</ArticleId><ArticleId IdType="doi">10.1080/03079450120078653</ArticleId><ArticleId IdType="pii">713651297</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19184927</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3338</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>4</Issue><PubDate><Year>2001</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Protection of chickens against renal damage caused by a nephropathogenic infectious bronchitis virus.</ArticleTitle><Pagination><StartPage>423</StartPage><EndPage>426</EndPage><MedlinePgn>423-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079450120066421</ELocationID><Abstract><AbstractText>The ability of the infectious bronchitis (IB) Ma5 and 4/91 live-attenuated vaccines to protect against kidney damage caused by a nephropathogenic strain of IB virus (B1648) was investigated. Protection parameters considered were gross and microscopic renal pathology, and the use of a polymerase chain reaction to detect IB RNA in kidney tissue. By each parameter, Ma5 vaccine alone provided poor protection, but 4/91 alone or the combined program both protected well.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Chesher</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Baxendale</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19184927</ArticleId><ArticleId IdType="doi">10.1080/03079450120066421</ArticleId><ArticleId IdType="pii">713651272</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19184905</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2009</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3338</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Infectious bronchitis virus vaccine interferes with the replication of avian pneumovirus vaccine in domestic fowl.</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>242</EndPage><MedlinePgn>233-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079450120054640</ELocationID><Abstract><AbstractText>Experiments were performed in chickens to ascertain whether application of infectious bronchitis (IB) H120 vaccine had an effect on the replication of an attenuated avian pneumovirus (APV) strain, using as indicators virus detection, humoral antibody responses and clinical protection against in vivo APV challenge. A preliminary experiment demonstrated that pharyngeal swabs were as efficient for recovery of APV as were buccal cavity swabs, and that either site was superior to swabbing the nasal cavity. APV was detected to a similar extent by both a reverse transcriptase-polymerase chain reaction (RT-PCR) and virus isolation; therefore, RT-PCR was used in subsequent experiments. In chickens vaccinated with APV alone, APV was detected by RT-PCR in most birds for 1 week after vaccination. When IB vaccine had been applied 1 week earlier, APV detection was delayed and much reduced. This interference by IBV resulted in a lower APV antibody response to vaccination. Following challenge with virulent APV, birds that had been vaccinated with APV alone were fully protected both clinically and virologically. Chickens that had received both vaccines were still protected clinically, but challenge virus could be detected in some pharyngeal swabs 4 days after challenge. In contrast, the APV vaccine had no effect on either the antibody response to the IB vaccine or the level of protection against IB challenge. It is concluded that IB vaccination interferes with the replication of APV, resulting in a reduction in the antibody response but with no adverse effect on the induction of protective immunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Mawditt</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Cavanagh</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19184905</ArticleId><ArticleId IdType="doi">10.1080/03079450120054640</ArticleId><ArticleId IdType="pii">713651263</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11243505</PMID><DateCompleted><Year>2001</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0961-2033</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2001</Year></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>CD40 ligand--an important target for immunotherapy?</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>3</EndPage><MedlinePgn>1-3</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>147205-72-9</RegistryNumber><NameOfSubstance UI="D023201">CD40 Ligand</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D023201" MajorTopicYN="Y">CD40 Ligand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="Y">Immunotherapy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>3</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>6</Month><Day>15</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>3</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11243505</ArticleId><ArticleId IdType="doi">10.1191/096120301666788782</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19184850</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2009</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3338</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2000</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Avian pneumovirus infection of laying hens: experimental studies.</ArticleTitle><Pagination><StartPage>545</StartPage><EndPage>556</EndPage><MedlinePgn>545-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079450020016788</ELocationID><Abstract><AbstractText>Administration of a virulent strain of avian pneumovirus (APV) to specific pathogen free laying hens by the oculonasal route failed to induce a drop in egg production or any adverse effects on eggshell quality. However, intravenous (i.v.) inoculation of the same strain caused a substantial drop in egg production and a high incidence of soft and thin-shelled eggs. Some respiratory signs were also observed and the hens appeared sick, with diarrhoea being observed in approximately one-half of the hens between 4 and 11 days post-inoculation (p.i.). APV antigen was detected in the oviduct epithelium up to 9 days p.i. This challenge model was then used to investigate the efficacy of live attenuated turkey rhinotracheitis (TRT) vaccine administered alone at 1 day old, or an inactivated TRT vaccine (at 16 weeks), or a combined programme using both vaccines, in protecting against this challenge. Neither the live nor the inactivated vaccine alone protected against clinical signs (respiratory infection or diarrhoea). However, the inactivated, but not the live, vaccine did protect against the effect of the i.v. challenge on laying performance. In contrast, the combined vaccination programme protected completely against both clinical signs and poor egg-laying performance. This protection lasted until at least 60 weeks of age. On the basis of the results with this experimental model, it is concluded that the use of live priming followed by administration of inactivated TRT vaccine is necessary to provide complete protection of laying chickens against APV challenge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Chesher</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Orthel</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Baxendale</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19184850</ArticleId><ArticleId IdType="doi">10.1080/03079450020016788</ArticleId><ArticleId IdType="pii">713651207</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">11007005</PMID><DateCompleted><Year>2001</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2003</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0005-2086</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>3</Issue><PubDate><Year>2000</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Avian diseases</Title><ISOAbbreviation>Avian Dis</ISOAbbreviation></Journal><ArticleTitle>Characterization of infectious bronchitis viruses isolated from outbreaks of disease in commercial flocks in Brazil.</ArticleTitle><Pagination><StartPage>582</StartPage><EndPage>589</EndPage><MedlinePgn>582-9</MedlinePgn></Pagination><Abstract><AbstractText>Fifteen isolations of infectious bronchitis (IB) virus were made from a total of 126 Brazilian poultry flocks of all ages that were examined. These flocks (14 chicken and 1 quail) were experiencing a variety of IB-like conditions including respiratory disease, digestive and kidney problems, and drops in egg production. One of the isolates was of the Massachusetts serotype. The remainder were examined by means of cross-neutralization tests in tracheal organ cultures and were shown to belong to at least four antigenic groups, all different from ones described previously in other countries. Some, but not all, of the flocks from which they were isolated had been vaccinated against IB with vaccines of the Massachusetts serotype. In vivo protection studies showed that the MA5 vaccine (of the Massachusetts serotype) protected well against challenge with four of these isolates, representing the different serotypes reported in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Fabio</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>J F Laboratorio Patolog&#xed;a Animal, Campinas, SP., Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossini</LastName><ForeName>L I</ForeName><Initials>LI</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Malo</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Avian Dis</MedlineTA><NlmUniqueID>0370617</NlmUniqueID><ISSNLinking>0005-2086</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008404" MajorTopicYN="N" Type="Geographic">Massachusetts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010058" MajorTopicYN="N">Oviposition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011784" MajorTopicYN="N">Quail</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>9</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>9</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11007005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10987933</PMID><DateCompleted><Year>2000</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3263</ISSN><JournalIssue CitedMedium="Print"><Volume>65</Volume><Issue>19</Issue><PubDate><Year>2000</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>The Journal of organic chemistry</Title><ISOAbbreviation>J Org Chem</ISOAbbreviation></Journal><ArticleTitle>Semirubin. A novel dipyrrinone strapped by intramolecular hydrogen bonds.</ArticleTitle><Pagination><StartPage>6001</StartPage><EndPage>6008</EndPage><MedlinePgn>6001-8</MedlinePgn></Pagination><Abstract><AbstractText>(4Z)-9-(5-Carboxypentyl)-2,3,7,8-tetramethyl-(10H)-dipyrrin- 1-one (1, semirubin), a new dipyrrinone model for one-half of bilirubin, the yellow-orange neurotoxic pigment of jaundice, was synthesized following Friedel-Crafts acylation of 2,3,7, 8-tetramethyl-(10H)-dipyrrin-1-one (5) with the half-ester acid chloride of adipic acid. Unlike other dipyrrinone models for bilirubin, such as the xanthobilirubic acids, which engage only in intermolecular hydrogen bonding, 1 is unique in having been designed and found to engage in intramolecular hydrogen bonding, between the carboxylic acid and the dipyrrinone lactam and pyrrole. This important conformation-determining structural characteristic, shared by 1 and bilirubin, renders them less polar than their methyl esters and leaves them monomeric in nonpolar solvents, where their esters are dimeric. The corresponding 10-oxo analogue (3) of 1 serves as a model for 10-oxo-bilirubin, a presumed bilirubin metabolite in alternate pathways for bilirubin excretion. Like 1, 3 is found to engage in intramolecular hydrogen bonding. Unlike the methyl ester of 1, the ethyl ester of 3 is not intermolecularly hydrogen bonded in nonpolar solvents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Nevada, Reno, Nevada 89557-0020, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightner</LastName><ForeName>D A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD-17779</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Org Chem</MedlineTA><NlmUniqueID>2985193R</NlmUniqueID><ISSNLinking>0022-3263</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012996">Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C415191">semirubin</NameOfSubstance></Chemical><Chemical><RegistryNumber>RFM9X3LJ49</RegistryNumber><NameOfSubstance UI="D001663">Bilirubin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000215" MajorTopicYN="N">Acylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001663" MajorTopicYN="N">Bilirubin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002855" MajorTopicYN="N">Chromatography, Thin Layer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012996" MajorTopicYN="N">Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013055" MajorTopicYN="N">Spectrophotometry, Infrared</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>9</Month><Day>16</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>9</Month><Day>16</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10987933</ArticleId><ArticleId IdType="doi">10.1021/jo000393k</ArticleId><ArticleId IdType="pii">jo000393k</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10852374</PMID><DateCompleted><Year>2000</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0009-9163</ISSN><JournalIssue CitedMedium="Print"><Volume>57</Volume><Issue>5</Issue><PubDate><Year>2000</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical genetics</Title><ISOAbbreviation>Clin Genet</ISOAbbreviation></Journal><ArticleTitle>Holoprosencephaly, sacral anomalies, and situs ambiguus in an infant with partial monosomy 7q/trisomy 2p and SHH and HLXB9 haploinsufficiency.</ArticleTitle><Pagination><StartPage>388</StartPage><EndPage>393</EndPage><MedlinePgn>388-93</MedlinePgn></Pagination><Abstract><AbstractText>We report an infant with holoprosencephaly (HPE), sacral anomalies, and situs ambiguus with a 46,XY,der(7)t(2;7)(p23.2;q36.1) karyotype as a result of an adjacent-1 segregation of a t(2;7)pat. The chromosomal abnormality was diagnosed prenatally after sonographic detection of HPE in the fetus. The baby was born at 37 weeks gestation, and died in the newborn period; he had dysmorphic features consistent with HPE sequence. Postmortem internal evaluation showed semilobar HPE, abdominal situs ambiguus, multiple segments of bowel atresia, dilatation of the ureters, and bony sacral anomalies. Molecular analysis confirmed hemizygosity for the SHH and HLXB9 genes, which are likely to be responsible for the HPE and sacral phenotypes, respectively. Immunohistochemical studies showed intact dopaminergic pathways in the mesencephalon, suggesting that midbrain dopamine neuron induction appears to require only one functioning SHH allele.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nowaczyk</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, Hamilton Health Sciences Corporation and McMaster University, Canada. nowaczyk@hhsc.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Tomkins</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Ramsay</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Woulfe</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>S W</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Belloni</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Genet</MedlineTA><NlmUniqueID>0253664</NlmUniqueID><ISSNLinking>0009-9163</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509239">SHH protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000015" MajorTopicYN="N">Abnormalities, Multiple</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002889" MajorTopicYN="Y">Chromosomes, Human, Pair 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002897" MajorTopicYN="Y">Chromosomes, Human, Pair 7</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005801" MajorTopicYN="N">Genes, Homeobox</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016142" MajorTopicYN="N">Holoprosencephaly</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017404" MajorTopicYN="N">In Situ Hybridization, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009006" MajorTopicYN="N">Monosomy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011860" MajorTopicYN="N">Radiography, Abdominal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012445" MajorTopicYN="N">Sacrococcygeal Region</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="Y">Trans-Activators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014314" MajorTopicYN="N">Trisomy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>9</Month><Day>30</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10852374</ArticleId><ArticleId IdType="doi">10.1034/j.1399-0004.2000.570510.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10825575</PMID><DateCompleted><Year>2000</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0197-0186</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2000</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurochemistry international</Title><ISOAbbreviation>Neurochem Int</ISOAbbreviation></Journal><ArticleTitle>Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>361</EndPage><MedlinePgn>351-61</MedlinePgn></Pagination><Abstract><AbstractText>Alpha II-spectrin (alpha-fodrin) is a demonstrated endogenous substrate for caspase-3 in neurons undergoing unscheduled apoptotic death. We have previously identified the caspase cleavage site that yields the distinctive 120 kDa spectrin breakdown product (SBDP120) as (DSLD(1478)*SVEAL). Here, by using a synthetic peptide (NH(2)-SVEALC) mimicking the neo-N-terminal of SBDP120 as antigen, we report the development of chicken antibodies that specifically recognize the SBDP120 generated by in vitro caspase-3 digestion of bovine alpha-spectrin on Western blot. These anti-SBDP120 antibodies recognize SBDP120 generated by two apoptotic challenges (staurosporine, EGTA) to human neuroblastoma SH-SY5Y cells. Yet they neither react with intact alpha-spectrin nor its other fragments on Western blots. These anti-SBDP120 work equally well in detecting SBDP120 generated in rat cerebellar granule neurons undergoing potassium withdrawal-induced apoptosis. In immunocytochemical studies, these antibodies also specifically stained apoptotic SH-SY5Y or CGN's undergoing apoptosis in a caspase- inhibitor-sensitive manner. These anti-SBDP120s might become powerful markers for apoptotic neurons in various neurological or neurodegenerative conditions in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Neuro-biochemistry, Department of Neuroscience Therapeutics, Ann Arbor, MI 48105, USA. rathna.nath@wl.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Glantz</LastName><ForeName>S B</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Morrow</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>McGinnis</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nadimpalli</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Wanga</LastName><ForeName>K K</ForeName><Initials>KK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neurochem Int</MedlineTA><NlmUniqueID>8006959</NlmUniqueID><ISSNLinking>0197-0186</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008840">Microfilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>12634-43-4</RegistryNumber><NameOfSubstance UI="D013049">Spectrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505410">Casp3 protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008840" MajorTopicYN="N">Microfilament Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013049" MajorTopicYN="N">Spectrin</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>5</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>5</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10825575</ArticleId><ArticleId IdType="doi">10.1016/s0197-0186(00)00040-1</ArticleId><ArticleId IdType="pii">S0197018600000401</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27266432</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3338</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>1999</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Preliminary antigenic characterization of an avian pneumovirus isolated from commercial turkeys in Colorado, USA.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>617</EndPage><MedlinePgn>607-617</MedlinePgn></Pagination><Abstract><AbstractText>An avian pneumovirus (APV) isolated from turkeys showing respiratory disease in Colorado, USA, shared some characteristics with earlier subgroup A and B APV strains. This virus, designated the Colorado isolate (Colorado), when used after either seven passages in chick embryo fibroblasts (CEF), or seven passages in CEF followed by six turkey passages, induced clinical signs in turkeys that were similar to those caused by earlier APV strains. Although it induced an antibody response in specific pathogen free chickens, clinical signs were not seen. Unlike subgroups A or B, Colorado did not cause ciliostasis in tracheal organ cultures, but produced a cytopathic effect in chick embryo fibroblasts typical of that seen with other APV strains. Monospecific antisera to A or B strains did not neutralize Colorado and vice versa; nor did monoclonal antibodies, which neutralize subgroup A or B strains, neutralize Colorado. However, it was partially neutralized by a subgroup A hyperimmune serum. A homologous enzyme-linked immunosorbent assay (ELISA) antigen was essential for the detection of Colorado antibodies, since ELISAs in which subgroup A or B strains were used detected antibody to Colorado very poorly. Subgroup A and B vaccines protected turkeys against challenge with Colorado. However, while Colorado protected turkeys, and to some extent chickens, against subgroup A strains, protection against a subgroup B challenge was less good in both species. These results indicate that Colorado should be classified as an APV, but the antigenic differences suggest that it does not belong to subgroups A or B, and represents a separate subgroup (subgroup C) or possibly a separate serotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Jane K A</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>a Intervet UK , The Elms, Thicket Road, Houghton , Huntingdon , Cambs. , PE17 2BQ , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>a Intervet UK , The Elms, Thicket Road, Houghton , Huntingdon , Cambs. , PE17 2BQ , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>a Intervet UK , The Elms, Thicket Road, Houghton , Huntingdon , Cambs. , PE17 2BQ , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senne</LastName><ForeName>Dennis A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>b National Veterinary Services Laboratories , P.O. Box 844 , Ames , IA , 50010 , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27266432</ArticleId><ArticleId IdType="doi">10.1080/03079459994407</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10564875</PMID><DateCompleted><Year>1999</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>87</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Prenatal sonographic diagnosis of hypochondroplasia in a high-risk fetus.</ArticleTitle><Pagination><StartPage>226</StartPage><EndPage>229</EndPage><MedlinePgn>226-9</MedlinePgn></Pagination><Abstract><AbstractText>Hypochondroplasia (HCH) is caused by mutations in the fibroblast growth factor receptor type 3 (FGFR 3). Prenatal diagnosis of HCH based exclusively on the sonographic measurements of the fetal skeleton is difficult and has not been reported. We describe a newborn infant with HCH who was born to a mother with achondroplasia (ACH) and a father with HCH. Serial sonographic measurements were recorded from 16 weeks of gestation. All measurements remained normal up to 22 weeks of gestation. At 25 weeks of gestation, the long bones began to appear shorter than expected for gestational age, while the head measurements (biparietal diameter and head circumference) remained normal. The measurements were sufficiently different to distinguish from findings in normal and achondroplastic fetuses. Our findings suggest that it is possible to distinguish the normal fetus from a fetus affected with HCH and to distinguish HCH and ACH from each other based on the sonographic measurements alone. To our knowledge, this is the first report of longitudinal sonographic measurements of HCH in the second and third trimesters.</AbstractText><CopyrightInformation>Copyright 1999 Wiley-Liss, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hamilton Health Sciences Corporation, and McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mernagh</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Nowaczyk</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017468">Receptors, Fibroblast Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C496365">FGFR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D051498">Receptor, Fibroblast Growth Factor, Type 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000130" MajorTopicYN="N">Achondroplasia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005269" MajorTopicYN="N">Femur</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005315" MajorTopicYN="N">Fetal Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010009" MajorTopicYN="N">Osteochondrodysplasias</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011262" MajorTopicYN="N">Pregnancy Trimester, Second</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018566" MajorTopicYN="Y">Pregnancy, High-Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="Y">Protein-Tyrosine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051498" MajorTopicYN="N">Receptor, Fibroblast Growth Factor, Type 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017468" MajorTopicYN="N">Receptors, Fibroblast Growth Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016216" MajorTopicYN="Y">Ultrasonography, Prenatal</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10564875</ArticleId><ArticleId IdType="pii">10.1002/(SICI)1096-8628(19991126)87:3&lt;226::AID-AJMG6&gt;3.0.CO;2-S</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10540198</PMID><DateCompleted><Year>1999</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0009-9104</ISSN><JournalIssue CitedMedium="Print"><Volume>118</Volume><Issue>2</Issue><PubDate><Year>1999</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Clinical and experimental immunology</Title><ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation></Journal><ArticleTitle>Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis.</ArticleTitle><Pagination><StartPage>322</StartPage><EndPage>328</EndPage><MedlinePgn>322-8</MedlinePgn></Pagination><Abstract><AbstractText>SLE is an autoimmune disease characterized by a wide range of anti-cellular and anti-nuclear autoantibodies. Many of these antigens are exposed or altered during apoptosis when the nucleus is dismantled in a controlled manner by caspases. We used Western blotting techniques to demonstrate that autoantibodies in SLE sera recognize antigens released during apoptosis. Reproducible bands, not seen in the untreated cells, with the characteristics of histones were seen when staining apoptotic cell lysates with SLE sera. Normal sera recognized some of these bands but much less strongly. Different triggers of apoptosis did not produce marked differences in the antigens recognized. We also compared different cell lines (Jurkat and U937) and found that the staining differed for one autoantigen in particular. The differential release of autoantigens by apoptotic cells may have relevance to the variety of autoantibodies seen in SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Molecular and Clinical Immunology, School of Clinical Laboratory Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. Mary.Huggins@nottingham.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Cavers</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Pavuluri</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Tighe</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>368GB5141J</RegistryNumber><NameOfSubstance UI="D012967">Sodium Dodecyl Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012967" MajorTopicYN="N">Sodium Dodecyl Sulfate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020298" MajorTopicYN="N">U937 Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2000</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10540198</ArticleId><ArticleId IdType="pmc">PMC1905419</ArticleId><ArticleId IdType="doi">10.1046/j.1365-2249.1999.01063.x</ArticleId><ArticleId IdType="pii">cei1063</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stollar B. The antigenic potential and specificity of nucleic acids, nucleoproteins, and their modified derivatives. Arthritis Rheum. 1981;28:1010&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">6169348</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994;179:1317&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191465</ArticleId><ArticleId IdType="pubmed">7511686</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Miller D, Anhalt G, et al. Specific cleavage of the 70kDa protein component of the U1-small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem. 1994;269:30757&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">7983001</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Anhalt G, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med. 1995;182:1625&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192237</ArticleId><ArticleId IdType="pubmed">7500007</ArticleId></ArticleIdList></Reference><Reference><Citation>Casiano C, Martin S, Green D, et al. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med. 1996;184:765&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192733</ArticleId><ArticleId IdType="pubmed">8760832</ArticleId></ArticleIdList></Reference><Reference><Citation>Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9422506</ArticleId></ArticleIdList></Reference><Reference><Citation>Stemmer C, Muller S. Histone autoantibodies other than (H2A-H2B)-DNA autoantibodies. In: Peter J, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science B. V.; 1996. pp. 373&#x2013;84.</Citation></Reference><Reference><Citation>Fritzler M. Antibodies to histone and the role of the nucleosome. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Baltimore: Williams &amp; Wilkins; 1997. pp. 423&#x2013;41.</Citation></Reference><Reference><Citation>Rubin R. Histone (H2A-H2B)-DNA autoantibodies. In: Peter J, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science BV; 1996. pp. 364&#x2013;71.</Citation></Reference><Reference><Citation>Desai-Mehta A, Mao C, Rajagopalan S, et al. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest. 1995;95:531&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC295507</ArticleId><ArticleId IdType="pubmed">7860735</ArticleId></ArticleIdList></Reference><Reference><Citation>Voll R, Roth E, Girkontaite I, et al. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 1997;40:2162&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416853</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrespines A, Laderach D, Lebosse C, et al. Isolation and characterization of apoptotic nucleosomes, free and complexed with lupus autoantibody generated during hybridoma B cell apoptosis. J Autoimmun. 1998;11:19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9480720</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoura Z, Piette J, Chabre H, et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus&#x2014;correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 1997;40:2217&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416860</ArticleId></ArticleIdList></Reference><Reference><Citation>Subiza JL, Caturla A, Pascual-Salcedo D, et al. DNA&#x2013;anti-DNA complexes account for part of the anti-histone activity found in patients with systemic lupus erythematosus. Arthritis Rheum. 1989;32:406&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">2706026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubler PH, Perrin LH, Greighton WD. Use of polyethylene glycol (PEG) to concentrate immune complexes from serum or plasma samples. Ann Rheum Dis. 1977;36:23&#x2013;25.</Citation></Reference><Reference><Citation>Amoura Z, Piette J-C, Bach J-F, et al. The key role of nucleosomes in lupus. Arthritis Rheum. 1999;42:833&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10323438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustos A, Boimorto R, Subiza J, et al. Inhibition of histone/anti-histone reactivity by histone binding serum components; differential effect on anti-H1 versus anti-H2B antibodies. Clin Exp Immunol. 1994;95:408&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1535099</ArticleId><ArticleId IdType="pubmed">8137538</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Dell JR, Bizar-Schneebaum A, Kotzin BL. In vitro anti-histone antibody production by peripheral blood cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1988;47:343&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">3259482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohda S, Kanayam Y, Okamura M, et al. Clinical significance of antibodies to histones in systemic lupus erythematosus. J Rheumatol. 1989;16:24&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">2785597</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade F, Roy S, Nicholson D, et al. Granzyme-B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity. 1998;8:451&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9586635</ArticleId></ArticleIdList></Reference><Reference><Citation>Treves S, Bajocchi G, Zorzato F, et al. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus. Lupus. 1998;7:479&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">9796851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Savill J. Apoptosis: the importance of being eaten. Cell Death Diff. 1998;5:563&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10200510</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M, Voll R, Zoller D, et al. Impaired phagocytosis apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1241&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9663482</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert M, Pearce S, Francisco L, et al. Immature dendritic cells phagocytose apoptotic cells via &#x3b1;v&#x3b2;5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;7:1359&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212488</ArticleId><ArticleId IdType="pubmed">9763615</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus. 1997;6:175&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">9061666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26911602</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>5</Issue><PubDate><Year>1999</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Breadth of protection of the respiratory tract provided by different live-attenuated infectious bronchitis vaccines against challenge with infectious bronchitis viruses of heterologous serotypes.</ArticleTitle><Pagination><StartPage>477</StartPage><EndPage>485</EndPage><MedlinePgn>477-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03079459994506</ELocationID><Abstract><AbstractText>The regime of administering the infectious bronchitis (IB) Ma5 vaccine (Massachusetts serotype) at 1 day old and the heterologous 4/91 vaccine at 2 weeks of age, was shown to be highly effective in protecting the respiratory tract of specified pathogen free chickens. Protection, as measured by assessing ciliary activity of the tracheal epithelium following challenge, was excellent against challenge at 5 weeks of age with IB strains of many serotypes, isolated from disease outbreaks in different parts of the world. This vaccination protocol was more effective than revaccination with a vaccine of the same serotype as the first vaccine. Furthermore, significantly better protection was seen when the Ma5 vaccine was given before, rather than at the same time as or following, the 4/91 vaccine. It is suggested that the use of these two IB vaccines will frequently broaden the protection possible against challenge with IB isolates of many different serotypes, without the need to develop a new IB vaccine to combat each new IB serotype that emerges.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26911602</ArticleId><ArticleId IdType="doi">10.1080/03079459994506</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10360392</PMID><DateCompleted><Year>1999</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>84</Volume><Issue>5</Issue><PubDate><Year>1999</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Achondroplasia-hypochondroplasia complex in a newborn infant.</ArticleTitle><Pagination><StartPage>396</StartPage><EndPage>400</EndPage><MedlinePgn>396-400</MedlinePgn></Pagination><Abstract><AbstractText>We describe the case of an 8-month-old girl with achondroplasia-hypochondroplasia complex. The diagnosis was suggested antenatally when obstetrical ultrasonography at 27 weeks of gestation showed short limbs, small chest, and macrocephaly. The father has achondroplasia due to the common G1138A (G380R) mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, while the mother has hypochondroplasia due to the C1620G (N450K) mutation in the FGFR3 gene. Neither had had genetic counseling or molecular testing prior to the pregnancy. Antenatal ultrasound study at 29 weeks of gestation showed a large head, very short limbs, and a small chest; the findings were more severe than in achondroplasia or hypochondroplasia alone. The patient was born by cesarean section at 37 weeks of gestation and had rhizomelic shortness of limbs with excess skin creases, large head, and small chest, diagnostic of achondroplasia. Radiographs showed shortness of the long bones and flaring of the metaphyses. She had mild hypoplasia of lungs. Molecular testing showed both the G1138A and the C1620G mutations in FGFR3, confirming the diagnosis of achondroplasia-hypochondroplasia complex. At 8 months, she has disproportionate shortness of the long bones and a large head with frontal bossing and a depressed nasal bridge. Her chest remains small, and she is on home oxygen at times of respiratory stress. She has a large gibbus. She is delayed in her motor development and has significant head lag. To our knowledge, there is only one previously published report of achondroplasia-hypochondroplasia complex.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Hamilton Health Sciences Corporation, Ontario, Canada. hugginsm@exchange1.cmh.on.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>P N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>D T</ForeName><Initials>DT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017468">Receptors, Fibroblast Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C496365">FGFR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D051498">Receptor, Fibroblast Growth Factor, Type 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000015" MajorTopicYN="N">Abnormalities, Multiple</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000130" MajorTopicYN="N">Achondroplasia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001842" MajorTopicYN="N">Bone and Bones</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010009" MajorTopicYN="N">Osteochondrodysplasias</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="Y">Protein-Tyrosine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051498" MajorTopicYN="N">Receptor, Fibroblast Growth Factor, Type 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017468" MajorTopicYN="N">Receptors, Fibroblast Growth Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016216" MajorTopicYN="N">Ultrasonography, Prenatal</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>6</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>6</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>6</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10360392</ArticleId><ArticleId IdType="pii">10.1002/(SICI)1096-8628(19990611)84:5&lt;396::AID-AJMG2&gt;3.0.CO;2-L</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10053020</PMID><DateCompleted><Year>1999</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Mar</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>The duty to recontact: attitudes of genetics service providers.</ArticleTitle><Pagination><StartPage>852</StartPage><EndPage>860</EndPage><MedlinePgn>852-60</MedlinePgn></Pagination><Abstract><AbstractText>The term "duty to recontact" refers to the possible ethical and/or legal obligation of genetics service providers (GSPs) to recontact former patients about advances in research that might be relevant to them. Although currently this practice is not part of standard care, some argue that such an obligation may be established in the future. Little information is available, however, on the implications of this requirement, from the point of view of GSPs. To explore the opinions of genetics professionals on this issue, we sent a self-administered questionnaire to 1,000 randomly selected U.S. and Canadian members of the American Society of Human Genetics. We received 252 completed questionnaires. The major categories of respondents were physician geneticist (41%), Ph.D. geneticist (30%), and genetic counselor (18%); 72% of the total stated that they see patients. Respondents indicated that responsibility for staying in contact should be shared between health professionals and patients. Respondents were divided about whether recontacting patients should be the standard of care: 46% answered yes, 43% answered no, and 11% did not know. Those answering yes included 44% of physician geneticists, 53% of Ph.D. geneticists, and 31% of genetic counselors; answers were statistically independent of position or country of practice but were dependent on whether the respondent sees patients (43% answered yes) or not (54% answered yes). There also was a lack of consensus about the possible benefits and burdens of recontacting patients and about various alternative methods of informing patients about research advances. Analysis of qualitative data suggested that most respondents consider recontacting patients an ethically desirable, but not feasible, goal. Points to consider in the future development of guidelines for practice are presented.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Division of Human Genetics, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Hum Genet. 1999 Oct;65(4):1201-4. doi: 10.1086/302587.</RefSource><PMID Version="1">10486341</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017007" MajorTopicYN="Y">Duty to Warn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004992" MajorTopicYN="Y">Ethics, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005826" MajorTopicYN="N">Genetics, Medical</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009456" MajorTopicYN="N">Neurofibromatosis 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">105747</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="N">Empirical Approach</Keyword><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1999</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10053020</ArticleId><ArticleId IdType="pmc">PMC1377803</ArticleId><ArticleId IdType="doi">10.1086/302293</ArticleId><ArticleId IdType="pii">S0002-9297(07)61723-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Behav Sci Law. 1996 Autumn;14(4):393-410</Citation><ArticleIdList><ArticleId IdType="pubmed">9156420</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1997 Oct;61(4):945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9382108</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Genet. 1985 Feb;27(2):199-205</Citation><ArticleIdList><ArticleId IdType="pubmed">3978857</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1996 Oct;59(4):A335</Citation><ArticleIdList><ArticleId IdType="pubmed">11644832</ArticleId></ArticleIdList></Reference><Reference><Citation>South Med J. 1980 Aug;73(8):1041-3, 1045</Citation><ArticleIdList><ArticleId IdType="pubmed">7403915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1996 Oct 12;348(9033):1005-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8855863</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1991 Jun 1;39(3):347-54</Citation><ArticleIdList><ArticleId IdType="pubmed">1867289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale J Biol Med. 1991 Jan-Feb;64(1):29-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1897258</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1993 Aug 15;47(2):257-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8213916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1993 Nov 27;342(8883):1317-22</Citation><ArticleIdList><ArticleId IdType="pubmed">7901634</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1994 Apr 15;50(3):234-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8042666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10025597</PMID><DateCompleted><Year>1999</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0961-2033</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>1999</Year></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>38</EndPage><MedlinePgn>29-38</MedlinePgn></Pagination><Abstract><AbstractText>We have investigated the effects of interleukin-2 (IL-2) and transforming growth factor-beta (TGF-beta) gene therapy on the progress of autoimmune disease in MRL-lpr/lpr mice, a murine model of systemic lupus erythematosus (SLE). These mice have uncontrolled proliferation of T cells, an impaired response to T cell mitogen and produce autoantibodies against nuclear antigens, including DNA. Immune complexes formed by these autoantibodies are believed to cause glomerulonephritis and vasculitis in lupus mice and human SLE. Since there is an imbalance of cytokine production in both SLE patients and lupus mice, we examined the effects of cytokine gene therapy on the progression of autoimmune disease in MRL-lpr/lpr mice. The mice were treated orally with a non-pathogenic strain of Salmonella typhimurium bearing the aroA-aroD- mutations and carrying the murine genes encoding IL-2 and TGF-beta. The bacteria synthesise and slowly release the cytokines in vivo. Our results show that, contrary to expectation, TGF-beta gene therapy produced no improvement in pathology and generally had opposite effects to those of IL-2. IL-2 gene therapy restored the defective T cell proliferative response to mitogen and suppressed the autoantibody response, glomerulonephritis and growth of lymphoid tumours.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Immunology, University of Glasgow, Western Infirmary, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>F P</ForeName><Initials>FP</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lindop</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Stott</LastName><ForeName>D I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="Y">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007376" MajorTopicYN="N">Interleukin-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>2</Month><Day>20</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>2</Month><Day>20</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10025597</ArticleId><ArticleId IdType="doi">10.1191/096120399678847308</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9782438</PMID><DateCompleted><Year>1998</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0191-3913</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>1998</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Journal of pediatric ophthalmology and strabismus</Title><ISOAbbreviation>J Pediatr Ophthalmol Strabismus</ISOAbbreviation></Journal><ArticleTitle>Deletion 3q in two patients with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>276</EndPage><MedlinePgn>271-6</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant condition mapped to chromosome 3q23. There are several reports of chromosomal abnormalities involving this region with a resultant phenotype that includes BPES.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We reassessed two unrelated boys ages 3 and 5 with BPES and associated nonocular abnormalities. Karyotype, which had been previously reported as normal, was repeated using high-resolution banding techniques, to look specifically at 3q23. Clinical findings were tabulated and compared with previously reported cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both patients proved to have interstitial deletions of chromosome 3, the first involving bands q22.2q25.1 and the second q22.2q24. The first patient exhibited prenatal and postnatal growth retardation, with global developmental delay, while the second patient had normal growth and development except for speech delay. Both had dysmorphic facies with BPES, flat philtrum, a thin upper lip, and small chin. In addition, the first boy had an inguinal hernia and hypospadius; the second boy had abnormal auricles and metatarsus adductus. The eight cases of interstitial deletions of 3q2 and six rearrangements involving this region have a remarkably similar phenotype.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Deletion of 3q23 is a recognizable contiguous gene syndrome. Microdeletions of 3q23 should be ruled out in any sporadic case of BPES especially if there are associated nonocular abnormalities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pashby</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Teshima</LastName><ForeName>I E</ForeName><Initials>IE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Ophthalmol Strabismus</MedlineTA><NlmUniqueID>7901143</NlmUniqueID><ISSNLinking>0191-3913</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016569" MajorTopicYN="N">Blepharophimosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001763" MajorTopicYN="N">Blepharoptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002872" MajorTopicYN="Y">Chromosome Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002893" MajorTopicYN="Y">Chromosomes, Human, Pair 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005143" MajorTopicYN="N">Eyelids</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007621" MajorTopicYN="N">Karyotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9782438</ArticleId><ArticleId IdType="doi">10.3928/0191-3913-19980901-06</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9682393</PMID><DateCompleted><Year>1998</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0264-410X</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>13</Issue><PubDate><Year>1998</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host.</ArticleTitle><Pagination><StartPage>1290</StartPage><EndPage>1298</EndPage><MedlinePgn>1290-8</MedlinePgn></Pagination><Abstract><AbstractText>The objectives of this work were to clone and express Chinese strain Schistosoma japonicum antigens and evaluate their immunogenicity and protective efficacy in the natural ovine host in China. Recombinant antigens selected for testing were: isoforms of glutathione S-transferase Sj28GST and Sj26GST; the large hydrophilic domain of Sj23, the homologue of the protective S. mansoni membrane antigen Sm23; and a 3' fragment of S. japonicum paramyosin. In addition, Chinese strain S. japonicum native paramyosin and GST were purified and used for vaccination. Antigens were co-administered with Freund's adjuvants or BCG. We also examined the effects of co-administration of native unfractionated GSTs with keyhole limpet haemocyanin (KLH), which shares a cross-reactive protective epitope with schistosomes. These are the first side-by-side comparisons of candidate defined-antigen schistosomiasis vaccines in a natural host. Significant partial protection was obtained with each of the antigens tested. Less protection was obtained with a recombinant fragment of S. japonicum paramyosin compared with native paramyosin. Co-administration of native GST and KLH was no more effective than vaccination with either antigen alone. Although encouraging levels of protection against S. japonicum were demonstrated using each of these antigens, further work is needed to optimise vaccine delivery and vaccination schedules.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>M G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>C G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>B F</ForeName><Initials>BF</Initials></Author><Author ValidYN="Y"><LastName>Bickle</LastName><ForeName>Q D</ForeName><Initials>QD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015801">Helminth Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014335">Tropomyosin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance></Chemical><Chemical><RegistryNumber>9013-72-3</RegistryNumber><NameOfSubstance UI="D006433">Hemocyanins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>FV4Y0JO2CX</RegistryNumber><NameOfSubstance UI="C032808">keyhole-limpet hemocyanin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015801" MajorTopicYN="Y">Helminth Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006433" MajorTopicYN="N">Hemocyanins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010270" MajorTopicYN="N">Parasite Egg Count</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012549" MajorTopicYN="N">Schistosoma japonicum</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012554" MajorTopicYN="N">Schistosomiasis japonica</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012757" MajorTopicYN="N">Sheep Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014335" MajorTopicYN="N">Tropomyosin</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9682393</ArticleId><ArticleId IdType="doi">10.1016/s0264-410x(98)00055-3</ArticleId><ArticleId IdType="pii">S0264410X98000553</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9186709</PMID><DateCompleted><Year>1997</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0077-8923</ISSN><JournalIssue CitedMedium="Print"><Volume>815</Volume><PubDate><Year>1997</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Annals of the New York Academy of Sciences</Title><ISOAbbreviation>Ann N Y Acad Sci</ISOAbbreviation></Journal><ArticleTitle>Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-beta genes.</ArticleTitle><Pagination><StartPage>499</StartPage><EndPage>502</EndPage><MedlinePgn>499-502</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>University Department of Immunology, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>F P</ForeName><Initials>FP</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lindop</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Stott</LastName><ForeName>D I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann N Y Acad Sci</MedlineTA><NlmUniqueID>7506858</NlmUniqueID><ISSNLinking>0077-8923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007376" MajorTopicYN="N">Interleukin-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>4</Month><Day>5</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>4</Month><Day>5</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9186709</ArticleId><ArticleId IdType="doi">10.1111/j.1749-6632.1997.tb52114.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="KIE" IndexingMethod="Manual"><PMID Version="1">11644832</PMID><DateCompleted><Year>1999</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>1996</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Staying informed and recontacting patients about research advances: a study of patient attitudes.</ArticleTitle><Pagination><StartPage>A335</StartPage><MedlinePgn>A335</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="Y">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030881" MajorTopicYN="Y">Disclosure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033002" MajorTopicYN="Y">Duty to Recontact</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005817" MajorTopicYN="Y">Genetic Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030342" MajorTopicYN="N">Genetic Diseases, Inborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036281" MajorTopicYN="Y">Genetic Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005823" MajorTopicYN="Y">Genetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="Y">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="Y">Patients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">60094</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword><Keyword MajorTopicYN="N">Empirical Approach</Keyword><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword><Keyword MajorTopicYN="N">Toronto</Keyword></KeywordList><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic counseling</GeneralNote><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic research</GeneralNote><GeneralNote Owner="KIE">Abstract</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>11</Month><Day>2</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11644832</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18645855</PMID><DateCompleted><Year>2009</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2008</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>1996</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>An experimental turkey rhinotracheitis (TRT) infection in breeding turkeys and the prevention of its clinical effects using live-attenuated and inactivated TRT vaccines.</ArticleTitle><Pagination><StartPage>231</StartPage><EndPage>243</EndPage><MedlinePgn>231-43</MedlinePgn></Pagination><Abstract><AbstractText>The experimental inoculation of 38-week-old turkey hens with a pool of field isolates of turkey rhinotracheitis virus (TRTV) induced a marked respiratory infection and a substantial drop in egg production. Administration of a live-attenuated TRT vaccine at 1 week of age did not protect the layers against respiratory infection, but provided good protection against the effects of challenge on laying performance. However, a combination of live priming followed by injection of inactivated vaccine provided excellent protection against both respiratory infection and drops in egg production.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Intervet UK, The Elms, The Thicket, Houghton, Huntingdon, Cambridgeshire, PE17 2BQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orthel</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18645855</ArticleId><ArticleId IdType="doi">10.1080/03079459608419138</ArticleId><ArticleId IdType="pii">784694740</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8688865</PMID><DateCompleted><Year>1996</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0943-0938</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>1996</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Applied parasitology</Title><ISOAbbreviation>Appl Parasitol</ISOAbbreviation></Journal><ArticleTitle>Lung eosinophilia in response to intravenously injected Trichinella spiralis.</ArticleTitle><Pagination><StartPage>87</StartPage><EndPage>95</EndPage><MedlinePgn>87-95</MedlinePgn></Pagination><Abstract><AbstractText>Mice were injected intravenously with killed muscle-stage larvae of the parasitic nematode Trichinella spiralis. This induced eosinophilic lung inflammation, the degree of eosinophilia was detected and measured by broncho-alveolar lavage. Subsequent in vivo restimulation by Trichinella antigens produced an enhanced lung response, showing that exposure to killed larvae generated an effective immunological memory. The kinetics and characteristics of the eosinophil response suggested that it was locally rather than systemically controlled. This conclusion is based on the fact that, in contrast to the situation seen after oral infection with T. spiralis, there was little change in bone marrow eosinophilopoiesis, blood eosinophil numbers or in serum interleukin-5 levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Life Science, University of Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakelin</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Parasitol</MedlineTA><NlmUniqueID>9308726</NlmUniqueID><ISSNLinking>0943-0938</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015848">Interleukin-5</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001853" MajorTopicYN="N">Bone Marrow</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004802" MajorTopicYN="N">Eosinophilia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015848" MajorTopicYN="N">Interleukin-5</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017160" MajorTopicYN="N">Trichinella spiralis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014235" MajorTopicYN="N">Trichinellosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8688865</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8677618</PMID><DateCompleted><Year>1996</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-4900</ISSN><JournalIssue CitedMedium="Print"><Volume>138</Volume><Issue>8</Issue><PubDate><Year>1996</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>The Veterinary record</Title><ISOAbbreviation>Vet Rec</ISOAbbreviation></Journal><ArticleTitle>A survey of the presence of a new infectious bronchitis virus designated 4/91 (793B).</ArticleTitle><Pagination><StartPage>178</StartPage><EndPage>180</EndPage><MedlinePgn>178-80</MedlinePgn></Pagination><Abstract><AbstractText>On the basis of virus isolation and the demonstration of specific neutralising antibody in sera, infectious bronchitis virus (IBV) 4/91 (commonly called 793B) has been shown to be present in broiler, breeder and layer flocks of chickens in many parts of western Europe and also in Thailand and Mexico. These flocks had all been vaccinated against infectious bronchitis and the need for improved methods to control this new virus, still prevalent at least four years after it was first isolated, is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Intervet UK, The Elms, Houghton, Huntingdon, Cambridgeshire.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vet Rec</MedlineTA><NlmUniqueID>0031164</NlmUniqueID><ISSNLinking>0042-4900</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>2</Month><Day>24</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>2</Month><Day>24</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8677618</ArticleId><ArticleId IdType="doi">10.1136/vr.138.8.178</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7553141</PMID><DateCompleted><Year>1995</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0376-2491</ISSN><JournalIssue CitedMedium="Print"><Volume>75</Volume><Issue>6</Issue><PubDate><Year>1995</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Zhonghua yi xue za zhi</Title><ISOAbbreviation>Zhonghua Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Isolation and expression of recombinant diagnostic antigen gene of Schistosoma japonicum].</ArticleTitle><Pagination><StartPage>329</StartPage><EndPage>381</EndPage><MedlinePgn>329-32, 381</MedlinePgn></Pagination><Abstract><AbstractText>The sera of patients with chronic infection of Schistosoma japonicum (Sj) were used for screening the cDNA expression library constructed from Sj adult worm, and an antigen-positive clone Sjgt4 which expressed an 148 KD fusion protein was identified. The inserted Sj cDNA fragment was amplified by PCR and subcloned into the vector pGEX with high level of expression. A positive clone SjpG5 which expressed a fusion protein with a molecular weight of 58 KD was obtained. When the fusion protein was used for detection of Sj patients' sera by Western blot, 24 out of 25 sera were positive, a positive rate of 96%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Nanjing Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7511141</NlmUniqueID><ISSNLinking>0376-2491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017238" MajorTopicYN="Y">Genes, Helminth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="Y">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012549" MajorTopicYN="N">Schistosoma japonicum</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012554" MajorTopicYN="N">Schistosomiasis japonica</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7553141</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7604520</PMID><DateCompleted><Year>1995</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-4900</ISSN><JournalIssue CitedMedium="Print"><Volume>136</Volume><Issue>15</Issue><PubDate><Year>1995</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>The Veterinary record</Title><ISOAbbreviation>Vet Rec</ISOAbbreviation></Journal><ArticleTitle>Protection provided by a commercially available vaccine against different strains of turkey rhinotracheitis virus.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>393</EndPage><MedlinePgn>392-3</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Intervet UK Ltd., Huntingdon, Cambridgeshire.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Mockett</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vet Rec</MedlineTA><NlmUniqueID>0031164</NlmUniqueID><ISSNLinking>0042-4900</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018111" MajorTopicYN="N">Pneumovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018186" MajorTopicYN="N">Pneumovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014422" MajorTopicYN="N">Turkeys</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>4</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>4</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7604520</ArticleId><ArticleId IdType="doi">10.1136/vr.136.15.392</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7630385</PMID><DateCompleted><Year>1995</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0166-6851</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>1</Issue><PubDate><Year>1995</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Molecular and biochemical parasitology</Title><ISOAbbreviation>Mol Biochem Parasitol</ISOAbbreviation></Journal><ArticleTitle>Cloning of a Schistosoma japonicum gene encoding an antigen with homology to calreticulin.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>87</EndPage><MedlinePgn>81-7</MedlinePgn></Pagination><Abstract><AbstractText>A recombinant lambda gt11 clone, IVGS3, encoding part of a 55-kDa antigen was isolated from an adult Schistosoma japonicum cDNA library. The protein expressed by this clone was recognised strongly by serum from rats that had been vaccinated with irradiated cercariae (VrS) rendering them highly immune to a challenge infection. Antibodies in VrS which were specific for IVGS3 did not recognise adult worm antigens of S. mansoni, suggesting that the recombinant antigen contains species-specific epitopes, although IVGS3 was weakly recognised by rat serum raised against irradiated S. mansoni cercariae, indicating the presence of a related antigen in this species. A further clone, AM1(p), was obtained which, together with IVGS3 encompasses the entire coding region of the gene which has been called Sj55. Sequence analysis revealed similarities with murine calreticulin, a protein resident in the endoplasmic reticulum. As with murine calreticulin, Sj55 was shown to be a calcium-binding protein. Antigens with homologies to calreticulin have also been described in two other helminths, S. mansoni and Onchocerca volvulus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbs</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Moloney</LastName><ForeName>N A</ForeName><Initials>NA</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>M80524</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biochem Parasitol</MedlineTA><NlmUniqueID>8006324</NlmUniqueID><ISSNLinking>0166-6851</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037282">Calreticulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015801">Helminth Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094889">RAL-1 protein, Schistosoma japonicum</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012261">Ribonucleoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002135" MajorTopicYN="N">Calcium-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037282" MajorTopicYN="N">Calreticulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017238" MajorTopicYN="N">Genes, Helminth</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015801" MajorTopicYN="N">Helminth Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012261" MajorTopicYN="N">Ribonucleoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012549" MajorTopicYN="N">Schistosoma japonicum</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7630385</ArticleId><ArticleId IdType="doi">10.1016/0166-6851(95)00038-3</ArticleId><ArticleId IdType="pii">0166685195000383</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7641528</PMID><DateCompleted><Year>1995</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0361-4336</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>1995</Year></PubDate></JournalIssue><Title>Children today</Title><ISOAbbreviation>Child Today</ISOAbbreviation></Journal><ArticleTitle>Healthy Child Care America campaign: you can make a difference in your community.</ArticleTitle><Pagination><StartPage>11</StartPage><EndPage>13</EndPage><MedlinePgn>11-3</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Child Today</MedlineTA><NlmUniqueID>0320227</NlmUniqueID><ISSNLinking>0361-4336</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002662" MajorTopicYN="Y">Child Health Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002669" MajorTopicYN="Y">Child Welfare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7641528</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7927727</PMID><DateCompleted><Year>1994</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-9567</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><Issue>10</Issue><PubDate><Year>1994</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection and immunity</Title><ISOAbbreviation>Infect Immun</ISOAbbreviation></Journal><ArticleTitle>Host specificity of Salmonella infection in chickens and mice is expressed in vivo primarily at the level of the reticuloendothelial system.</ArticleTitle><Pagination><StartPage>4602</StartPage><EndPage>4610</EndPage><MedlinePgn>4602-10</MedlinePgn></Pagination><Abstract><AbstractText>By experimental infection, host-specific Salmonella serotypes were shown to demonstrate specificities for chickens, mice, and other laboratory animals. Following oral inoculation, four strains of Salmonella gallinarum and two S. pullorum strains, isolated from diseased poultry, were more virulent for chickens than for mice. By contrast, four strains each of S. choleraesuis and S. dublin, isolated from diseased pigs and cattle, respectively, were more virulent for mice than for chickens. These results were also reflected in the degree of virulence expressed after parenteral inoculation. In addition, S. choleraesuis, but not other serotypes, killed rats, guinea pigs, and rabbits. S. typhimurium strains varied widely in their virulence, and some strains were virulent for both mice and chickens. Four other serotypes isolated from poultry or human food poisoning cases and a nonpathogenic Escherichia coli strain were much less virulent for both experimental host species. Most of the host-specific Salmonella serotypes studied were able to colonize the distal alimentary tract and invade the tissues in both mice and chickens to various degrees. There was, however, a greater difference in the ability to survive and multiply in the visceral organs, particularly the spleen and the liver, once invasion had occurred which correlated with the virulence for the host species involved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barrow</LastName><ForeName>P A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Houghton Laboratory, AFRC Institute for Animal Health, Huntingdon, Cambridgeshire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Lovell</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Immun</MedlineTA><NlmUniqueID>0246127</NlmUniqueID><ISSNLinking>0019-9567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012157" MajorTopicYN="N">Mononuclear Phagocyte System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012475" MajorTopicYN="N">Salmonella</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012481" MajorTopicYN="N">Salmonella Infections, Animal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1994</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7927727</ArticleId><ArticleId IdType="pmc">PMC303149</ArticleId><ArticleId IdType="doi">10.1128/iai.62.10.4602-4610.1994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Immunology. 1965 Jul;9(1):67-73</Citation><ArticleIdList><ArticleId IdType="pubmed">5320256</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1965 Mar;63:117-35</Citation><ArticleIdList><ArticleId IdType="pubmed">14271921</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1967 Feb;46(2):247-53</Citation><ArticleIdList><ArticleId IdType="pubmed">6029733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol Bacteriol. 1967 Jan;93(1):141-56</Citation><ArticleIdList><ArticleId IdType="pubmed">6029752</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Microbiol. 1968 Nov;1(2):203-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4917364</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Microbiol. 1968 Aug;1(1):45-59</Citation><ArticleIdList><ArticleId IdType="pubmed">4918220</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1970 Dec;64(3):255-68</Citation><ArticleIdList><ArticleId IdType="pubmed">4930444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1979 Feb;82(1):95-100</Citation><ArticleIdList><ArticleId IdType="pubmed">570201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1982 Jun 10;297(5866):506-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7045675</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1982 Sep;146(3):322-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7108281</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1980 Jun;84(3):479-88</Citation><ArticleIdList><ArticleId IdType="pubmed">7052226</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1985 Oct;95(2):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">3905956</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Microbiol. 1986 May;21(3):239-43</Citation><ArticleIdList><ArticleId IdType="pubmed">3009818</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1987 Feb;55(2):388-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3804442</ArticleId></ArticleIdList></Reference><Reference><Citation>Res Vet Sci. 1987 Mar;42(2):194-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3296063</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1987 Dec;55(12):2891-901</Citation><ArticleIdList><ArticleId IdType="pubmed">3316027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1988 Jul;107(1):221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">3292541</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Poult Sci. 1988 Sep;29(3):521-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3066449</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 1989 Apr;102(2):239-52</Citation><ArticleIdList><ArticleId IdType="pubmed">2522883</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1989 Jul;86(13):5173-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2662196</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1988 Aug;134(8):2307-16</Citation><ArticleIdList><ArticleId IdType="pubmed">3253408</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1989 Aug;86(16):6383-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2548211</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1989 Oct;57(10):3136-41</Citation><ArticleIdList><ArticleId IdType="pubmed">2674016</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1991 Sep;59(9):2901-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1879916</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 1992 Jun;174(11):3587-92</Citation><ArticleIdList><ArticleId IdType="pubmed">1592813</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 1992 Jun;174(12):3945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1317843</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1992 Jul;60(7):2758-68</Citation><ArticleIdList><ArticleId IdType="pubmed">1612743</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 1992 Jul;174(13):4338-49</Citation><ArticleIdList><ArticleId IdType="pubmed">1624429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Microbiol. 1993 Jan;7(1):89-98</Citation><ArticleIdList><ArticleId IdType="pubmed">8382333</ArticleId></ArticleIdList></Reference><Reference><Citation>Microb Pathog. 1992 Sep;13(3):181-90</Citation><ArticleIdList><ArticleId IdType="pubmed">1291841</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Microbiol. 1993 Mar;38(3):171-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8455187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Microbiol. 1993 Mar;7(6):825-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8483415</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comp Pathol. 1955 Jan;65(1):37-54</Citation><ArticleIdList><ArticleId IdType="pubmed">13233365</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Rec. 1961 Dec 2;73:1284-96</Citation><ArticleIdList><ArticleId IdType="pubmed">13898406</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1966 Oct 1;124(4):601-19</Citation><ArticleIdList><ArticleId IdType="pubmed">5922286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8074163</PMID><DateCompleted><Year>1994</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>1994</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Mood Disorder Service Genetic Database: morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II.</ArticleTitle><Pagination><StartPage>132</StartPage><EndPage>140</EndPage><MedlinePgn>132-40</MedlinePgn></Pagination><Abstract><AbstractText>There is increasing evidence that genetic factors play a role in the etiology of mood disorders. As a result, relatives of affected individuals are more often asking about their own risks to develop a mood disorder. From 1988 to 1990, all consecutive, unrelated inpatients and outpatients (index cases) presenting to the Mood Disorders Service, Department of Psychiatry, University of British Columbia, had detailed family histories taken, thus creating the Mood Disorders Service Genetic Database. Diagnoses for index cases and their first-degree relatives were made according to Research Diagnostic Criteria and Family History Research Diagnostic Criteria respectively. Morbidity risks for mood disorders were calculated for first-degree relatives (parents, siblings, children--aged 10 and above) of all index cases with a diagnosis of single depression, recurrent depression, bipolar I, or bipolar II disorder. Morbidity risks were calculated using the maximum likelihood approach. Morbidity risk data are presented according to the sex and diagnosis for the index case in an easy reference format for risk counselling. The risks are presented twice, including and excluding data for "high-risk" families whose genetic pedigree is suggestive of "autosomal dominant" inheritance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadovnick</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remick</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Zis</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Yee</LastName><ForeName>I M</ForeName><Initials>IM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Baird</LastName><ForeName>P A</ForeName><Initials>PA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>6</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>6</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8074163</ArticleId><ArticleId IdType="doi">10.1002/ajmg.1320540208</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7825230</PMID><DateCompleted><Year>1995</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0041-3232</ISSN><JournalIssue CitedMedium="Print"><Volume>46</Volume><Issue>4 Spec No</Issue><PubDate><Year>1994</Year></PubDate></JournalIssue><Title>Tropical and geographical medicine</Title><ISOAbbreviation>Trop Geogr Med</ISOAbbreviation></Journal><ArticleTitle>Evaluation of defined antigen vaccines against Schistosoma bovis and S. japonicum in bovines.</ArticleTitle><Pagination><StartPage>255</StartPage><EndPage>258</EndPage><MedlinePgn>255-8</MedlinePgn></Pagination><Abstract><AbstractText>Our objective is to contribute to the development of defined antigen vaccines for schistosomiasis by evaluating the protective efficacy of Schistosoma bovis and S. japonicum antigens in their natural bovine hosts. Antigens under evaluation include some already identified as vaccine candidates: glutathione S-transferases (GSTs); KLH, which shares protective epitopes with the protective antigen GP38 of S. mansoni; and Sj23, the analogue of the vaccine candidate Sm23 antigen. In another approach, since crude freeze/thaw schistosomular antigen plus BCG(F/T vaccine) has proved protective against S. japonicum in bovines, as it was against S. mansoni in mice, we are carrying out further evaluations both of this crude antigen and of recombinant-derived paramyosins. In a third line of work, novel vaccine candidate antigens identified by screening our cDNA libraries with various passively protective animal sera are being evaluated in animal experiments. In the Sudan we have shown that vaccination of calves with either native S. bovis GSTs or KLH induces high levels of fecundity-suppression without causing a significant reduction in adult worm recoveries. Therefore, recombinant-derived S. bovis 28kD GST is now being evaluated, as are the effects of combined GST/KLH vaccination. In China, sheep have been vaccinated with either S. japonicum GSTs, with KLH, or with the F/T vaccine, as a prelude to trials in bovines. As judged by adult worm recoveries, each type of vaccine induced significant protection, and there was also evidence, particularly with the GST and F/T vaccines, of fecundity-suppressive effects. As with the S. bovis/cattle system therefore, both GST and KLH showed protective effects against S. japonicum in sheep.(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Veterinary Science, University of Khartoum, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bickle</LastName><ForeName>Q</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Bushara</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Moloney</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Trop Geogr Med</MedlineTA><NlmUniqueID>0376231</NlmUniqueID><ISSNLinking>0041-3232</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002418" MajorTopicYN="N">Cattle Diseases</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012549" MajorTopicYN="N">Schistosoma japonicum</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012552" MajorTopicYN="N">Schistosomiasis</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012757" MajorTopicYN="N">Sheep Diseases</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>31</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7825230</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7800764</PMID><DateCompleted><Year>1995</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0741-5206</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>1994</Year><Season>Spring</Season></PubDate></JournalIssue><Title>Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses</Title><ISOAbbreviation>Plast Surg Nurs</ISOAbbreviation></Journal><ArticleTitle>Intercultural communication.</ArticleTitle><Pagination><StartPage>47</StartPage><EndPage>53</EndPage><MedlinePgn>47-9, 53</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Plast Surg Nurs</MedlineTA><NlmUniqueID>8403490</NlmUniqueID><ISSNLinking>0741-5206</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004645" MajorTopicYN="N">Empathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007697" MajorTopicYN="N">Kinesics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016746" MajorTopicYN="Y">Transcultural Nursing</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7800764</ArticleId><ArticleId IdType="doi">10.1097/00006527-199403000-00013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18671059</PMID><DateCompleted><Year>2009</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>1993</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>A comparison of three serological methods to detect chicken and turkey antibodies to avian nephritis virus and the use of virus-specific monoclonal antibodies.</ArticleTitle><Pagination><StartPage>751</StartPage><EndPage>770</EndPage><MedlinePgn>751-70</MedlinePgn></Pagination><Abstract><AbstractText>Avian nephritis virus (ANV) strain G-4260 was inoculated orally in to 1-day-old and 3-week-old chickens and the sequential antibody response to the virus was monitored by serum neutralization, ELISA and immunofluorescence tests. The order of sensitivity of the serological tests was in the sequence given above, with the neutralization test being by far the most sensitive. There was no obvious difference in the antibody titres produced by either age group. Virus was recovered from kidney tissue, the highest titres being obtained 3 to 5 days post-inoculation. Histological examination revealed mainly lymphocytic infiltration of the interstitium and degenerative changes in the tubular epithelium of the kidney. The G-4260 strain of ANV was given orally to 1-day-old turkey poults, but no serological response was induced. Virus was not recovered from the kidneys and no histological lesions were produced in this organ. Monoclonal antibodies were produced which neutralized the infectivity of ANV. An antigen trap ELISA was developed using a monoclonal antibody and infected chicken kidney tissue cultures. However, this assay did not detect ANV in kidney samples taken directly from infected chickens, with the exception of one sample which was shown to contain the highest concentration of infectious virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mockett</LastName><ForeName>A P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Internet UK, Houghton, Cambs, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Orbell</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18671059</ArticleId><ArticleId IdType="doi">10.1080/03079459308418962</ArticleId><ArticleId IdType="pii">784665988</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8230594</PMID><DateCompleted><Year>1993</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>270</Volume><Issue>19</Issue><PubDate><Year>1993</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.</ArticleTitle><Pagination><StartPage>2321</StartPage><EndPage>2325</EndPage><MedlinePgn>2321-5</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess attitudes toward, and projected utilization of, direct mutation testing by individuals at risk for Huntington disease (HD).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prior to the cloning of the gene for HD, a questionnaire concerning the use of a definitive test was constructed and mailed to 354 participants in the Canadian Collaborative Study for HD. Completed questionnaires were received from 250 participants (response rate, 71%). Persons were asked to indicate whether they would participate in a new predictive test that was either 100% accurate (the definitive test, requiring blood only from the proband) or only 99% accurate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most (72%) of the persons who had previously received a result in a predictive testing program said they would request testing in either situation. Significantly more persons would request the definitive test than the 99% accurate test (72% vs 58%; P &lt; .02). Respondents for whom testing was uninformative in the linkage test program or who had previously received an increased-risk result were more likely to indicate they would use the test than those who received a decreased-risk result or chose not to have the original test (P = .0003). Less than half (46%) of the participants who initially chose not to have the linkage test said they would return for the new direct test. The major factor that has limited acceptance of predictive testing for this group is the concern about receiving an increased-risk result in the absence of any therapy to alter progression of the disease.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A direct mutation test for HD will most readily be accepted by persons who wanted but could not previously receive a result in the linkage test program and those who previously received an increased-risk result. In the absence of therapy, the majority of persons who previously chose not to have predictive testing are unlikely to participate in a new test despite improved accuracy. This has implications for the expected demands for testing services for other adult-onset genetic disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babul</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Dufrasne</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Theilmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001294" MajorTopicYN="Y">Attitude to Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="Y">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035842" MajorTopicYN="N">Research Subjects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">42466</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="Y">Canadian Collaborative Group on Predictive Testing for Huntington Disease</Keyword><Keyword MajorTopicYN="N">Empirical Approach</Keyword><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword></KeywordList><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic screening</GeneralNote><GeneralNote Owner="KIE">Full author name: Babul, Riyana</GeneralNote><GeneralNote Owner="KIE">Full author name: Adam, Shelin</GeneralNote><GeneralNote Owner="KIE">Full author name: Kremer, Berry</GeneralNote><GeneralNote Owner="KIE">Full author name: Dufrasne, Suzanne</GeneralNote><GeneralNote Owner="KIE">Full author name: Wiggins, Sandi</GeneralNote><GeneralNote Owner="KIE">Full author name: Huggins, Marlene</GeneralNote><GeneralNote Owner="KIE">Full author name: Theilmann, Jane</GeneralNote><GeneralNote Owner="KIE">Full author name: Bloch, Maurice</GeneralNote><GeneralNote Owner="KIE">Full author name: Hayden, Michael R</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>11</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>11</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8230594</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8306230</PMID><DateCompleted><Year>1994</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0706-7437</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>1993</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Canadian journal of psychiatry. Revue canadienne de psychiatrie</Title><ISOAbbreviation>Can J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Obtaining a family psychiatric history: is it worth the effort?</ArticleTitle><Pagination><StartPage>590</StartPage><EndPage>594</EndPage><MedlinePgn>590-4</MedlinePgn></Pagination><Abstract><AbstractText>The purpose of this study was to determine whether, for first-degree relatives of patients presenting to a mood disorders clinic, family history information on psychiatric conditions collected by a psychiatrist and incorporated into the patient's medical records is as informative as that gathered during an interview specifically designed to collect family history data. The study group consisted of 472 first-degree relatives of 78 randomly selected index cases from a large mood disorders genetic database. Family history of psychiatric disorders recorded in regular psychiatric medical records ("clinician history"), and data obtained by a genetic counsellor administering specific family psychiatric history questionnaires to patients and multiple family informants ("family history") were compared using a kappa statistic. Good agreement between the two methods on the presence or absence of a psychiatric disorder was found among first-degree relatives of index cases, but poor agreement was found with respect to the presence or absence of a specific mood disorder diagnosis(es) in a relative. The results suggest that a clinician-generated family psychiatric history is sensitive to the presence or absence of a psychiatric disorder when compared to a more structured detailed genetic interview. However, for research purposes, a clinician-generated family psychiatric history of a specific mood disorder diagnosis, without supporting collateral information, may not be reliable for use in supporting a mood disorder diagnosis in a patient and/or his relatives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Remick</LastName><ForeName>R A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, St. Paul's Hospital, Vancouver, British Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadovnick</LastName><ForeName>A D</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>Gimbarzevsky</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>R W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Zis</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Psychiatry</MedlineTA><NlmUniqueID>7904187</NlmUniqueID><ISSNLinking>0706-7437</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008487" MajorTopicYN="Y">Medical History Taking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="N">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8306230</ArticleId><ArticleId IdType="doi">10.1177/070674379303800904</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8135283</PMID><DateCompleted><Year>1994</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>1993</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.</ArticleTitle><Pagination><StartPage>368</StartPage><EndPage>374</EndPage><MedlinePgn>368-74</MedlinePgn></Pagination><Abstract><AbstractText>Persons diagnosed as affected with Huntington's disease (HD) may have similar stages of psychological response to the clinical presentation of the illness. Here we describe a model of these stages of response based on our experience during a predictive testing program for HD. During the Warning Stage, asymptomatic persons are aware of their risk status for HD and develop defenses which favor adaptation to their genetic risk. In response to the initial signs and symptoms of HD (the Incipient Stage) unconscious working through of this realization occurs while it is still kept out of conscious awareness. When symptoms become obvious such that recognition of disease onset is inevitable (Breakthrough Stage) the possibility of the diagnosis of HD is assimilated. After the delivery of the diagnosis during the Adjustment Stage, short- and long-term adaptive responses to living with HD occur. Recognition of the stage of psychological response of a patient who presents with HD is important prior to delivering a clinical diagnosis. In a significant minority of cases, the psychological readiness lags behind the clinical symptomatology and premature presentation of a diagnosis may result in significant untoward adverse events. Understanding of the stages of response may provide a framework for evaluating the psychological state of the person with HD and determining their readiness to receiving the diagnosis. This model may have relevance to the psychological responses of patients to the diagnosis of other late onset autosomal dominant disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Whyte</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Theilmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Med Genet. 1994 Aug 1;52(1):118-20. doi: 10.1002/ajmg.1320520125.</RefSource><PMID Version="1">7977455</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001294" MajorTopicYN="N">Attitude to Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003674" MajorTopicYN="N">Defense Mechanisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014342" MajorTopicYN="N">Truth Disclosure</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>13</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8135283</ArticleId><ArticleId IdType="doi">10.1002/ajmg.1320470314</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18670987</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>The secretory antibody response of inbred lines of chicken to avian infectious bronchitis virus infection.</ArticleTitle><Pagination><StartPage>681</StartPage><EndPage>692</EndPage><MedlinePgn>681-92</MedlinePgn></Pagination><Abstract><AbstractText>Two-week-old chicks of a line highly resistant (line C) or highly susceptible (line 151) to infectious bronchitis virus (IBV) were inoculated with the Massachusetts-41 strain of IBV. Tracheal washings, saliva, lachrymal fluid and serum were collected at intervals after inoculation and titrated for their antibody content using neutralization tests and ELISAs. There was no marked difference in antibody concentrations in tracheal washings of the two lines, nor in neutralizing antibody or IBV-specific IgG titres in serum or respiratory tract secretions. However, more IBV-specific IgA was detected in both saliva and lachrymal fluid of the line C chicks following either intranasal or eyedrop inoculation. The different IgA response in lachrymal fluid, but not saliva, was also observed in another pair of inbred chicken lines of different susceptibility to IBV infection, namely lines 6, and 7(2).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>K A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Houghton Laboratory, AFRC Institute for Animal Health, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>N R</ForeName><Initials>NR</Initials></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18670987</ArticleId><ArticleId IdType="doi">10.1080/03079459208418890</ArticleId><ArticleId IdType="pii">784678936</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1406858</PMID><DateCompleted><Year>1992</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2010</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-4793</ISSN><JournalIssue CitedMedium="Print"><Volume>327</Volume><Issue>20</Issue><PubDate><Year>1992</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.</ArticleTitle><Pagination><StartPage>1401</StartPage><EndPage>1405</EndPage><MedlinePgn>1401-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Advances in molecular genetics have led to the development of tests that can predict the risk of inheriting the genes for several adult-onset diseases. However, the psychological consequences of such testing are not well understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The 135 participants in the Canadian program of genetic testing to predict the risk of Huntington's disease were followed prospectively in three groups according to their test results: the increased-risk group (37 participants), the decreased-risk group (58 participants), and the group with no change in risk (the no-change group) (40 participants). All the participants received counseling before and after testing. Standard measures of psychological distress (the General Severity Index of the Symptom Check List 90-R), depression (the Beck Depression Inventory), and well-being (the General Well-Being Scale) were administered before genetic testing and again at intervals of 7 to 10 days, 6 months, and 12 months after the participants received their test results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At each follow-up assessment, the decreased-risk group had lower scores for distress than before testing (P &lt; 0.001). The increased-risk group showed no significant change from base line on any follow-up measure, but over the year of study there were small linear declines (P &lt; 0.023) for distress and depression. The no-change group had scores lower than at base line on the index of general well-being at each follow-up (P &lt; or = 0.045). At the 12-month follow-up, both the increased-risk group and the decreased-risk group had lower scores for depression and higher scores for well-being than the no-change group (P &lt; or = 0.049).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Predictive testing for Huntington's disease has potential benefits for the psychological health of persons who receive results that indicate either an increase or a decrease in the risk of inheriting the gene for the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whyte</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Theilmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sheps</LastName><ForeName>S B</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Schechter</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 1992 Nov 12;327(20):1449-51. doi: 10.1056/NEJM199211123272008.</RefSource><PMID Version="1">1406861</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 1993 Apr 8;328(14):1046. doi: 10.1056/NEJM199304083281418.</RefSource><PMID Version="1">8450869</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005817" MajorTopicYN="N">Genetic Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011581" MajorTopicYN="N">Psychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>12</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>12</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1406858</ArticleId><ArticleId IdType="doi">10.1056/NEJM199211123272001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1473342</PMID><DateCompleted><Year>1993</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0169-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.</ArticleTitle><Pagination><StartPage>227</StartPage><EndPage>239</EndPage><MedlinePgn>227-39</MedlinePgn></Pagination><Abstract><AbstractText>APIS is a software package based on mathematical modelling which provides a reliable approach in optimizing drug therapy. It was designed to assist clinicians in interpreting blood drug levels so that drug therapy may be better and more cost-effective. It is a methodological approach to describe, predict and control the kinetic behaviour of a drug. This software incorporates the principle of Bayesian procedures, i.e. one can use all available patient information (population) to determine patient-specific parameter estimates. These estimates can then be used to design an optimal and individualized drug regimen. APIS is an attractive and useful tool for clinical and experimental pharmacokinetics. APIS may be used on any IBM compatible computer using the Microsoft-Windows environment. The software is menu driven to provide a very user-friendly tool for analysing pharmacokinetic data and for designing dosage regimens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iliadis</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INSERM U278, Facult&#xe9; de Pharmacie, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>84319SGC3C</RegistryNumber><NameOfSubstance UI="D000583">Amikacin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000583" MajorTopicYN="N">Amikacin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016527" MajorTopicYN="N">Drug Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="Y">Drug Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016905" MajorTopicYN="N">Gram-Negative Bacterial Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012986" MajorTopicYN="Y">Software Validation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1473342</ArticleId><ArticleId IdType="doi">10.1016/0169-2607(92)90103-e</ArticleId><ArticleId IdType="pii">0169-2607(92)90103-E</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1437277</PMID><DateCompleted><Year>1992</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0031-1820</ISSN><JournalIssue CitedMedium="Print"><Volume>105 ( Pt 1)</Volume><PubDate><Year>1992</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Parasitology</Title><ISOAbbreviation>Parasitology</ISOAbbreviation></Journal><ArticleTitle>Schistosoma mansoni: adult males and females differentially express antigens encoded by repetitive genomic DNA.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>69</EndPage><MedlinePgn>63-9</MedlinePgn></Pagination><Abstract><AbstractText>Two repetitive DNA sequences have been characterized from Schistosoma mansoni which were transcribed into mRNAs and translated to give two families of cross-reactive proteins. One DNA element, which was present as a 230 bp Pst I fragment was arranged in tandem arrays of at least 17 copies in the genome. The second element, which could be localized to a 1800 bp Pst I fragment, was dispersed in the genome. The 1800 bp repeat was found on the mRNA encoding the 45 kDa polypeptide precursor of a potential surface antigen. This precursor was post-translationally modified to give a 50 kDa antigen (Sm50) which was expressed from the cercaria to the adult worm and in the egg. However, a proportion of this antigen was differentially modified in females and eggs to give a 60 kDa form. Two copies of the 230 bp repeat and one copy of the 1800 bp repeat were found on a second cDNA clone. The antiserum raised against the fusion protein of this clone recognized a family of cross-reactive proteins ranging from 14 to 70 kDa in size. The members of this family were also differentially expressed between the sexes. Consequently, two families of antigens have been identified which were both encoded by repetitive DNA elements and whose members were both differentially expressed in adult male and female worms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>A L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Cambridge.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Havercroft</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parasitology</MedlineTA><NlmUniqueID>0401121</NlmUniqueID><ISSNLinking>0031-1820</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015139" MajorTopicYN="N">Blotting, Southern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012091" MajorTopicYN="N">Repetitive Sequences, Nucleic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015183" MajorTopicYN="N">Restriction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012550" MajorTopicYN="N">Schistosoma mansoni</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1437277</ArticleId><ArticleId IdType="doi">10.1017/s0031182000073698</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1533425</PMID><DateCompleted><Year>1992</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0306-6800</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>1992</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of medical ethics</Title><ISOAbbreviation>J Med Ethics</ISOAbbreviation></Journal><ArticleTitle>Predictive testing for Huntington disease.</ArticleTitle><Pagination><StartPage>47</StartPage><EndPage>48</EndPage><MedlinePgn>47-8</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Ethics</MedlineTA><NlmUniqueID>7513619</NlmUniqueID><ISSNLinking>0306-6800</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Med Ethics. 1990 Dec;16(4):196-9. doi: 10.1136/jme.16.4.196.</RefSource><PMID Version="1">2149571</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003219" MajorTopicYN="Y">Confidentiality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026684" MajorTopicYN="N">Personal Autonomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">36276</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword><Keyword MajorTopicYN="N">Professional Patient Relationship</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1992</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1533425</ArticleId><ArticleId IdType="pmc">PMC1376086</ArticleId><ArticleId IdType="doi">10.1136/jme.18.1.47</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Hum Genet. 1990 Jul;47(1):4-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1971997</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr. 1990 Apr;149(7):513</Citation><ArticleIdList><ArticleId IdType="pubmed">2140774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1535178</PMID><DateCompleted><Year>1992</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.</ArticleTitle><Pagination><StartPage>508</StartPage><EndPage>515</EndPage><MedlinePgn>508-15</MedlinePgn></Pagination><Abstract><AbstractText>By January 1, 1991, a total of 388 persons had enrolled in the Canadian collaborative study of predictive testing for Huntington disease (HD). Of these participants, 105 persons have been given a decreased risk result. Contrary to expectations, approximately 10% of persons with a decreased risk result have had psychological difficulties coping with their new status. Here, we describe the individual responses of 6 such persons and experimental themes emerging after following these persons for up to 2 years. Individuals who are more likely to suffer an adverse reaction to a decreased risk result include those persons who have made irreversible decisions based on the belief they would develop HD or those who had unrealistic overoptimistic expectations of the positive effects of a decreased risk result. In contrast to those receiving an increased risk result, the most vulnerable time for persons receiving a decreased risk result is between 2 and 12 months after learning the outcome. The need for assessment and counselling of participants in predictive testing programs, even when there is a decreased risk result, is emphasized.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Suchowersky</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Trew</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Klimek</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author><Author ValidYN="Y"><LastName>Eleff</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>L P</ForeName><Initials>LP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Med Genet. 1992 Feb 15;42(4):491-8. doi: 10.1002/ajmg.1320420415.</RefSource><PMID Version="1">1535176</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005817" MajorTopicYN="N">Genetic Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006167" MajorTopicYN="N">Guilt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1535178</ArticleId><ArticleId IdType="doi">10.1002/ajmg.1320420417</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1535177</PMID><DateCompleted><Year>1992</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.</ArticleTitle><Pagination><StartPage>499</StartPage><EndPage>507</EndPage><MedlinePgn>499-507</MedlinePgn></Pagination><Abstract><AbstractText>Predictive testing for Huntington disease (HD) has been offered in some parts of Canada for nearly 5 years. Candidates who were expected to have a significant likelihood for psychological problems were those who received an increased risk for developing HD. Sixty-six persons have now received such an increased risk result. In this manuscript we describe in detail the experience of 4 such persons who were chosen to illustrate recurrent and common themes which have emerged during counselling, and to highlight the strategies of coping with this information. Themes include difficulties communicating about HD, defensive postures adopted in preparing for testing, ramifications of testing for the whole family, and the impact of being at high risk on the candidates' perception of the future. One candidate has had testing postponed due to active suicidal risk. Only a few candidates have expressed regret at taking the test and no person receiving an increased risk result has made a suicide attempt or required hospitalization. After receiving results, symptoms of depression and anxiety are most common in the first 2 months, but over 1 year, candidates, in general, have less depression but live with a heightened perception of the present. The potential risk of premature diagnosis of HD in an individual with an increased risk results is highlighted. The significant ramifications of testing for the relative are shown. The importance of communication as a means of establishing a social support network, as well as the hazards of open communication, are discussed. Longitudinal evaluation will provide much needed data on the long-term effects of living at increased risk for HD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Med Genet. 1992 Feb 15;42(4):491-8. doi: 10.1002/ajmg.1320420415.</RefSource><PMID Version="1">1535176</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005817" MajorTopicYN="N">Genetic Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">37676</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="Y">Canadian Collaborative Study of Predictive Testing for Huntington Disease</Keyword><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword></KeywordList><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic counseling</GeneralNote><GeneralNote Owner="KIE">KIE BoB Subject Heading: genetic screening</GeneralNote><GeneralNote Owner="KIE">Full author name: Bloch, Maurice</GeneralNote><GeneralNote Owner="KIE">Full author name: Adam, Shelin</GeneralNote><GeneralNote Owner="KIE">Full author name: Wiggins, Sandy</GeneralNote><GeneralNote Owner="KIE">Full author name: Huggins, Marlene</GeneralNote><GeneralNote Owner="KIE">Full author name: Hayden, Michael R</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1535177</ArticleId><ArticleId IdType="doi">10.1002/ajmg.1320420416</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18680059</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>1991</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Use of an infectious bronchitis virus and Escherichia coli model infection to assess the ability to vaccinate successfully against infectious bronchitis in the presence of maternally-derived immunity.</ArticleTitle><Pagination><StartPage>619</StartPage><EndPage>626</EndPage><MedlinePgn>619-26</MedlinePgn></Pagination><Abstract><AbstractText>Using as challenge, a mixed infectious bronchitis virus (IBV) and Escherichia coli infection, specified pathogen-free (SPF) chicks and chicks with maternally-derived immunity (MDI) could be protected by a single intra-nasal vaccination with a live-attenuated IB vaccine given at 1 day of age against intranasal challenge with either a homologous or a heterologous IBV strain for at least 7 weeks. However, protection was incomplete if challenge occurred within approximately 14 days of vaccination. Vaccination at 7 or 14 days of age was also equally effective in protecting both SPF and MDI chicks for at least 4 weeks. The value of using in challenge studies a mixed IBV and E. coli infection, which takes account of the response of the intact chicken to challenge, is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>AFRC Institute for Animal Health, Houghton Laboratory, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18680059</ArticleId><ArticleId IdType="doi">10.1080/03079459108418801</ArticleId><ArticleId IdType="pii">784665156</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18680019</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>1991</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Comparative study of respiratory lesions in two chicken lines of different susceptibility infected with infectious bronchitis virus: histology, ultrastructure and immunohistochemistry.</ArticleTitle><Pagination><StartPage>241</StartPage><EndPage>257</EndPage><MedlinePgn>241-57</MedlinePgn></Pagination><Abstract><AbstractText>Infectious bronchitis virus (IBV) was inoculated intranasally into line C and line 151 chickens, which were resistant and highly susceptible, respectively, to IBV infection, and the resulting respiratory lesions compared. Histologically, damage to the mucociliary system of the respiratory tract in line 151 persisted longer than in line C. Using the avidin-biotin-peroxidase complex method, IBV antigens were detected in histological sections of the tracheas of line 151 for a longer time than in line C. Ultrastructural studies confirmed the histological findings. Immuno-globulin G-, IgM- and IgA-containing cells were seen in the lamina propria and between epithelial cells in the trachea of both lines from at least 7 to 12 days after IBV inoculation but in greater numbers in line 151.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Houghton Laboratory, AFRC Institute for Animal Health, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Otsuki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Frazier</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18680019</ArticleId><ArticleId IdType="doi">10.1080/03079459108418761</ArticleId><ArticleId IdType="pii">784676580</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18680008</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>1991</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>The pathogenesis of turkey rhinotracheitis virus in turkey poults inoculated with the virus alone or together with two strains of bacteria.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>166</EndPage><MedlinePgn>155-66</MedlinePgn></Pagination><Abstract><AbstractText>Turkey rhinotracheitis virus (TRTV) was recovered in large amounts from the upper respiratory tract of young turkey poults for about 5 days after experimental eyedrop inoculation with either a virulent or an attenuated strain. Thereafter, small amounts of virus were isolated, but only for up to 14 days after inoculation. Virulent TRTV could be recovered infrequently from the internal organs or the intestinal tract but only if bacteria (Bordetella avium and a Pasteurella-like organism) were administered contemporaneously. The results of transmission studies were in agreement with the virus isolation results since they showed that virus could be transmitted from inoculated poults to TRTV-free poults placed in direct contact with them only during the first 9 days after inoculation. Whether inoculated alone or together with TRTV, B. avium colonised the upper respiratory tract to the same degree but apparently did not invade. In contrast, the Pasteurella-like organism did not colonise when inoculated alone but could be recovered from the respiratory tract when administered simultaneously with either a virulent or an attenuated strain of TRTV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Houghton Laboratory, AFRC Institute for Animal Health, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18680008</ArticleId><ArticleId IdType="doi">10.1080/03079459108418750</ArticleId><ArticleId IdType="pii">784677524</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1671809</PMID><DateCompleted><Year>1991</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>3</Issue><PubDate><Year>1991</Year><Month>Mar</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Linkage disequilibrium and modification of risk for Huntington disease.</ArticleTitle><Pagination><StartPage>595</StartPage><EndPage>603</EndPage><MedlinePgn>595-603</MedlinePgn></Pagination><Abstract><AbstractText>The major limitation in performing predictive testing for Huntington disease (HD) is the unavailability of DNA from crucial family members. In our program approximately 20% (36/183) of persons have been excluded from predictive testing because of this reason. The major aim of this study was to examine whether data derived from linkage disequilibrium could modify risk analysis for persons at risk for HD. As a first step, we assessed whether the previously reported linkage disequilibrium between alleles recognized by probe pBS674E-D at locus D4S95 remained significant in a much larger data set. A total of 1,150 chromosomes from 622 individuals--200 affected and 422 unaffected--from 118 families were assessed. Significant haplotype association was detected with AccI and MboI RFLPs at the locus D4S95, with all the families (P = .00003), as well as for a subset from the United Kingdom (P = .0037). Data derived from linkage disequilibrium studies using D4S95 modifies the risk for HD, especially in persons of U.K. descent. Utilization of this approach for risk modification of HD awaits both validation of these data and additional information concerning ethnic-specific alleles at the D4S95 locus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theilmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Buetow</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hedrick</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM40864</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.21.4</RegistryNumber><NameOfSubstance UI="D015252">Deoxyribonucleases, Type II Site-Specific</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.21.4</RegistryNumber><NameOfSubstance UI="C024405">GATC-specific type II deoxyribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.21.4</RegistryNumber><NameOfSubstance UI="C067488">GTMKAC-specific type II deoxyribonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015252" MajorTopicYN="N">Deoxyribonucleases, Type II Site-Specific</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="Y">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012150" MajorTopicYN="N">Polymorphism, Restriction Fragment Length</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1991</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1671809</ArticleId><ArticleId IdType="pmc">PMC1682983</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Mol Biol. 1975 Nov 5;98(3):503-17</Citation><ArticleIdList><ArticleId IdType="pubmed">1195397</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 1983 Jul 1;132(1):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">6312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 1986 Jan;112(1):135-56</Citation><ArticleIdList><ArticleId IdType="pubmed">3510942</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1989 Mar;44(3):319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">2916578</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1987 May;40(5):421-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2883893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Apr 21;332(6166):734-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2895895</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1988 Mar 3;318(9):535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">2893260</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Feb;42(2):335-44</Citation><ArticleIdList><ArticleId IdType="pubmed">2963539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1987 Aug 14;50(4):565-71</Citation><ArticleIdList><ArticleId IdType="pubmed">2886227</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 1989 Aug;3(2):183-90</Citation><ArticleIdList><ArticleId IdType="pubmed">2576211</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Nov;43(5):689-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2973229</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Nov;43(5):695-704</Citation><ArticleIdList><ArticleId IdType="pubmed">2973230</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1988 Dec 23;16(24):11769-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2905444</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1989 Mar;44(3):422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2521771</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1989 Sep;45(3):477-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2528290</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 1989 Nov;26(11):676-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2531224</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 1989 Nov;26(11):673-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2531223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1989 Aug 26;2(8661):463-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2570183</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1989 Sep;84(3):1013-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2569477</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1989 Jun 2;261(21):3108-14</Citation><ArticleIdList><ArticleId IdType="pubmed">2523979</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1648896</PMID><DateCompleted><Year>1991</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0304-8608</ISSN><JournalIssue CitedMedium="Print"><Volume>118</Volume><Issue>3-4</Issue><PubDate><Year>1991</Year></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Effect of in ovo bursectomy on the course of an infectious bronchitis virus infection in line C White Leghorn chickens.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>234</EndPage><MedlinePgn>225-34</MedlinePgn></Pagination><Abstract><AbstractText>White Leghorn line C chicks were surgically bursectomised (Bx) in ovo to eliminate antibody production. After inoculation with infectious bronchitis virus (IBV) at 14 days after hatching, Bx chicks experienced a more severe and longer lasting infection than intact chicks. The severity and duration of clinical infection in the Bx chicks resembled that previously observed in the highly susceptible line 15I chicks, however no increase in mortality was observed, in contrast to the high levels of mortality recorded in IBV-inoculated line 15I chicks. After secondary challenge the degree of damage to the ciliated epithelium of the trachea was greater in the Bx chicks than in the intact chicks. The results indicate that, although antibodies play an important role in recovery from IBV infection, other immunological factor(s) may also be involved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>AFRC Institute for Animal Health, Houghton Laboratory, Huntingdon, Cambridgeshire, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>T F</ForeName><Initials>TF</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>McLaughlan</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002060" MajorTopicYN="N">Bursa of Fabricius</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="Y">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002923" MajorTopicYN="N">Cilia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="Y">Infectious bronchitis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011180" MajorTopicYN="N">Postmortem Changes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1648896</ArticleId><ArticleId IdType="pmc">PMC7087224</ArticleId><ArticleId IdType="doi">10.1007/BF01314032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boyle JF, Weismiller DG, Holmes KV. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J Virol. 1987;61:185&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255233</ArticleId><ArticleId IdType="pubmed">3023696</ArticleId></ArticleIdList></Reference><Reference><Citation>Bumstead N, Huggins MB, Cook JKA. Genetic differences in susceptibility to a mixture of avian infectious bronchitis virus andEscherichia coli. Br Poult Sci. 1989;30:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">2545316</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook JKA, Darbyshire JH, Peters RW. The use of chicken tracheal organ cultures for the isolation and assay of avian infectious bronchitis virus. Arch Virol. 1976;50:109&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">176965</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook JKA, Smith HW, Huggins MB. Infectious bronchitis immunity: its study in chickens experimentally infected with mixtures of infectious bronchitis virus andEscherichia coli. J Gen Virol. 1986;67:1427&#x2013;1434.</Citation><ArticleIdList><ArticleId IdType="pubmed">3014052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper MD, Cain WA, Van Alten PJ, Good RA. Development and function of the immunoglobulin producing system. Int Arch Allergy. 1969;35:242&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">4179663</ArticleId></ArticleIdList></Reference><Reference><Citation>Davelaar FG, Kouwenhoven B. Changes in the Harderian gland of the chicken following conjunctival and intranasal infection with infectious bronchitis virus in one-and 20-day-old chickens. Avian Pathol. 1976;5:39&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18777328</ArticleId></ArticleIdList></Reference><Reference><Citation>Davelaar FG, Kouwenhoven B. Influence of maternal antibodies on vaccination of chicks of different ages against infectious bronchitis. Avian Pathol. 1977;6:41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18770311</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillette KG. Local antibody response to avian infectious bronchitis: virus-neutralising antibody in tracheobronchial secretions. Avian Dis. 1981;25:431&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">6266389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez L, Raggi LG. Local immunity to avian infectious bronchitis in tracheal organ culture. Avian Dis. 1974;18:346&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">4368876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough RE, Alexander DJ. Comparison of duration of immunity in chickens infected with a live infectious bronchitis vaccine by three different routes. Res Vet Sci. 1979;26:329&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">229532</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbert WJ, Kristensen F. Laboratory animal techniques for immunology. In: Weir DM, editor. Handbook of experimental immunology, vol 4, applications of immunological methods in biomedical sciences. 4th edn. Oxford: Blackwell; 1986. pp. 133&#xb7;1&#x2013;133&#xb7;36.</Citation></Reference><Reference><Citation>Hofstad MS. Avian infectious bronchitis. In: Hofstad MS, Barnes HJ, Calnek BW, Reid WH, Yoder HW Jr, editors. Diseases of poultry. 8th edn. Ames, Iowa: The Iowa State University Press; 1984. pp. 429&#x2013;443.</Citation></Reference><Reference><Citation>Mockett APA, Cook JKA. The detection of specific IgM to infectious bronchitis virus in chicken serum using an ELISA. Avian Pathol. 1986;15:437&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K, Cook JKA, Otsuki K, Huggins MB, Frazier JA (1991) Comparative study of respiratory lesions in two chicken lines of different susceptibility infected with infectious bronchitis virus: histology, ultrastructure and immunohistochemistry. Avian Pathol (in press)</Citation><ArticleIdList><ArticleId IdType="pubmed">18680019</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuki K, Huggins MB, Cook JKA. Comparison of the susceptibility to avian infectious bronchitis virus infection of two inbred lines of White Leghorn chickens. Avian Pathol. 1990;19:467&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">18679958</ArticleId></ArticleIdList></Reference><Reference><Citation>Raggi LG, Lee GG. Lack of correlation between infectivity, serologic response and challenge results in immunization with an avian infectious bronchitis vaccine. J Immunol. 1965;94:538&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">14299027</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating fifty percent end points. Am J Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Schat KA, Calnek BW, Fabricant J. Influence of the bursa of Fabricius on the pathogenesis of Marek's disease. Infect Immun. 1980;31:199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC351770</ArticleId><ArticleId IdType="pubmed">6260660</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith HW, Cook JKA, Parsell ZE. The experimental infection of chickens with mixtures of infectious bronchitis virus andEscherichia coli. J Gen Virol. 1985;66:777&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">2984320</ArticleId></ArticleIdList></Reference><Reference><Citation>Timms LM, Bracewell CD, Alexander DJ. Cell mediated and humoral immune response in chickens infected with avian infectious bronchitis. Br Vet J. 1980;136:349&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">6250665</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterfield RW, Fadly AM. Some characteristics of isolates of infectious bronchitis virus from commercial vaccines. Avian Dis. 1972;16:746&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">5079872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18679958</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>1990</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Comparison of the susceptibility to avian infectious bronchitis virus infection of two inbred lines of white leghorn chickens.</ArticleTitle><Pagination><StartPage>467</StartPage><EndPage>475</EndPage><MedlinePgn>467-75</MedlinePgn></Pagination><Abstract><AbstractText>Two inbred lines of White Leghorn chickens, line C which are highly resistant to infection with avian infectious bronchitis virus (IBV), and line 151, which are highly susceptible, were challenged at 11 days of age with IBV Massachusetts-41 (M41) strain. Line 151 chickens showed more severe respiratory signs than line C and although similar amounts of virus were recovered from the tracheas of both lines for the first four days after inoculation, overall more virus was recovered from the respiratory tract organs and from kidneys of line 151 chicks. There was however, no difference in the rate of virus production or in the amount produced by explants of tissues from each line following inoculation with IBV in vitro. When tracheal ciliary movement of lines C and 151 chickens was examined following inoculation with M41. ciliostasis was observed earlier in line 151 than in line C and lasted for a longer time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Otsuki</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Houghton Laboratory, AFRC Insititute for Animal Health, Houghton, Huntingdon, Cambs, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18679958</ArticleId><ArticleId IdType="doi">10.1080/03079459008418700</ArticleId><ArticleId IdType="pii">784695711</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1971997</PMID><DateCompleted><Year>1990</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>1</Issue><PubDate><Year>1990</Year><Month>Jul</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease.</ArticleTitle><Pagination><StartPage>4</StartPage><EndPage>12</EndPage><MedlinePgn>4-12</MedlinePgn></Pagination><Abstract><AbstractText>The goal of predictive testing is to modify the risk for currently healthy individuals to develop a genetic disease in the future. Such testing using polymorphic DNA markers has had major application in Huntington disease. The Canadian Collaborative Study of Predictive Testing for Huntington Disease has been guided by major principles of medical ethics, including autonomy, beneficence, confidentiality, and justice. Numerous ethical and legal dilemmas have arisen in this program, challenging these principles and occasionally casting them into conflict. The present report describes these dilemmas and offers our approach to resolving them. These issues will have relevance to predictive-testing programs for other adult-onset disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kanani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Quarrell</LastName><ForeName>O W</ForeName><Initials>OW</Initials></Author><Author ValidYN="Y"><LastName>Theilman</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hedrick</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Dickens</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000025" MajorTopicYN="N">Abortion, Eugenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026686" MajorTopicYN="N">Beneficence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004992" MajorTopicYN="Y">Ethics, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026684" MajorTopicYN="N">Personal Autonomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012150" MajorTopicYN="N">Polymorphism, Restriction Fragment Length</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="KIE">37693</OtherID><KeywordList Owner="KIE"><Keyword MajorTopicYN="N">Analytical Approach</Keyword><Keyword MajorTopicYN="Y">Canadian Collaborative Study of Predictive Testing for Huntington Disease</Keyword><Keyword MajorTopicYN="N">Genetics and Reproduction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1991</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1971997</ArticleId><ArticleId IdType="pmc">PMC1683755</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1983 Nov 17-23;306(5940):234-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6316146</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J (Clin Res Ed). 1986 Jul 26;293(6541):249-51</Citation><ArticleIdList><ArticleId IdType="pubmed">2942216</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1987 Feb;26(2):243-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2949608</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1987 Feb;26(2):307-14</Citation><ArticleIdList><ArticleId IdType="pubmed">2949614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1987 Jun 6;1(8545):1281-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2884411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 1989 Jun;26(6):353-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2525622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Apr 21;332(6166):734-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2895895</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Nov;43(5):689-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2973229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1988 Dec 23;16(24):11769-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2905444</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1989 Jun 2;261(21):3108-14</Citation><ArticleIdList><ArticleId IdType="pubmed">2523979</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1988 Mar 3;318(9):535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">2893260</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2160495</PMID><DateCompleted><Year>1990</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0263-6352</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>1990</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of hypertension</Title><ISOAbbreviation>J Hypertens</ISOAbbreviation></Journal><ArticleTitle>An evaluation of the A&amp;D UA-751 semi-automated cuff-oscillometric sphygmomanometer.</ArticleTitle><Pagination><StartPage>377</StartPage><EndPage>381</EndPage><MedlinePgn>377-81</MedlinePgn></Pagination><Abstract><AbstractText>We compared blood pressure recordings made with the A&amp;D UA-751 semi-automated cuff-oscillometric sphygmomanometer (A&amp;D Co. Ltd, Tokyo, Japan) and with a conventional Hawksley random-zero mercury sphygmomanometer (Hawksley and Sons Ltd, Lancing, UK). Simultaneous single-arm recordings were obtained in duplicate with both devices in 200 subjects having blood pressure in the ranges 92-221/51-121 mmHg. The measurements obtained by three observers using the Hawksley sphygmomanometer were compared with recordings from two A&amp;D UA-751 devices. In most cases, there was an acceptable level of agreement between the results, according to the criteria suggested by the Association for the Advancement of Medical Instrumentation (range of differences systolic: mean - 0.9 to 1.4 mmHg, s.d. 4.6-9.8 mmHg; diastolic: mean - 0.6 to 1.3 mmHg, s.d. 2.9-5.1 mmHg), although there were sizeable discrepancies in individual subjects. Thus the A&amp;D UA-751 device appears to be an acceptable alternative to a conventional sphygmomanometer; it should be suitable for routine clinical and limited research use, including intermittent home blood pressure recording.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamieson</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Aberdeen University, Foresterhill, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>T M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>de Beaux</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Petrie</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Hypertens</MedlineTA><NlmUniqueID>8306882</NlmUniqueID><ISSNLinking>0263-6352</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2160495</ArticleId><ArticleId IdType="doi">10.1097/00004872-199004000-00012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2325706</PMID><DateCompleted><Year>1990</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0166-6851</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>1990</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Molecular and biochemical parasitology</Title><ISOAbbreviation>Mol Biochem Parasitol</ISOAbbreviation></Journal><ArticleTitle>Characterisation of Sm20, a 20-kilodalton calcium-binding protein of Schistosoma mansoni.</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>219</EndPage><MedlinePgn>211-9</MedlinePgn></Pagination><Abstract><AbstractText>A cDNA clone encoding part of a 20-kDa antigen of Schistosoma mansoni (Sm20) has been isolated. The amino acid sequence of this antigen, as predicted from the sequence of the cDNA, has significant homology to the family of calcium binding proteins which include calmodulin, troponin C and the light chain of myosin. Although we have been unable to show any immunological cross-reactivity between Sm20 and calmodulins from a range of other species, we have verified that Sm20 is a functional calcium binding protein. Sm20 is encoded by a small multigene family and is expressed in schistosomula and adult worms but not in eggs. The 20-kDa nascent polypeptide appears to be post-translationally modified to give a 38-kDa species. Sm20 is present in preparations of tegumental membranes and is easily removed from intact schistosomula by detergent treatment, suggesting that it is associated with the tegument. However, the cloned portion does not appear to be exposed on the surface.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Havercroft</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Cambridge, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>M28888</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biochem Parasitol</MedlineTA><NlmUniqueID>8006324</NlmUniqueID><ISSNLinking>0166-6851</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002147">Calmodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015801">Helminth Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015139" MajorTopicYN="N">Blotting, Southern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002135" MajorTopicYN="N">Calcium-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002147" MajorTopicYN="N">Calmodulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015801" MajorTopicYN="N">Helminth Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012550" MajorTopicYN="N">Schistosoma mansoni</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>1</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>1</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2325706</ArticleId><ArticleId IdType="doi">10.1016/0166-6851(90)90024-g</ArticleId><ArticleId IdType="pii">0166-6851(90)90024-G</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1966442</PMID><DateCompleted><Year>1991</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>276</Volume><PubDate><Year>1990</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation></Journal><ArticleTitle>Investigations into resistance of chicken lines to infection with infectious bronchitis virus.</ArticleTitle><Pagination><StartPage>491</StartPage><EndPage>496</EndPage><MedlinePgn>491-6</MedlinePgn></Pagination><Abstract><AbstractText>Although nine inbred and partially inbred lines of chickens were equally susceptible initially to infection with infectious bronchitis virus (IBV), the outcome of that infection varied considerably between the lines. A more detailed study of a line which was resistant (line C) and one which was highly susceptible (line 15I) confirmed that both lines could be infected initially with IBV but showed that the respiratory tract epithelium of line C chicks recovered more rapidly than that of line 15I chicks. Whereas more virus could be recovered from tissues of line 15I chicks following IBV inoculation, explants of tissues from each line inoculated in vitro appeared equally susceptible. The possibility of a different immunological response to IBV infection in the two lines is discussed and it is clear that further work is required to elucidate the mechanism involved in the differing susceptibility of the inbred chicken lines to inoculation with IBV.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IAH Institute for Animal Health, Houghton Laboratory, Huntingdon, Cambridgeshire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bumstead</LastName><ForeName>N</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="Y">Poultry Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1966442</ArticleId><ArticleId IdType="doi">10.1007/978-1-4684-5823-7_68</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2531224</PMID><DateCompleted><Year>1989</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2593</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>1989</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of medical genetics</Title><ISOAbbreviation>J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene.</ArticleTitle><Pagination><StartPage>676</StartPage><EndPage>681</EndPage><MedlinePgn>676-81</MedlinePgn></Pagination><Abstract><AbstractText>Analysis of many families with linked DNA markers has provided support for the Huntington's disease (HD) gene being close to the telomere on the short arm of chromosome 4. However, analysis of recombination events in particular families has provided conflicting results about the precise location of the HD gene relative to these closely linked DNA markers. Here we report an investigation of linkage disequilibrium between six DNA markers and the HD gene in 75 separate families of varied ancestry. We show significant non-random association between alleles detected at D4S95 and D4S98 and the mutant gene. These data suggest that it may be possible to construct high and low risk haplotypes, which may be helpful in DNA analysis and genetic counselling for HD, and represent independent evidence that the gene for HD is centromeric to more distally located DNA markers such as D4S90. This information may be helpful in defining a strategy to clone the gene for HD based on its location in the human genome.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Theilmann</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shiang</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Robbins</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Quarrell</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hedrick</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wasmuth</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM07091</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM40864</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Genet</MedlineTA><NlmUniqueID>2985087R</NlmUniqueID><ISSNLinking>0022-2593</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015342">DNA Probes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015342" MajorTopicYN="N">DNA Probes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009656" MajorTopicYN="N" Type="Geographic">North America</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1989</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2531224</ArticleId><ArticleId IdType="pmc">PMC1015737</ArticleId><ArticleId IdType="doi">10.1136/jmg.26.11.676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Mol Biol. 1975 Nov 5;98(3):503-17</Citation><ArticleIdList><ArticleId IdType="pubmed">1195397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 1964 Sep-Oct;1(5):405-20</Citation><ArticleIdList><ArticleId IdType="pubmed">14221937</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 1983 Jul 1;132(1):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">6312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Nov 17-23;306(5940):234-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6316146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1984 Jan;36(1):131-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6198090</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1987 Apr;40(4):338-50</Citation><ArticleIdList><ArticleId IdType="pubmed">2883890</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1987 May;40(5):421-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2883893</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1987 Aug 14;50(4):565-71</Citation><ArticleIdList><ArticleId IdType="pubmed">2886227</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Jan;42(1):125-31</Citation><ArticleIdList><ArticleId IdType="pubmed">2892395</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Feb;42(2):335-44</Citation><ArticleIdList><ArticleId IdType="pubmed">2963539</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1988 Feb 25;16(4):1648</Citation><ArticleIdList><ArticleId IdType="pubmed">2894638</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Apr 21;332(6166):734-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2895895</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1988 Nov;43(5):689-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2973229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1988 Dec 23;16(24):11769-80</Citation><ArticleIdList><ArticleId IdType="pubmed">2905444</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 1989 Jan;4(1):76-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2783679</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1989 Mar;44(3):319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">2916578</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1989 Mar;44(3):422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2521771</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Med Assoc J. 1962 Dec 8;87:1242-3</Citation><ArticleIdList><ArticleId IdType="pubmed">13966499</ArticleId></ArticleIdList></Reference><Reference><Citation>S Afr Med J. 1980 Aug 2;58(5):197-200</Citation><ArticleIdList><ArticleId IdType="pubmed">6447365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18679882</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>A live attenuated turkey rhinotracheitis virus vaccine. 2. The use of the attenuated strain as an experimental vaccine.</ArticleTitle><Pagination><StartPage>523</StartPage><EndPage>534</EndPage><MedlinePgn>523-34</MedlinePgn></Pagination><Abstract><AbstractText>An attenuated turkey rhinotracheitis (TRT) vaccine strain, when given either by eye drop or by aerosol, has been shown to be effective in protecting 1- to 11-day-old turkey poults against an experimental challenge with TRTV up to 14 weeks later. TRT antibody-free poults and poults hatched from TRT-immune dams were both equally well protected, although a high proportion of the latter did not respond serologically to the vaccine. As little as 1 CD50 of vaccine was found to be effective in protecting poults against challenge. Immunity developed within about 6 days of vaccination of 7-day-old TRT antibody-free poults and humoral antibody persisted for at least 14 weeks after a single vaccination at 4 weeks of age.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>AFRC Institute for Animal Health, Houghton Laboratory, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>H C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Finney</LastName><ForeName>P M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Dolby</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18679882</ArticleId><ArticleId IdType="doi">10.1080/03079458908418624</ArticleId><ArticleId IdType="pii">784687354</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18679881</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2008</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>A live attenuated turkey rhinotracheitis virus vaccine. 1. Stability of the attenuated strain.</ArticleTitle><Pagination><StartPage>511</StartPage><EndPage>522</EndPage><MedlinePgn>511-22</MedlinePgn></Pagination><Abstract><AbstractText>Compared with the severe clinical disease caused by two virulent strains of turkey rhinotracheitis virus (TRTV), an attenuated strain has been shown to cause only slight respiratory infection in 7-day-old TRT-free turkey poults, yet still to be capable of stimulating TRT antibodies and of protecting the poults against challenge with virulent TRTV 21 days later. The stability of the attenuation during 12 turkey-turkey passages of the strain has been demonstrated; the poult passaged and prepassaged strains causing only mild respiratory signs even when bacteria, known to be associated with severe outbreaks of TRT in the field, were included in the inoculum.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>AFRC Institute for Animal Health, Houghton Laboratory, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Dolby</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>H C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Finney</LastName><ForeName>P M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18679881</ArticleId><ArticleId IdType="doi">10.1080/03079458908418623</ArticleId><ArticleId IdType="pii">784687353</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2545316</PMID><DateCompleted><Year>1989</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2008</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0007-1668</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>1989</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British poultry science</Title><ISOAbbreviation>Br Poult Sci</ISOAbbreviation></Journal><ArticleTitle>Genetic differences in susceptibility to a mixture of avian infectious bronchitis virus and Escherichia coli.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>48</EndPage><MedlinePgn>39-48</MedlinePgn></Pagination><Abstract><AbstractText>Two-week-old chickens of 9 inbred and partially inbred lines of chickens were challenged intranasally with a mixed infection consisting of a pool of virulent strains of infectious bronchitis virus and a pool of pathogenic strains of Escherichia coli. 2. Wide differences in mortality were observed in the different lines, ranging from 3% in a Brown Leghorn line to 87% in White Leghorn line 7(2). 3. Experiments involving challenge with E. coli alone or virus alone suggested that this variation reflected resistance to the virus rather than to E. coli. 4. Reciprocal F1 matings suggested these differences in mortality were not attributable to maternal effects and indicated that the inheritance of resistance was fully dominant. 5. The pattern of mortality in F2 and backcross progeny of matings was compatible with the inheritance of a dominant autosomal resistance gene and showed no evidence of association with the major histocompatibility complex.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bumstead</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>AFRC Institute for Animal Health, Houghton Laboratory, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br Poult Sci</MedlineTA><NlmUniqueID>15740290R</NlmUniqueID><ISSNLinking>0007-1668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003433" MajorTopicYN="N">Crosses, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008285" MajorTopicYN="N">Major Histocompatibility Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2545316</ArticleId><ArticleId IdType="doi">10.1080/00071668908417123</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2969455</PMID><DateCompleted><Year>1988</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0166-6851</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>1988</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular and biochemical parasitology</Title><ISOAbbreviation>Mol Biochem Parasitol</ISOAbbreviation></Journal><ArticleTitle>Cloning of the gene encoding a 50 kilodalton potential surface antigen of Schistosoma mansoni.</ArticleTitle><Pagination><StartPage>83</StartPage><EndPage>88</EndPage><MedlinePgn>83-8</MedlinePgn></Pagination><Abstract><AbstractText>A cDNA library was constructed from the mRNA of adult worms of Schistosoma mansoni, in the expression vector lambda gt11. This library was screened with a pool of sera raised against either soluble egg antigens or purified schistosomulum tegumental membranes. An antiserum raised against the fusion protein of one clone immunoprecipitated a 45 kDa polypeptide from the in vitro translation products of adult worm mRNA and recognised a 50 kDa antigen in homogenates of adult worms. This serum gave positive fluorescence of the surface of schistosomula in indirect immunofluorescence assays and was able to mediate killing of schistosomula by human eosinophils in vitro, suggesting that this clone contained part of a gene encoding a surface antigen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Havercroft</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Cambridge, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Nene</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>B A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Butterworth</LastName><ForeName>A E</ForeName><Initials>AE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biochem Parasitol</MedlineTA><NlmUniqueID>8006324</NlmUniqueID><ISSNLinking>0166-6851</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007106">Immune Sera</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000954" MajorTopicYN="N">Antigens, Surface</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010582" MajorTopicYN="N">Bacteriophage lambda</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="Y">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007106" MajorTopicYN="N">Immune Sera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007158" MajorTopicYN="N">Immunologic Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012550" MajorTopicYN="N">Schistosoma mansoni</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1988</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2969455</ArticleId><ArticleId IdType="doi">10.1016/0166-6851(88)90135-1</ArticleId><ArticleId IdType="pii">0166-6851(88)90135-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3053022</PMID><DateCompleted><Year>1988</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0147-9571</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>1988</Year></PubDate></JournalIssue><Title>Comparative immunology, microbiology and infectious diseases</Title><ISOAbbreviation>Comp Immunol Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Antibiotic resistance of Escherichia coli strains isolated from chickens with colisepticaemia in Morocco.</ArticleTitle><Pagination><StartPage>121</StartPage><EndPage>124</EndPage><MedlinePgn>121-4</MedlinePgn></Pagination><Abstract><AbstractText>Sixty-two strains of Escherichia coli were isolated in 58 farms from broiler chickens showing respiratory signs and lesions characteristic of avian colibacillosis. Serological examination of these strains showed that the types 078, 01 and 02 (for the somatic antigen) and K1 (for the capsular antigen) were the most frequently found. Newcastle disease virus was also isolated in two cases. All the strains of E. coli isolated were sensitive to colistin, flumequine and gentamicin. A few strains were resistant to neomycin, nalidixic acid and trimethoprim. The frequency of strains resistant to nitrofurans, sulfonamides, chloramphenicol, spectinomycin and ampicillin was intermediate. Most strains were resistant to tetracycline. Multiple resistance was common.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Filali</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Pathologie Aviaire, Institut Agronomique et V&#xe9;t&#xe9;rinaire Hassan II, Rabat-Instituts, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>el Houadfi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Comp Immunol Microbiol Infect Dis</MedlineTA><NlmUniqueID>7808924</NlmUniqueID><ISSNLinking>0147-9571</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009018" MajorTopicYN="N" Type="Geographic">Morocco</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1988</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1988</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1988</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3053022</ArticleId><ArticleId IdType="doi">10.1016/0147-9571(88)90027-6</ArticleId><ArticleId IdType="pii">0147-9571(88)90027-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28311962</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-1939</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>4</Issue><PubDate><Year>1987</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Oecologia</Title><ISOAbbreviation>Oecologia</ISOAbbreviation></Journal><ArticleTitle>Reduction in locomotor ability as a cost of reproduction in gravid snakes.</ArticleTitle><Pagination><StartPage>481</StartPage><EndPage>485</EndPage><MedlinePgn>481-485</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/BF00379404</ELocationID><Abstract><AbstractText>Recent studies suggest that lower survival among gravid squamate reptiles may be partially the result of decreased locomotor ability during gestation. In this study, we compared the speed and endurance of female garter snakes (Thamnophis marcianus), before, during, and after pregnancy. Gravid snakes had significantly lower locomotor performance than did non-gravid females, and performance varied among stages of gestation, reaching a minimum 0-6 weeks prior to parturition. Both number of offspring and relative clutch mass were inversely correlated with locomotor performance; as females increased these traits, locomotor ability decreased. If reduced locomotor performance results in greater risk of predation and/or lowered foraging ability, then natural selection (operating via differential mortality or feeding rates of gravid females) may result in important constraints on both clutch size and relative clutch mass in squamates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seigel</LastName><ForeName>R A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Savannah River Ecology Laboratory, Drawer E, 29802, Aiken, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Savannah River Ecology Laboratory, Drawer E, 29802, Aiken, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>N B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Savannah River Ecology Laboratory, Drawer E, 29802, Aiken, SC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Oecologia</MedlineTA><NlmUniqueID>0150372</NlmUniqueID><ISSNLinking>0029-8549</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Costs of reproduction</Keyword><Keyword MajorTopicYN="N">Life history</Keyword><Keyword MajorTopicYN="N">Locomotor ability</Keyword><Keyword MajorTopicYN="N">Snakes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>1987</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28311962</ArticleId><ArticleId IdType="doi">10.1007/BF00379404</ArticleId><ArticleId IdType="pii">10.1007/BF00379404</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oecologia. 1980 Jul;46(1):92-100</Citation><ArticleIdList><ArticleId IdType="pubmed">28310632</ArticleId></ArticleIdList></Reference><Reference><Citation>Oecologia. 1984 Mar;61(3):293-301</Citation><ArticleIdList><ArticleId IdType="pubmed">28311053</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol. 1987 Mar;252(3 Pt 2):R439-49</Citation><ArticleIdList><ArticleId IdType="pubmed">3826408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">2439848</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-4790</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>1987</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of surgical oncology</Title><ISOAbbreviation>J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives.</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>179</EndPage><MedlinePgn>173-9</MedlinePgn></Pagination><Abstract><AbstractText>The case of a young woman is presented who had a long history of oral contraceptive use and who was found to have a focal hepatic adenoma within a large spindle cell carcinoma of the liver. The pleomorphic tumor is positive for keratin and alpha 1-antitrypsin by immunohistochemistry, has intracellular lumina by electron microscopy, a moderately high thymidine labeling index, and is negative for estrogen and progesterone receptors. A review of the literature concerning liver tumors occurring in young patients indicates that there is an underlying disturbance of the hormonal milieu in all instances reported. The prognosis is widely variable and unpredictable.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grigsby</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Sicard</LastName><ForeName>G A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Lamar</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>DeSchryver-Kecskemeti</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Oncol</MedlineTA><NlmUniqueID>0222643</NlmUniqueID><ISSNLinking>0022-4790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003277">Contraceptives, Oral, Combined</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000515">alpha 1-Antitrypsin</NameOfSubstance></Chemical><Chemical><RegistryNumber>423D2T571U</RegistryNumber><NameOfSubstance UI="D004997">Ethinyl Estradiol</NameOfSubstance></Chemical><Chemical><RegistryNumber>68238-35-7</RegistryNumber><NameOfSubstance UI="D007633">Keratins</NameOfSubstance></Chemical><Chemical><RegistryNumber>8015-12-1</RegistryNumber><NameOfSubstance UI="C036657">norlestrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>T18F433X4S</RegistryNumber><NameOfSubstance UI="D009640">Norethindrone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001707" MajorTopicYN="N">Biopsy, Needle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003277" MajorTopicYN="N">Contraceptives, Oral, Combined</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004997" MajorTopicYN="N">Ethinyl Estradiol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007633" MajorTopicYN="N">Keratins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009640" MajorTopicYN="N">Norethindrone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000515" MajorTopicYN="N">alpha 1-Antitrypsin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="PIP">056304</OtherID><OtherID Source="POP">00189200</OtherID><OtherAbstract Type="PIP" Language="eng"><AbstractText>Clinical and laboratory evidence of an association of oral contraceptive (OC) use with the subsequent development of benign and malignant hepatobiliary neoplasia is growing. The authors present a case in which an adenoma within a large, multicentric anaplastic spindle cell carcinoma occurred in a woman with a long history of OC use. The patient, a 38-year-old gravida 2, para 2, was diagnosed following low-grade fevers and right upper quadrant pain. A partial hepatectomy was performed with no complications; however, a follow-up examination 2 months later revealed widespread intra-abdominal tumor recurrence histologically identical to the original tumor. Immunostaining for alpha 1 antitrypsin and keratin was strongly positive in tumor cells, indicating a biliary derivation. Electron microscopy indicated an epithelial derivation as well, including the presence of intracellular lumens, intermediary filaments, and numerous intercellular junctions. Estrogen and progesterone receptors were negative in the tumor. The tritiated thymidine labeling index was 5.05%, with an estimated potential doubling time of 11 days. This woman had no history of hepatitis, no family or personal history of neoplasms, and no known hepatotoxin exposure. The only medication used by the patient was Norlestrin, an OC containing 1 mg norethindrone and 50 mcg ethinyl estradiol that she had taken continuously for the past 8 years.</AbstractText></OtherAbstract><KeywordList Owner="PIP"><Keyword MajorTopicYN="N">Biology</Keyword><Keyword MajorTopicYN="Y">Case Studies</Keyword><Keyword MajorTopicYN="N">Contraception</Keyword><Keyword MajorTopicYN="N">Contraceptive Methods--side effects</Keyword><Keyword MajorTopicYN="N">Demographic Factors</Keyword><Keyword MajorTopicYN="N">Diseases</Keyword><Keyword MajorTopicYN="N">Family Planning</Keyword><Keyword MajorTopicYN="Y">Hepatic Effects</Keyword><Keyword MajorTopicYN="Y">Histology</Keyword><Keyword MajorTopicYN="Y">Liver Neoplasms</Keyword><Keyword MajorTopicYN="Y">Longterm Effects</Keyword><Keyword MajorTopicYN="N">Neoplasms</Keyword><Keyword MajorTopicYN="Y">Oral Contraceptives--side effects</Keyword><Keyword MajorTopicYN="N">Physiology</Keyword><Keyword MajorTopicYN="N">Population</Keyword><Keyword MajorTopicYN="N">Population Dynamics</Keyword><Keyword MajorTopicYN="N">Research Methodology</Keyword><Keyword MajorTopicYN="N">Studies</Keyword><Keyword MajorTopicYN="N">Time Factors</Keyword></KeywordList><GeneralNote Owner="PIP">TJ: JOURNAL OF SURGICAL ONCOLOGY.</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2439848</ArticleId><ArticleId IdType="doi">10.1002/jso.2930350307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3662676</PMID><DateCompleted><Year>1987</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4983</ISSN><JournalIssue CitedMedium="Print"><Volume>81</Volume><Issue>3</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of tropical medicine and parasitology</Title><ISOAbbreviation>Ann Trop Med Parasitol</ISOAbbreviation></Journal><ArticleTitle>Oxamniquine resistance in Schistosoma mansoni: fact or fiction?</ArticleTitle><Pagination><StartPage>337</StartPage><EndPage>339</EndPage><MedlinePgn>337-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeang</LastName><ForeName>F S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Liverpool School of Tropical Medicine, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Trop Med Parasitol</MedlineTA><NlmUniqueID>2985178R</NlmUniqueID><ISSNLinking>0003-4983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009600">Nitroquinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0O977R722D</RegistryNumber><NameOfSubstance UI="D010073">Oxamniquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009600" MajorTopicYN="N">Nitroquinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010073" MajorTopicYN="N">Oxamniquine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012550" MajorTopicYN="N">Schistosoma mansoni</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3662676</ArticleId><ArticleId IdType="doi">10.1080/00034983.1987.11812128</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3309178</PMID><DateCompleted><Year>1987</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>133</Volume><Issue>5</Issue><PubDate><Year>1987</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>Factors influencing the survival and multiplication of bacteriophages in calves and in their environment.</ArticleTitle><Pagination><StartPage>1127</StartPage><EndPage>1135</EndPage><MedlinePgn>1127-35</MedlinePgn></Pagination><Abstract><AbstractText>Seven phages were fairly susceptible in vitro to the lethal effect of acidified whey, more so than the enteropathogenic Escherichia coli strains on which they were active. The low acidity that prevailed in the abomasum contents of calves shortly after a milk feed had little harmful effect on orally administered organisms of these phages; they flooded into the small intestine. The high acidity that prevailed later was lethal to orally administered phage organisms; few entered the small intestine. The lethal effect could be counteracted by giving CaCO3 in the feed. Low concentrations of phage-neutralizing antibodies were found in some serum samples from human beings, cattle and pigs. Antibodies to one of the seven phages were common in the human samples and antibodies to another, phage B44/1, were common in the cattle and pig samples and in bovine colostrum. Phage B44/1 antibodies in a sample of colostral whey were destroyed at pH 3.25 or less. Giving colostrum containing phage B44/1 antibodies with CaCO3 to a calf greatly reduced the numbers of orally administered phage B44/1 organisms in its alimentary tract. Antibodies to another phage were induced in the serum of a calf suffering from E. coli diarrhoea by treating it with that phage. The phages were as susceptible as the E. coli strains to the lethal action of formaldehyde and sodium hypochlorite. In contrast to the E. coli strains, they were almost completely resistant to phenol and chloroxylenol. The in vitro virulence of 21 phages varied according to the temperature at which tests were performed.(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Institute for Animal Disease Research, Houghton Laboratory, Huntingdon, Cambridgeshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>K M</ForeName><Initials>KM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004202">Disinfectants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000018" MajorTopicYN="N">Abomasum</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001435" MajorTopicYN="N">Bacteriophages</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003126" MajorTopicYN="N">Colostrum</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004202" MajorTopicYN="N">Disinfectants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008892" MajorTopicYN="N">Milk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3309178</ArticleId><ArticleId IdType="doi">10.1099/00221287-133-5-1127</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3309177</PMID><DateCompleted><Year>1987</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>133</Volume><Issue>5</Issue><PubDate><Year>1987</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.</ArticleTitle><Pagination><StartPage>1111</StartPage><EndPage>1126</EndPage><MedlinePgn>1111-26</MedlinePgn></Pagination><Abstract><AbstractText>Seven phages highly active in vitro and in vivo against one or other of seven bovine enteropathogenic strains of Escherichia coli belonging to six different serotypes were isolated from sewage. Severe experimentally induced E. coli diarrhoea in calves could be cured by a single dose of 10(5) phage organisms. It could be prevented by doses as low as 10(2), by spraying the litter in the calf rooms with aqueous phage suspensions or simply by keeping the calves in uncleaned rooms previously occupied by calves whose E. coli infections had been treated with phage. Microbiological examinations of calves used in these experiments revealed that the phage organisms multiplied rapidly and profusely after gaining entry to the E. coli-infected small intestine, quickly reducing the E. coli to numbers that were virtually harmless. The only phage-resistant E. coli that emerged in the studies on calves infected with one or other of the seven E. coli strains were K-. These organisms were much less virulent than the K+ organisms from which they were derived and did not present a serious problem in calves given adequate amounts of colostrum. Infections produced by oral inoculation of a mixture of six strains of the E. coli could be controlled by administration of a pool of the six phages that were active against them but, in general, the control was less complete than that observed in the single-strain infections. K+ phage-resistant bacteria emerged in some of the calves used in these mixed infections and they were as virulent as their parent organisms; evidence from in vitro studies suggested that they might have arisen by genetic transfer between organisms of the different infecting strains. Infections produced by these K+ mutants and their parents could be controlled by the use of mutant phages derived from phages that were active on their parents. During the experiments with mixed E. coli infection, an extraneous phage active against one of the six E. coli strains suddenly appeared in calves kept in the same rooms. Microbiological examinations revealed that this phage was effectively controlling the multiplication of organisms of that particular strain of E. coli in the small intestines of the calves.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Institute for Animal Disease Research, Houghton Laboratory, Huntingdon, Cambridgeshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>K M</ForeName><Initials>KM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001435" MajorTopicYN="Y">Bacteriophages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3309177</ArticleId><ArticleId IdType="doi">10.1099/00221287-133-5-1111</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3296063</PMID><DateCompleted><Year>1987</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2003</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0034-5288</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Research in veterinary science</Title><ISOAbbreviation>Res Vet Sci</ISOAbbreviation></Journal><ArticleTitle>Observations on the pathogenesis of experimental Salmonella typhimurium infection in chickens.</ArticleTitle><Pagination><StartPage>194</StartPage><EndPage>199</EndPage><MedlinePgn>194-9</MedlinePgn></Pagination><Abstract><AbstractText>The virulence of Salmonella typhimurium strains for day-old chickens was examined. The mortality following oral inoculation varied from 0 to 100 per cent. Some breeds were more susceptible than others. There was no correlation between oral and parenteral virulence. Pathogenesis studies associated with one of the most virulent strains suggested that, after invasion, organisms multiplied in the liver and spleen and spread to other organs producing a systemic infection. The cause of death was probably a combination of anorexia and dehydration resulting from general malaise and diarrhoea. A virulent strain studied in detail spread through the body faster, persisted for a longer period and was more invasive than an avirulent strain. In the system studied invasiveness was the virulence determinant of overriding importance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barrow</LastName><ForeName>P A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Lovell</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Res Vet Sci</MedlineTA><NlmUniqueID>0401300</NlmUniqueID><ISSNLinking>0034-5288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="Y">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012481" MajorTopicYN="N">Salmonella Infections, Animal</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015017" MajorTopicYN="N">Yolk Sac</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3296063</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18766630</PMID><DateCompleted><Year>2008</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2008</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>1987</Year></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Maternally-derived antibody to infectious bronchitis virus: Its detection in chick trachea and serum and its role in protection.</ArticleTitle><Pagination><StartPage>407</StartPage><EndPage>416</EndPage><MedlinePgn>407-16</MedlinePgn></Pagination><Abstract><AbstractText>Chicks with maternally-derived IgG antibodies to infectious bronchitis virus (IBV) were protected against challenge with a mixture of IBV and Escherichia coli. This protective immunity lasted for at least 1 week. IBV-specific IgG was detected, using an ELISA, in the majority of tracheal washes taken from chicks aged 1 day and 1 week that had been hatched from IBV-infected hens. Some of the 2-week-old chicks also had detectable antibody. This tracheal IgG may be an important factor in mediating protective immunity. The origin and transport of the IgG into the trachea are discussed. IBV-specific IgG was detected in chick serum and had a half-life of 4.5 days. Yolk samples, collected from eggs laid by IBV-infected hens, were tested for the presence of viral-specific IgG antibodies. The sequential IgG antibody response to IBV in yolk was determined. Specific antibodies were detected at highest concentrations 16 to 18 days after infection and then declined. A second inoculation of an inactivated oil-based vaccine induced high concentrations of IBV-specific antibodies in the yolk which were maintained for the 60 days of the experiment. Detection of specific IgG in the yolk could be used as a means of assessing response to vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mockett</LastName><ForeName>A P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Houghton Poultry Research Station, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18766630</ArticleId><ArticleId IdType="doi">10.1080/03079458708436391</ArticleId><ArticleId IdType="pii">789080250</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3014052</PMID><DateCompleted><Year>1986</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2003</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1317</ISSN><JournalIssue CitedMedium="Print"><Volume>67 ( Pt 7)</Volume><PubDate><Year>1986</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of general virology</Title><ISOAbbreviation>J Gen Virol</ISOAbbreviation></Journal><ArticleTitle>Infectious bronchitis immunity: its study in chickens experimentally infected with mixtures of infectious bronchitis virus and Escherichia coli.</ArticleTitle><Pagination><StartPage>1427</StartPage><EndPage>1434</EndPage><MedlinePgn>1427-34</MedlinePgn></Pagination><Abstract><AbstractText>The live infectious bronchitis (IB) vaccine, H120, protected chickens against intranasal challenge with a mixture of Escherichia coli strains (E. coli Pool) and IB virus (IBV) strains of the same (Massachusetts) serotype as H120; it usually also protected against challenge with the E. coli Pool and IBV strains of other serological types. When these challenge strains were themselves used as vaccines they usually protected against challenge with a mixture of the E. coli Pool and an IBV strain of the Massachusetts serotype (VF69-149) or an IBV strain not of the Massachusetts serotype (HVI-116). Poor protection, when observed, was most common in those experiments involving a minority of the IBV strains that had been incriminated in recent outbreaks of disease in vaccinated flocks of chickens. Much lower concentrations of IBV strain VF69-149 and E. coli O18 were found in the nose, trachea and spleen of H120-vaccinated chickens killed at different times after they were given a mixture of these organisms than were found in these sites in similarly challenged unvaccinated chickens. Some protection against challenge with IBV and the E. coli Pool was also observed in chickens vaccinated with an inactivated IBV strain; it was much less effective than that obtained following vaccination with the corresponding live IBV strain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Virol</MedlineTA><NlmUniqueID>0077340</NlmUniqueID><ISSNLinking>0022-1317</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003332" MajorTopicYN="N">Coronaviridae</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="N">Poultry Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3014052</ArticleId><ArticleId IdType="doi">10.1099/0022-1317-67-7-1427</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3941984</PMID><DateCompleted><Year>1986</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0090-3019</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>1986</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Surgical neurology</Title><ISOAbbreviation>Surg Neurol</ISOAbbreviation></Journal><ArticleTitle>Ocular bobbing with ruptured giant distal posterior inferior cerebellar artery aneurysm.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>152</EndPage><MedlinePgn>149-52</MedlinePgn></Pagination><Abstract><AbstractText>A patient presented comatose with an intraventricular hemorrhage of unknown etiology, and manifested the unusual clinical phenomenon of ocular bobbing. Further evaluation revealed a giant aneurysm of the distal posterior inferior cerebellar artery, which was successfully treated surgically. The pathophysiology of ocular bobbing is discussed as well as the association of this unusual sign with a rare aneurysm.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osenbach</LastName><ForeName>R K</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Blumenkopf</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>McComb</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Neurol</MedlineTA><NlmUniqueID>0367070</NlmUniqueID><ISSNLinking>0090-3019</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000783" MajorTopicYN="N">Aneurysm</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005133" MajorTopicYN="Y">Eye Movements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011149" MajorTopicYN="N">Pons</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3941984</ArticleId><ArticleId IdType="doi">10.1016/0090-3019(86)90284-3</ArticleId><ArticleId IdType="pii">0090-3019(86)90284-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">18766511</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2008</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0307-9457</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>1986</Year></PubDate></JournalIssue><Title>Avian pathology : journal of the W.V.P.A</Title><ISOAbbreviation>Avian Pathol</ISOAbbreviation></Journal><ArticleTitle>Newly isolated serotypes of infectious bronchitis virus: their role in disease.</ArticleTitle><Pagination><StartPage>129</StartPage><EndPage>138</EndPage><MedlinePgn>129-38</MedlinePgn></Pagination><Abstract><AbstractText>The pathogenicity of isolates of infectious bronchitis virus (IBV) made from broiler or breeder flocks in Britain between 1981 and 1983, together with three made from flocks of commercial laying hens during 1984, has been investigated. When 11-day-old IBV-free chicks were challenged with these IBV isolates, together with a pool of pathogenic strains of E. coli, some mortality was recorded, together with a high incidence of morbidity. Three IBV isolates, when given to groups of IBV-free brown-egg laying hens, caused only a minimal effect on egg production but markedly affected egg shell colour.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Houghton Poultry Research Station, Houghton, Huntingdon, Cambridgeshire, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Avian Pathol</MedlineTA><NlmUniqueID>8210638</NlmUniqueID><ISSNLinking>0307-9457</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18766511</ArticleId><ArticleId IdType="doi">10.1080/03079458608436272</ArticleId><ArticleId IdType="pii">789079632</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">4075680</PMID><DateCompleted><Year>1986</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0363-9762</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>1985</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Clinical nuclear medicine</Title><ISOAbbreviation>Clin Nucl Med</ISOAbbreviation></Journal><ArticleTitle>Right pulmonary vein occlusion detected by ventilation-perfusion lung scanning.</ArticleTitle><Pagination><StartPage>827</StartPage><EndPage>828</EndPage><MedlinePgn>827-8</MedlinePgn></Pagination><Abstract><AbstractText>Absence of perfusion of a right lung was initially misinterpreted as pulmonary embolic disease. Pulmonary angiography revised this diagnosis to obstruction of the right pulmonary vein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hartshorne</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Bauman</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Cawthon</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Nucl Med</MedlineTA><NlmUniqueID>7611109</NlmUniqueID><ISSNLinking>0363-9762</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013668">Technetium Tc 99m Aggregated Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014980">Xenon Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011667" MajorTopicYN="N">Pulmonary Veins</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013668" MajorTopicYN="N">Technetium Tc 99m Aggregated Albumin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="N">Vascular Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014692" MajorTopicYN="N">Ventilation-Perfusion Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014980" MajorTopicYN="N">Xenon Radioisotopes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1985</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4075680</ArticleId><ArticleId IdType="doi">10.1097/00003072-198511000-00024</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">4069332</PMID><DateCompleted><Year>1986</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-396X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>1985</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Neurosurgery</Title><ISOAbbreviation>Neurosurgery</ISOAbbreviation></Journal><ArticleTitle>Tuberous sclerosis and multiple intracranial aneurysms: case report.</ArticleTitle><Pagination><StartPage>797</StartPage><EndPage>800</EndPage><MedlinePgn>797-800</MedlinePgn></Pagination><Abstract><AbstractText>A 6-year-old girl with tuberous sclerosis was found to have multiple intracranial fusiform arterial aneurysms. This represents the fifth reported case of this association. The concepts of an arterial dysplasia being present in cases of tuberous sclerosis and of developmental defects being the cause of some intracranial aneurysms are discussed. The need for a prospective study to assess the prevalence of intracranial aneurysms in patients with tuberous sclerosis is suggested.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blumenkopf</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurosurgery</MedlineTA><NlmUniqueID>7802914</NlmUniqueID><ISSNLinking>0148-396X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002533" MajorTopicYN="N">Cerebral Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002536" MajorTopicYN="N">Cerebral Arteries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002548" MajorTopicYN="N">Cerebral Revascularization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002532" MajorTopicYN="N">Intracranial Aneurysm</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014402" MajorTopicYN="N">Tuberous Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1985</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4069332</ArticleId><ArticleId IdType="doi">10.1227/00006123-198511000-00012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3905956</PMID><DateCompleted><Year>1986</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1724</ISSN><JournalIssue CitedMedium="Print"><Volume>95</Volume><Issue>2</Issue><PubDate><Year>1985</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of hygiene</Title><ISOAbbreviation>J Hyg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice.</ArticleTitle><Pagination><StartPage>363</StartPage><EndPage>374</EndPage><MedlinePgn>363-74</MedlinePgn></Pagination><Abstract><AbstractText>The virulence of intracranially-inoculated mutant forms of an O18ac:K1:H7 ColV+ strain of Escherichia coli (designated MW) that lacked different combinations of its O and K antigens and ColV, and of an E. coli K12 strain to which these characters had been transmitted was studied in mice, chickens, ducks and guinea-pigs. The O18+K1+ColV+ form of MW was highly virulent for chickens and mice but the corresponding form of K12 was only highly virulent for chickens; the O18-K1-ColV- forms of both strains were of low virulence for chickens and mice. K1 was more important than O18 or ColV in determining virulence for both animal species. Ducks and guinea-pigs resembled chickens, not mice, in their response to infection with the O18+K1+ColV+form of K12. Pathogenesis studies revealed that the virulence of the forms of MW and K12 was associated with their ability to proliferate in the central nervous system; only low numbers of organisms were found in the blood and spleen of inoculated animals. The O18+K1+ColV+ form of K12 multiplied in mouse brain and in mouse blood in vitro; its multiplication in chicken blood was partially inhibited. Agglutinins to this and other forms of K12 were found in chicken serum but not in mouse serum. Large doses of mouse serum given to chickens and large doses of chicken serum given to mice did not alter the manner in which these animals responded to K12 O18+K1+ColV+ infection. Vaccination protected chickens and mice against lethal intracranial infection with the O18+K1+ColV+ forms of K12 or MW; it produced a much stronger immunity in mice against intraperitoneal challenge than against intracranial challenge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hyg (Lond)</MedlineTA><NlmUniqueID>0375374</NlmUniqueID><ISSNLinking>0022-1724</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003086" MajorTopicYN="N">Bacteriocin Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004372" MajorTopicYN="N">Ducks</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005798" MajorTopicYN="N">Genes, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1985</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1985</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3905956</ArticleId><ArticleId IdType="pmc">PMC2129539</ArticleId><ArticleId IdType="doi">10.1017/s0022172400062781</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1979 Jun 28;279(5716):778-81</Citation><ArticleIdList><ArticleId IdType="pubmed">377103</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1979 Dec;26(3):925-32</Citation><ArticleIdList><ArticleId IdType="pubmed">160892</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 1980 Jul;143(1):35-42</Citation><ArticleIdList><ArticleId IdType="pubmed">6995437</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1980 Aug;29(2):411-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7011976</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1980 Dec;121(2):387-400</Citation><ArticleIdList><ArticleId IdType="pubmed">7021764</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1984 Feb;149(2):184-93</Citation><ArticleIdList><ArticleId IdType="pubmed">6199436</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1983 Apr;40(1):359-68</Citation><ArticleIdList><ArticleId IdType="pubmed">6339405</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1983 Dec;42(3):907-13</Citation><ArticleIdList><ArticleId IdType="pubmed">6196296</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1984 Feb;43(2):684-92</Citation><ArticleIdList><ArticleId IdType="pubmed">6198283</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1984 Mar;43(3):947-53</Citation><ArticleIdList><ArticleId IdType="pubmed">6365788</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1982 Feb;35(2):654-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7035371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">4040453</PMID><DateCompleted><Year>1985</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0149-936X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>1985</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of computed tomography</Title><ISOAbbreviation>J Comput Tomogr</ISOAbbreviation></Journal><ArticleTitle>Computed tomography detection of cervical spinal cord hemangioblastoma: a case report.</ArticleTitle><Pagination><StartPage>249</StartPage><EndPage>252</EndPage><MedlinePgn>249-52</MedlinePgn></Pagination><Abstract><AbstractText>Hemangioblastomas of the spinal cord are uncommon, accounting for 1.6% and 2.1% of all spinal cord tumors (1). Until recently these vascular lesions were best evaluated angiographically. Several cervical hemangioblastomas have been studied by computed tomography with intravenous contrast medium enhancement (2-4). This report illustrates the use of computed tomography with combined intravenous and intrathecal contrast medium enhancement, which permitted preoperative diagnosis and treatment planning of an intramedullary hemangioblastoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Keefe</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>H</ForeName><Initials>H</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>W F</ForeName><Initials>WF</Initials></Author><Author ValidYN="Y"><LastName>Blumenkopf</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Comput Tomogr</MedlineTA><NlmUniqueID>7805373</NlmUniqueID><ISSNLinking>0149-936X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006394" MajorTopicYN="N">Hemangiosarcoma</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013120" MajorTopicYN="N">Spinal Cord Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4040453</ArticleId><ArticleId IdType="doi">10.1016/0149-936x(85)90070-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">3884734</PMID><DateCompleted><Year>1985</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>131</Volume><Issue>2</Issue><PubDate><Year>1985</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>The toxic role of alpha-haemolysin in the pathogenesis of experimental Escherichia coli infection in mice.</ArticleTitle><Pagination><StartPage>395</StartPage><EndPage>403</EndPage><MedlinePgn>395-403</MedlinePgn></Pagination><Abstract><AbstractText>Filtrates from strains of Escherichia coli possessing plasmid-cloned haemolysin (Hly) genes and from strains possessing 'wild' Hly plasmids were lethal for mice on intravenous inoculation; similar doses of preparations from derivatives of these strains in which the Hly genes had been rendered non-functional or which did not possess the 'wild' plasmids were not. Live cultures of both kinds of Hly+ strain usually had a lower lethal dose for mice on intraperitoneal inoculation than the corresponding Hly- forms. Mice that had been inoculated with Hly+ forms had shorter survival times and lower numbers of organisms in peritoneal washings, lungs and blood at point of death than mice that had been inoculated with the corresponding Hly- forms; this was also so for mice pre-treated with FeSO4, a procedure which rendered mice equally susceptible to the lethal effects of the Hly+ and Hly- forms of a strain. In FeSO4-treated mice the numbers of organisms in the tissues of those dying from infection with Hly+ organisms were no higher than they were at the same time after inoculation in others given the corresponding Hly- forms; before mice of the latter category died the numbers of organisms in their tissues increased greatly. The clinical and pathological signs exhibited by mice inoculated with Hly+ organisms, but not with Hly- organisms, resembled those exhibited by mice inoculated with bacteria-free haemolysin preparations. These results suggest that haemolysin played a significant role in the pathogenesis of the disease produced by the Hly+ organisms by having a direct toxic action on the host.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029968">Escherichia coli Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006460">Hemolysin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036507">Hlya protein, E coli</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029968" MajorTopicYN="Y">Escherichia coli Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005798" MajorTopicYN="N">Genes, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006460" MajorTopicYN="N">Hemolysin Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010537" MajorTopicYN="N">Peritoneum</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1985</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3884734</ArticleId><ArticleId IdType="doi">10.1099/00221287-131-2-395</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">10267519</PMID><DateCompleted><Year>1984</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2009</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0300-0508</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>1984</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Physiotherapy Canada. Physiotherapie Canada</Title><ISOAbbreviation>Physiother Can</ISOAbbreviation></Journal><ArticleTitle>A training program for operation of a head-controlled electric wheelchair.</ArticleTitle><Pagination><StartPage>204</StartPage><EndPage>207</EndPage><MedlinePgn>204-7</MedlinePgn></Pagination><Abstract><AbstractText>A biofeedback training device providing auditory and visual feedback regarding head position in space was used to teach the head control necessary for the operation of a head-driven electric wheelchair. A case study of an adolescent with severe athetoid cerebral palsy is presented. The training program consists of four short-term goals: to provide trunk stability; to promote limb and postural control; to teach static head control; and to teach dynamic head control. The authors found that the biofeedback training device was a useful tool for teaching the head control required to operate a head-driven electric wheelchair. Among the recommendations discussed in the conclusion of this paper is the suggestion that certain pieces of equipment, such as a time-event counter and videotape equipment, would be very useful tools for collecting objective information about the patient's progress.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gallen</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Physiother Can</MedlineTA><NlmUniqueID>0346574</NlmUniqueID><ISSNLinking>0300-0508</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006743" MajorTopicYN="N">Hospital Bed Capacity, under 100</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014910" MajorTopicYN="Y">Wheelchairs</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1984</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1984</Year><Month>6</Month><Day>9</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1984</Year><Month>6</Month><Day>9</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10267519</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">6419173</PMID><DateCompleted><Year>1984</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0026-4075</ISSN><JournalIssue CitedMedium="Print"><Volume>148</Volume><Issue>12</Issue><PubDate><Year>1983</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Military medicine</Title><ISOAbbreviation>Mil Med</ISOAbbreviation></Journal><ArticleTitle>Transhepatic removal of impacted intrahepatic and common duct stones: case report.</ArticleTitle><Pagination><StartPage>935</StartPage><EndPage>937</EndPage><MedlinePgn>935-7</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Fenster</LastName><ForeName>H A</ForeName><Initials>HA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mil Med</MedlineTA><NlmUniqueID>2984771R</NlmUniqueID><ISSNLinking>0026-4075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002404" MajorTopicYN="N">Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002769" MajorTopicYN="N">Cholelithiasis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042882" MajorTopicYN="N">Gallstones</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1983</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1983</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1983</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6419173</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">6355391</PMID><DateCompleted><Year>1983</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2005</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>129</Volume><Issue>8</Issue><PubDate><Year>1983</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs.</ArticleTitle><Pagination><StartPage>2659</StartPage><EndPage>2675</EndPage><MedlinePgn>2659-75</MedlinePgn></Pagination><Abstract><AbstractText>A mixture of two phages, B44/1 and B44/2, protected calves against a potentially lethal oral infection with an O9:K30,99 enteropathogenic strain of Escherichia coli, called B44, when given before, but not after, the onset of diarrhoea; a mixture in which phage B44/3 was replaced by phage B44/3 was effective after the onset of diarrhoea. Calves that responded to phage treatment had much lower numbers of E. coli B44 in their alimentary tract than untreated calves. Usually, high numbers of phage B44/1 and rather lower numbers of phage B44/2 or B44/3 were present in the alimentary tract of these animals. At death, most calves that had not responded to treatment with phages B44/1 and B44/2 had high numbers of mutants of E. coli B44 resistant to phage B44/1 in their small intestine. Phage-treated calves that survived E. coli infection continued to excrete phage in their faeces, at least until the numbers of E. coli B44 also excreted were low. The phages survived longer than E. coli B44 in faecal samples taken from phage-treated calves and exposed to the atmosphere in an unheated animal house. Calves inoculated orally with faecal samples from phage-treated calves that contained sufficient E. coli B44 to cause a lethal infection remained healthy. A mixture of two phages, P433/1 and P433/2, and phage P433/1 alone cured diarrhoea in piglets caused by an O20:K101,987P strain of E. coli called P433. The numbers of the infecting bacteria and phages in the alimentary tract of the piglets resembled those in the calves. Another phage given to lambs 8 h after they were infected with an O8:K85,99 enteropathogenic strain of E. coli, called S13, reduced the numbers of these organisms in the alimentary tract and had an ameliorating effect on the course of the disease. No phage-resistant mutants of E. coli S13 were isolated from the lambs. The only mutants of E. coli B44 and P433 that emerged in the calves and piglets were K30- or K101- and resistant to phage B44/1 or P433/1 respectively; those tested were much less virulent than their parent strains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003090" MajorTopicYN="Y">Coliphages</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003126" MajorTopicYN="N">Colostrum</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008242" MajorTopicYN="N">Lysogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1983</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1983</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1983</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6355391</ArticleId><ArticleId IdType="doi">10.1099/00221287-129-8-2659</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">6222502</PMID><DateCompleted><Year>1983</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0039-6060</ISSN><JournalIssue CitedMedium="Print"><Volume>94</Volume><Issue>1</Issue><PubDate><Year>1983</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Surgery</Title><ISOAbbreviation>Surgery</ISOAbbreviation></Journal><ArticleTitle>Percutaneous transluminal balloon angioplasty of the iliac artery for contralateral ischemia.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>103</EndPage><MedlinePgn>100-3</MedlinePgn></Pagination><Abstract><AbstractText>The cases of three patients with lower extremity ischemia from ipsilateral iliac artery occlusion and contralateral iliac artery stenosis are presented. Planned treatment was percutaneous transluminal angioplasty (PTA) of the contralateral iliac artery, rendering it an adequate donor vessel for subsequent femorofemoral bypass. Because of adequate collateral vessels across the pelvis, cross-femoral bypass was unnecessary following PTA. Current technology allows simultaneous intraoperative PTA and femorofemoral bypass. We do not recommend this on the basis of our experience.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Youkey</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Clagett</LastName><ForeName>G P</ForeName><Initials>GP</Initials></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Nodalo</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Salander</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>N M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>Hutton</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surgery</MedlineTA><NlmUniqueID>0417347</NlmUniqueID><ISSNLinking>0039-6060</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000800" MajorTopicYN="N">Angioplasty, Balloon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003097" MajorTopicYN="N">Collateral Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007083" MajorTopicYN="Y">Iliac Artery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1983</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6222502</ArticleId><ArticleId IdType="pii">0039-6060(83)90171-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">6842772</PMID><DateCompleted><Year>1983</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>249</Volume><Issue>19</Issue><PubDate><Year>1983</Year><Month>May</Month><Day>20</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Intramuscular hemangioma.</ArticleTitle><Pagination><StartPage>2680</StartPage><EndPage>2682</EndPage><MedlinePgn>2680-2</MedlinePgn></Pagination><Abstract><AbstractText>In two cases of intramuscular hemangioma of the paraspinous muscles, the tumors were treated with arteriographic embolization followed by immediate local excision. We found that this technique creates a hypovascular surgical field and facilitates the dissection. We believe this approach will decrease morbidity and potential mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Youkey</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Clagett</LastName><ForeName>G P</ForeName><Initials>GP</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Nadalo</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>d'Avis</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="N">Embolization, Therapeutic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006391" MajorTopicYN="Y">Hemangioma</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009135" MajorTopicYN="Y">Muscular Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1983</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1983</Year><Month>5</Month><Day>20</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1983</Year><Month>5</Month><Day>20</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6842772</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7042903</PMID><DateCompleted><Year>1982</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>128</Volume><Issue>2</Issue><PubDate><Year>1982</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics.</ArticleTitle><Pagination><StartPage>307</StartPage><EndPage>318</EndPage><MedlinePgn>307-18</MedlinePgn></Pagination><Abstract><AbstractText>Anti-K 1 phages were more active in vitro and in vivo against an 018:K1:H7 ColV+ Escherichia coli strain, designated MW, than were other phages. A single intramuscular dose of one anti-K1 phage was more effective than multiple intramuscular does of tetracycline, ampicillin, chloramphenicol, or trimethoprim plus sulphafurazole in curing mice of a potentially lethal intramuscularly or intracerebrally induced infection of MW; it was at least as effective as multiple intramuscular doses of streptomycin. When MW and the phage were inoculated into different gastrocnemius muscles of the same mice, a rapid reduction in numbers of MW organisms occurred in the MW-inoculated muscle and in other tissues; the numbers of phage particles in the MW-inoculated muscle increased rapidly and greatly. MW failed to proliferate in the brains of intracerebrally infected mice that had been inoculated intramuscularly with the phage at the same time; many more phage particles were found in the brains of these mice than in other sites. The few phage-resistant mutants of MW found in the phage-treated mich were K1-; previous studies had shown such mutants to be of greatly reduced virulence. The phage administered intramuscularly 3-5 d before challenge with a potentially lethal intramuscularly induced infection of MW was protective, the protective effect varying between phage propagated on different bacterial strains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003090" MajorTopicYN="Y">Coliphages</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1982</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1982</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1982</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7042903</ArticleId><ArticleId IdType="doi">10.1099/00221287-128-2-307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7067574</PMID><DateCompleted><Year>1982</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0163-2116</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>1982</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Digestive diseases and sciences</Title><ISOAbbreviation>Dig Dis Sci</ISOAbbreviation></Journal><ArticleTitle>Adult acquired antral web.</ArticleTitle><Pagination><StartPage>80</StartPage><EndPage>83</EndPage><MedlinePgn>80-3</MedlinePgn></Pagination><Abstract><AbstractText>Gastric antral webs in adults have been considered to be either congenital or acquired lesions. We present the first radiographically documented progression from a normal antrum to the development of an antral ulcer followed by healing with web formation. In a single study we feel that irregularity of the web and deformity or eccentricity of the antrum favor an acquired rather than a congenital web. Obtaining prior radiographs as well as follow-up examinations may be the only way to prove association with peptic disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Lichtenstein</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Bova</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dig Dis Sci</MedlineTA><NlmUniqueID>7902782</NlmUniqueID><ISSNLinking>0163-2116</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011706" MajorTopicYN="Y">Pyloric Antrum</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013272" MajorTopicYN="N">Stomach Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013276" MajorTopicYN="N">Stomach Ulcer</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1982</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1982</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1982</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7067574</ArticleId><ArticleId IdType="doi">10.1007/BF01308125</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Radiol. 1968 Jan;19(1):95-9</Citation><ArticleIdList><ArticleId IdType="pubmed">5648349</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1959 Sep;47:162-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14439727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointest Endosc. 1976 Nov;23(2):88-90</Citation><ArticleIdList><ArticleId IdType="pubmed">992289</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 1979 Dec;133(6):1105-11</Citation><ArticleIdList><ArticleId IdType="pubmed">116501</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointest Radiol. 1976;1(1):37-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1052443</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 1966 May;45(5):366-73</Citation><ArticleIdList><ArticleId IdType="pubmed">5930786</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 1969 Mar;92 (3):513-7</Citation><ArticleIdList><ArticleId IdType="pubmed">5774960</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 1971 Jul;100(1):27-35</Citation><ArticleIdList><ArticleId IdType="pubmed">5147036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 1977 Oct;52(10 ):650-3</Citation><ArticleIdList><ArticleId IdType="pubmed">909317</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1949 Oct;37(146):244-6, illust</Citation><ArticleIdList><ArticleId IdType="pubmed">15395097</ArticleId></ArticleIdList></Reference><Reference><Citation>AMA Arch Pathol. 1953 Mar;55(3):223-6</Citation><ArticleIdList><ArticleId IdType="pubmed">13030042</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ky State Med Assoc. 1956 Feb;54(2):149-51</Citation><ArticleIdList><ArticleId IdType="pubmed">13295653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointest Endosc. 1977 Aug;24(1):33-4</Citation><ArticleIdList><ArticleId IdType="pubmed">892396</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Roentgenol Radium Ther Nucl Med. 1974 Jun;121(2):236-47</Citation><ArticleIdList><ArticleId IdType="pubmed">4846550</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1959 Mar;46(199):534-40</Citation><ArticleIdList><ArticleId IdType="pubmed">13651639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7028759</PMID><DateCompleted><Year>1982</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0008-2902</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>1981</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of the Canadian Association of Radiologists</Title><ISOAbbreviation>J Can Assoc Radiol</ISOAbbreviation></Journal><ArticleTitle>Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.</ArticleTitle><Pagination><StartPage>164</StartPage><EndPage>165</EndPage><MedlinePgn>164-5</MedlinePgn></Pagination><Abstract><AbstractText>A prospectively randomized trial in advanced gastric and pancreatic carcinoma compared multi-drug chemotherapy, with and without radiotherapy to the local lesion, in terms of median survival and toxicity. Of 29 patients with gastric adenocarcinoma, 14 were randomized to receive 5-FU and Methyl-CCNU, and 15 to receive 5-FU and local radiotherapy to a dose of 4600 rad, and then Methyl-CCNU. Thirty patients with advanced adenocarcinoma of the pancreas were similarly randomized. There was no significant difference between the two arms of the gastric or pancreatic adenocarcinoma groups, with a median survival of 13 months and 11.5 months respectively in gastric carcinoma, and 7.8 months and 7.3 months in pancreatic carcinoma. Complications were minimal in both groups. There was more hematopoietic depression in the radiation-treated patients, but none had radiotherapy discontinued because of toxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hazel</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Thirlwell</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Maksymiuk</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>MacFarlane</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Can Assoc Radiol</MedlineTA><NlmUniqueID>7505589</NlmUniqueID><ISSNLinking>0008-2902</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009607">Nitrosourea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>13909-09-6</RegistryNumber><NameOfSubstance UI="D012673">Semustine</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009607" MajorTopicYN="N">Nitrosourea Compounds</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012673" MajorTopicYN="N">Semustine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1981</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1981</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1981</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7028759</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7021764</PMID><DateCompleted><Year>1981</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2006</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>121</Volume><Issue>2</Issue><PubDate><Year>1980</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.</ArticleTitle><Pagination><StartPage>387</StartPage><EndPage>400</EndPage><MedlinePgn>387-400</MedlinePgn></Pagination><Abstract><AbstractText>From an O18ac:K1:H7 ColV+ strain of Escherichia coli (designated MW) that had caused meningitis in a human baby, mutant forms were isolated that lacked different combinations of its O, K and H antigens and its ColV plasmid. These characters were also transmitted by conjugation to E. coli K12 and the virulence, immunogenicity and other properties of the different forms of both strains were studied. All the forms of the MW strain that lacked either the O18 or K1 antigens or the ColV plasmid, but not the H7 antigen, were much less virulent for chickens and mice than the parent form of MW. Another form derived by N-methyl-N'-nitro-N-nitrosoguanidine (NTG) treatment of the parent strain and that possessed all these four characters was also much less virulent. Some of the forms of the K12 strain to which the characters had been transferred were slightly more virulent than the K12 parent, but the virulence of all of them, including one possessing the O18 and K1 antigens and the ColV plasmid, did not approach that of the MW parent. Pathogenesis studies in chickens and colostrum-deprived calves revealed that the loss of virulence exhibited by the forms of the MW strain that lacked O18, K1 and ColV and by the NTG-derived form was associated with decreased ability to invade the body. This was also the reason for the ow virulence of the forms of the K12 strain that had acquired these characters. Possession of both the O18 and K1 antigens was largely responsible for the ability of the different forms of the MW strain to survive in fresh chicken serum; organisms of K12 that possessed the K1 antigen survived as long as those of the parent form of the MW strain. A substantial degree of immunity against lethal infection with the parent form of the MW strain was produced in chickens and mice by all the forms of the MW and K12 strains that possessed the O18 antigen. The K1 and H7 antigens and the ColV plasmid produced no detectable immunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="Y">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1980</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1980</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1980</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7021764</ArticleId><ArticleId IdType="doi">10.1099/00221287-121-2-387</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">7365024</PMID><DateCompleted><Year>1980</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0363-8715</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>2</Issue><PubDate><Year>1980</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of computer assisted tomography</Title><ISOAbbreviation>J Comput Assist Tomogr</ISOAbbreviation></Journal><ArticleTitle>Left atrial myxoma: computed tomography as a diagnostic modality.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>255</EndPage><MedlinePgn>253-5</MedlinePgn></Pagination><Abstract><AbstractText>The workup of left atrial myxomas has variably ranged from a physical examination, laboratory tests, and echocardiography to the invasive modalities of angiography and cardiac surgery. We propose that computed tomography (CT) be considered a sensitive, noninvasive adjuvant in the diagnosis of these tumors. This report describes successful utilization of CT imaging in one such case of proven left atrial myxoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Schnapf</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Brott</LastName><ForeName>W H</ForeName><Initials>WH</Initials></Author><Author ValidYN="Y"><LastName>Sinnott</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Shawl</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Comput Assist Tomogr</MedlineTA><NlmUniqueID>7703942</NlmUniqueID><ISSNLinking>0363-8715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006325" MajorTopicYN="N">Heart Atria</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006338" MajorTopicYN="N">Heart Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009232" MajorTopicYN="N">Myxoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1980</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1980</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1980</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7365024</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">390157</PMID><DateCompleted><Year>1980</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2003</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2615</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>1979</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of medical microbiology</Title><ISOAbbreviation>J Med Microbiol</ISOAbbreviation></Journal><ArticleTitle>Experimental infection of calves, piglets and lambs with mixtures of invasive and enteropathogenic strains of Escherichia coli.</ArticleTitle><Pagination><StartPage>507</StartPage><EndPage>510</EndPage><MedlinePgn>507-10</MedlinePgn></Pagination><Abstract><AbstractText>Mixtures of mutant organisms of an invasive (IN) strain, a strain enteropathogenic (EP) for calves, lambs and piglets, and a non-pathogenic (NP) strain of Escherichia coli, that could be differentiated from each other by their antibiotic resistances, were given orally to an immunoglobulin-negative (IG-) and an immunoglobulin-positive (IG+) calf, lamb and piglet. By the use of appropriate antibiotic-containing culture media, the concentrations of organisms of each of the three strains in the contents of the alimentary tracts and tissues (liver, spleen, kidney, blood and mesenteric lymph glands) of the animals were estimated when they were killed. In the three IG- animals, the IN strain proliferated in the tissues and the EP strain proliferated in the small intestines; in general, the concentrations of the IN strain in the small intestines and the EP strain in the tissues, apart from the mesenteric lymph glands, were as low as those of the NP strain in these sites. The only strain that proliferated in the small intestine of the IG+ animals was the EP strain, which proliferated in the small intestine of the calf and piglet; no organisms of either strain were isolated from the tissues of these three animals, except from their mesenteric lymph glands.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Microbiol</MedlineTA><NlmUniqueID>0224131</NlmUniqueID><ISSNLinking>0022-2615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000361" MajorTopicYN="N">Agammaglobulinemia</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002418" MajorTopicYN="N">Cattle Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012757" MajorTopicYN="N">Sheep Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013553" MajorTopicYN="N">Swine Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1979</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1979</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1979</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">390157</ArticleId><ArticleId IdType="doi">10.1099/00222615-12-4-507</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">370346</PMID><DateCompleted><Year>1979</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2006</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>109</Volume><Issue>2</Issue><PubDate><Year>1978</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>The effect of plasmid-determined and other characteristics on the survival of Escherichia coli in the alimentary tract of two human beings.</ArticleTitle><Pagination><StartPage>375</StartPage><EndPage>379</EndPage><MedlinePgn>375-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002876" MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="Y">Plasmids</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1978</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1978</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1978</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">370346</ArticleId><ArticleId IdType="doi">10.1099/00221287-109-2-375</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">364065</PMID><DateCompleted><Year>1979</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2006</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2615</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>1978</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of medical microbiology</Title><ISOAbbreviation>J Med Microbiol</ISOAbbreviation></Journal><ArticleTitle>The influence of plasmid-determined and other characteristics of enteropathogenic Escherichia coli on their ability to proliferate in the alimentary tracts of piglets, calves and lambs.</ArticleTitle><Pagination><StartPage>471</StartPage><EndPage>492</EndPage><MedlinePgn>471-92</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Microbiol</MedlineTA><NlmUniqueID>0224131</NlmUniqueID><ISSNLinking>0022-2615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004768">Enterotoxins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004768" MajorTopicYN="N">Enterotoxins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011815" MajorTopicYN="N">R Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1978</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">364065</ArticleId><ArticleId IdType="doi">10.1099/00222615-11-4-471</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">335071</PMID><DateCompleted><Year>1977</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2615</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>1977</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of medical microbiology</Title><ISOAbbreviation>J Med Microbiol</ISOAbbreviation></Journal><ArticleTitle>Treatment of experimental Escherichia coli infection in mice with colicine V.</ArticleTitle><Pagination><StartPage>479</StartPage><EndPage>482</EndPage><MedlinePgn>479-82</MedlinePgn></Pagination><Abstract><AbstractText>Concentrated non-toxic preparations of colicine V were obtained by filtering centrifugates of soft-agar cultures of a Col V+ K12 strain of E. coli through Millipore filters in which the colicine V was retained. These preparations, given subcutaneously, favourably influenced the course of disease in mice infected intraperitoneally with a pathogenic strain of E. coli that was very sensitive to colicine V in vitro. A beneficial effect was noted even when treatment was delayed until the mice were visibly ill.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Microbiol</MedlineTA><NlmUniqueID>0224131</NlmUniqueID><ISSNLinking>0022-2615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003087">Colicins</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y45QSO73OB</RegistryNumber><NameOfSubstance UI="D013307">Streptomycin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003087" MajorTopicYN="N">Colicins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004927" MajorTopicYN="N">Escherichia coli Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013307" MajorTopicYN="N">Streptomycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1977</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1977</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1977</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">335071</ArticleId><ArticleId IdType="doi">10.1099/00222615-10-4-479</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">916734</PMID><DateCompleted><Year>1977</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0024-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>1977</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Macromolecules</Title><ISOAbbreviation>Macromolecules</ISOAbbreviation></Journal><ArticleTitle>The structure of alpha-keratin.</ArticleTitle><Pagination><StartPage>893</StartPage><EndPage>898</EndPage><MedlinePgn>893-8</MedlinePgn></Pagination><Abstract><AbstractText>Known structural principles (close packing, maximum hydrogen bonding, the tendency of like groups to be surrounded in like manner, and the approximate constancy of interatomic distances and bond angles) are used, with meridional and equatorial x-ray data, to deduce and check the structure pattern for alpha-keratin. Internally hydrogen-bonded polypeptide helices are grouped into "3-stacks", in which each chain is rotated and shifted vertically a distance equal to the helix pitch (5.15 A, average), relative to the other two. This shift accounts simply for the meridional x-ray reflection at this spacing. The 3-stack structure repeats after three turns, except for differences in the R groups and a slight twist, required to give satisfaction of both intrachain and interchain forces. The 3-stacks are grouped into 9-stacks and these into 27-stacks (all twisting), giving a crystallographic unit containing 81 chains, with the chain axes spaced approximately like those of close-packed cylinders. When the twisting reaches the limit of stability for good interchain contacting and cross-linking, the residue/turn ratio in each chain helix shifts to another, with twisting in the opposite direction. The twisting reversal mechanism keeps all the helix axes approximately straight, parallel, and in a close-packed arrangement. Interchain distances and orientations are suitable for cystine cross-linking. The dimensions of the 27-stacks agree well with estimates of the "effective radius" of microfibrils. X-ray measurements of spacing changes during fiber extension are explained as due to alternation of zones with much cross-linking and zones with few cross-links.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Macromolecules</MedlineTA><NlmUniqueID>0365316</NlmUniqueID><ISSNLinking>0024-9297</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>68238-35-7</RegistryNumber><NameOfSubstance UI="D007633">Keratins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055598" MajorTopicYN="N">Chemical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002621" MajorTopicYN="N">Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007633" MajorTopicYN="Y">Keratins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1977</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1977</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1977</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">916734</ArticleId><ArticleId IdType="doi">10.1021/ma60059a004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">768410</PMID><DateCompleted><Year>1976</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>92</Volume><Issue>2</Issue><PubDate><Year>1976</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract.</ArticleTitle><Pagination><StartPage>335</StartPage><EndPage>350</EndPage><MedlinePgn>335-50</MedlinePgn></Pagination><Abstract><AbstractText>A high proportion of invasive strains of Escherichia coli produced colicine V. This property was easily eliminated from 20 of 21 of these strains by 'curing' agents, especially sodium lauryl sulphate, indicating that the genes determining it were located on a plasmid (ColV) which was transmitted from ten of the strains by conjugation. Inoculated intramuscularly, the ColV- forms of all 17 strains tested were less pathogenic for chickens than the corresponding ColV+ forms. The pathogenicity of the ColV- forms of four strains was increased, usually to that of the ColV+ form from which they were derived, by implanting other ColV determinants in them. Much higher concentrations of organisms were found in the blood and liver of chickens infected with ColV+ forms than in chickens infected with ColV- forms. Inoculated intraperitoneally, the ColV+ form of one of the strains, BI88, was more pathogenic for mice than the ColV- form; much higher concentrations of organisms were found in the peritoneal fluid and blood of ColV+-inoculated mice than of ColV--inoculated mice. Inoculated orally and intravenously, ColV+ forms were more pathogenic for colostrum-deprived calves than the corresponding ColV- forms. After mixtures of ColV+ and ColV- organisms of the same strain in ratios of 1:10,1:100 or 1:1000 were given orally, they were found in a similar ratio in the contents of the alimentary tract 1 to 2 days later, when the calves were near to death. Many more ColV+ than ColV- organisms were found in the mesenteric lymph nodes, the deeper tissues and the blood; in the urinary and gall bladders, locations remote from the defence mechanisms of the body, the numbers of ColV- organisms sometimes exceeded those of ColV+ organisms. Colicine V, although demonstrated in the blood at death, did not appear adversely to influence the concentration of ColV- organisms in these calves. Several days after mixtures of ColV+ and ColV- organisms of strain BI88 were taken orally by two human beings, the ColV+ organisms became much more numerous in their faeces than the ColV- ones. Similar results were obtained when colVr organisms of BI88 were included in the inoculum or when a strain whose ColV- form was completely colicine V-resistant was studied. A ColE+ form of BI88 ColV- was no more pathogenic for chickens, mice or colostrum-deprived calves than was a ColE- form of this strain, and it did not persist in the faeces of the two human beings for longer than the ColE- form.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003087">Colicins</NameOfSubstance></Chemical><Chemical><RegistryNumber>368GB5141J</RegistryNumber><NameOfSubstance UI="D012967">Sodium Dodecyl Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003087" MajorTopicYN="N">Colicins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004064" MajorTopicYN="N">Digestive System</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005111" MajorTopicYN="Y">Extrachromosomal Inheritance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="Y">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012967" MajorTopicYN="N">Sodium Dodecyl Sulfate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1976</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1976</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1976</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">768410</ArticleId><ArticleId IdType="doi">10.1099/00221287-92-2-335</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1097591</PMID><DateCompleted><Year>1975</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2006</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1287</ISSN><JournalIssue CitedMedium="Print"><Volume>89</Volume><Issue>1</Issue><PubDate><Year>1975</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of general microbiology</Title><ISOAbbreviation>J Gen Microbiol</ISOAbbreviation></Journal><ArticleTitle>Sex pili as immunogens.</ArticleTitle><Pagination><StartPage>133</StartPage><EndPage>136</EndPage><MedlinePgn>133-6</MedlinePgn></Pagination><Abstract><AbstractText>Groups of chickens were vaccinated intravenously with live cultures of Escherichia coli K12 possessing transfer factors F, I, A2 or no transfer factor (Tra-minus) and their immunity challenged by injecting them intravenously with an F-plus strain of Salmonella heidelberg or an F-plus or I-plus strain of Salmonella typhimurium. Compared with the Tra-minus strain, vaccination with the F-plus, but not the I-plus or A2-plus, K12 strain significantly reduced the mortality rate caused by the F-plus salmonella strains; vaccination with the I-plus or A2-plus, but not the F-plus, K12 strain significantly reduced the mortality rate caused by the I-plus salmonella strain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Microbiol</MedlineTA><NlmUniqueID>0375371</NlmUniqueID><ISSNLinking>0022-1287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000372" MajorTopicYN="N">Agglutination Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="Y">Antigens, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003227" MajorTopicYN="Y">Conjugation, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005144" MajorTopicYN="Y">F Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012475" MajorTopicYN="N">Salmonella</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012480" MajorTopicYN="N">Salmonella Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1975</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1975</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1975</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1097591</ArticleId><ArticleId IdType="doi">10.1099/00221287-89-1-133</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">48360</PMID><DateCompleted><Year>1975</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4975</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>1975</Year><Month>May</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Clinical evaluation of priming solutions for pump oxygenator perfusion.</ArticleTitle><Pagination><StartPage>529</StartPage><EndPage>536</EndPage><MedlinePgn>529-36</MedlinePgn></Pagination><Abstract><AbstractText>Various hemodilution agents are now used routinely to prime heart-lung machines for cardiac operations. Hemodilution has resulted in considerable conservation of blood as well as diminution of plasma and corpuscle damage by decreasing the concentration of these elements in blood during extracorporeal circulation. Controversy has existed regarding the relative efficacy of various hemodilution solutions. This study covers 68 patients, divided into three groups, for whom hemodilution was done as follows: (1) the pump was primed with a 5% dextrose solution containing no colloid; (2) Ringer's lactate solution containing approximately 1% low-molecular-weight dextran was used; and (3) a new plasma expander, hydroxyethyl starch, was used as the colloid component of an electrolyte solution. Evaluations and comparisons were carried out for flow rates, blood pressure, urine volume, hematocrit, BUN, blood loss, clotting factors, and the patient's clinical course with regard to pulmonary and neurological complications. We conclude that a colloid is beneficial, especially with longer perfusions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>W H</ForeName><Initials>WH</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Rubin</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003911">Dextrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007773">Lactates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012996">Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>451W47IQ8X</RegistryNumber><NameOfSubstance UI="D012965">Sodium Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001806" MajorTopicYN="N">Blood Urea Nitrogen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="N">Colloids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003911" MajorTopicYN="N">Dextrans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007773" MajorTopicYN="N">Lactates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010106" MajorTopicYN="Y">Oxygenators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012965" MajorTopicYN="N">Sodium Chloride</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012996" MajorTopicYN="Y">Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014556" MajorTopicYN="N">Urine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1975</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1975</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">48360</ArticleId><ArticleId IdType="doi">10.1016/s0003-4975(10)64428-1</ArticleId><ArticleId IdType="pii">S0003-4975(10)64428-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1055273</PMID><DateCompleted><Year>1975</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0038-3139</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>1975</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the South Carolina Medical Association (1975)</Title><ISOAbbreviation>J S C Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Prediction of postcardiotomy psychosis.</ArticleTitle><Pagination><StartPage>40</StartPage><EndPage>43</EndPage><MedlinePgn>40-3</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caston</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>W C</ForeName><Initials>WC</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Mlott</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>W F</ForeName><Initials>WF</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J S C Med Assoc</MedlineTA><NlmUniqueID>7503045</NlmUniqueID><ISSNLinking>0038-3139</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1975</Year><Month>2</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1975</Year><Month>2</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1055273</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1124273</PMID><DateCompleted><Year>1975</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0033-3174</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>1</Issue><PubDate><Year>1975</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Psychosomatic medicine</Title><ISOAbbreviation>Psychosom Med</ISOAbbreviation></Journal><ArticleTitle>The use of psychological test data to predict open-heart surgery outcome: a prospective study.</ArticleTitle><Pagination><StartPage>62</StartPage><EndPage>73</EndPage><MedlinePgn>62-73</MedlinePgn></Pagination><Abstract><AbstractText>In an attempt to predict survival of open-heart surgery, particularly among high risk subjects who undergo extra-corporeal circulation [ECG] using pump oxygenation perfusion, a preoperative battery including intellectual, personality and neuropsychological instruments and also ratings of cardiac impairment, was administered to 15 control [cardiac surgery without ECG] and 72 experimental [ECG] subjects. Subjects were divided into survivor [S] and fatality [F] groups, and preoperative test data were analyzed using multivariate stepwise discrimination techniques. In a variety of analyses, at least 86% and as high as 100% of subjects were correctly classified as survivors or fatalities on the basis of variables sampled, indicating the outcome of cardiac surgery may be predicted preoperatively with a high degree of accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kilpatrick</LastName><ForeName>D G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>W C</ForeName><Initials>WC</Initials></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>A N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>W H</ForeName><Initials>WH</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychosom Med</MedlineTA><NlmUniqueID>0376505</NlmUniqueID><ISSNLinking>0033-3174</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007361" MajorTopicYN="Y">Intelligence Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008950" MajorTopicYN="N">MMPI</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019965" MajorTopicYN="N">Neurocognitive Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010106" MajorTopicYN="N">Oxygenators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010555" MajorTopicYN="Y">Personality Inventory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011581" MajorTopicYN="N">Psychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014145" MajorTopicYN="N">Trail Making Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014888" MajorTopicYN="N">Wechsler Scales</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1975</Year><Month>1</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1975</Year><Month>1</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1124273</ArticleId><ArticleId IdType="doi">10.1097/00006842-197501000-00007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">4690819</PMID><DateCompleted><Year>1973</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4975</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>1973</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Effects of extracorporeal circulation upon blood lipids.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>242</EndPage><MedlinePgn>230-42</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arrants</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Gadsden</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>W H</ForeName><Initials>WH</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005230">Fatty Acids, Nonesterified</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.3</RegistryNumber><NameOfSubstance UI="D008049">Lipase</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001810" MajorTopicYN="N">Blood Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004620" MajorTopicYN="N">Embolism, Fat</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005230" MajorTopicYN="N">Fatty Acids, Nonesterified</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005374" MajorTopicYN="N">Filtration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005654" MajorTopicYN="N">Fundus Oculi</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008049" MajorTopicYN="N">Lipase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013249" MajorTopicYN="N">Sternum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013903" MajorTopicYN="Y">Thoracic Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013909" MajorTopicYN="N">Thorax</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1973</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1973</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4690819</ArticleId><ArticleId IdType="doi">10.1016/s0003-4975(10)65290-3</ArticleId><ArticleId IdType="pii">S0003-4975(10)65290-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">14089821</PMID><DateCompleted><Year>1996</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3476</ISSN><JournalIssue CitedMedium="Print"><Volume>63</Volume><PubDate><Year>1963</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of pediatrics</Title><ISOAbbreviation>J Pediatr</ISOAbbreviation></Journal><ArticleTitle>PRENATAL HISTORY OF INFANTS WITH BIRTH WEIGHTS OF 1,500 GRAMS OR LESS.</ArticleTitle><Pagination><StartPage>1140</StartPage><EndPage>1150</EndPage><MedlinePgn>1140-50</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>WILSON</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>PARMELEE</LastName><ForeName>A H</ForeName><Initials>AH</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M H</ForeName><Initials>MH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr</MedlineTA><NlmUniqueID>0375410</NlmUniqueID><ISSNLinking>0022-3476</ISSNLinking></MedlineJournalInfo><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001699" MajorTopicYN="Y">Biometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="Y">Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="Y">Pregnancy Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="Y">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">BIRTH WEIGHT</Keyword><Keyword MajorTopicYN="Y">INFANT, NEWBORN</Keyword><Keyword MajorTopicYN="Y">INFANT, PREMATURE</Keyword><Keyword MajorTopicYN="Y">PREGNANCY</Keyword><Keyword MajorTopicYN="Y">PREGNANCY COMPLICATIONS</Keyword><Keyword MajorTopicYN="Y">STATISTICS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1963</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1963</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1963</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14089821</ArticleId><ArticleId IdType="doi">10.1016/s0022-3476(63)80197-3</ArticleId><ArticleId IdType="pii">S0022-3476(63)80197-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">14449784</PMID><DateCompleted><Year>1998</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-0996</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><PubDate><Year>1962</Year><Month>Sep</Month></PubDate></JournalIssue><Title>American scientist</Title><ISOAbbreviation>Am Sci</ISOAbbreviation></Journal><ArticleTitle>Physicochemical aspects of hydrogen bonds and their application to biology.</ArticleTitle><Pagination><StartPage>485</StartPage><EndPage>496</EndPage><MedlinePgn>485-96</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Sci</MedlineTA><NlmUniqueID>0370514</NlmUniqueID><ISSNLinking>0003-0996</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7YNJ3PO35Z</RegistryNumber><NameOfSubstance UI="D006859">Hydrogen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001695" MajorTopicYN="Y">Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006859" MajorTopicYN="N">Hydrogen</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006860" MajorTopicYN="Y">Hydrogen Bonding</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">BIOLOGY</Keyword><Keyword MajorTopicYN="Y">HYDROGEN/chemistry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1962</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1962</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1962</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14449784</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">16590000</PMID><DateCompleted><Year>2006</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>1957</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>THE STRUCTURE OF COLLAGEN.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>213</EndPage><MedlinePgn>209-13</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>RESEARCH LABORATORIES, EASTMAN KODAK COMPANY, ROCHESTER, NEW YORK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1957</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16590000</ArticleId><ArticleId IdType="pmc">PMC528413</ArticleId><ArticleId IdType="doi">10.1073/pnas.43.2.209</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1955 Nov 12;176(4489):915-6</Citation><ArticleIdList><ArticleId IdType="pubmed">13272717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1956 Apr 14;177(4511):710-1</Citation><ArticleIdList><ArticleId IdType="pubmed">13321944</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Protein Chem. 1952;7:69-160</Citation><ArticleIdList><ArticleId IdType="pubmed">14933252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">16589999</PMID><DateCompleted><Year>2006</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>1957</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>THE STRUCTURE OF ALPHA KERATIN.</ArticleTitle><Pagination><StartPage>204</StartPage><EndPage>209</EndPage><MedlinePgn>204-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>RESEARCH LABORATORIES, EASTMAN KODAK COMPANY, ROCHESTER, NEW YORK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1957</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1957</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16589999</ArticleId><ArticleId IdType="pmc">PMC528412</ArticleId><ArticleId IdType="doi">10.1073/pnas.43.2.204</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1953 Jan 10;171(4341):59-61</Citation><ArticleIdList><ArticleId IdType="pubmed">13025480</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Protein Chem. 1954;9:243-97</Citation><ArticleIdList><ArticleId IdType="pubmed">13217919</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1951 Apr;37(4):205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">14816373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 1951 Mar;53(3):627-48</Citation><ArticleIdList><ArticleId IdType="pubmed">14819889</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1951 May;37(5):256-61</Citation><ArticleIdList><ArticleId IdType="pubmed">14834148</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">18918873</PMID><DateCompleted><Year>2008</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-7023</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>1948</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of physical and colloid chemistry</Title><ISOAbbreviation>J Phys Colloid Chem</ISOAbbreviation></Journal><ArticleTitle>The effect of size, shape, and flexibility of the solute molecules on the properties of colloidal solutions.</ArticleTitle><Pagination><StartPage>248</StartPage><EndPage>259</EndPage><MedlinePgn>248-59</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Phys Colloid Chem</MedlineTA><NlmUniqueID>0405527</NlmUniqueID><ISSNLinking>0092-7023</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012996">Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="Y">Colloids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012996" MajorTopicYN="Y">Solutions</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="CLML">4814:186q</OtherID><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">COLLOIDS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1948</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1948</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18918873</ArticleId><ArticleId IdType="doi">10.1021/j150457a021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">20286420</PMID><DateCompleted><Year>2010</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-7023</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>2</Issue><PubDate><Year>1947</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Journal of physical and colloid chemistry</Title><ISOAbbreviation>J Phys Colloid Chem</ISOAbbreviation></Journal><ArticleTitle>Energy additivity in oxygen-containing crystals and glasses.</ArticleTitle><Pagination><StartPage>438</StartPage><EndPage>443</EndPage><MedlinePgn>438-43</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>SUN</LastName><ForeName>K H</ForeName><Initials>KH</Initials></Author><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Phys Colloid Chem</MedlineTA><NlmUniqueID>0405527</NlmUniqueID><ISSNLinking>0092-7023</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="Y">Oxygen</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="CLML">4712:649k</OtherID><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">ENERGY</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1947</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1947</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20286420</ArticleId><ArticleId IdType="doi">10.1021/j150452a009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">20245834</PMID><DateCompleted><Year>2010</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>23-24</Issue><PubDate><Year>1946</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Schweizer Chemiker-Zeitung und Technik-Industrie</Title><ISOAbbreviation>Schweizer Chem Ztg Tech Ind</ISOAbbreviation></Journal><ArticleTitle>[Images of molecules and atoms, based on X-ray findings].</ArticleTitle><Pagination><StartPage>402</StartPage><MedlinePgn>402</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Bilder von Molek&#xfc;len und Atomen, nach r&#xf6;ntgenographischen Befunden.</VernacularTitle></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Schweizer Chem Ztg Tech Ind</MedlineTA><NlmUniqueID>20630140R</NlmUniqueID></MedlineJournalInfo><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="Y">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009686" MajorTopicYN="Y">Nuclear Physics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014965" MajorTopicYN="Y">X-Rays</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="CLML">4713:361i</OtherID><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">ATOMS</Keyword><Keyword MajorTopicYN="Y">MOLECULES</Keyword><Keyword MajorTopicYN="Y">ROENTGEN RAYS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1946</Year><Month>12</Month><Day>20</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20245834</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">21008018</PMID><DateCompleted><Year>2010</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0093-2922</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>1945</Year></PubDate></JournalIssue><Title>Radiography and clinical photography</Title><ISOAbbreviation>Radiogr Clin Photogr</ISOAbbreviation></Journal><ArticleTitle>Pictures of organic molecules from x-ray diffraction data.</ArticleTitle><Pagination><StartPage>67</StartPage><MedlinePgn>67</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>HUGGINS</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Radiogr Clin Photogr</MedlineTA><NlmUniqueID>0414244</NlmUniqueID><ISSNLinking>0093-2922</ISSNLinking></MedlineJournalInfo><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014961" MajorTopicYN="Y">X-Ray Diffraction</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="CLML">4610:239p</OtherID><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">MOLECULES</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1945</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21008018</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">17729762</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>2608</Issue><PubDate><Year>1944</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>PHOTOGRAPHY OF CRYSTAL STRUCTURES.</ArticleTitle><Pagination><StartPage>570</StartPage><MedlinePgn>570</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1944</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1944</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1944</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17729762</ArticleId><ArticleId IdType="doi">10.1126/science.100.2608.570</ArticleId><ArticleId IdType="pii">100/2608/570</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">17745761</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>93</Volume><Issue>2421</Issue><PubDate><Year>1941</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>A NEW SOCIETY FOR X-RAY AND ELECTRON DIFFRACTION RESEARCH WORKERS.</ArticleTitle><Pagination><StartPage>489</StartPage><EndPage>490</EndPage><MedlinePgn>489-90</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1941</Year><Month>5</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1941</Year><Month>5</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1941</Year><Month>5</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17745761</ArticleId><ArticleId IdType="doi">10.1126/science.93.2421.489</ArticleId><ArticleId IdType="pii">93/2421/489</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">17741664</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>63</Volume><Issue>1635</Issue><PubDate><Year>1926</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>ADSORPTION MECHANISMS.</ArticleTitle><Pagination><StartPage>454</StartPage><EndPage>455</EndPage><MedlinePgn>454-5</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>J</ForeName><Initials>J</Initials><Suffix>2nd</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1926</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1926</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1926</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17741664</ArticleId><ArticleId IdType="doi">10.1126/science.63.1635.454-b</ArticleId><ArticleId IdType="pii">63/1635/454-b</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">17793924</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>1434</Issue><PubDate><Year>1922</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>THE STRUCTURE OF BENZENE.</ArticleTitle><Pagination><StartPage>679</StartPage><EndPage>680</EndPage><MedlinePgn>679-80</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1922</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1922</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1922</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17793924</ArticleId><ArticleId IdType="doi">10.1126/science.55.1434.679</ArticleId><ArticleId IdType="pii">55/1434/679</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">17809302</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2010</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>1426</Issue><PubDate><Year>1922</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>ATOMIC STRUCTURE.</ArticleTitle><Pagination><StartPage>459</StartPage><EndPage>460</EndPage><MedlinePgn>459-60</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1922</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1922</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1922</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17809302</ArticleId><ArticleId IdType="doi">10.1126/science.55.1426.459</ArticleId><ArticleId IdType="pii">55/1426/459</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19974094</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-9157</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>Clin Sect</Issue><PubDate><Year>1910</Year></PubDate></JournalIssue><Title>Proceedings of the Royal Society of Medicine</Title><ISOAbbreviation>Proc R Soc Med</ISOAbbreviation></Journal><ArticleTitle>Py&#xe6;mic Knee- and Shoulder-joints treated by Tapping and Incision.</ArticleTitle><Pagination><StartPage>120</StartPage><EndPage>121</EndPage><MedlinePgn>120-1</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corner</LastName><ForeName>E M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc R Soc Med</MedlineTA><NlmUniqueID>7505890</NlmUniqueID><ISSNLinking>0035-9157</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1910</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1910</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1910</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19974094</ArticleId><ArticleId IdType="pmc">PMC1961531</ArticleId><ArticleId IdType="doi">10.1177/003591571000300261</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">19974050</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-9157</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>Surg Sect</Issue><PubDate><Year>1909</Year></PubDate></JournalIssue><Title>Proceedings of the Royal Society of Medicine</Title><ISOAbbreviation>Proc R Soc Med</ISOAbbreviation></Journal><ArticleTitle>The Repeated Strangulation of an Obturator Hernia necessitating its Radical Cure, with Remarks upon Obturator Herni&#xe6; in General.</ArticleTitle><Pagination><StartPage>137</StartPage><EndPage>148</EndPage><MedlinePgn>137-48</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corner</LastName><ForeName>E M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc R Soc Med</MedlineTA><NlmUniqueID>7505890</NlmUniqueID><ISSNLinking>0035-9157</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>1909</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1909</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1909</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19974050</ArticleId><ArticleId IdType="pmc">PMC2046474</ArticleId><ArticleId IdType="doi">10.1177/003591570900201505</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Surg. 1908 Apr;47(4):573-87</Citation><ArticleIdList><ArticleId IdType="pubmed">17862140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>